0001104659-23-122042.txt : 20231129 0001104659-23-122042.hdr.sgml : 20231129 20231129161359 ACCESSION NUMBER: 0001104659-23-122042 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 103 CONFORMED PERIOD OF REPORT: 20230930 FILED AS OF DATE: 20231129 DATE AS OF CHANGE: 20231129 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bioceres Crop Solutions Corp. CENTRAL INDEX KEY: 0001769484 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE CHEMICALS [2870] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38836 FILM NUMBER: 231452368 BUSINESS ADDRESS: STREET 1: PO BOX 309, UGLAND HOUSE CITY: GEORGE TOWN, GRAND CAYMAN STATE: E9 ZIP: KY1-1104 BUSINESS PHONE: 54 341 486 1122 MAIL ADDRESS: STREET 1: OCAMPO 210 BIS, PREDIO CCT CITY: ROSARIO STATE: C1 ZIP: 2000 6-K 1 biox-20230930x6k.htm FORM 6-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

Report of Foreign Private Issuer

Pursuant to Rules 13a-16 or 15d-16 under

the Securities Exchange Act of 1934

For the month of November 2023

Commission File Number: 001-38836

BIOCERES CROP SOLUTIONS CORP.

(Translation of registrant’s name into English)

Ocampo 210 bis, Predio CCT, Rosario

Province of Santa Fe, Argentina

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

EXPLANATORY NOTE

This Form 6-K is incorporated by reference into the Company’s registration statements on Form F-3 (Registration No. 333-272280) and Form S-8 (Registration Nos. 333-255635, 333-266333 and 333-271941), and the following exhibit is filed as part of this Form 6-K:

Exhibit List


Exhibit No.		Description
99.1		Bioceres Crop Solutions Corp. unaudited interim condensed consolidated financial statements as of September 30, 2023 and June 30, 2023, and for the three -month periods ended September 30, 2023 and 2022.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


	BIOCERES CROP SOLUTIONS CORP.
	(Registrant)


Dated: November 29, 2023	By:	/s/ Federico Trucco
	Name:	Federico Trucco
	Title:	Chief Executive Officer

EX-99.1 2 biox-20230930xex99d1.htm EXHIBIT 99.1

Table of Contents

Exhibit 99.1

BIOCERES CROP SOLUTIONS CORP.

Unaudited interim condensed consolidated financial statements
as of September 30, 2023 and June 30, 2023,

and for the three-month periods ended

September 30, 2023 and 2022.

Table of Contents

INDEX

Unaudited interim condensed consolidated financial statements as of September 30, 2023 and June 30, 2023, and for the three-month periods ended September 30, 2023 and 2022.
Unaudited interim condensed consolidated statements of financial position as of September 30, 2023 and June 30, 2023.	F-3
Unaudited interim condensed consolidated statements of comprehensive income for the three-month periods ended September 30, 2023 and 2022.	F-5
Unaudited interim condensed consolidated statements of changes in equity for the three-month periods ended September 30, 2023 and 2022.	F-6
Unaudited interim condensed consolidated statements of cash flows for the three-month periods ended September 30, 2023 and 2022.	F-8
Notes to the unaudited interim condensed consolidated financial statements	F-11

F-2

Table of Contents

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

As of September 30, 2023, and June 30, 2023

(Amounts in US$)


	Notes	09/30/2023	06/30/2023
ASSETS
CURRENT ASSETS
Cash and cash equivalents	5.1	28,373,924	48,129,194
Other financial assets	5.2	14,628,202	12,135,020
Trade receivables	5.3	186,276,319	158,006,474
Other receivables	5.4	24,902,503	28,824,998
Income and minimum presumed recoverable income taxes		2,022,328	9,444,898
Inventories	5.5	138,076,822	140,426,975
Biological assets	5.6	1,141,113	146,842
Total current assets		395,421,211	397,114,401

NON-CURRENT ASSETS
Other financial assets	5.2	502,910	444,909
Other receivables	5.4	2,393,939	2,546,241
Income and minimum presumed recoverable income taxes		5,446	16,286
Deferred tax assets	7	8,230,402	7,312,964
Investments in joint ventures and associates	11	40,820,784	39,296,810
Investment properties	5.10	3,675,493	3,589,749
Property, plant and equipment	5.7	69,930,709	67,853,835
Intangible assets	5.8	173,034,536	173,783,956
Goodwill	5.9	112,163,432	112,163,432
Right of use asset	14	13,519,199	13,936,575
Total non-current assets		424,276,850	420,944,757
Total assets		819,698,061	818,059,158

The accompanying Notes are an integral part of these unaudited interim condensed consolidated financial statements. Related parties’ balances and transactions are disclosed in Note 15.

F-3

Table of Contents

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

As of September 30, 2023, and June 30, 2023

(Amounts in US$)


LIABILITIES	Notes	09/30/2023	06/30/2023

CURRENT LIABILITIES
Trade and other payables	5.11	159,125,358	150,807,674
Borrowings	5.12	100,720,985	107,639,659
Employee benefits and social security	5.14	10,019,165	9,606,707
Deferred revenue and advances from customers	5.15	32,771,902	24,875,662
Income tax payable		536,840	509,034
Consideration for acquisition		4,202,389	1,415,099
Lease liabilities	14	4,326,889	3,858,699
Total current liabilities		311,703,528	298,712,534

NON-CURRENT LIABILITIES
Borrowings	5.12	48,789,492	60,670,946
Deferred revenue and advances from customers	5.15	2,202,374	2,057,805
Joint ventures and associates	11	638,126	622,823
Deferred tax liabilities	7	34,393,580	35,785,347
Provisions		668,775	891,769
Consideration for acquisition		2,540,181	3,578,157
Secured notes	5.13	76,911,874	75,213,146
Lease liabilities	14	9,225,862	10,030,524
Total non-current liabilities		175,370,264	188,850,517
Total liabilities		487,073,792	487,563,051

EQUITY
Equity attributable to owners of the parent		298,966,341	298,594,088
Non-controlling interest		33,657,928	31,902,019
Total equity		332,624,269	330,496,107
Total equity and liabilities		819,698,061	818,059,158

The accompanying Notes are an integral part of these unaudited interim condensed consolidated financial statements. Related parties’ balances and transactions are disclosed in Note 15.

F-4

Table of Contents

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

For the three-month periods ended of September 30, 2023, and 2022

(Amounts in US$)


	Notes	09/30/2023	09/30/2022
Revenues from contracts with customers	6.1	116,182,805	126,843,248
Initial recognition and changes in the fair value of biological assets at the point of harvest		410,913	490,006

Cost of sales	6.2	(71,615,781)	(75,675,878)
Changes in the net realizable value of agricultural products after harvest		(1,446,316)	(227,936)
Research and development expenses	6.3	(4,581,241)	(3,852,014)
Selling, general and administrative expenses	6.4	(33,932,848)	(31,904,911)
Share of profit or loss of joint ventures and associates	11	1,508,671	842,240
Other income or expenses, net	6.5	(1,231,635)	478,041
Operating profit		5,294,568	16,992,796

Financial cost	6.6	(7,661,857)	(6,779,847)
Other financial results	6.6	117,865	(1,288,306)
(Loss) profit before income tax		(2,249,424)	8,924,643
Income tax	7	(429,040)	(5,012,643)
(Loss) profit for the period		(2,678,464)	3,912,000

(Loss) profit for the period attributable to:
Equity holders of the parent		(4,591,634)	498,297
Non-controlling interests		1,913,170	3,413,703
		(2,678,464)	3,912,000
(Loss) profit per share
Basic (loss) profit attributable to ordinary equity holders of the parent	8	(0.0731)	0.0082
Diluted (loss) profit attributable to ordinary equity holders of the parent	8	(0.0731)	0.0081

(Loss) profit for the period		(2,678,464)	3,912,000
Other comprehensive (loss) income		(929,957)	31,025
Items that may be subsequently reclassified to profit and loss		(929,957)	31,025
Foreign exchange differences on translation of foreign operations from joint ventures		—	100,868
Foreign exchange differences on translation of foreign operations		(929,957)	(69,843)
Total comprehensive (loss) profit		(3,608,421)	3,943,025

Total comprehensive (loss) profit attributable to:
Equity holders of the parent		(5,364,330)	401,715
Non-controlling interests		1,755,909	3,541,310
		(3,608,421)	3,943,025

The accompanying Notes are an integral part of these unaudited interim condensed consolidated financial statements. Related parties’ balances and transactions are disclosed in Note 15.

F-5

Table of Contents

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

For the three-month periods ended of September 30, 2023, and 2022

(Amounts in US$)


	Attributable to the equity holders of the parent
											Equity /
					Stock					Revaluation	(deficit)
			Changes in	Own	options		Cost of		Foreign	of PP&E	attributable
			non-	shares	and share		own		currency	and effect	to owners	Non-
	Issued	Share	controlling	trading	based	Convertible	shares	Retained	translation	of tax rate	of the	controlling	Total
Description	capital	premium	interests	premium	incentives	instruments	held	deficit	reserve	change	parent	Interests	equity
06/30/2022	4,637	158,819,506	(255,893)	(916,202)	3,767,925	175,745	(3,530,926)	(32,682,893)	969,402	1,007,272	127,358,573	30,940,275	158,298,848
Share-based incentives	6	554,999	—	135,361	55,892	—	—	—	—	—	746,258	—	746,258
Business combination	1,640	153,357,564	—	—	1,620,140	—	—	—	—	—	154,979,344	—	154,979,344
Capitalization of convertible notes (Note 5.13)	153	12,211,485	—	—	—	—	—	—	—	—	12,211,638	—	12,211,638
Purchase of own shares	—	—	—	—	—	—	(24,291,047)	—	—	—	(24,291,047)	—	(24,291,047)
Issuance of convertible notes (Note 7.13)	—	—	—	—	—	9,109,516	—	—	—	—	9,109,516	—	9,109,516
Distribution of dividends by subsidiary	—	—	—	—	—	—	—	—	—	—	—	(187,977)	(187,977)
(Loss) profit for the period	—	—	—	—	—	—	—	498,297	—	—	498,297	3,413,703	3,912,000
Other comprehensive income (loss)	—	—	—	—	—	—	—	—	(96,582)	—	(96,582)	127,607	31,025
09/30/2022	6,436	324,943,554	(255,893)	(780,841)	5,443,957	9,285,261	(27,821,973)	(32,184,596)	872,820	1,007,272	280,515,997	34,293,608	314,809,605

The accompanying Notes are an integral part of these unaudited interim condensed consolidated financial statements. Related parties’ balances and transactions are disclosed in Note 15.

F-6

Table of Contents

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

For the three-month periods ended of September 30, 2023, and 2022

(Amounts in US$)


	Attributable to the equity holders of the parent
					Stock					Revaluation	Equity /
			Changes	Own	options		Cost of		Foreign	of PP&E	(deficit)
			in non-	shares	and share		own		currency	and effect	attributable	Non-
	Issued	Share	controlling	trading	based	Convertible	shares	Retained	translation	of tax rate	to owners of	controlling	Total
Description	capital	premium	interests	premium	incentives	instruments	held	deficit	reserve	change	the parent	Interests	equity
06/30/2023	6,493	327,028,559	(255,893)	(780,841)	6,645,442	9,285,261	(30,553,591)	(13,903,017)	1,282,377	(160,702)	298,594,088	31,902,019	330,496,107
Share-based incentives	—	—	—	—	6,193,668	—	—	—	—	—	6,193,668	—	6,193,668
Purchase of own shares	—	—	—	—	—	—	(457,085)	—	—	—	(457,085)	—	(457,085)
(Loss) profit for the period	—	—	—	—	—	—	—	(4,591,634)	—	—	(4,591,634)	1,913,170	(2,678,464)
Other comprehensive loss	—	—	—	—	—	—	—	—	(772,696)	—	(772,696)	(157,261)	(929,957)
09/30/2023	6,493	327,028,559	(255,893)	(780,841)	12,839,110	9,285,261	(31,010,676)	(18,494,651)	509,681	(160,702)	298,966,341	33,657,928	332,624,269

The accompanying Notes are an integral part of these unaudited interim condensed consolidated financial statements. Related parties’ balances and transactions are disclosed in Note 15.

F-7

Table of Contents

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

For the three-month periods ended of September 30, 2023, and 2022

(Amounts in US$)


	Notes	09/30/2023	09/30/2022
OPERATING ACTIVITIES
(Loss) profit for the period		(2,678,464)	3,912,000

Adjustments to reconcile profit to net cash flows
Income tax	7	429,040	5,012,643
Financial results		7,543,992	8,068,153
Depreciation of property, plant and equipment	5.7	1,243,403	1,382,093
Amortization of intangible assets	5.8	2,747,206	2,476,832
Depreciation of leased assets	14	837,199	676,427
Transactional expenses		—	2,794,339
Share-based incentive and stock options		6,193,668	227,351
Share of profit or loss of joint ventures and associates	11	(1,508,671)	(842,240)
Provisions for contingencies		27,109	2,448
Allowance for impairment of trade debtors		352,920	156,053
Allowance for obsolescence		505,285	618,489
Initial recognition and changes in the fair value of biological assets		(410,913)	(490,006)
Changes in the net realizable value of agricultural products after harvest		1,446,316	227,936
Gain or loss on sale of equipment and intangible assets		(26,669)	(115,942)

Working capital adjustments
Trade receivables		(31,012,196)	(29,709,414)
Other receivables		3,722,853	(5,665,708)
Income and minimum presumed income taxes payable		7,113,764	(376,576)
Inventories and biological assets		(197,454)	(7,391,556)
Trade and other payables		7,499,929	(18,108,556)
Employee benefits and social security		412,458	3,226,505
Deferred revenue and advances from customers		8,040,809	373,181
Income taxes paid		(163,205)	(1,051,644)
Interest collected		2,293,676	2,125,194
Inflation effects on working capital adjustments		321,539	69,662
Net cash flows generated (used) by operating activities		14,733,594	(32,402,336)

The accompanying Notes are an integral part of these unaudited interim condensed consolidated financial statements. Related parties’ balances and transactions are disclosed in Note 15.

F-8

Table of Contents

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

For the three-month periods ended of September 30, 2023, and 2022

(Amounts in US$)


	Notes	09/30/2023	09/30/2022
INVESTMENT ACTIVITIES
Proceeds from sale of property, plant and equipment		35,682	115,942
Net cash received from business combination		—	5,933,265
Net loans granted to shareholders and other related parties		—	1,609
Proceeds from financial assets		(509,534)	2,729,598
Investment in financial assets		(2,215,965)	(889,342)
Purchase of property, plant and equipment	5.7	(3,985,249)	(1,414,730)
Capitalized development expenditures	5.8	(1,947,504)	(3,241,008)
Purchase of intangible assets	5.8	(64,486)	(209,863)
Net cash flows (used) generated by investing activities		(8,687,056)	3,025,471

FINANCING ACTIVITIES
Proceeds from borrowings		26,837,346	93,327,748
Repayment of borrowings and financed payments		(46,865,499)	(47,061,271)
Interest payments		(4,539,455)	(3,016,078)
Other financial proceeds or payments, net		(781,199)	(1,717,070)
Purchase of own shares		(457,085)	(376,018)
Leased assets payments	14	(1,170,039)	(744,365)
Cash dividend distributed by subsidiary		—	(187,977)
Net cash flows (used) generated by financing activities		(26,975,931)	40,224,969

Net (decrease) increase in cash and cash equivalents		(20,929,393)	10,848,104

Inflation effects on cash and cash equivalents		(24,266)	(12,404)

Cash and cash equivalents as of beginning of the period	5.1	48,129,194	33,475,266
Effect of exchange rate changes on cash and equivalents		1,198,389	3,076,600
Cash and cash equivalents as of the end of the period	5.1	28,373,924	47,387,566

The accompanying Notes are an integral part of these unaudited interim condensed consolidated financial statements. Related parties’ balances and transactions are disclosed in Note 15.

F-9

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)

Index

1.	General information.

2.	Accounting standards and basis of preparation.

3.	New standards, amendments and interpretations issued by the IASB.

4.	Seasonality

5.	Information about components of unaudited interim condensed consolidated statement of financial position.

6.	Information about components of unaudited interim condensed consolidated statement of comprehensive income.

7.	Taxation.

8.	Earnings per share.

9.	Equity information.

10.	Cash flow information.

11.	Joint ventures and associates.

12.	Segment information.

13.	Financial instruments – Risk management.

14.	Leases.

15.	Shareholders and other related parties’ balances and transactions.

16.	Key management personnel compensation.

17.	Share-based payments.

18.	Contingencies, commitments and restrictions on the distribution of profits.

19.	Events occurring after the reporting period.

F-10

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)

1. GENERAL INFORMATION

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) is a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change. To do this, Bioceres’ products create economic incentives for farmers and other stakeholders to adopt environmentally friendly production practices. Bioceres has a unique biotech platform with high impact, patented technologies for seeds and microbial ag inputs, as well as next generation crop nutrition and protection solutions.

Bioceres is a global company with an extensive geographic footprint. The Group’s agricultural inputs are marketed across more than 40 countries, mainly in Argentina, Brazil, United States, Europe and South Africa.

Unless the context otherwise requires, “we”, “us”, “our”, “Bioceres”, “BIOX”, “the Group”, and “Bioceres Crop Solutions” will refer to Bioceres Crop Solutions Corp. and its subsidiaries.

2. ACCOUNTING STANDARDS AND BASIS OF PREPARATION

Statement of compliance with IFRS as issued by IASB

These unaudited interim condensed consolidated financial statements for the three-month period ended September 30, 2023, have been prepared in accordance with Accounting Standard IAS 34 Interim Financial Reporting.

These unaudited interim condensed consolidated financial statements do not include all notes of the type normally included in an annual financial statement. Accordingly, these unaudited interim condensed consolidated financial statements are to be read in conjunction with the consolidated financial statements for the fiscal year ended June 30, 2023.

Authorization for the issue of the consolidated financial statements

These unaudited interim condensed consolidated financial statements of the Group as of September 30, 2023, June 30, 2023 and for the three-month periods ended September 30, 2023 and 2022 were authorized by the Board of Directors of Bioceres Crop Solutions Corp. on November 29, 2023.

Basis of measurement

The consolidated financial statements of the Group have been prepared using:

●	Going concern basis of accounting, considering the conclusion of the assessment made by the Group’s Management about the ability of the Group and its subsidiaries to continue as a going concern, in accordance with the requirements of paragraph 25 of IAS 1, “Presentation of Financial Statements”.

●	Accrual basis of accounting (except for cash flows information). Under this basis of accounting, the effects of transactions and other events are recognized as they occur, even when there are no cash flows.

Functional currency and presentation currency

a)	Functional currency

Items included in the financial statements of each of the Group’s entities are measured using the currency of the primary economic market in which the entity operates (i.e., “the functional currency”).

F-11

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)

b)	Presentation currency

The consolidated financial statements of the Group are presented in US dollars.

c)	Foreign currency

Transactions entered into by Group entities in a currency other than their functional currency are recorded at the relevant exchange rates as of the date upon which such transactions occur. Foreign currency monetary assets and liabilities are translated at the prevailing exchanges rates as of the final day of each reporting period. Exchange differences arising from the retranslation of unsettled monetary assets and liabilities are recognized immediately in profit or loss, except for foreign currency borrowings qualifying as a hedge of a net investment in a foreign operation for which exchange differences are recognized in other comprehensive income and accumulated in the foreign exchange reserve along with the exchange differences arising from the retranslation of the foreign operation. Upon the disposal of a foreign operation, the cumulative exchange differences recognized in the foreign exchange reserve relating to such operation up to the date of disposal are transferred to the consolidated statement of profit or loss and other comprehensive income as part of the gain or loss recognized upon such disposal.

Changes in accounting policies

The accounting policies adopted in the preparation of these unaudited interim condensed consolidated financial statements are consistent with those adopted for the preparation of the consolidated financial statements as of June 30, 2023.

3. NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS ISSUED BY THE IASB

a)The following new standards, amendments and interpretations became applicable for the current reporting period and adopted by the Group.

Amendment to IAS 12 –Deferred tax related to assets and liabilities arising from a single transaction.

International Tax Reform—Pillar Two Model Rules (Amendments to IAS 12)

Amendments to IAS 1 and IFRS Practice Statement 2- Disclosure of Accounting Policies

Amendments to IAS 8-Definition of Accounting Estimates

IFRS 17, “Insurance Contracts”

These new standards and amendments did not have any material impact on the Group.

b)The following new standards are not yet adopted by the Group.

Amendments to IFRS 16- Lease Liability in a Sale and Leaseback. The amendments are effective for annual reporting periods beginning on or after 1 January 2024.

Amendments to IAS1 – Non- current liabilities with covenants. The amendments are effective for annual reporting periods beginning on or after 1 January 2024.

Amendments to IAS 7- Statement of Cash Flows & to IFRS 7- Financial Instruments: Disclosures. The amendments are effective for annual reporting periods beginning on or after 1 January 2024.

Amendments to IAS 21- The Effects of Changes in Foreign Exchange Ratestitled Lack of Exchangeability. The amendments are effective for annual reporting periods beginning on or after 1 January 2025.

Amendment to IAS 7 and IFRS 7 - Supplier Financing. The amendments are effective for annual periods beginning on or after January 1, 2024.

These amendments are not expected to have material impact on the Group.

F-12

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)

4. SEASONALITY

Our revenues fluctuate depending on the timing of orders from our distributors and customers and on prevailing market prices, which influence the purchase decisions of growers, the end users of our seed and integrated products, crop protection products and crop nutrition products. Given the cyclicality of crop planting and harvesting, as well as growing seasons, which vary from year to year, our business is highly seasonal. This results in substantial fluctuations in quarterly sales and profitability. Our portfolio is highly oriented to crop planting. Generally, our sales are concentrated in the third and fourth quarters of each calendar year, when demand for our seed and integrated products, crop protection products and crop nutrition products increases as growers begin planting their summer crops in South America, while winter crop season occurs in the Northern hemisphere. With our seed and integrated products business, we contract with growers and seed suppliers based upon our anticipated market demand. Generally, in our seed and integrated products business we stock the seed during the harvest season and ship from inventory throughout the year, with the objective of selling most of the inventory from the current year’s harvest before the next year’s, with our crop protection and our crop nutrition business following a similar cycle to the seed cycle. Milestone, royalty, and license revenues are also likely to fluctuate from period to period given the seasonality of agriculture and time required to progress from one milestone to the next.

Our seed and integrated products, crop protection and crop nutrition businesses are also affected by unpredictable weather conditions such as heavy rains, hail, floods, freezing conditions, windstorms, drought or fire, as well as other hazardous situations beyond our control, which may cause our sales and operating results to fluctuate significantly. In addition, disruptions that cause delays by growers in harvesting or planting can result in the movement of orders to a future quarter, which also causes fluctuations in our quarterly operating results. Finally, some of our customers and distributors order in bulk only one or two times a year, which may further cause our seed product revenues to fluctuate from period to period.

5. INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

5.1. Cash and cash equivalents


	09/30/2023	06/30/2023
Cash at bank and on hand	25,954,730	48,129,194
Mutual funds	2,419,194	—
	28,373,924	48,129,194

5.2. Other financial assets


	09/30/2023	06/30/2023
Current
Restricted short-term deposits	—	212,703
US Treasury bills	9,719,486	9,163,298
Mutual funds	3,236,702	1,596,539
Other investments	1,672,014	1,162,480
	14,628,202	12,135,020

	09/30/2023	06/30/2023
Non-current
Shares of Bioceres S.A.	444,575	444,635
Other investments	58,335	274
	502,910	444,909

F-13

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)

5.3. Trade receivables


	09/30/2023	06/30/2023
Current
Trade debtors	189,222,562	160,269,233
Allowance for impairment of trade debtors	(7,615,433)	(7,425,604)
Shareholders and other related parties (Note 15)	1,368,373	—
Allowance for credit notes to be issued	(2,610,596)	(3,694,019)
Trade debtors - Joint ventures and associates (Note 15)	781,451	865,627
Deferred checks	5,129,962	7,991,237
	186,276,319	158,006,474

The book value is reasonably approximate to the fair value given its short-term nature.

5.4. Other receivables


	09/30/2023	06/30/2023
Current
Taxes	6,009,626	6,113,764
Receivables for PP&E sales	89,715	156,423
Shareholders and other related parties (Note 15)	2,919,431	3,792,429
Other receivables - Joint ventures and associates (Note 15)	6,469,863	6,104,219
Prepayments to suppliers	5,010,022	10,956,831
Reimbursements over exports	10,558	10,558
Prepaid expenses and other receivables	3,657,633	1,302,221
Miscellaneous	735,655	388,553
	24,902,503	28,824,998

	09/30/2023	06/30/2023
Non-current
Taxes	865,588	873,699
Reimbursements over exports	1,268,928	1,290,227
Loans receivables	230,000	230,000
Miscellaneous	29,423	152,315
	2,393,939	2,546,241

F-14

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)

5.5. Inventories


	09/30/2023	06/30/2023
Seeds	9,293,210	1,542,159
Resale products	71,973,203	58,544,931
Manufactured products	19,604,930	25,881,761
Goods in transit	2,298,136	3,620,606
Supplies	18,709,303	24,893,187
Agricultural products	19,111,345	28,436,830
Allowance for obsolescence	(2,913,305)	(2,492,499)
	138,076,822	140,426,975

Net of agricultural products	118,965,477	111,990,145

5.6. Biological assets

Changes in Biological assets:


	Soybean	Corn	Wheat	Barley	Sunflower	Total
Beginning of the period	—	—	87,785	59,057	—	146,842
Initial recognition and changes in the fair value of biological assets at the point of harvest	—	—	276,511	134,402	—	410,913
Costs incurred during the period	374,456	177,601	—	—	31,301	583,358
Period ended September 30, 2023	374,456	177,601	364,296	193,459	31,301	1,141,113


	Wheat	Barley	Total
Beginning of the period	44,413	12,900	57,313
Initial recognition and changes in the fair value of biological assets at the point of harvest	365,833	124,173	490,006
Costs incurred during the period	378,631	122,837	501,468
Exchange differences	(16,699)	(5,344)	(22,043)
Period ended September 30, 2022	772,178	254,566	1,026,744

5.7. Property, plant and equipment

Property, plant and equipment as of September 30, 2023 and June 30, 2023 included the following:


	09/30/2023	06/30/2023
Gross carrying amount	96,833,359	93,634,779
Accumulated depreciation	(26,902,650)	(25,780,944)
Net carrying amount	69,930,709	67,853,835

F-15

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)

Net carrying amount for each class of assets is as follows:


	Net carrying	Net carrying
	amount	amount
Class	09/30/2023	06/30/2023
Office equipment	280,905	263,892
Vehicles	1,862,542	2,032,853
Equipment and computer software	167,741	174,399
Fixtures and fittings	2,676,861	2,862,949
Machinery and equipment	13,970,593	14,463,756
Land and buildings	35,640,076	36,144,792
Buildings in progress	15,331,991	11,911,194
Total	69,930,709	67,853,835

1. Gross carrying amount as of September 30, 2023 is as follows:


	Gross carrying amount
	As of the
	beginning			Foreign	As of the
	of the			currency	end of the
Class	period	Additions	Disposals	translation	period
Office equipment	968,088	34,918	—	(2,764)	1,000,242
Vehicles	5,492,319	28,680	(45,062)	(1,498)	5,474,439
Equipment and computer software	974,509	30,188	—	(5,857)	998,840
Fixtures and fittings	7,663,899	—	—	(2,126)	7,661,773
Machinery and equipment	23,513,047	176,837	—	(91,465)	23,598,419
Land and buildings	43,111,723	—	—	(344,068)	42,767,655
Buildings in progress	11,911,194	3,678,037	—	(257,240)	15,331,991
Total	93,634,779	3,948,660	(45,062)	(705,018)	96,833,359

2. Accumulated depreciation as of September 30, 2023 is as follows:


	Depreciation
	Accumulated
	as of the			Foreign	Accumulated
	beginning of			currency	as of the end
Class	the period	Disposals	Of the period	translation	of the period
Office equipment	704,196	—	17,004	(1,863)	719,337
Vehicles	3,459,466	(36,049)	188,532	(52)	3,611,897
Equipment and computer software	800,110	—	35,963	(4,974)	831,099
Fixtures and fittings	4,800,950	—	184,877	(915)	4,984,912
Machinery and equipment	9,049,291	—	595,729	(17,194)	9,627,826
Land and buildings	6,966,931	—	221,298	(60,650)	7,127,579
Total	25,780,944	(36,049)	1,243,403	(85,648)	26,902,650

F-16

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)

3. Gross carrying amount as of September 30, 2022 is as follows:


	Gross carrying amount
	As of the		Additions		Foreign	As of the
	beginning		from business		currency	end of the
Class	of the period	Additions	combination	Disposals	translation	period
Office equipment	908,004	—	—	—	(15,172)	892,832
Vehicles	5,261,979	226,051	—	(59,744)	(6,243)	5,422,043
Equipment and computer software	925,349	41,658	12,469	—	(6,667)	972,809
Fixtures and fittings	7,606,389	33,869	5,379	—	(5,539)	7,640,098
Machinery and equipment	13,017,830	107,717	7,047,496	—	(24,469)	20,148,574
Land and buildings	40,659,129	—	4,750,136	—	(313,148)	45,096,117
Buildings in progress	3,142,774	1,005,435	1,285,092	—	(17,941)	5,415,360
Total	71,521,454	1,414,730	13,100,572	(59,744)	(389,179)	85,587,833

4. Accumulated depreciation as of September 30, 2022 is as follows:


	Depreciation
	Accumulated
	as of the			Foreign	Accumulated
	beginning of		Of the	currency	as of the end
Class	the period	Disposals	period	translation	of the period
Office equipment	638,466	—	17,053	(16,931)	638,588
Vehicles	2,596,905	(59,744)	226,899	(3,364)	2,760,696
Equipment and computer software	693,673	—	28,914	(476)	722,111
Fixtures and fittings	4,059,470	—	206,830	(23,814)	4,242,486
Machinery and equipment	7,205,870	—	679,201	(180,089)	7,704,982
Land and buildings	6,418,745	—	223,196	(695)	6,641,246
Total	21,613,129	(59,744)	1,382,093	(225,369)	22,710,109

The depreciation charge is included in Notes 6.3 and 6.4. The Group has no commitments to purchase property, plant and equipment items.

5.8. Intangible assets

Intangible assets as of September 30, 2023 and June 30, 2023 included the following:


	09/30/2023	06/30/2023
Gross carrying amount	204,300,750	202,306,618
Accumulated amortization	(31,266,214)	(28,522,662)
Net carrying amount	173,034,536	173,783,956

F-17

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)

Net carrying amount of each class of intangible assets is as follows:


	Net carrying	Net carrying
	amount	amount
Class	09/30/2023	06/30/2023
Seed and integrated products
HB4 soy and breeding program	31,476,363	31,679,681
Integrated seed products	2,786,562	2,841,008
Crop nutrition
Microbiological products	50,506,239	49,508,801
Other intangible assets
Trademarks and patents	58,730,415	59,760,753
Software	1,609,367	1,987,690
Customer loyalty	22,925,590	23,006,023
RG/RS/OX Wheat	5,000,000	5,000,000
Total	173,034,536	173,783,956

1. Gross carrying amount as of September 30, 2023 is as follows:


	Gross carrying amount
	As of the		Foreign	As of the
	beginning of		currency	end of the
Class	the period	Additions	translation	period
Seed and integrated products
HB4 soy and breeding program	34,958,425	224,230	—	35,182,655
Integrated seed products	3,219,808	—	(8,178)	3,211,630
Crop nutrition
Microbiological products	55,645,028	1,723,274	(6,119)	57,362,183
Other intangible assets
Trademarks and patents	67,653,234	62,543	—	67,715,777
Software	5,582,411	1,943	(3,561)	5,580,793
Customer loyalty	30,247,712	—	—	30,247,712
RG/RS/OX Wheat	5,000,000	—	—	5,000,000
Total	202,306,618	2,011,990	(17,858)	204,300,750

F-18

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)

2. Accumulated amortization as of September 30, 2023 is as follows:


	Amortization
	Accumulated		Foreign	Accumulated as
	as of beginning		currency	of the end of the
Class	of the period	Of the period	translation	period
Seed and integrated products
HB4 soy and breeding program	3,278,744	427,548	—	3,706,292
Integrated seed products	378,800	47,229	(961)	425,068
Crop nutrition
Microbiological products	6,136,227	719,717	—	6,855,944
Other intangible assets
Trademarks and patents	7,892,481	1,092,881	—	8,985,362
Software	3,594,721	379,398	(2,693)	3,971,426
Customer loyalty	7,241,689	80,433	—	7,322,122
Total	28,522,662	2,747,206	(3,654)	31,266,214

3. Gross carrying amount as of September 30, 2022 is as follows:


	Gross carrying amount
	As of the		Additions from
	beginning		business	Foreign currency	As of the end of
Class	of the period	Additions	combination	translation	the period
Seed and integrated products
HB4 soy and breeding program	31,371,088	361,006	—	—	31,732,094
Integrated seed products	3,181,155	—	—	—	3,181,155
Crop nutrition
Microbiological products	8,855,421	2,880,002	39,613,280	(3,945)	51,344,758
Other intangible assets
Trademarks and patents	12,183,045	3,679	55,420,441	—	67,607,165
Software	5,176,373	206,184	—	(1,652)	5,380,905
Customer loyalty	28,462,475	—	1,785,237	—	30,247,712
RG/RS/OX Wheat	5,000,000	—	—	—	5,000,000
Total	94,229,557	3,450,871	96,818,958	(5,597)	194,493,789

F-19

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)

4. Accumulated amortization as of September 30, 2022 is as follows:


	Amortization
	Accumulated as		Foreign	Accumulated
	of beginning of		currency	as of the end
Class	the period	Of the period	translation	of the period
Seed and integrated products
HB4 soy and breeding program	1,568,554	396,701	—	1,965,255
Integrated seed products	43,997	13,019	—	57,016
Crop nutrition
Microbiological products	3,063,073	1,057,149	—	4,120,222
Other intangible assets
Trademarks and patents	3,916,004	542,868	—	4,458,872
Software	3,008,388	141,044	(1,221)	3,148,211
Customer loyalty	5,924,672	326,051	—	6,250,723
Total	17,524,688	2,476,832	(1,221)	20,000,299

The amortization charge is included in Notes 6.3 and 6.4.

5.9. Goodwill


	09/30/2023	06/30/2023

Rizobacter Argentina S.A.	28,080,271	28,080,271
Bioceres Crops S.A.	7,523,322	7,523,322
Pro farm Group, Inc.	76,089,749	76,089,749
Insumos Agroquímicos S.A.	470,090	470,090
	112,163,432	112,163,432

There were no indicators of goodwill impairment.

5.10. Investment properties


	09/30/2023	06/30/2023

Investment properties	3,675,493	3,589,749
	3,675,493	3,589,749

5.11. Trade and other payables


	09/30/2023	06/30/2023

Trade creditors	106,222,415	104,211,238
Shareholders and other related parties (Note 15)	27,708	35,292
Trade creditors - Parent company (Note 15)	270,645	644,191
Trade creditors - Joint ventures and associates (Note 15)	47,282,380	41,402,594
Taxes	5,138,674	3,561,058
Miscellaneous	183,536	953,301
	159,125,358	150,807,674

F-20

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)

5.12. Borrowings


	09/30/2023	06/30/2023
Current
Bank borrowings	60,473,023	61,303,952
Corporate bonds	29,745,450	35,547,510
Trust debt securities	6,936,758	7,296,506
Net loans payables- Parents companies and related parties to Parent (Note 15)	3,565,754	3,491,691
	100,720,985	107,639,659
Non-current
Bank borrowings	7,586,944	10,663,266
Corporate bonds	41,202,548	50,007,680
	48,789,492	60,670,946

The carrying value of some borrowings as of September 30, 2023 are measured at amortized cost differ from their fair value. The following fair values measured are based on discounted cash flows (Level 3) due to the use of unobservable inputs, including own credit risk.


	09/30/2023		06/30/2023
	Amortized cost	Fair value	Amortized cost	Fair value
Current
Bank borrowings	60,473,023	57,553,255	61,303,952	57,209,155
Corporate Bonds	29,745,450	29,389,136	35,547,510	34,725,828

Non-current
Bank borrowings	7,586,944	5,620,759	10,663,266	10,374,646
Corporate Bonds	41,202,548	39,984,876	50,007,680	47,014,542

5.13. Secured Notes

Secured Guaranteed Notes

The carrying value of $25.9 million of the Secured Guaranteed Notes as of September 30, 2023 are measured at amortized cost. Its fair value based on discounted cash flows, using a fair interest rate, would amount to $26.1 million.

Secured Convertible Guaranteed Notes

The carrying value of $51.0 million of the Secured Convertible Guaranteed Notes as of September 30, 2023 are measured at amortized cost. Its fair value based on discounted cash flows, using a fair interest rate, would amount to $53.3 million.

Under the terms of the Secured Convertible Guaranteed Notes, the Group is in compliance with covenants.

5.14. Employee benefits and social security


	09/30/2023	06/30/2023
Salaries, accrued incentives, vacations and social security	9,685,549	9,388,639
Key management personnel (Note 15)	333,616	218,068
	10,019,165	9,606,707

F-21

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)

5.15. Deferred revenue and advances from customers


	09/30/2023	06/30/2023
Current
Advances from customers	17,019,407	9,216,032
Deferred revenue	15,752,495	15,659,630
	32,771,902	24,875,662
Non-current
Advances from customers	272,334	620,893
Deferred revenue	1,930,040	1,436,912
	2,202,374	2,057,805

6. INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

6.1. Revenue from contracts with customers


	09/30/2023	09/30/2022
Sale of goods and services	115,628,792	126,113,636
Royalties	554,013	729,612
	116,182,805	126,843,248

Transactions of sales of goods and services with joint ventures and with shareholders and other related parties are reported in Note 15.

6.2. Cost of sales


Item	09/30/2023	09/30/2022
Inventories as of the beginning of the period	111,990,145	78,759,610
Business combination	—	11,064,908
Purchases of the period	71,694,655	79,325,509
Production costs	7,123,255	8,440,830
Foreign currency translation	(226,797)	(236,263)
Subtotal	190,581,258	177,354,594
Inventories as of the end of the period (*)	(118,965,477)	(101,678,716)
Cost of sales	71,615,781	75,675,878

(*)Net of agricultural products.

F-22

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)

6.3. R&D classified by nature


	Research and	Research and
	development	development
	expenses	expenses
Item	09/30/2023	09/30/2022
Amortization of intangible assets	1,164,940	1,511,118
Analysis and storage	—	11,568
Import and export expenses	—	850
Depreciation of property, plant and equipment	157,808	142,373
Freight and haulage	3,917	5,300
Employee benefits and social securities	1,307,126	861,312
Maintenance	206,778	217,066
Energy and fuel	3,628	79,121
Supplies and materials	847,382	559,044
Mobility and travel	13,771	108,694
Share-based incentives	188,250	6,975
Professional fees and outsourced services	491,787	293,776
Office supplies	170,375	21,454
Information technology expenses	4,375	11,996
Insurance	21,049	10,537
Depreciation of leased assets	—	10,650
Miscellaneous	55	180
Total	4,581,241	3,852,014


	09/30/2023	09/30/2022
R&D capitalized (Note 5.8)	1,947,504	3,241,008
R&D profit and loss	4,581,241	3,852,014
Total	6,528,745	7,093,022

F-23

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)

6.4. Expenses classified by nature and function


		Selling,
		general and
	Production	administrative	Total
Item	costs	expenses	09/30/2023
Amortization of intangible assets	30,478	1,551,788	1,582,266
Analysis and storage	570	153,473	154,043
Commissions and royalties	134,592	794,058	928,650
Import and export expenses	67,228	120,345	187,573
Depreciation of property, plant and equipment	643,006	442,589	1,085,595
Depreciation of leased assets	339,378	497,821	837,199
Impairment of receivables	—	352,920	352,920
Freight and haulage	643,877	2,989,094	3,632,971
Employee benefits and social securities	2,806,939	10,238,931	13,045,870
Maintenance	422,757	568,155	990,912
Energy and fuel	163,122	16,397	179,519
Supplies and materials	260,043	831,454	1,091,497
Mobility and travel	33,407	1,348,563	1,381,970
Publicity and advertising	—	1,161,498	1,161,498
Contingencies	—	27,109	27,109
Share-based incentives	275,432	5,729,986	6,005,418
Professional fees and outsourced services	509,450	1,575,982	2,085,432
Office supplies and registrations fees	149,888	370,770	520,658
Insurance	27,024	473,850	500,874
Information technology expenses	18,361	743,163	761,524
Obsolescence	505,285	—	505,285
Taxes	70,819	3,766,419	3,837,238
Miscellaneous	21,599	178,483	200,082
Total	7,123,255	33,932,848	41,056,103

F-24

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)


		Selling,
		general and
	Production	administrative	Total
Item	costs	expenses	09/30/2022
Amortization of intangible assets	43,456	922,258	965,714
Analysis and storage	5,425	113,265	118,690
Commissions and royalties	118,960	623,459	742,419
Import and export expenses	98,186	256,070	354,256
Depreciation of property, plant and equipment	746,609	493,111	1,239,720
Depreciation of leased assets	395,972	269,805	665,777
Impairment of receivables	—	156,053	156,053
Freight and haulage	241,533	3,474,028	3,715,561
Employee benefits and social securities	3,994,761	10,041,033	14,035,794
Maintenance	462,743	980,742	1,443,485
Energy and fuel	500,359	58,400	558,759
Supplies and materials	339,843	491,811	831,654
Mobility and travel	20,940	994,919	1,015,859
Publicity and advertising	—	1,888,497	1,888,497
Contingencies	—	2,448	2,448
Share-based incentives	100,206	120,170	220,376
Professional fees and outsourced services	674,014	4,610,610	5,284,624
Office supplies and registrations fees	32,546	289,467	322,013
Insurance	28,430	760,276	788,706
Information technology expenses	13,243	993,378	1,006,621
Obsolescence	539,382	79,107	618,489
Taxes	45,049	4,130,539	4,175,588
Miscellaneous	39,173	155,465	194,638
Total	8,440,830	31,904,911	40,345,741

6.5. Other income or expenses, net


	09/30/2023	09/30/2022
Net result from commercialization of agricultural products	(1,316,393)	6,327
Expenses recovery	87,053	126,061
Other income or expenses, net	(2,295)	345,653
	(1,231,635)	478,041

F-25

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)

6.6. Finance results


	09/30/2023	09/30/2022
Financial costs
Interest expenses with the Parents (Note 15)	(97,063)	(149,734)
Interest expenses	(6,935,241)	(5,569,576)
Financial commissions	(629,553)	(1,060,537)
	(7,661,857)	(6,779,847)

Other financial results
Exchange differences generated by assets	(9,685,066)	(833,428)
Exchange differences generated by liabilities	10,335,537	6,322
Changes in fair value of financial assets or liabilities and other financial results	(151,646)	(569,032)
Net gain of inflation effect on monetary items	(380,960)	107,832
	117,865	(1,288,306)

7. TAXATION

Taxes on income in the interim periods are accrued using the tax rate that would be applicable to expected total annual earnings.


	09/30/2023	09/30/2022
Current tax expense	(6,457,134)	(6,020,201)
Deferred tax	6,028,094	1,007,558
Total	(429,040)	(5,012,643)


	09/30/2023	09/30/2022
Beginning of the period deferred tax	(28,472,383)	(24,994,569)
Additions for business combination	—	(16,704,770)
Charge for the period	6,028,094	1,007,558
Conversion difference	(3,718,889)	(261,014)
Total net deferred tax	(26,163,178)	(40,952,795)

The tax on the Group’s profit before tax differs from the theoretical amount that would arise using the weighted average tax rate applicable to profits of the consolidated entities as follows:


	09/30/2023	09/30/2022
Earning before income tax-rate	(2,249,424)	8,924,643
Income tax expense by applying tax rate in force in the respective countries	(1,721,853)	(5,739,069)
Share of profit or loss of subsidiaries, joint ventures and associates	530,177	313,280
Stock options charge	(1,226,796)	(57,818)
Non-deductible expenses	(383,074)	(805,883)
Unrecognized deferred tax	—	(895,896)
Tax inflation adjustment	4,826,023	1,822,594
Result of inflation effect on monetary items and other finance results	(2,352,623)	213,857
Others	(100,894)	136,292
Income tax expenses	(429,040)	(5,012,643)

F-26

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)

8. EARNING PER SHARE

The numerators and denominators used in the calculation of basic EPS and diluted EPS are presented below:


	09/30/2023	09/30/2022
Numerator
(Loss) profit for the period (basic EPS)	(4,591,634)	498,297
(Loss) profit for the period (diluted EPS)	(4,591,634)	498,297
Denominator
Weighted average number of shares (basic EPS)	62,846,690	60,537,110
Weighted average number of shares (diluted EPS)	62,846,690	61,736,679

Basic (loss) profit attributable to ordinary equity holders of the parent	(0.0731)	0.0082
Diluted (loss) profit attributable to ordinary equity holders of the parent	(0.0731)	0.0081

For the three-month period ended September 30, 2023 diluted EPS was equal to basic EPS as the effect of potential ordinary shares would be antidilutive.

For the three-month period ended September 30, 2022, diluted earnings per share was calculated by adjusting the weighted average number of shares outstanding to assume conversion of all dilutive potential shares. The Group had two categories of dilutive potential shares, share-based incentives and the convertible notes.

The stock options were included in the diluted EPS calculation for the period ended September 30, 2022 only for the tranches in which the average market price of ordinary shares during the periods was higher than the assumed proceeds per option.

Convertible notes outstanding were not included in the diluted EPS calculations for the period ended September 30, 2022 because the interest (net of tax and other changes in income or expense) per ordinary share obtainable on conversion exceeds basic earnings per share.

9. EQUITY INFORMATION

Capital issued

As of September 30, 2023, we had (i) 100,000,000 ordinary shares ($0.0001 par value) authorized, (ii) 62,849,997 ordinary shares issued and outstanding, (iii) 1,000,000 preferred shares ($0.0001 par value) authorized, (iv) no preferred shares issued and outstanding, (v) 3,951,917 ordinary shares reserved for our equity compensation plans. Of the total issued shares, we have repurchased 2,231,761 shares of our own.

Holders of the ordinary shares are entitled to one vote for each ordinary share.

F-27

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)

10. CASH FLOW INFORMATION

Significant non-cash transactions related to investing and financing activities are as follows:


	09/30/2023	09/30/2022
Investment activities
Net assets acquisition by business combination	—	150,510,313
Investment in-kind in other related parties (Note 15)	—	550,183
Capitalization of interest on buildings in progress	36,589	—
	36,589	151,060,496

	09/30/2023	09/30/2022
Financing activities
Capitalization of convertible notes (Note 5.13)	—	12,211,638
Purchase of own shares	—	(23,915,029)
	—	(11,703,391)

11. JOINT VENTURES AND ASSOCIATES


	09/30/2023	06/30/2023
Assets
Synertech Industrias S.A.	37,550,684	36,026,710
Alfalfa Technologies S.R.L.	36,502	36,502
Moolec Science S.A.	3,233,598	3,233,598
	40,820,784	39,296,810


	09/30/2023	06/30/2023
Liabilities
Trigall Genetics S.A.	638,126	622,823
	638,126	622,823

Changes in joint ventures investments and affiliates:


	09/30/2023	09/30/2022
As of the beginning of the period	38,673,987	37,836,144
Foreign currency translation	—	100,868
Share of profit or loss	1,508,671	842,240
As of the end of the period	40,182,658	38,779,252

Share of profit or loss of joint ventures and affiliates:


	09/30/2023	09/30/2022
Trigall Genetics S.A.	(15,303)	(132,117)
Synertech Industrias S.A.	1,523,974	974,357
	1,508,671	842,240

F-28

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)

12. SEGMENT INFORMATION

The tables present information with respect to the Group´s reporting segments:


	Seed and
	integrated		Crop		Crop
Period ended September 30, 2023	products		protection		nutrition		Consolidated
Revenues from contracts with customers
Sale of goods and services	21,677,053		55,754,360		38,197,379		115,628,792
Royalties	554,013		—		—		554,013
Others
Initial recognition and changes in the fair value of biological assets at the point of harvest	87,844		172,118		150,951		410,913
Total	22,318,910		55,926,478		38,348,330		116,593,718

Cost of sales	(14,110,381)		(36,183,792)		(21,321,608)		(71,615,781)
Gross profit per segment	8,208,529		19,742,686		17,026,722		44,977,937
% Gross margin	37	%	35	%	44	%	39	%


	Seed and
	integrated		Crop		Crop
Period ended September 30, 2022	products		protection		nutrition		Consolidated
Revenues from contracts with customers
Sale of goods and services	13,073,640		62,986,173		50,053,823		126,113,636
Royalties	729,612		—		—		729,612
Others
Initial recognition and changes in the fair value of biological assets at the point of harvest	51,451		89,573		348,982		490,006
Total	13,854,703		63,075,746		50,402,805		127,333,254

Cost of sales	(5,539,489)		(45,035,250)		(25,101,139)		(75,675,878)
Gross profit per segment	8,315,214		18,040,496		25,301,666		51,657,376
% Gross margin	60	%	29	%	50	%	41	%

As of the current period, changes in the net realizable value of agricultural products after harvest have been excluded from segment information since those results depend on market fluctuations which are beyond the Group’s operating control. The company has recast the comparative amounts.

F-29

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)

13. FINANCIAL INSTRUMENTS – RISK MANAGEMENT

Financial instruments by category

The following tables show additional information required under IFRS 7 on the financial assets and liabilities recorded as of September 30, 2023, and June 30, 2023.

Financial assets by category


			Mandatorily measured at fair
	Amortized cost		value through profit or loss
Financial asset	09/30/2023	06/30/2023	09/30/2023	06/30/2023
Cash and cash equivalents	25,954,730	48,129,194	2,419,194	—
Other financial assets	502,910	657,612	14,628,202	11,922,317
Trade receivables	186,276,319	158,006,474	—	—
Other receivables (*)	11,753,573	12,124,724	—	—
Total	224,487,532	218,918,004	17,047,396	11,922,317

(*)	Advances expenses and tax balances are not included.

Financial liabilities by category


			Mandatorily measured at fair
	Amortized cost		value through profit or loss
Financial liability	09/30/2023	06/30/2023	09/30/2023	06/30/2023
Trade and other payables	152,753,083	142,582,166	6,372,275	8,225,508
Borrowings	149,510,477	168,310,605	—	—
Secured notes	76,911,874	75,213,146	—	—
Lease liability	13,552,751	13,889,223	—	—
Consideration for acquisition of assets	6,742,570	4,993,256	—	—
Total	399,470,755	404,988,396	6,372,275	8,225,508

F-30

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)

Financial instruments measured at fair value


Measurement at fair value at 09/30/2023	Level 1	Level 2	Level 3

Financial assets at fair value
US Treasury bills	9,719,486	—	—
Mutual funds	3,236,702	—	—
Other investments	1,672,014	—	—
Financial liability at fair value
Trade and other payables	—	6,372,275	—

Measurement at fair value at 06/30/2023	Level 1	Level 2	Level 3

Financial assets at fair value
US Treasury bills	9,163,298	—	—
Mutual funds	1,596,539	—	—
Other investments	1,162,480	—	—
Financial liability at fair value
Trade and other payables	—	8,225,508	—

Estimation of fair value

The fair value of marketable securities, mutual funds and US Treasury Bills is calculated using the market approach using quoted prices in active markets for identical assets. The quoted marked price used for financial assets held by the Group is the current bid price. These instruments are included in level 1.

The Group’s financial liabilities, which were not traded in an active market, were determined using valuation techniques that maximize the use of available market information, and thus rely as little as possible on specific estimates of the entity specific estimates. If all significant inputs required to fair value an instrument are observable, the instruments are included in level 2.

If one or more of the significant inputs is not based on observable market data, the instruments are included in level 3.

The Group’s policy is to recognize transfers between different categories of the fair value hierarchy at the time they occur or when there are changes in the circumstances that cause the transfer. There were no transfers between levels of the fair value hierarchy. There were no changes in economic or business circumstances affecting fair value.

Financial instruments not measured at fair value

The financial instruments not measured at fair value include cash and cash equivalents, trade accounts receivable, other accounts receivable, trade payables and other debts, borrowings, financed payments and convertible notes.

The carrying value of financial instruments not measured at fair value does not differ significantly from their fair value, except for borrowings (Note 5.12).

Management estimates that the carrying value of the financial instruments measured at amortized cost approximates their fair value.

F-31

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)

Currency risk

Foreign currency risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rate. Currency on foreign exchange risk arises when the Group enters into transactions denominated in a currency other than its functional currency.

The table below sets forth our net exposure to currency risk as of September 30, 2023:


Net foreign currency position		09/30/2023
Amount expressed in US$		(5,353,860)

Considering only this net currency exposure as of September 30, 2023 if an US Dollar revaluation or depreciation in relation to other foreign currencies with the remaining variables remaining constant, would have a positive or a negative impact on comprehensive income as a result of foreign exchange gains or losses. We estimate that a devaluation or an appreciation of the US Dollar other currencies of 10% during the period ended September 30, 2023 would have resulted in a net pre-tax loss or gain of approximately $0.5 million.

14. LEASES


Right-of-use leased asset	09/30/2023	06/30/2023
Book value at the beginning of the period/year	21,163,192	15,828,032
Additions of the period/year	1,072,418	3,154,950
Additions from business combination	—	3,005,000
Disposals	(461,631)	(1,839,921)
Exchange differences	(513,269)	1,015,131
Book value at the end of the period/year	21,260,710	21,163,192

Depreciation	09/30/2023	06/30/2023
Book value at the beginning of the period/year	7,226,617	3,684,006
Depreciation of the period/year	837,199	3,565,894
Disposals	(274,431)	(171,870)
Exchange differences	(47,874)	148,587
Accumulated depreciation at the end of the period/year	7,741,511	7,226,617
Total	13,519,199	13,936,575


Lease liability	09/30/2023	06/30/2023
Book value at the beginning of the period/year	13,889,223	11,751,284
Additions of the period/year	1,072,418	3,154,950
Additions from business combination	—	3,245,000
Interest expenses, exchange differences and inflation effects	(238,851)	(406,494)
Payments of the period/year	(1,170,039)	(3,855,517)
Total	13,552,751	13,889,223

F-32

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)


Lease Liabilities	09/30/2023	06/30/2023
Non-current	9,225,862	10,030,524
Current	4,326,889	3,858,699
Total	13,552,751	13,889,223

The recognized right-of-use assets relate to the following types of assets:


	09/30/2023	06/30/2023
Machinery and equipment	3,655,741	3,655,741
Vehicles	1,433,616	1,475,581
Equipment and computer software	1,011,490	903,306
Land and buildings	15,159,863	15,128,564
	21,260,710	21,163,192

The incremental borrowing rate used was 2.13 %.

15. SHAREHOLDERS AND OTHER RELAED PARTIES BALANCES AND TRANSACTIONS

During the period ended September 30, 2023, and 2022, the transactions between the Group and related parties, and the related balances owed by and to them, are as follows:


		Value of transactions for the period ended
Party	Transaction type	09/30/2023	09/30/2022
Joint ventures and associates	Sales and services	6,801,117	17,083,027
Joint ventures and associates	Purchases of goods and services	(20,691,171)	(25,314,814)
Key management personnel	Salaries, social security benefits and other benefits	(6,702,803)	(648,494)
Shareholders and other related parties	Sales of goods and services	1,590,568	261,418
Shareholders and other related parties	Purchases of goods and services	(196,051)	(239,772)
Shareholders and other related parties	In-kind contributions	—	550,183
Shareholders and other related parties	Net loans granted/(cancelled)	—	(1,609)
Shareholders and other related parties	Interest expenses	(23,000)	—
Parent company and related parties to Parent (Note 6.6)	Interest expenses	(97,063)	(149,734)
Total		(19,318,403)	(8,459,795)


		Amounts receivable from related parties
Party	Transaction type	09/30/2023	06/30/2023
Shareholders and other related parties	Other receivables	1,368,373	—
Shareholders and other related parties	Other receivables	2,919,431	3,792,429
Joint ventures and associates	Trade debtors	781,451	865,627
Joint ventures and associates	Other receivables	6,699,863	6,334,219
Total		11,769,118	10,992,275

F-33

Table of Contents

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Amounts in US$, except otherwise indicated)


		Amounts payable to related parties
Party	Transaction type	09/30/2023	06/30/2022
Parent company and related parties to Parent	Trade creditors	(270,645)	(644,191)
Parent company and related parties to Parent	Net loans payables	(3,565,754)	(3,491,691)
Key management personnel	Salaries, social security benefits and other benefits	(333,616)	(218,068)
Shareholders and other related parties	Trade and other payables	(27,708)	(35,292)
Joint ventures and associates	Trade creditors	(47,282,380)	(41,402,594)
Total		(51,480,103)	(45,791,836)

16. KEY MANAGEMENT PERSONNEL COMPENSATION

The compensation of directors and other members of key management personnel, including social contributions and other benefits, were as follows for the period ended September 30, 2023, and 2022.


	09/30/2023	09/30/2022

Salaries, social security and other benefits	509,135	421,143
Share-based incentives	6,193,668	227,351
Total	6,702,803	648,494

17. SHARE-BASED PAYMENT

Pursuant to the 2023 Omnibus Equity Incentive Plan approved on May 12, 2023, in August 2023 the Board has granted the following stock options plan to certain directors, executives and management of the Group.

-	Past Share Option plan: immediately vested options with a strike price between $11.93 and $13.24.

-	Base Share Option plan: to vest and become exercisable in equal installments on June 30, 2023, June 30, 2024, and June 30, 2025, with a strike price of $10.47.

-	Performance Share Option plan: to vest and become exercisable if the Company’s fiscal year 2025 EBITDA reaches at least US$120 million, at 0% of the award, and linearly thereafter up to 100% of the awarded options when reaching at least US$150 million. This option has also a strike price of $10.47.

The fair value of the stock options at the grant date was estimated using the “Black-Scholes” model considering the terms and conditions under which the stock options were granted and adjusted to consider the possible dilutive effect of the future exercise of options. As of September 30, 2023, the expenses associated with share-based incentive plans are included in results within “Share-based incentives” along with the associated increase in net worth.

18. CONTINGENCIES, COMMITMENTS AND RESTRICTIONS ON THE DISTRIBUTION OF PROFITS

There were no other significant changes to the contingencies, commitments and restrictions on the distribution of profits from the disclosure made in the Consolidated financial statement as of June 30, 2023.

19. EVENTS OCCURRING AFTER THE REPORTING PERIOD

Subsequent to September 30, 2023, there have been no other situations or circumstances that may require significant adjustments or further disclosure in these consolidated financial statements that were not mentioned above.

F-34

EX-101.SCH 3 biox-20230930.xsd XBRL TAXONOMY EXTENSION SCHEMA 00100 - Statement - UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Calc2 link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME link:presentationLink link:calculationLink link:definitionLink 00400 - Statement - UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Cash and cash equivalents (Details) link:presentationLink link:calculationLink link:definitionLink 40502 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Other financial assets (Details) link:presentationLink link:calculationLink link:definitionLink 40503 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Trade receivables (Details) link:presentationLink link:calculationLink link:definitionLink 40504 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Other receivables (Details) link:presentationLink link:calculationLink link:definitionLink 40517 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Trade and other payable (Details) link:presentationLink link:calculationLink link:definitionLink 40522 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Employee benefits and social security (Details) link:presentationLink link:calculationLink link:definitionLink 40523 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Deferred revenue and advances from customers (Details) link:presentationLink link:calculationLink link:definitionLink 40603 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - R&D classified by nature (Details) link:presentationLink link:calculationLink link:definitionLink 40604 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Expenses classified by nature and functions (Details) link:presentationLink link:calculationLink link:definitionLink 40605 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Other income or expenses, net (Details) link:presentationLink link:calculationLink link:definitionLink 40606 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Finance results (Details) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - TAXATION - Taxes on income (Details) link:presentationLink link:calculationLink link:definitionLink 40703 - Disclosure - TAXATION - Reconciliation of the statutory tax rate (Details) link:presentationLink link:calculationLink link:definitionLink 41001 - Disclosure - CASH FLOW INFORMATION (Details) link:presentationLink link:calculationLink link:definitionLink 41201 - Disclosure - SEGMENT INFORMATION - Group's reporting segments (Details) link:presentationLink link:calculationLink link:definitionLink 41402 - Disclosure - LEASES - Lease liability (Details) link:presentationLink link:calculationLink link:definitionLink 41501 - Disclosure - SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS - Transactions (Details) link:presentationLink link:calculationLink link:definitionLink 41601 - Disclosure - KEY MANAGEMENT PERSONNEL COMPENSATION - Summary of compensation of directors and other members (Details) link:presentationLink link:calculationLink link:definitionLink 00300 - Statement - UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY link:presentationLink link:calculationLink link:definitionLink 40505 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 40506 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Biological assets (Details) link:presentationLink link:calculationLink link:definitionLink 40507 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment (Details) link:presentationLink link:calculationLink link:definitionLink 40508 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment - net carrying amount (Details) link:presentationLink link:calculationLink link:definitionLink 40509 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment - gross carrying amounts (Details) link:presentationLink link:calculationLink link:definitionLink 40510 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment - accumulated depreciation (Details) link:presentationLink link:calculationLink link:definitionLink 40511 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets (Details) link:presentationLink link:calculationLink link:definitionLink 40512 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets, net carrying amount (Details) link:presentationLink link:calculationLink link:definitionLink 40513 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets, gross carrying amount (Details) link:presentationLink link:calculationLink link:definitionLink 40514 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets, accumulated amortization (Details) link:presentationLink link:calculationLink link:definitionLink 40515 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 40518 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Borrowings (Details) link:presentationLink link:calculationLink link:definitionLink 40519 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Borrowings, carrying amount (Details) link:presentationLink link:calculationLink link:definitionLink 40521 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Secured Notes (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 40901 - Disclosure - EQUITY INFORMATION (Details) link:presentationLink link:calculationLink link:definitionLink 41101 - Disclosure - JOINT VENTURES AND ASSOCIATES (Details) link:presentationLink link:calculationLink link:definitionLink 41301 - Disclosure - FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Financial assets by category (Details) link:presentationLink link:calculationLink link:definitionLink 41302 - Disclosure - FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Financial liabilities by category (Details) link:presentationLink link:calculationLink link:definitionLink 41303 - Disclosure - FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Fair value by hierarchy (Details) link:presentationLink link:calculationLink link:definitionLink 41304 - Disclosure - FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Currency risk (Details) link:presentationLink link:calculationLink link:definitionLink 41401 - Disclosure - LEASES - Right-of-use leased asset (Details) link:presentationLink link:calculationLink link:definitionLink 41403 - Disclosure - LEASES - Right-of-use asset by type (Details) link:presentationLink link:calculationLink link:definitionLink 41502 - Disclosure - SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS - Receivable (Details) link:presentationLink link:calculationLink link:definitionLink 41503 - Disclosure - SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS - Payables (Details) link:presentationLink link:calculationLink link:definitionLink 41701 - Disclosure - SHARE-BASED PAYMENT (Details) link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - GENERAL INFORMATION link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - ACCOUNTING STANDARDS AND BASIS OF PREPARATION link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS ISSUED BY THE IASB link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - SEASONALITY link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION link:presentationLink link:calculationLink link:definitionLink 10601 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME link:presentationLink link:calculationLink link:definitionLink 10701 - Disclosure - TAXATION link:presentationLink link:calculationLink link:definitionLink 10801 - Disclosure - EARNING PER SHARE link:presentationLink link:calculationLink link:definitionLink 10901 - Disclosure - EQUITY INFORMATION link:presentationLink link:calculationLink link:definitionLink 11001 - Disclosure - CASH FLOW INFORMATION link:presentationLink link:calculationLink link:definitionLink 11101 - Disclosure - JOINT VENTURES AND ASSOCIATES link:presentationLink link:calculationLink link:definitionLink 11201 - Disclosure - SEGMENT INFORMATION link:presentationLink link:calculationLink link:definitionLink 11301 - Disclosure - FINANCIAL INSTRUMENTS - RISK MANAGEMENT link:presentationLink link:calculationLink link:definitionLink 11401 - Disclosure - LEASES link:presentationLink link:calculationLink link:definitionLink 11501 - Disclosure - SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 11601 - Disclosure - KEY MANAGEMENT PERSONNEL COMPENSATION link:presentationLink link:calculationLink link:definitionLink 11701 - Disclosure - SHARE-BASED PAYMENT link:presentationLink link:calculationLink link:definitionLink 11801 - Disclosure - CONTINGENCIES, COMMITMENTS AND RESTRICTIONS ON THE DISTRIBUTION OF PROFITS link:presentationLink link:calculationLink link:definitionLink 11901 - Disclosure - EVENTS OCCURRING AFTER THE REPORTING PERIOD link:presentationLink link:calculationLink link:definitionLink 20102 - Disclosure - ACCOUNTING STANDARDS AND BASIS OF PRESENTATION (Policies) link:presentationLink link:calculationLink link:definitionLink 30503 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Tables) link:presentationLink link:calculationLink link:definitionLink 30603 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Tables) link:presentationLink link:calculationLink link:definitionLink 30703 - Disclosure - TAXATION (Tables) link:presentationLink link:calculationLink link:definitionLink 30803 - Disclosure - EARNING PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 31003 - Disclosure - CASH FLOW INFORMATION (Tables) link:presentationLink link:calculationLink link:definitionLink 31103 - Disclosure - JOINT VENTURES AND ASSOCIATES (Tables) link:presentationLink link:calculationLink link:definitionLink 31203 - Disclosure - SEGMENT INFORMATION (Tables) link:presentationLink link:calculationLink link:definitionLink 31303 - Disclosure - FINANCIAL INSTRUMENTS - RISK MANAGEMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 31403 - Disclosure - LEASES (Tables) link:presentationLink link:calculationLink link:definitionLink 31503 - Disclosure - SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 31603 - Disclosure - KEY MANAGEMENT PERSONNEL COMPENSATION (Tables) link:presentationLink link:calculationLink link:definitionLink 40101 - Disclosure - GENERAL INFORMATION - (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - SEASONALITY (Details) link:presentationLink link:calculationLink link:definitionLink 40516 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Investment properties (Details) link:presentationLink link:calculationLink link:definitionLink 40602 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Cost of Sales (Details) link:presentationLink link:calculationLink link:definitionLink 40702 - Disclosure - TAXATION - Movement on the deferred income tax (Details) link:presentationLink link:calculationLink link:definitionLink 40801 - Disclosure - EARNING PER SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 41102 - Disclosure - JOINT VENTURES AND ASSOCIATES - Changes in joint ventures investments (Details) link:presentationLink link:calculationLink link:definitionLink 99900 - Disclosure - Standard And Custom Axis Domain Defaults link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 4 biox-20230930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 5 biox-20230930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 6 biox-20230930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document and Entity Information [Abstract] Document Type Entity Registrant Name Entity Central Index Key Document Period End Date Current Fiscal Year End Date Document Fiscal Year Focus Document Fiscal Period Focus Amendment Flag UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION ASSETS. ASSETS CURRENT ASSETS Current Cash and cash equivalents Cash and cash equivalents Cash and cash equivalents Other current financial assets Other financial assets Other financial assets Trade and other current receivables Trade receivables Trade receivables Other current receivables Other receivables Other receivables Current tax assets Income and minimum presumed recoverable income taxes Current inventories Inventories Biological assets End of period Beginning of the period Biological assets Total current assets Total current assets NON-CURRENT ASSETS.. NON-CURRENT ASSETS Non-current Other non-current financial assets Other financial assets Other financial assets Other non-current receivables Other receivables Other receivables Current tax assets, non-current Income and minimum presumed recoverable income taxes Deferred tax assets Deferred tax assets The amount of investments accounted for using the equity method, asset position. Investments Accounted For Using Equity Method, Assets Investments in joint ventures and associates Assets in joint ventures and associates Investment property Investment properties Property, plant and equipment As of the end of period As of the beginning of period Property, plant and equipment Intangible assets Balance at end of the period Balance at beginning of the period Intangible assets Goodwill Goodwill Right-of-use assets Book value at the end of the period/year Book value at the beginning of the period/year Right of use asset Non-current assets Total non-current assets Assets Total assets LIABILITIES. LIABILITIES CURRENT LIABILITIES. Current CURRENT LIABILITIES Trade and other current payables Trade and other payables Trade and other payable Current borrowings Borrowings Employee Benefits and Social Security, Current Employee benefits and social security Employee benefits and social security Current deferred income including current contract liabilities Deferred revenue and advances from customers Deferred revenue and advances from customers Current tax liabilities Income tax payable The amount of consideration for acquisition of assets recognised as of balance sheet date, classified as current. Consideration for Acquisition of Assets, Current Consideration for acquisition Current lease liabilities Lease liabilities Current Current liabilities Total current liabilities NON-CURRENT LIABILITIES. Non-current NON-CURRENT LIABILITIES Non-current portion of non-current borrowings Borrowings Non-current contract liabilities Deferred revenue and advances from customers Deferred revenue and advances from customers The amount of investments accounted for using the equity method, liability position. Investments accounted for using equity method, liability Joint ventures and associates Liabilities in joint ventures and associates Deferred tax liabilities Deferred tax liabilities Non-current provisions Provisions The amount of consideration for acquisition of assets recognised as of balance sheet date, classified as non-current. Consideration for Acquisition of Assets, Non Current Consideration for acquisition Amount of secured debt, non-current. Secured Debt, Non-Current Secured notes Non-current lease liabilities Lease liabilities Non-current Non-current liabilities Total non-current liabilities Liabilities Total liabilities EQUITY. EQUITY Equity attributable to owners of parent Equity attributable to owners of the parent Non-controlling interests. Non-controlling interest Equity Balance Balance Total equity Equity and liabilities Total equity and liabilities UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Revenue from contracts with customers Revenues from contracts with customers Sale of goods and services Gains (losses) on fair value adjustment, biological assets Initial recognition and changes in the fair value of biological assets at the point of harvest Initial recognition and changes in the fair value of biological assets at the point of harvest Cost of sales Cost of sales Cost of sales Change in the net realizable value of agricultural. Change In The Net Realizable Value Of Agricultural Changes in the net realizable value of agricultural products after harvest Research and development expense Research and development expenses Total Selling, general and administrative expense Selling, general and administrative expenses Share of profit (loss) of associates and joint ventures accounted for using equity method Share of profit or loss of joint ventures and associates Share of profit or loss of joint ventures and associates Share of profit or loss Other operating income (expense) Other income or expenses, net Total Profit (loss) from operating activities Operating profit Finance income (cost) Financial cost Other finance income (cost) Other financial results Other finance results Profit (loss) before tax (Loss) profit before income tax Tax expense (income), continuing operations Income tax Income tax expenses Result for the year (Loss) profit for the period (Loss) profit for the period Other comprehensive income Other comprehensive (loss) income Other comprehensive income (loss) Other comprehensive income that will be reclassified to profit or loss, net of tax Items that may be subsequently reclassified to profit and loss The gains (losses) recognised in other comprehensive income on exchange differences on the translation from joint venture of financial statements of foreign operations, net of tax. Gains Losses On Exchange Differences On Translation From Joint Venture Net Of Tax Foreign exchange differences on translation of foreign operations from joint ventures Gains (losses) on exchange differences on translation, net of tax Foreign exchange differences on translation of foreign operations Comprehensive income Total comprehensive (loss) profit (Loss) profit for the period attributable to: Profit (loss), attributable to owners of parent Equity holders of the parent Profit (loss), attributable to non-controlling interests Non-controlling interests EARNING PER SHARE (Loss) profit per share Basic earnings (loss) per share Basic (loss) profit attributable to ordinary equity holders of the parent Diluted earnings (loss) per share Diluted (loss) profit attributable to ordinary equity holders of the parent Total comprehensive (Loss) profit attributable to: Comprehensive income, attributable to owners of parent Equity holders of the parent Comprehensive income, attributable to non-controlling interests Non-controlling interests UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY Statement of changes in equity [table] Components of equity [axis] Equity [member] Equity / (deficit) attributable to owners of the parent Issued capital Share premium The member stands for the changes in non-controlling interest. Changes in non-controlling interest The member stands for the own shares trading premium. Own shares trading premium This member stands for Stock Options And Share Based Incentives. Stock options and share based incentives Convertible instruments Cost of own shares held Retained deficit Foreign currency translation reserve This member stands for revaluation of PP&E and effect of tax rate change. Revaluation of PP&E and effect of tax rate change Non-controlling Interests Statement of changes in equity [line items] Statement of changes in equity Increase (decrease) through share-based payment transactions, equity Share-based incentives The increase (decrease) in equity resulting from business combination transactions. Increase (Decrease) Through Business Combination Transactions, Equity Business combination The increase (decrease) in equity resulting from capitalization of convertible notes Increase (Decrease) Through Capitalization of Convertible Notes, Equity Capitalization of convertible notes Increase (decrease) through treasury share transactions, equity Purchase of own shares Issue of convertible instruments Issuance of convertible notes Dividends recognised as distributions to owners Distribution of dividends by subsidiary UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS OPERATING ACTIVITIES Adjustments to reconcile loss to net cash flows Adjustments to reconcile profit to net cash flows Adjustments for income tax expense Income tax Adjustments for finance costs Financial results Adjustments for depreciation expense Depreciation of property, plant and equipment Adjustments for amortisation expense Amortization of intangible assets Depreciation, right-of-use assets Depreciation of leased assets Depreciation of the period/year Adjustments for transaction expenses to reconcile profit (loss) to net cash flow from (used in) operating activities. Adjustments for Transaction Expenses Transactional expenses Adjustments for share-based payments Share-based incentive and stock options Adjustments for provisions Provisions for contingencies Impairment loss recognised in profit or loss, trade receivables Allowance for impairment of trade debtors Adjustments for obsolescence to reconcile profit (loss) to net cash flow from (used in) operating activities. Adjustments for Obsolescence Allowance for obsolescence Obsolescence Gains (losses) on fair value adjustment attributable to price changes, biological assets Initial recognition and changes in the fair value of biological assets Gains (losses) on change in fair value less costs to sell of biological assets for current period Changes in the net realizable value of agricultural products after harvest Adjustments for losses (gains) on disposal of non-current assets Gain or loss on sale of equipment and intangible assets No definition available. Working capital adjustments Adjustments for decrease (increase) in trade accounts receivable Trade receivables Adjustments for decrease (increase) in other operating receivables Other receivables Adjustments for decrease (increase) in income and minimum presumed income taxes to reconcile profit (loss) to net cash flow from (used in) operating activities. Adjustments for Decrease (Increase) in Income and Minimum Presumed Income Taxes Income and minimum presumed income taxes payable Adjustments for decrease (increase) in inventories Inventories and biological assets Adjustments for increase (decrease) in trade and other payables Trade and other payables Adjustments for decrease (increase) in employee benefits and social security to reconcile profit (loss) to net cash flow from (used in) operating activities. Adjustments for Decrease (Increase) in Employee Benefits and Social Security Employee benefits and social security Adjustments for decrease (increase) in deferred revenue and advances from customers to reconcile profit (loss) to net cash flow from (used in) operating activities. Adjustments for Decrease (Increase) in Deferred Revenue and Advances from Customers Deferred revenue and advances from customers Adjustments for decrease (increase) in income and minimum presumed income taxes paid/payable to reconcile profit (loss) to net cash flow from (used in) operating activities. Adjustments For Decrease Increase In Income And Minimum Presumed Income Taxes Payable Income taxes paid Finance income received, classified as operating activities Interest collected Adjustments for decrease (increase) in Inflation effects on working capital adjustments to reconcile profit (loss) to net cash flow from (used in) operating activities. Adjustments for Decrease (Increase) in Inflation Effects on Working Capital Adjustments Inflation effects on working capital adjustments Cash flows from (used in) operating activities Net cash flows generated (used) by operating activities INVESTMENT ACTIVITIES Proceeds from sales of property, plant and equipment, classified as investing activities Proceeds from sale of property, plant and equipment Amount of aggregate cash flows from obtaining control of subsidiaries or other businesses, classified as investing activities. Cash Flows From Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities Net cash received from business combination Amount of net loans granted to shareholders and other related parties investing activities. Net Loans Granted To Shareholders And Other Related Parties Net loans granted to shareholders and other related parties The cash inflow (outflow) generated from financial assets that the entity classifies as investing activities. Proceeds from financial assets Purchase of available-for-sale financial assets Investment in financial assets Purchase of property, plant and equipment, classified as investing activities Purchase of property, plant and equipment Payments for development project expenditure Capitalized development expenditures Purchase of intangible assets, classified as investing activities Purchase of intangible assets Cash flows from (used in) investing activities Net cash flows (used) generated by investing activities FINANCING ACTIVITIES Proceeds from borrowings, classified as financing activities Proceeds from borrowings Repayments of borrowings, classified as financing activities Repayment of borrowings and financed payments Interest paid, classified as financing activities Interest payments Other inflows (outflows) of cash, classified as financing activities Other financial proceeds or payments, net Payments to acquire or redeem entity's shares Purchase of own shares Payments of lease liabilities, classified as financing activities Leased assets payments Dividends paid, classified as financing activities Cash dividend distributed by subsidiary Cash flows from (used in) financing activities Net cash flows (used) generated by financing activities Increase (decrease) in cash and cash equivalents before effect of exchange rate changes Net (decrease) increase in cash and cash equivalents The effect of inflation effects on cash and cash equivalents. Inflation Effects on Cash and Cash Equivalents Inflation effects on cash and cash equivalents Cash and cash equivalents if different from statement of financial position Cash and cash equivalents as of the end of the period Cash and cash equivalents as of beginning of the period Effect of exchange rate changes on cash and cash equivalents Effect of exchange rate changes on cash and equivalents No Definition Available GENERAL INFORMATION Disclosure of general information about financial statements [text block] GENERAL INFORMATION No definition available. ACCOUNTING STANDARDS AND BASIS OF PREPARATION The entire disclosure on accounting standards and basis of presentation. Disclosure Of Accounting Standards And Basis Of Presentation [Text Block] ACCOUNTING STANDARDS AND BASIS OF PREPARATION n/a NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS ISSUED BY THE IASB Disclosure of expected impact of initial application of new standards or interpretations [text block] NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS ISSUED BY THE IASB No definition availability. SEASONALITY The entire disclosure of the seasonality of the entity's business. Disclosure of Seasonality [Text Block] SEASONALITY n/a INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION The disclosure of components of Consolidated Statements of Financial Position. Disclosure Of Components Of Consolidated Statements Of Financial Position INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME The entire disclosure of information about components of consolidated statement of comprehensive income. Disclosure of Information About Components of Consolidated Statements of Comprehensive Income [Text Block] INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME TAXATION Disclosure of income tax [text block] TAXATION Disclosure of earnings per share [text block] EARNING PER SHARE EQUITY INFORMATION Disclosure of share capital, reserves and other equity interest [text block] EQUITY INFORMATION It represents the information pertaining to non cash transactions in cash flow. CASH FLOW INFORMATION Disclosure of cash flow statement [text block] CASH FLOW INFORMATION JOINT VENTURES AND ASSOCIATES The entire disclosure on investments in joint ventures and associates. Investments In Joint Ventures And Associates [Text Block] JOINT VENTURES AND ASSOCIATES SEGMENT INFORMATION Disclosure of entity's operating segments [text block] SEGMENT INFORMATION FINANCIAL INSTRUMENTS - RISK MANAGEMENT Disclosure of financial risk management [text block] FINANCIAL INSTRUMENTS - RISK MANAGEMENT LEASES Disclosure of leases [text block] LEASES SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS Disclosure of related party [text block] SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS No definition available. KEY MANAGEMENT PERSONNEL COMPENSATION EX-101.PRE 7 biox-20230930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 8 biox-20230930xex99d1001.jpg GRAPHIC begin 644 biox-20230930xex99d1001.jpg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biox-20230930xex99d1002.jpg GRAPHIC begin 644 biox-20230930xex99d1002.jpg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end XML 10 R1.htm IDEA: XBRL DOCUMENT v3.23.3

Document and Entity Information
3 Months Ended

Sep. 30, 2023

Document and Entity Information [Abstract]

Document Type 6-K

Entity Registrant Name Bioceres Crop Solutions Corp.

Entity Central Index Key 0001769484

Document Period End Date Sep. 30, 2023

Current Fiscal Year End Date --06-30

Document Fiscal Year Focus 2024

Document Fiscal Period Focus Q1

Amendment Flag false

X

- References
No definition available.
+ Details

Name: biox_DocumentAndEntityInformationAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
No definition available.
+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
End date of current fiscal year in the format --MM-DD.
+ References
No definition available.
+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition
Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition
For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
No definition available.
+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

XML 11 R2.htm IDEA: XBRL DOCUMENT v3.23.3

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - USD ($)

Sep. 30, 2023

Jun. 30, 2023

CURRENT ASSETS

Cash and cash equivalents $ 28,373,924 $ 48,129,194

Other financial assets 14,628,202 12,135,020

Trade receivables 186,276,319 158,006,474

Other receivables 24,902,503 28,824,998

Income and minimum presumed recoverable income taxes 2,022,328 9,444,898

Inventories 138,076,822 140,426,975

Biological assets 1,141,113 146,842

Total current assets 395,421,211 397,114,401

NON-CURRENT ASSETS

Other financial assets 502,910 444,909

Other receivables 2,393,939 2,546,241

Income and minimum presumed recoverable income taxes 5,446 16,286

Deferred tax assets 8,230,402 7,312,964

Investments in joint ventures and associates 40,820,784 39,296,810

Investment properties 3,675,493 3,589,749

Property, plant and equipment 69,930,709 67,853,835

Intangible assets 173,034,536 173,783,956

Goodwill 112,163,432 112,163,432

Right of use asset 13,519,199 13,936,575

Total non-current assets 424,276,850 420,944,757

Total assets 819,698,061 818,059,158

CURRENT LIABILITIES

Trade and other payables 159,125,358 150,807,674

Borrowings 100,720,985 107,639,659

Employee benefits and social security 10,019,165 9,606,707

Deferred revenue and advances from customers 32,771,902 24,875,662

Income tax payable 536,840 509,034

Consideration for acquisition 4,202,389 1,415,099

Lease liabilities 4,326,889 3,858,699

Total current liabilities 311,703,528 298,712,534

NON-CURRENT LIABILITIES

Borrowings 48,789,492 60,670,946

Deferred revenue and advances from customers 2,202,374 2,057,805

Joint ventures and associates 638,126 622,823

Deferred tax liabilities 34,393,580 35,785,347

Provisions 668,775 891,769

Consideration for acquisition 2,540,181 3,578,157

Secured notes 76,911,874 75,213,146

Lease liabilities 9,225,862 10,030,524

Total non-current liabilities 175,370,264 188,850,517

Total liabilities 487,073,792 487,563,051

EQUITY

Equity attributable to owners of the parent 298,966,341 298,594,088

Non-controlling interest 33,657,928 31,902,019

Total equity 332,624,269 330,496,107

Total equity and liabilities $ 819,698,061 $ 818,059,158

X

- Definition
The amount of consideration for acquisition of assets recognised as of balance sheet date, classified as current.
+ References
No definition available.
+ Details

Name: biox_ConsiderationForAcquisitionOfAssetsCurrent

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of consideration for acquisition of assets recognised as of balance sheet date, classified as non-current.
+ References
No definition available.
+ Details

Name: biox_ConsiderationForAcquisitionOfAssetsNonCurrent

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of investments accounted for using the equity method, asset position.
+ References
No definition available.
+ Details

Name: biox_InvestmentsAccountedForUsingEquityMethodAssets

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of investments accounted for using the equity method, liability position.
+ References
No definition available.
+ Details

Name: biox_InvestmentsAccountedForUsingEquityMethodLiability

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of secured debt, non-current.
+ References
No definition available.
+ Details

Name: biox_SecuredDebtNonCurrent

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 13
-IssueDate 2023-01-01
-Paragraph 93
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_a&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 28
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_c&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 13
-IssueDate 2023-01-01
-Paragraph 93
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_b&doctype=Standard
-URIDate 2023-03-23

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 13
-IssueDate 2023-01-01
-Paragraph 93
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_e&doctype=Standard
-URIDate 2023-03-23

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 23
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard
-URIDate 2023-03-23

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_Assets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of living animals or plants recognised as assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 41
-IssueDate 2023-01-01
-Paragraph 43
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_43&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 41
-IssueDate 2023-01-01
-Paragraph 50
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_50&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph f
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_f&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_BiologicalAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 45
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B13
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_i&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CashAndCashEquivalents

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B10
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B12
-Subparagraph b
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 66
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_66&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CurrentAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: ifrs-full_CurrentAssetsAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of current deferred income including current contract liabilities. [Refer: Deferred income including contract liabilities]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of current lease liabilities. [Refer: Lease liabilities]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 16
-IssueDate 2023-01-01
-Paragraph 47
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_47_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CurrentLeaseLiabilities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B10
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B12
-Subparagraph b
-Clause iii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 69
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_69&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CurrentLiabilities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: ifrs-full_CurrentLiabilitiesAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of current provisions for employee benefits. [Refer: Provisions for employee benefits]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_d&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CurrentProvisionsForEmployeeBenefits

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The excess of amount paid for current tax in respect of current and prior periods over the amount due for those periods. Current tax is the amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph n
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_n&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CurrentTaxAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The non-current amount of current tax assets. [Refer: Current tax assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph n
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_n&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CurrentTaxAssetsNoncurrent

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of current tax for current and prior periods to the extent unpaid. Current tax is the amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph n
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_n&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CurrentTaxLiabilities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 12
-IssueDate 2023-01-01
-Paragraph 81
-Subparagraph g
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_g_i&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph o
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_o&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 56
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_56&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DeferredTaxAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 12
-IssueDate 2023-01-01
-Paragraph 81
-Subparagraph g
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_g_i&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph o
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_o&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 56
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_56&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DeferredTaxLiabilities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of residual interest in the assets of the entity after deducting all its liabilities.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 1
-IssueDate 2023-01-01
-Paragraph 24
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_24_a&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 1
-IssueDate 2023-01-01
-Paragraph 32
-Subparagraph a
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_32_a_i&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 13
-IssueDate 2023-01-01
-Paragraph 93
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_a&doctype=Standard
-URIDate 2023-03-23

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 13
-IssueDate 2023-01-01
-Paragraph 93
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_b&doctype=Standard
-URIDate 2023-03-23

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 13
-IssueDate 2023-01-01
-Paragraph 93
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_e&doctype=Standard
-URIDate 2023-03-23

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard
-URIDate 2023-03-23

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_e&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_Equity

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: ifrs-full_EquityAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_EquityAndLiabilities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of equity attributable to the owners of the parent. This specifically excludes non-controlling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph r
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_r&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_EquityAttributableToOwnersOfParent

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Business combinations [member]]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 36
-IssueDate 2023-01-01
-Paragraph 134
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_134_a&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 36
-IssueDate 2023-01-01
-Paragraph 135
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_135_a&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 3
-IssueDate 2023-01-01
-Paragraph B67
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_Goodwill

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 38
-IssueDate 2023-01-01
-Paragraph 118
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_IntangibleAssetsOtherThanGoodwill

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of current inventories. [Refer: Inventories]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 2
-IssueDate 2023-01-01
-Paragraph 36
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2023-en-r&anchor=para_36_b&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph g
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_g&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 68
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_68&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_Inventories

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of property (land or a building - or part of a building - or both) held (by the owner or by the lessee as a right-of-use asset) to earn rentals or for capital appreciation or both, rather than for: (a) use in the production or supply of goods or services or for administrative purposes; or (b) sale in the ordinary course of business.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 40
-IssueDate 2023-01-01
-Paragraph 76
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_76&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 40
-IssueDate 2023-01-01
-Paragraph 79
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_79_d&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_InvestmentProperty

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 13
-IssueDate 2023-01-01
-Paragraph 93
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_a&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 13
-IssueDate 2023-01-01
-Paragraph 93
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_b&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 13
-IssueDate 2023-01-01
-Paragraph 93
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_e&doctype=Standard
-URIDate 2023-03-23

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 28
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_d&doctype=Standard
-URIDate 2023-03-23

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 23
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard
-URIDate 2023-03-23

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_Liabilities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The non-current portion of non-current borrowings. [Refer: Borrowings]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_LongtermBorrowings

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Subsidiaries [member]]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph 12
-Subparagraph f
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_12_f&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 10
-IssueDate 2023-01-01
-Paragraph 22
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=10&code=ifrs-tx-2023-en-r&anchor=para_22&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph q
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_q&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_NoncontrollingInterests

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of assets that do not meet the definition of current assets. [Refer: Current assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B12
-Subparagraph b
-Clause ii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B10
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 66
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_66&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_NoncurrentAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: ifrs-full_NoncurrentAssetsAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of non-current contract liabilities. [Refer: Contract liabilities]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 15
-IssueDate 2023-01-01
-Paragraph 105
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_105&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_NoncurrentContractLiabilities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of non-current lease liabilities. [Refer: Lease liabilities]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 16
-IssueDate 2023-01-01
-Paragraph 47
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_47_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_NoncurrentLeaseLiabilities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B12
-Subparagraph b
-Clause iv
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B10
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 69
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_69&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_NoncurrentLiabilities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: ifrs-full_NoncurrentLiabilitiesAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of current financial assets that the entity does not separately disclose in the same statement or note. [Refer: Other financial assets; Current financial assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_d&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_OtherCurrentFinancialAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of current other receivables. [Refer: Other receivables]
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_OtherCurrentReceivables

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of non-current provisions other than provisions for employee benefits. [Refer: Non-current provisions]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_d&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_OtherLongtermProvisions

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of non-current financial assets that the entity does not separately disclose in the same statement or note. [Refer: Other financial assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_d&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_OtherNoncurrentFinancialAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of non-current other receivables. [Refer: Other receivables]
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_OtherNoncurrentReceivables

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 16
-IssueDate 2023-01-01
-Paragraph 73
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_PropertyPlantAndEquipment

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 16
-IssueDate 2023-01-01
-Paragraph 53
-Subparagraph j
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_j&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 16
-IssueDate 2023-01-01
-Paragraph 47
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_47_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_RightofuseAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of current borrowings. [Refer: Borrowings]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ShorttermBorrowings

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph k
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_k&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_TradeAndOtherCurrentPayables

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph h
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_h&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_TradeAndOtherCurrentReceivables

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 12 R3.htm IDEA: XBRL DOCUMENT v3.23.3

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
3 Months Ended

Sep. 30, 2023

Sep. 30, 2022

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

Revenues from contracts with customers $ 116,182,805 $ 126,843,248

Initial recognition and changes in the fair value of biological assets at the point of harvest 410,913 490,006

Cost of sales (71,615,781) (75,675,878)

Changes in the net realizable value of agricultural products after harvest (1,446,316) (227,936)

Research and development expenses (4,581,241) (3,852,014)

Selling, general and administrative expenses (33,932,848) (31,904,911)

Share of profit or loss of joint ventures and associates 1,508,671 842,240

Other income or expenses, net (1,231,635) 478,041

Operating profit 5,294,568 16,992,796

Financial cost (7,661,857) (6,779,847)

Other financial results 117,865 (1,288,306)

(Loss) profit before income tax (2,249,424) 8,924,643

Income tax (429,040) (5,012,643)

(Loss) profit for the period (2,678,464) 3,912,000

Other comprehensive (loss) income (929,957) 31,025

Items that may be subsequently reclassified to profit and loss (929,957) 31,025

Foreign exchange differences on translation of foreign operations from joint ventures 100,868

Foreign exchange differences on translation of foreign operations (929,957) (69,843)

Total comprehensive (loss) profit (3,608,421) 3,943,025

(Loss) profit for the period attributable to:

Equity holders of the parent (4,591,634) 498,297

Non-controlling interests 1,913,170 3,413,703

(Loss) profit for the period $ (2,678,464) $ 3,912,000

(Loss) profit per share

Basic (loss) profit attributable to ordinary equity holders of the parent $ (0.0731) $ 0.0082

Diluted (loss) profit attributable to ordinary equity holders of the parent $ (0.0731) $ 0.0081

Total comprehensive (Loss) profit attributable to:

Equity holders of the parent $ (5,364,330) $ 401,715

Non-controlling interests 1,755,909 3,541,310

Total comprehensive (loss) profit $ (3,608,421) $ 3,943,025

X

- Definition
Change in the net realizable value of agricultural.
+ References
No definition available.
+ Details

Name: biox_ChangeInNetRealizableValueOfAgricultural

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The gains (losses) recognised in other comprehensive income on exchange differences on the translation from joint venture of financial statements of foreign operations, net of tax.
+ References
No definition available.
+ Details

Name: biox_GainsLossesOnExchangeDifferencesOnTranslationFromJointVentureNetOfTax

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator).
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 33
-IssueDate 2023-01-01
-Paragraph 66
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_66&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 33
-IssueDate 2023-01-01
-Paragraph 67
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_67&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_BasicEarningsLossPerShare

Namespace Prefix: ifrs-full_

Data Type: dtr-types:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 1
-IssueDate 2023-01-01
-Paragraph 32
-Subparagraph a
-Clause ii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_32_a_ii&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 1
-IssueDate 2023-01-01
-Paragraph 24
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_24_b&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B10
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 81A
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_c&doctype=Standard
-URIDate 2023-03-23

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B12
-Subparagraph b
-Clause ix
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 106
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ComprehensiveIncome

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_ComprehensiveIncomeAttributableToAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of comprehensive income attributable to non-controlling interests. [Refer: Comprehensive income; Non-controlling interests]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 81B
-Subparagraph b
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81B_b_i&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 106
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of comprehensive income attributable to owners of the parent. [Refer: Comprehensive income]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 81B
-Subparagraph b
-Clause ii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81B_b_ii&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 106
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 99
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_99&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 103
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CostOfSales

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 33
-IssueDate 2023-01-01
-Paragraph 66
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_66&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 33
-IssueDate 2023-01-01
-Paragraph 67
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_67&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DilutedEarningsLossPerShare

Namespace Prefix: ifrs-full_

Data Type: dtr-types:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_EarningsPerShareAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of income or cost associated with interest and other financing activities of the entity.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 85
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_85&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_FinanceIncomeCost

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The gains (losses) recognised in other comprehensive income on exchange differences on the translation of financial statements of foreign operations, net of tax, before reclassification adjustments. [Refer: Other comprehensive income]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 91
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_91_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The gains (losses) arising from changes in fair value less costs to sell of biological assets due to both physical and price changes in the market. [Refer: Biological assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 41
-IssueDate 2023-01-01
-Paragraph 50
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_50_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_IncomeStatementAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 23
-Subparagraph h
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_h&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 26
-IssueDate 2023-01-01
-Paragraph 35
-Subparagraph b
-Clause viii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2023-en-r&anchor=para_35_b_viii&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 12
-IssueDate 2023-01-01
-Paragraph 79
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_79&doctype=Standard
-URIDate 2023-03-23

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 12
-IssueDate 2023-01-01
-Paragraph 81
-Subparagraph c
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_i&doctype=Standard
-URIDate 2023-03-23

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 12
-IssueDate 2023-01-01
-Paragraph 81
-Subparagraph c
-Clause ii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_ii&doctype=Standard
-URIDate 2023-03-23

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B13
-Subparagraph g
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 82
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_d&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_IncomeTaxExpenseContinuingOperations

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B12
-Subparagraph b
-Clause viii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_viii&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 81A
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_b&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 91
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_91_a&doctype=Standard
-URIDate 2023-03-23

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 106
-Subparagraph d
-Clause ii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_ii&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_OtherComprehensiveIncome

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of other comprehensive income that will be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph IG6
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_IG6&doctype=Implementation%20Guidance
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 82A
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82A&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of finance income or cost that the entity does not separately disclose in the same statement or note. [Refer: Finance income (cost)]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 85
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_85&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_OtherFinanceIncomeCost

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of operating income (expense) that the entity does not separately disclose in the same statement or note.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 85
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_85&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_OtherOperatingIncomeExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 18
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_18_b&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 1
-IssueDate 2023-01-01
-Paragraph 32
-Subparagraph a
-Clause ii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_32_a_ii&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 1
-IssueDate 2023-01-01
-Paragraph 24
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_24_b&doctype=Standard
-URIDate 2023-03-23

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 28
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_b&doctype=Standard
-URIDate 2023-03-23

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 23
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard
-URIDate 2023-03-23

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B10
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 17
-IssueDate 2023-01-01
-Paragraph 113
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_113_b&doctype=Standard
-URIDate 2023-03-23

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 81A
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_a&doctype=Standard
-URIDate 2023-03-23

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 106
-Subparagraph d
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_i&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ProfitLoss

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_ProfitLossAttributableToAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph 12
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_12_e&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 81B
-Subparagraph a
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81B_a_i&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ProfitLossAttributableToNoncontrollingInterests

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 81B
-Subparagraph a
-Clause ii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81B_a_ii&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ProfitLossAttributableToOwnersOfParent

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The profit (loss) before tax expense or income. [Refer: Profit (loss)]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 5
-IssueDate 2023-01-01
-Paragraph 33
-Subparagraph b
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2023-en-r&anchor=para_33_b_i&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 28
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_b&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 23
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard
-URIDate 2023-03-23

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 103
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard
-URIDate 2023-03-23

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 102
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_102&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ProfitLossBeforeTax

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 32
-IssueDate 2023-01-01
-Paragraph IE33
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2023-en-r&anchor=para_IE33&doctype=Illustrative%20Examples
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 85
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_85&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ProfitLossFromOperatingActivities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of expenditure directly attributable to research or development activities, recognised in profit or loss.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 38
-IssueDate 2023-01-01
-Paragraph 126
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_126&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ResearchAndDevelopmentExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity’s ordinary activities in exchange for consideration.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 15
-IssueDate 2023-01-01
-Paragraph 114
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_114&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 15
-IssueDate 2023-01-01
-Paragraph 113
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_113_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_RevenueFromContractsWithCustomers

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of expense relating to selling, general and administrative activities of the entity.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 85
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_85&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_SellingGeneralAndAdministrativeExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The entity's share of the profit (loss) of associates and joint ventures accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Joint ventures [member]; Profit (loss)]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 28
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_e&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 23
-Subparagraph g
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_g&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 82
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.3

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)

Equity / (deficit) attributable to owners of the parent

Issued capital

Share premium

Changes in non-controlling interest

Own shares trading premium

Stock options and share based incentives

Convertible instruments

Cost of own shares held

Retained deficit

Foreign currency translation reserve

Revaluation of PP&E and effect of tax rate change

Non-controlling Interests

Total

Balance at Jun. 30, 2022 $ 127,358,573 $ 4,637 $ 158,819,506 $ (255,893) $ (916,202) $ 3,767,925 $ 175,745 $ (3,530,926) $ (32,682,893) $ 969,402 $ 1,007,272 $ 30,940,275 $ 158,298,848

Share-based incentives 746,258 6 554,999 135,361 55,892 746,258

Business combination 154,979,344 1,640 153,357,564 1,620,140 154,979,344

Capitalization of convertible notes 12,211,638 153 12,211,485 12,211,638

Purchase of own shares (24,291,047) (24,291,047) (24,291,047)

Issuance of convertible notes 9,109,516 9,109,516 9,109,516

Distribution of dividends by subsidiary (187,977) (187,977)

(Loss) profit for the period 498,297 498,297 3,413,703 3,912,000

Other comprehensive income (loss) (96,582) (96,582) 127,607 31,025

Balance at Sep. 30, 2022 280,515,997 6,436 324,943,554 (255,893) (780,841) 5,443,957 9,285,261 (27,821,973) (32,184,596) 872,820 1,007,272 34,293,608 314,809,605

Balance at Jun. 30, 2023 298,594,088 6,493 327,028,559 (255,893) (780,841) 6,645,442 9,285,261 (30,553,591) (13,903,017) 1,282,377 (160,702) 31,902,019 330,496,107

Share-based incentives 6,193,668 6,193,668 6,193,668

Purchase of own shares (457,085) (457,085) (457,085)

(Loss) profit for the period (4,591,634) (4,591,634) 1,913,170 (2,678,464)

Other comprehensive income (loss) (772,696) (772,696) (157,261) (929,957)

Balance at Sep. 30, 2023 $ 298,966,341 $ 6,493 $ 327,028,559 $ (255,893) $ (780,841) $ 12,839,110 $ 9,285,261 $ (31,010,676) $ (18,494,651) $ 509,681 $ (160,702) $ 33,657,928 $ 332,624,269

X

- Definition
The increase (decrease) in equity resulting from business combination transactions.
+ References
No definition available.
+ Details

Name: biox_IncreaseDecreaseThroughBusinessCombinationTransactionsEquity

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) in equity resulting from capitalization of convertible notes
+ References
No definition available.
+ Details

Name: biox_IncreaseDecreaseThroughCapitalizationOfConvertibleNotesEquity

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of dividends recognised as distributions to owners.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 107
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_107&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DividendsPaid

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of residual interest in the assets of the entity after deducting all its liabilities.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 1
-IssueDate 2023-01-01
-Paragraph 24
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_24_a&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 1
-IssueDate 2023-01-01
-Paragraph 32
-Subparagraph a
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_32_a_i&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 13
-IssueDate 2023-01-01
-Paragraph 93
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_a&doctype=Standard
-URIDate 2023-03-23

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 13
-IssueDate 2023-01-01
-Paragraph 93
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_b&doctype=Standard
-URIDate 2023-03-23

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 13
-IssueDate 2023-01-01
-Paragraph 93
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_e&doctype=Standard
-URIDate 2023-03-23

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard
-URIDate 2023-03-23

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_e&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_Equity

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 106
-Subparagraph d
-Clause iii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_iii&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) in equity resulting from treasury share transactions. [Refer: Equity; Treasury shares]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 106
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The change in equity resulting from the issuing of convertible instruments.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 106
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_IssueOfConvertibleInstruments

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B12
-Subparagraph b
-Clause viii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_viii&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 81A
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_b&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 91
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_91_a&doctype=Standard
-URIDate 2023-03-23

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 106
-Subparagraph d
-Clause ii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_ii&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_OtherComprehensiveIncome

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 18
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_18_b&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 1
-IssueDate 2023-01-01
-Paragraph 32
-Subparagraph a
-Clause ii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_32_a_ii&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 1
-IssueDate 2023-01-01
-Paragraph 24
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_24_b&doctype=Standard
-URIDate 2023-03-23

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 28
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_b&doctype=Standard
-URIDate 2023-03-23

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 23
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard
-URIDate 2023-03-23

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B10
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 17
-IssueDate 2023-01-01
-Paragraph 113
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_113_b&doctype=Standard
-URIDate 2023-03-23

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 81A
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_a&doctype=Standard
-URIDate 2023-03-23

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 106
-Subparagraph d
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_i&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ProfitLoss

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 14 R5.htm IDEA: XBRL DOCUMENT v3.23.3

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
3 Months Ended 12 Months Ended

Sep. 30, 2023

Sep. 30, 2022

Jun. 30, 2023

OPERATING ACTIVITIES

(Loss) profit for the period $ (2,678,464) $ 3,912,000

Adjustments to reconcile profit to net cash flows

Income tax 429,040 5,012,643

Financial results 7,543,992 8,068,153

Depreciation of property, plant and equipment 1,243,403 1,382,093

Amortization of intangible assets 2,747,206 2,476,832

Depreciation of leased assets 837,199 676,427

Transactional expenses 2,794,339

Share-based incentive and stock options 6,193,668 227,351

Share of profit or loss of joint ventures and associates (1,508,671) (842,240)

Provisions for contingencies 27,109 2,448

Allowance for impairment of trade debtors 352,920 156,053

Allowance for obsolescence 505,285 618,489

Initial recognition and changes in the fair value of biological assets (410,913) (490,006)

Changes in the net realizable value of agricultural products after harvest 1,446,316 227,936

Gain or loss on sale of equipment and intangible assets (26,669) (115,942)

Working capital adjustments

Trade receivables (31,012,196) (29,709,414)

Other receivables 3,722,853 (5,665,708)

Income and minimum presumed income taxes payable 7,113,764 (376,576)

Inventories and biological assets (197,454) (7,391,556)

Trade and other payables 7,499,929 (18,108,556)

Employee benefits and social security 412,458 3,226,505

Deferred revenue and advances from customers 8,040,809 373,181

Income taxes paid (163,205) (1,051,644)

Interest collected 2,293,676 2,125,194

Inflation effects on working capital adjustments 321,539 69,662

Net cash flows generated (used) by operating activities 14,733,594 (32,402,336)

INVESTMENT ACTIVITIES

Proceeds from sale of property, plant and equipment 35,682 115,942

Net cash received from business combination 5,933,265

Net loans granted to shareholders and other related parties 1,609

Proceeds from financial assets (509,534) 2,729,598

Investment in financial assets (2,215,965) (889,342)

Purchase of property, plant and equipment (3,985,249) (1,414,730)

Capitalized development expenditures (1,947,504) (3,241,008)

Purchase of intangible assets (64,486) (209,863)

Net cash flows (used) generated by investing activities (8,687,056) 3,025,471

FINANCING ACTIVITIES

Proceeds from borrowings 26,837,346 93,327,748

Repayment of borrowings and financed payments (46,865,499) (47,061,271)

Interest payments (4,539,455) (3,016,078)

Other financial proceeds or payments, net (781,199) (1,717,070)

Purchase of own shares (457,085) (376,018)

Leased assets payments (1,170,039) (744,365)

Cash dividend distributed by subsidiary (187,977)

Net cash flows (used) generated by financing activities (26,975,931) 40,224,969

Net (decrease) increase in cash and cash equivalents (20,929,393) 10,848,104

Inflation effects on cash and cash equivalents (24,266) (12,404)

Cash and cash equivalents as of beginning of the period 48,129,194 33,475,266 $ 33,475,266

Effect of exchange rate changes on cash and equivalents 1,198,389 3,076,600

Cash and cash equivalents as of the end of the period $ 28,373,924 $ 47,387,566 $ 48,129,194

X

- Definition
Adjustments for decrease (increase) in deferred revenue and advances from customers to reconcile profit (loss) to net cash flow from (used in) operating activities.
+ References
No definition available.
+ Details

Name: biox_AdjustmentsForDecreaseIncreaseInDeferredRevenueAndAdvancesFromCustomers

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Adjustments for decrease (increase) in employee benefits and social security to reconcile profit (loss) to net cash flow from (used in) operating activities.
+ References
No definition available.
+ Details

Name: biox_AdjustmentsForDecreaseIncreaseInEmployeeBenefitsAndSocialSecurity

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Adjustments for decrease (increase) in income and minimum presumed income taxes to reconcile profit (loss) to net cash flow from (used in) operating activities.
+ References
No definition available.
+ Details

Name: biox_AdjustmentsForDecreaseIncreaseInIncomeAndMinimumPresumedIncomeTaxes

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Adjustments for decrease (increase) in income and minimum presumed income taxes paid/payable to reconcile profit (loss) to net cash flow from (used in) operating activities.
+ References
No definition available.
+ Details

Name: biox_AdjustmentsForDecreaseIncreaseInIncomeAndMinimumPresumedIncomeTaxesPayable

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Adjustments for decrease (increase) in Inflation effects on working capital adjustments to reconcile profit (loss) to net cash flow from (used in) operating activities.
+ References
No definition available.
+ Details

Name: biox_AdjustmentsForDecreaseIncreaseInInflationEffectsOnWorkingCapitalAdjustments

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Adjustments for obsolescence to reconcile profit (loss) to net cash flow from (used in) operating activities.
+ References
No definition available.
+ Details

Name: biox_AdjustmentsForObsolescence

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Adjustments for transaction expenses to reconcile profit (loss) to net cash flow from (used in) operating activities.
+ References
No definition available.
+ Details

Name: biox_AdjustmentsForTransactionExpenses

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of aggregate cash flows from obtaining control of subsidiaries or other businesses, classified as investing activities.
+ References
No definition available.
+ Details

Name: biox_CashFlowsFromObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The effect of inflation effects on cash and cash equivalents.
+ References
No definition available.
+ Details

Name: biox_InflationEffectsOnCashAndCashEquivalents

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of net loans granted to shareholders and other related parties investing activities.
+ References
No definition available.
+ Details

Name: biox_NetLoansGrantedToShareholdersAndOtherRelatedParties

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash inflow (outflow) generated from financial assets that the entity classifies as investing activities.
+ References
No definition available.
+ Details

Name: biox_ProceedsFromFinancialAssets

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: biox_WorkingCapitalAdjustmentsOperatingActivitiesAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Adjustments for amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss); Depreciation and amortisation expense]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 20
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AdjustmentsForAmortisationExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Adjustments for decrease (increase) in inventories to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Inventories; Profit (loss)]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 20
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AdjustmentsForDecreaseIncreaseInInventories

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Adjustments for decrease (increase) in other operating receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 20
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Adjustments for decrease (increase) in trade accounts receivable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 20
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Adjustments for depreciation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 20
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AdjustmentsForDepreciationExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Adjustments for finance costs to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Finance costs; Profit (loss)]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 20
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AdjustmentsForFinanceCosts

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Impairment loss (reversal of impairment loss) recognised in profit or loss]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 20
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Adjustments for income tax expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 35
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AdjustmentsForIncomeTaxExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Adjustments for increase (decrease) in trade and other payables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other payables; Profit (loss)]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 20
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Adjustments for losses (gains) on disposal of non-current assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Non-current assets; Profit (loss)]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 14
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_14&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Adjustments for provisions to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Provisions; Profit (loss)]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 20
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AdjustmentsForProvisions

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_AdjustmentsForReconcileProfitLossAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 20
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AdjustmentsForSharebasedPayments

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of cash and cash equivalents in the statement of cash flows when different from the amount of cash and cash equivalents in the statement of financial position. [Refer: Cash and cash equivalents]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 45
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 10
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_10&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 50
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_50_d&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CashFlowsFromUsedInFinancingActivities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 10
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_10&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 50
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_50_d&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CashFlowsFromUsedInInvestingActivities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 10
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_10&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 50
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_50_d&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CashFlowsFromUsedInOperatingActivities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 16
-IssueDate 2023-01-01
-Paragraph 53
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DepreciationRightofuseAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition
The cash outflow for dividends paid by the entity, classified as financing activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 31
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_31&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DividendsPaidClassifiedAsFinancingActivities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 25
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_25&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 28
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_28&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow from finance income received, classified as operating activities. [Refer: Finance income]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 31
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_31&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_FinanceIncomeReceivedClassifiedAsOperatingActivities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The gains (losses) arising during the current period on the change in fair value less costs to sell of biological assets. [Refer: Biological assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 41
-IssueDate 2023-01-01
-Paragraph 40
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_40&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_GainsLossesOnChangeInFairValueEstimatesOfBiologicalAssetsForCurrentPeriod

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The gains (losses) arising from changes in fair value less costs to sell of biological assets due to price changes in the market. [Refer: Biological assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 41
-IssueDate 2023-01-01
-Paragraph 51
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_51&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 41
-IssueDate 2023-01-01
-Section Example 1 XYZ Dairy Ltd
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&doctype=Illustrative%20Examples&dita_xref=IAS41_IE_ex1_TI
-URIDate 2023-03-23
+ Details

Name: ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition
The increase (decrease) in cash and cash equivalents before the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 45
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash outflow for interest paid, classified as financing activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 31
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_31&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_InterestPaidClassifiedAsFinancingActivities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Inflows (outflows) of cash, classified as financing activities, that the entity does not separately disclose in the same statement or note.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 21
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_21&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash outflow for expenditure related to development projects.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 16
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_16&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_PaymentsForDevelopmentProjectExpenditure

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 17
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_e&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow to acquire or redeem entity's shares.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 17
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_PaymentsToAcquireOrRedeemEntitysShares

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash inflow from borrowings obtained. [Refer: Borrowings]
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 17
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow from sales of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 16
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_16_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 18
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_18_b&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 1
-IssueDate 2023-01-01
-Paragraph 32
-Subparagraph a
-Clause ii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_32_a_ii&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 1
-IssueDate 2023-01-01
-Paragraph 24
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_24_b&doctype=Standard
-URIDate 2023-03-23

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 28
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_b&doctype=Standard
-URIDate 2023-03-23

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 23
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard
-URIDate 2023-03-23

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B10
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 17
-IssueDate 2023-01-01
-Paragraph 113
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_113_b&doctype=Standard
-URIDate 2023-03-23

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 81A
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_a&doctype=Standard
-URIDate 2023-03-23

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 106
-Subparagraph d
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_i&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ProfitLoss

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow for the purchase of available-for-sale financial assets. [Refer: Financial assets available-for-sale]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Note Expired 2023-01-01
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 16
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2017-en-b&anchor=para_16&doctype=Standard&book=b
-URIDate 2023-03-23
+ Details

Name: ifrs-full_PurchaseOfAvailableforsaleFinancialAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow for the purchases of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 16
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_16_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 16
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_16_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow to settle borrowings, classified as financing activities. [Refer: Borrowings]
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 17
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_d&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The entity's share of the profit (loss) of associates and joint ventures accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Joint ventures [member]; Profit (loss)]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 28
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_e&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 23
-Subparagraph g
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_g&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 82
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 15 R6.htm IDEA: XBRL DOCUMENT v3.23.3

GENERAL INFORMATION
3 Months Ended

Sep. 30, 2023

GENERAL INFORMATION

GENERAL INFORMATION
1. GENERAL INFORMATION
Bioceres Crop Solutions Corp. (NASDAQ:BIOX) is a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change. To do this, Bioceres’ products create economic incentives for farmers and other stakeholders to adopt environmentally friendly production practices. Bioceres has a unique biotech platform with high impact, patented technologies for seeds and microbial ag inputs, as well as next generation crop nutrition and protection solutions.
Bioceres is a global company with an extensive geographic footprint. The Group’s agricultural inputs are marketed across more than 40 countries, mainly in Argentina, Brazil, United States, Europe and South Africa.
Unless the context otherwise requires, “we”, “us”, “our”, “Bioceres”, “BIOX”, “the Group”, and “Bioceres Crop Solutions” will refer to Bioceres Crop Solutions Corp. and its subsidiaries.

X

- Definition
No Definition Available
+ References
No definition available.
+ Details

Name: biox_GeneralInformationAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for general information about financial statements.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 51
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_51&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.3

ACCOUNTING STANDARDS AND BASIS OF PREPARATION
3 Months Ended

Sep. 30, 2023

ACCOUNTING STANDARDS AND BASIS OF PREPARATION

ACCOUNTING STANDARDS AND BASIS OF PREPARATION
2. ACCOUNTING STANDARDS AND BASIS OF PREPARATION
Statement of compliance with IFRS as issued by IASB
These unaudited interim condensed consolidated financial statements for the three-month period ended September 30, 2023, have been prepared in accordance with Accounting Standard IAS 34 Interim Financial Reporting.
These unaudited interim condensed consolidated financial statements do not include all notes of the type normally included in an annual financial statement. Accordingly, these unaudited interim condensed consolidated financial statements are to be read in conjunction with the consolidated financial statements for the fiscal year ended June 30, 2023.
Authorization for the issue of the consolidated financial statements
These unaudited interim condensed consolidated financial statements of the Group as of September 30, 2023, June 30, 2023 and for the three-month periods ended September 30, 2023 and 2022 were authorized by the Board of Directors of Bioceres Crop Solutions Corp. on November 29, 2023.
Basis of measurement
The consolidated financial statements of the Group have been prepared using:
● Going concern basis of accounting, considering the conclusion of the assessment made by the Group’s Management about the ability of the Group and its subsidiaries to continue as a going concern, in accordance with the requirements of paragraph 25 of IAS 1, “Presentation of Financial Statements”.
● Accrual basis of accounting (except for cash flows information). Under this basis of accounting, the effects of transactions and other events are recognized as they occur, even when there are no cash flows.
Functional currency and presentation currency
a)
Functional currency
Items included in the financial statements of each of the Group’s entities are measured using the currency of the primary economic market in which the entity operates (i.e., “the functional currency”).
b)
Presentation currency
The consolidated financial statements of the Group are presented in US dollars.
c)
Foreign currency
Transactions entered into by Group entities in a currency other than their functional currency are recorded at the relevant exchange rates as of the date upon which such transactions occur. Foreign currency monetary assets and liabilities are translated at the prevailing exchanges rates as of the final day of each reporting period. Exchange differences arising from the retranslation of unsettled monetary assets and liabilities are recognized immediately in profit or loss, except for foreign currency borrowings qualifying as a hedge of a net investment in a foreign operation for which exchange differences are recognized in other comprehensive income and accumulated in the foreign exchange reserve along with the exchange differences arising from the retranslation of the foreign operation. Upon the disposal of a foreign operation, the cumulative exchange differences recognized in the foreign exchange reserve relating to such operation up to the date of disposal are transferred to the consolidated statement of profit or loss and other comprehensive income as part of the gain or loss recognized upon such disposal.
Changes in accounting policies
The accounting policies adopted in the preparation of these unaudited interim condensed consolidated financial statements are consistent with those adopted for the preparation of the consolidated financial statements as of June 30, 2023.

X

- References
No definition available.
+ Details

Name: biox_AccountingStandardsAndBasisOfPreparationAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure on accounting standards and basis of presentation.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfAccountingStandardsAndBasisOfPresentationTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

XML 17 R8.htm IDEA: XBRL DOCUMENT v3.23.3

NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS ISSUED BY THE IASB
3 Months Ended

Sep. 30, 2023

NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS ISSUED BY THE IASB

NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS ISSUED BY THE IASB
3. NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS ISSUED BY THE IASB
a)The following new standards, amendments and interpretations became applicable for the current reporting period and adopted by the Group.
- Amendment to IAS 12 –Deferred tax related to assets and liabilities arising from a single transaction.
- International Tax Reform—Pillar Two Model Rules (Amendments to IAS 12)
- Amendments to IAS 1 and IFRS Practice Statement 2- Disclosure of Accounting Policies
- Amendments to IAS 8-Definition of Accounting Estimates
- IFRS 17, “Insurance Contracts”
These new standards and amendments did not have any material impact on the Group.
b)The following new standards are not yet adopted by the Group.
- Amendments to IFRS 16- Lease Liability in a Sale and Leaseback. The amendments are effective for annual reporting periods beginning on or after 1 January 2024.
- Amendments to IAS1 – Non- current liabilities with covenants. The amendments are effective for annual reporting periods beginning on or after 1 January 2024.
- Amendments to IAS 7- Statement of Cash Flows & to IFRS 7- Financial Instruments: Disclosures. The amendments are effective for annual reporting periods beginning on or after 1 January 2024.
- Amendments to IAS 21- The Effects of Changes in Foreign Exchange Ratestitled Lack of Exchangeability. The amendments are effective for annual reporting periods beginning on or after 1 January 2025.
- Amendment to IAS 7 and IFRS 7 - Supplier Financing. The amendments are effective for annual periods beginning on or after January 1, 2024.
These amendments are not expected to have material impact on the Group.

X

- Definition
n/a
+ References
No definition available.
+ Details

Name: biox_NewStandardsAmendmentsAndInterpretationsIssuedByIasbAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of the known or reasonably estimable information relevant to assessing the possible impact that the application of a new IFRS, that has been issued but is not yet effective, will have.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 8
-IssueDate 2023-01-01
-Paragraph 30
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2023-en-r&anchor=para_30_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

XML 18 R9.htm IDEA: XBRL DOCUMENT v3.23.3

SEASONALITY
3 Months Ended

Sep. 30, 2023

SEASONALITY

SEASONALITY
4. SEASONALITY
Our revenues fluctuate depending on the timing of orders from our distributors and customers and on prevailing market prices, which influence the purchase decisions of growers, the end users of our seed and integrated products, crop protection products and crop nutrition products. Given the cyclicality of crop planting and harvesting, as well as growing seasons, which vary from year to year, our business is highly seasonal. This results in substantial fluctuations in quarterly sales and profitability. Our portfolio is highly oriented to crop planting. Generally, our sales are concentrated in the third and fourth quarters of each calendar year, when demand for our seed and integrated products, crop protection products and crop nutrition products increases as growers begin planting their summer crops in South America, while winter crop season occurs in the Northern hemisphere. With our seed and integrated products business, we contract with growers and seed suppliers based upon our anticipated market demand. Generally, in our seed and integrated products business we stock the seed during the harvest season and ship from inventory throughout the year, with the objective of selling most of the inventory from the current year’s harvest before the next year’s, with our crop protection and our crop nutrition business following a similar cycle to the seed cycle. Milestone, royalty, and license revenues are also likely to fluctuate from period to period given the seasonality of agriculture and time required to progress from one milestone to the next.

Our seed and integrated products, crop protection and crop nutrition businesses are also affected by unpredictable weather conditions such as heavy rains, hail, floods, freezing conditions, windstorms, drought or fire, as well as other hazardous situations beyond our control, which may cause our sales and operating results to fluctuate significantly. In addition, disruptions that cause delays by growers in harvesting or planting can result in the movement of orders to a future quarter, which also causes fluctuations in our quarterly operating results. Finally, some of our customers and distributors order in bulk only one or two times a year, which may further cause our seed product revenues to fluctuate from period to period.

X

- Definition
No definition availability.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfSeasonalityAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure of the seasonality of the entity's business.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfSeasonalityTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

XML 19 R10.htm IDEA: XBRL DOCUMENT v3.23.3

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
3 Months Ended

Sep. 30, 2023

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
5. INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
5.1. Cash and cash equivalents


09/30/2023

06/30/2023
Cash at bank and on hand

25,954,730

48,129,194
Mutual funds

2,419,194

—

28,373,924

48,129,194

5.2. Other financial assets


09/30/2023

06/30/2023
Current


Restricted short-term deposits

—

212,703
US Treasury bills

9,719,486

9,163,298
Mutual funds

3,236,702

1,596,539
Other investments

1,672,014

1,162,480

14,628,202

12,135,020

09/30/2023

06/30/2023
Non-current




Shares of Bioceres S.A.

444,575

444,635
Other investments

58,335

274

502,910

444,909

5.3. Trade receivables


09/30/2023

06/30/2023
Current

Trade debtors

189,222,562

160,269,233
Allowance for impairment of trade debtors

(7,615,433)

(7,425,604)
Shareholders and other related parties (Note 15)

1,368,373

—
Allowance for credit notes to be issued

(2,610,596)

(3,694,019)
Trade debtors - Joint ventures and associates (Note 15)

781,451

865,627
Deferred checks

5,129,962

7,991,237

186,276,319

158,006,474

The book value is reasonably approximate to the fair value given its short-term nature.

5.4. Other receivables


09/30/2023

06/30/2023
Current




Taxes

6,009,626

6,113,764
Receivables for PP&E sales

89,715

156,423
Shareholders and other related parties (Note 15)

2,919,431

3,792,429
Other receivables - Joint ventures and associates (Note 15)

6,469,863

6,104,219
Prepayments to suppliers

5,010,022

10,956,831
Reimbursements over exports

10,558

10,558
Prepaid expenses and other receivables

3,657,633

1,302,221
Miscellaneous

735,655

388,553

24,902,503

28,824,998


09/30/2023

06/30/2023
Non-current

Taxes

865,588

873,699
Reimbursements over exports

1,268,928

1,290,227
Loans receivables

230,000

230,000
Miscellaneous

29,423

152,315

2,393,939

2,546,241

5.5. Inventories


09/30/2023

06/30/2023
Seeds

9,293,210

1,542,159
Resale products

71,973,203

58,544,931
Manufactured products

19,604,930

25,881,761
Goods in transit

2,298,136

3,620,606
Supplies

18,709,303

24,893,187
Agricultural products

19,111,345

28,436,830
Allowance for obsolescence

(2,913,305)

(2,492,499)

138,076,822

140,426,975

Net of agricultural products

118,965,477

111,990,145

5.6. Biological assets
Changes in Biological assets:


Soybean

Corn

Wheat

Barley

Sunflower

Total
Beginning of the period

—

—

87,785

59,057

—

146,842
Initial recognition and changes in the fair value of biological assets at the point of harvest

—

—

276,511

134,402

—

410,913
Costs incurred during the period

374,456

177,601

—

—

31,301

583,358
Period ended September 30, 2023

374,456

177,601

364,296

193,459

31,301

1,141,113


Wheat

Barley

Total
Beginning of the period

44,413

12,900

57,313
Initial recognition and changes in the fair value of biological assets at the point of harvest

365,833

124,173

490,006
Costs incurred during the period

378,631

122,837

501,468
Exchange differences

(16,699)

(5,344)

(22,043)
Period ended September 30, 2022

772,178

254,566

1,026,744

5.7. Property, plant and equipment
Property, plant and equipment as of September 30, 2023 and June 30, 2023 included the following:


09/30/2023

06/30/2023
Gross carrying amount

96,833,359

93,634,779
Accumulated depreciation

(26,902,650)

(25,780,944)
Net carrying amount

69,930,709

67,853,835

Net carrying amount for each class of assets is as follows:

Net carrying

Net carrying

amount

amount
Class

09/30/2023

06/30/2023
Office equipment

280,905

263,892
Vehicles

1,862,542

2,032,853
Equipment and computer software

167,741

174,399
Fixtures and fittings

2,676,861

2,862,949
Machinery and equipment

13,970,593

14,463,756
Land and buildings

35,640,076

36,144,792
Buildings in progress

15,331,991

11,911,194
Total

69,930,709

67,853,835

1. Gross carrying amount as of September 30, 2023 is as follows:

Gross carrying amount

As of the

beginning

Foreign

As of the

of the

currency

end of the
Class

period

Additions

Disposals

translation

period
Office equipment

968,088

34,918

—

(2,764)

1,000,242
Vehicles

5,492,319

28,680

(45,062)

(1,498)

5,474,439
Equipment and computer software

974,509

30,188

—

(5,857)

998,840
Fixtures and fittings

7,663,899

—

—

(2,126)

7,661,773
Machinery and equipment

23,513,047

176,837

—

(91,465)

23,598,419
Land and buildings

43,111,723

—

—

(344,068)

42,767,655
Buildings in progress

11,911,194

3,678,037

—

(257,240)

15,331,991
Total

93,634,779

3,948,660

(45,062)

(705,018)

96,833,359

2. Accumulated depreciation as of September 30, 2023 is as follows:

Depreciation

Accumulated

as of the

Foreign

Accumulated

beginning of

currency

as of the end
Class

the period

Disposals

Of the period

translation

of the period
Office equipment

704,196

—

17,004

(1,863)

719,337
Vehicles

3,459,466

(36,049)

188,532

(52)

3,611,897
Equipment and computer software

800,110

—

35,963

(4,974)

831,099
Fixtures and fittings

4,800,950

—

184,877

(915)

4,984,912
Machinery and equipment

9,049,291

—

595,729

(17,194)

9,627,826
Land and buildings

6,966,931

—

221,298

(60,650)

7,127,579
Total

25,780,944

(36,049)

1,243,403

(85,648)

26,902,650

3. Gross carrying amount as of September 30, 2022 is as follows:

Gross carrying amount

As of the

Additions

Foreign

As of the

beginning

from business

currency

end of the
Class

of the period

Additions

combination

Disposals

translation

period
Office equipment

908,004

—

—

—

(15,172)

892,832
Vehicles

5,261,979

226,051

—

(59,744)

(6,243)

5,422,043
Equipment and computer software

925,349

41,658

12,469

—

(6,667)

972,809
Fixtures and fittings

7,606,389

33,869

5,379

—

(5,539)

7,640,098
Machinery and equipment

13,017,830

107,717

7,047,496

—

(24,469)

20,148,574
Land and buildings

40,659,129

—

4,750,136

—

(313,148)

45,096,117
Buildings in progress

3,142,774

1,005,435

1,285,092

—

(17,941)

5,415,360
Total

71,521,454

1,414,730

13,100,572

(59,744)

(389,179)

85,587,833

4. Accumulated depreciation as of September 30, 2022 is as follows:

Depreciation

Accumulated

as of the

Foreign

Accumulated

beginning of

Of the

currency

as of the end
Class

the period

Disposals

period

translation

of the period
Office equipment

638,466

—

17,053

(16,931)

638,588
Vehicles

2,596,905

(59,744)

226,899

(3,364)

2,760,696
Equipment and computer software

693,673

—

28,914

(476)

722,111
Fixtures and fittings

4,059,470

—

206,830

(23,814)

4,242,486
Machinery and equipment

7,205,870

—

679,201

(180,089)

7,704,982
Land and buildings

6,418,745

—

223,196

(695)

6,641,246
Total

21,613,129

(59,744)

1,382,093

(225,369)

22,710,109

The depreciation charge is included in Notes 6.3 and 6.4. The Group has no commitments to purchase property, plant and equipment items.
5.8. Intangible assets
Intangible assets as of September 30, 2023 and June 30, 2023 included the following:


09/30/2023

06/30/2023
Gross carrying amount

204,300,750

202,306,618
Accumulated amortization

(31,266,214)

(28,522,662)
Net carrying amount

173,034,536

173,783,956

Net carrying amount of each class of intangible assets is as follows:

Net carrying

Net carrying

amount

amount
Class

09/30/2023

06/30/2023
Seed and integrated products

HB4 soy and breeding program

31,476,363

31,679,681
Integrated seed products

2,786,562

2,841,008
Crop nutrition

Microbiological products

50,506,239

49,508,801
Other intangible assets

Trademarks and patents

58,730,415

59,760,753
Software

1,609,367

1,987,690
Customer loyalty

22,925,590

23,006,023
RG/RS/OX Wheat

5,000,000

5,000,000
Total

173,034,536

173,783,956

1. Gross carrying amount as of September 30, 2023 is as follows:

Gross carrying amount

As of the

Foreign

As of the

beginning of

currency

end of the
Class

the period

Additions

translation

period
Seed and integrated products

HB4 soy and breeding program

34,958,425

224,230

—

35,182,655
Integrated seed products

3,219,808

—

(8,178)

3,211,630
Crop nutrition

Microbiological products

55,645,028

1,723,274

(6,119)

57,362,183
Other intangible assets

Trademarks and patents

67,653,234

62,543

—

67,715,777
Software

5,582,411

1,943

(3,561)

5,580,793
Customer loyalty

30,247,712

—

—

30,247,712
RG/RS/OX Wheat

5,000,000

—

—

5,000,000
Total

202,306,618

2,011,990

(17,858)

204,300,750

2. Accumulated amortization as of September 30, 2023 is as follows:

Amortization

Accumulated

Foreign

Accumulated as

as of beginning

currency

of the end of the
Class

of the period

Of the period

translation

period
Seed and integrated products








HB4 soy and breeding program

3,278,744

427,548

—

3,706,292
Integrated seed products

378,800

47,229

(961)

425,068
Crop nutrition

Microbiological products

6,136,227

719,717

—

6,855,944
Other intangible assets

Trademarks and patents

7,892,481

1,092,881

—

8,985,362
Software

3,594,721

379,398

(2,693)

3,971,426
Customer loyalty

7,241,689

80,433

—

7,322,122
Total

28,522,662

2,747,206

(3,654)

31,266,214

3. Gross carrying amount as of September 30, 2022 is as follows:

Gross carrying amount

As of the

Additions from

beginning

business

Foreign currency

As of the end of
Class

of the period

Additions

combination

translation

the period
Seed and integrated products






HB4 soy and breeding program

31,371,088

361,006

—

—

31,732,094
Integrated seed products

3,181,155

—

—

—

3,181,155
Crop nutrition

Microbiological products

8,855,421

2,880,002

39,613,280

(3,945)

51,344,758
Other intangible assets

Trademarks and patents

12,183,045

3,679

55,420,441

—

67,607,165
Software

5,176,373

206,184

—

(1,652)

5,380,905
Customer loyalty

28,462,475

—

1,785,237

—

30,247,712
RG/RS/OX Wheat

5,000,000

—

—

—

5,000,000
Total

94,229,557

3,450,871

96,818,958

(5,597)

194,493,789

4. Accumulated amortization as of September 30, 2022 is as follows:

Amortization

Accumulated as



Foreign

Accumulated

of beginning of

currency

as of the end
Class

the period

Of the period

translation

of the period
Seed and integrated products

HB4 soy and breeding program

1,568,554

396,701

—

1,965,255
Integrated seed products

43,997

13,019

—

57,016
Crop nutrition

Microbiological products

3,063,073

1,057,149

—

4,120,222
Other intangible assets

Trademarks and patents

3,916,004

542,868

—

4,458,872
Software

3,008,388

141,044

(1,221)

3,148,211
Customer loyalty

5,924,672

326,051

—

6,250,723
Total

17,524,688

2,476,832

(1,221)

20,000,299

The amortization charge is included in Notes 6.3 and 6.4.
5.9. Goodwill


09/30/2023

06/30/2023

Rizobacter Argentina S.A.

28,080,271

28,080,271
Bioceres Crops S.A.

7,523,322

7,523,322
Pro farm Group, Inc.

76,089,749

76,089,749
Insumos Agroquímicos S.A.

470,090

470,090

112,163,432

112,163,432

There were no indicators of goodwill impairment.

5.10. Investment properties


09/30/2023

06/30/2023

Investment properties

3,675,493

3,589,749

3,675,493

3,589,749

5.11. Trade and other payables


09/30/2023

06/30/2023

Trade creditors

106,222,415

104,211,238
Shareholders and other related parties (Note 15)

27,708

35,292
Trade creditors - Parent company (Note 15)

270,645

644,191
Trade creditors - Joint ventures and associates (Note 15)

47,282,380

41,402,594
Taxes

5,138,674

3,561,058
Miscellaneous

183,536

953,301

159,125,358

150,807,674

5.12. Borrowings


09/30/2023

06/30/2023
Current

Bank borrowings

60,473,023

61,303,952
Corporate bonds

29,745,450

35,547,510
Trust debt securities

6,936,758

7,296,506
Net loans payables- Parents companies and related parties to Parent (Note 15)

3,565,754

3,491,691

100,720,985

107,639,659
Non-current

Bank borrowings

7,586,944

10,663,266
Corporate bonds

41,202,548

50,007,680

48,789,492

60,670,946

The carrying value of some borrowings as of September 30, 2023 are measured at amortized cost differ from their fair value. The following fair values measured are based on discounted cash flows (Level 3) due to the use of unobservable inputs, including own credit risk.

09/30/2023

06/30/2023


Amortized cost

Fair value

Amortized cost

Fair value
Current

Bank borrowings

60,473,023

57,553,255

61,303,952

57,209,155
Corporate Bonds

29,745,450

29,389,136

35,547,510

34,725,828

Non-current

Bank borrowings

7,586,944

5,620,759

10,663,266

10,374,646
Corporate Bonds

41,202,548

39,984,876

50,007,680

47,014,542

5.13. Secured Notes
Secured Guaranteed Notes
The carrying value of $25.9 million of the Secured Guaranteed Notes as of September 30, 2023 are measured at amortized cost. Its fair value based on discounted cash flows, using a fair interest rate, would amount to $26.1 million.
Secured Convertible Guaranteed Notes
The carrying value of $51.0 million of the Secured Convertible Guaranteed Notes as of September 30, 2023 are measured at amortized cost. Its fair value based on discounted cash flows, using a fair interest rate, would amount to $53.3 million.
Under the terms of the Secured Convertible Guaranteed Notes, the Group is in compliance with covenants.
5.14. Employee benefits and social security


09/30/2023

06/30/2023
Salaries, accrued incentives, vacations and social security

9,685,549

9,388,639
Key management personnel (Note 15)

333,616

218,068

10,019,165

9,606,707

5.15. Deferred revenue and advances from customers


09/30/2023

06/30/2023
Current




Advances from customers

17,019,407

9,216,032
Deferred revenue

15,752,495

15,659,630

32,771,902

24,875,662
Non-current

Advances from customers

272,334

620,893
Deferred revenue

1,930,040

1,436,912

2,202,374

2,057,805

X

- Definition
n/a
+ References
No definition available.
+ Details

Name: biox_ComponentsOfConsolidatedStatementsOfFinancialPositionAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of components of Consolidated Statements of Financial Position.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfComponentsOfConsolidatedStatementsOfFinancialPosition

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

XML 20 R11.htm IDEA: XBRL DOCUMENT v3.23.3

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
3 Months Ended

Sep. 30, 2023

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
6. INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
6.1. Revenue from contracts with customers


09/30/2023

09/30/2022
Sale of goods and services

115,628,792

126,113,636
Royalties

554,013

729,612

116,182,805

126,843,248

Transactions of sales of goods and services with joint ventures and with shareholders and other related parties are reported in Note 15.
6.2. Cost of sales

Item

09/30/2023

09/30/2022
Inventories as of the beginning of the period

111,990,145

78,759,610
Business combination

—

11,064,908
Purchases of the period

71,694,655

79,325,509
Production costs

7,123,255

8,440,830
Foreign currency translation

(226,797)

(236,263)
Subtotal

190,581,258

177,354,594
Inventories as of the end of the period (*)

(118,965,477)

(101,678,716)
Cost of sales

71,615,781

75,675,878
(*)Net of agricultural products.

6.3. R&D classified by nature


Research and

Research and

development

development

expenses

expenses
Item

09/30/2023

09/30/2022
Amortization of intangible assets

1,164,940

1,511,118
Analysis and storage

—

11,568
Import and export expenses

—

850
Depreciation of property, plant and equipment

157,808

142,373
Freight and haulage

3,917

5,300
Employee benefits and social securities

1,307,126

861,312
Maintenance

206,778

217,066
Energy and fuel

3,628

79,121
Supplies and materials

847,382

559,044
Mobility and travel

13,771

108,694
Share-based incentives

188,250

6,975
Professional fees and outsourced services

491,787

293,776
Office supplies

170,375

21,454
Information technology expenses

4,375

11,996
Insurance

21,049

10,537
Depreciation of leased assets

—

10,650
Miscellaneous

55

180
Total

4,581,241

3,852,014


09/30/2023

09/30/2022
R&D capitalized (Note 5.8)

1,947,504

3,241,008
R&D profit and loss

4,581,241

3,852,014
Total

6,528,745

7,093,022

6.4. Expenses classified by nature and function




Selling,


general and

Production

administrative

Total
Item

costs

expenses

09/30/2023
Amortization of intangible assets

30,478

1,551,788

1,582,266
Analysis and storage

570

153,473

154,043
Commissions and royalties

134,592

794,058

928,650
Import and export expenses

67,228

120,345

187,573
Depreciation of property, plant and equipment

643,006

442,589

1,085,595
Depreciation of leased assets

339,378

497,821

837,199
Impairment of receivables

—

352,920

352,920
Freight and haulage

643,877

2,989,094

3,632,971
Employee benefits and social securities

2,806,939

10,238,931

13,045,870
Maintenance

422,757

568,155

990,912
Energy and fuel

163,122

16,397

179,519
Supplies and materials

260,043

831,454

1,091,497
Mobility and travel

33,407

1,348,563

1,381,970
Publicity and advertising

—

1,161,498

1,161,498
Contingencies

—

27,109

27,109
Share-based incentives

275,432

5,729,986

6,005,418
Professional fees and outsourced services

509,450

1,575,982

2,085,432
Office supplies and registrations fees

149,888

370,770

520,658
Insurance

27,024

473,850

500,874
Information technology expenses

18,361

743,163

761,524
Obsolescence

505,285

—

505,285
Taxes

70,819

3,766,419

3,837,238
Miscellaneous

21,599

178,483

200,082
Total

7,123,255

33,932,848

41,056,103




Selling,


general and

Production

administrative

Total
Item

costs

expenses

09/30/2022
Amortization of intangible assets

43,456

922,258

965,714
Analysis and storage

5,425

113,265

118,690
Commissions and royalties

118,960

623,459

742,419
Import and export expenses

98,186

256,070

354,256
Depreciation of property, plant and equipment

746,609

493,111

1,239,720
Depreciation of leased assets

395,972

269,805

665,777
Impairment of receivables

—

156,053

156,053
Freight and haulage

241,533

3,474,028

3,715,561
Employee benefits and social securities

3,994,761

10,041,033

14,035,794
Maintenance

462,743

980,742

1,443,485
Energy and fuel

500,359

58,400

558,759
Supplies and materials

339,843

491,811

831,654
Mobility and travel

20,940

994,919

1,015,859
Publicity and advertising

—

1,888,497

1,888,497
Contingencies

—

2,448

2,448
Share-based incentives

100,206

120,170

220,376
Professional fees and outsourced services

674,014

4,610,610

5,284,624
Office supplies and registrations fees

32,546

289,467

322,013
Insurance

28,430

760,276

788,706
Information technology expenses

13,243

993,378

1,006,621
Obsolescence

539,382

79,107

618,489
Taxes

45,049

4,130,539

4,175,588
Miscellaneous

39,173

155,465

194,638
Total

8,440,830

31,904,911

40,345,741

6.5. Other income or expenses, net


09/30/2023

09/30/2022
Net result from commercialization of agricultural products

(1,316,393)

6,327
Expenses recovery

87,053

126,061
Other income or expenses, net

(2,295)

345,653

(1,231,635)

478,041

6.6. Finance results


09/30/2023

09/30/2022
Financial costs

Interest expenses with the Parents (Note 15)

(97,063)

(149,734)
Interest expenses

(6,935,241)

(5,569,576)
Financial commissions

(629,553)

(1,060,537)

(7,661,857)

(6,779,847)

Other financial results


Exchange differences generated by assets

(9,685,066)

(833,428)
Exchange differences generated by liabilities

10,335,537

6,322
Changes in fair value of financial assets or liabilities and other financial results

(151,646)

(569,032)
Net gain of inflation effect on monetary items

(380,960)

107,832

117,865

(1,288,306)

X

- Definition
The entire disclosure of information about components of consolidated statement of comprehensive income.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_StatementOfComprehensiveIncomeAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 21 R12.htm IDEA: XBRL DOCUMENT v3.23.3

TAXATION
3 Months Ended

Sep. 30, 2023

TAXATION

TAXATION
7. TAXATION
Taxes on income in the interim periods are accrued using the tax rate that would be applicable to expected total annual earnings.


09/30/2023

09/30/2022
Current tax expense

(6,457,134)

(6,020,201)
Deferred tax

6,028,094

1,007,558
Total

(429,040)

(5,012,643)


09/30/2023

09/30/2022
Beginning of the period deferred tax

(28,472,383)

(24,994,569)
Additions for business combination

—

(16,704,770)
Charge for the period

6,028,094

1,007,558
Conversion difference

(3,718,889)

(261,014)
Total net deferred tax

(26,163,178)

(40,952,795)

The tax on the Group’s profit before tax differs from the theoretical amount that would arise using the weighted average tax rate applicable to profits of the consolidated entities as follows:


09/30/2023

09/30/2022
Earning before income tax-rate

(2,249,424)

8,924,643
Income tax expense by applying tax rate in force in the respective countries

(1,721,853)

(5,739,069)
Share of profit or loss of subsidiaries, joint ventures and associates

530,177

313,280
Stock options charge

(1,226,796)

(57,818)
Non-deductible expenses

(383,074)

(805,883)
Unrecognized deferred tax

—

(895,896)
Tax inflation adjustment

4,826,023

1,822,594
Result of inflation effect on monetary items and other finance results

(2,352,623)

213,857
Others

(100,894)

136,292
Income tax expenses

(429,040)

(5,012,643)

X

- Definition
The entire disclosure for income taxes.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 12
-IssueDate 2023-01-01
-Section Disclosure
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS12_g79-88_TI
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfIncomeTaxExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 22 R13.htm IDEA: XBRL DOCUMENT v3.23.3

EARNING PER SHARE
3 Months Ended

Sep. 30, 2023

EARNING PER SHARE

EARNING PER SHARE
8. EARNING PER SHARE
The numerators and denominators used in the calculation of basic EPS and diluted EPS are presented below:


09/30/2023

09/30/2022
Numerator

(Loss) profit for the period (basic EPS)

(4,591,634)

498,297
(Loss) profit for the period (diluted EPS)

(4,591,634)

498,297
Denominator

Weighted average number of shares (basic EPS)

62,846,690

60,537,110
Weighted average number of shares (diluted EPS)

62,846,690

61,736,679

Basic (loss) profit attributable to ordinary equity holders of the parent

(0.0731)

0.0082
Diluted (loss) profit attributable to ordinary equity holders of the parent

(0.0731)

0.0081

For the three-month period ended September 30, 2023 diluted EPS was equal to basic EPS as the effect of potential ordinary shares would be antidilutive.
For the three-month period ended September 30, 2022, diluted earnings per share was calculated by adjusting the weighted average number of shares outstanding to assume conversion of all dilutive potential shares. The Group had two categories of dilutive potential shares, share-based incentives and the convertible notes.
The stock options were included in the diluted EPS calculation for the period ended September 30, 2022 only for the tranches in which the average market price of ordinary shares during the periods was higher than the assumed proceeds per option.
Convertible notes outstanding were not included in the diluted EPS calculations for the period ended September 30, 2022 because the interest (net of tax and other changes in income or expense) per ordinary share obtainable on conversion exceeds basic earnings per share.

X

- Definition
The entire disclosure for earnings per share.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 33
-IssueDate 2023-01-01
-Section Disclosure
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS33_g70-73A_TI
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfEarningsPerShareExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_EarningsPerShareAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 23 R14.htm IDEA: XBRL DOCUMENT v3.23.3

EQUITY INFORMATION
3 Months Ended

Sep. 30, 2023

EQUITY INFORMATION

EQUITY INFORMATION
9. EQUITY INFORMATION
Capital issued
As of September 30, 2023, we had (i) 100,000,000 ordinary shares ($0.0001 par value) authorized, (ii) 62,849,997 ordinary shares issued and outstanding, (iii) 1,000,000 preferred shares ($0.0001 par value) authorized, (iv) no preferred shares issued and outstanding, (v) 3,951,917 ordinary shares reserved for our equity compensation plans. Of the total issued shares, we have repurchased 2,231,761 shares of our own.
Holders of the ordinary shares are entitled to one vote for each ordinary share.

X

- References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfClassesOfShareCapitalAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for share capital, reserves and other equity interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 79
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

XML 24 R15.htm IDEA: XBRL DOCUMENT v3.23.3

CASH FLOW INFORMATION
3 Months Ended

Sep. 30, 2023

CASH FLOW INFORMATION

CASH FLOW INFORMATION
10. CASH FLOW INFORMATION
Significant non-cash transactions related to investing and financing activities are as follows:


09/30/2023

09/30/2022
Investment activities

Net assets acquisition by business combination

—

150,510,313
Investment in-kind in other related parties (Note 15)

—

550,183
Capitalization of interest on buildings in progress

36,589

—

36,589

151,060,496

09/30/2023

09/30/2022
Financing activities




Capitalization of convertible notes (Note 5.13)

—

12,211,638
Purchase of own shares

—

(23,915,029)

—

(11,703,391)

X

- Definition
It represents the information pertaining to non cash transactions in cash flow.
+ References
No definition available.
+ Details

Name: biox_StatementOfNonCashTransactionsCashFlowsAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for a statement of cash flows.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Section Presentation of a statement of cash flows
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS07_g10-17_TI
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfCashFlowStatementExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

XML 25 R16.htm IDEA: XBRL DOCUMENT v3.23.3

JOINT VENTURES AND ASSOCIATES
3 Months Ended

Sep. 30, 2023

JOINT VENTURES AND ASSOCIATES

JOINT VENTURES AND ASSOCIATES
11. JOINT VENTURES AND ASSOCIATES


09/30/2023

06/30/2023
Assets




Synertech Industrias S.A.

37,550,684

36,026,710
Alfalfa Technologies S.R.L.

36,502

36,502
Moolec Science S.A.

3,233,598

3,233,598

40,820,784

39,296,810


09/30/2023

06/30/2023
Liabilities




Trigall Genetics S.A.

638,126

622,823

638,126

622,823

Changes in joint ventures investments and affiliates:


09/30/2023

09/30/2022
As of the beginning of the period

38,673,987

37,836,144
Foreign currency translation

—

100,868
Share of profit or loss

1,508,671

842,240
As of the end of the period

40,182,658

38,779,252

Share of profit or loss of joint ventures and affiliates:


09/30/2023

09/30/2022
Trigall Genetics S.A.

(15,303)

(132,117)
Synertech Industrias S.A.

1,523,974

974,357

1,508,671

842,240

X

- Definition
The entire disclosure on investments in joint ventures and associates.
+ References
No definition available.
+ Details

Name: biox_InvestmentsInJointVenturesAndAssociatesTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_InvestmentsAccountedForUsingEquityMethodAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 26 R17.htm IDEA: XBRL DOCUMENT v3.23.3

SEGMENT INFORMATION
3 Months Ended

Sep. 30, 2023

SEGMENT INFORMATION

SEGMENT INFORMATION
12. SEGMENT INFORMATION
The tables present information with respect to the Group´s reporting segments:


Seed and






integrated

Crop

Crop

Period ended September 30, 2023

products

protection

nutrition

Consolidated

Revenues from contracts with customers

Sale of goods and services

21,677,053

55,754,360

38,197,379

115,628,792

Royalties

554,013

—

—

554,013

Others

Initial recognition and changes in the fair value of biological assets at the point of harvest

87,844

172,118

150,951

410,913

Total

22,318,910

55,926,478

38,348,330

116,593,718

Cost of sales

(14,110,381)

(36,183,792)

(21,321,608)

(71,615,781)

Gross profit per segment

8,208,529

19,742,686

17,026,722

44,977,937

% Gross margin

37
%
35
%
44
%
39
%


Seed and






integrated

Crop

Crop

Period ended September 30, 2022

products

protection

nutrition

Consolidated

Revenues from contracts with customers

Sale of goods and services

13,073,640

62,986,173

50,053,823

126,113,636

Royalties

729,612

—

—

729,612

Others

Initial recognition and changes in the fair value of biological assets at the point of harvest

51,451

89,573

348,982

490,006

Total

13,854,703

63,075,746

50,402,805

127,333,254

Cost of sales

(5,539,489)

(45,035,250)

(25,101,139)

(75,675,878)

Gross profit per segment

8,315,214

18,040,496

25,301,666

51,657,376

% Gross margin

60
%
29
%
50
%
41
%

As of the current period, changes in the net realizable value of agricultural products after harvest have been excluded from segment information since those results depend on market fluctuations which are beyond the Group’s operating control. The company has recast the comparative amounts.

X

- Definition
The entire disclosure for operating segments.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Section Disclosure
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS08_g20-24_TI
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfOperatingSegmentsAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 27 R18.htm IDEA: XBRL DOCUMENT v3.23.3

FINANCIAL INSTRUMENTS - RISK MANAGEMENT
3 Months Ended

Sep. 30, 2023

FINANCIAL INSTRUMENTS - RISK MANAGEMENT

FINANCIAL INSTRUMENTS - RISK MANAGEMENT
13. FINANCIAL INSTRUMENTS – RISK MANAGEMENT
Financial instruments by category
The following tables show additional information required under IFRS 7 on the financial assets and liabilities recorded as of September 30, 2023, and June 30, 2023.

Financial assets by category

Mandatorily measured at fair

Amortized cost

value through profit or loss
Financial asset

09/30/2023

06/30/2023

09/30/2023

06/30/2023
Cash and cash equivalents

25,954,730

48,129,194

2,419,194

—
Other financial assets

502,910

657,612

14,628,202

11,922,317
Trade receivables

186,276,319

158,006,474

—

—
Other receivables (*)

11,753,573

12,124,724

—

—
Total

224,487,532

218,918,004

17,047,396

11,922,317
(*)
Advances expenses and tax balances are not included.
Financial liabilities by category

Mandatorily measured at fair

Amortized cost

value through profit or loss
Financial liability

09/30/2023

06/30/2023

09/30/2023

06/30/2023
Trade and other payables

152,753,083

142,582,166

6,372,275

8,225,508
Borrowings

149,510,477

168,310,605

—

—
Secured notes

76,911,874

75,213,146

—

—
Lease liability

13,552,751

13,889,223

—

—
Consideration for acquisition of assets

6,742,570

4,993,256

—

—
Total

399,470,755

404,988,396

6,372,275

8,225,508

Financial instruments measured at fair value

Measurement at fair value at 09/30/2023

Level 1

Level 2

Level 3

Financial assets at fair value

US Treasury bills

9,719,486

—

—
Mutual funds

3,236,702

—

—
Other investments

1,672,014

—

—
Financial liability at fair value






Trade and other payables

—

6,372,275

—

Measurement at fair value at 06/30/2023

Level 1

Level 2

Level 3

Financial assets at fair value

US Treasury bills

9,163,298

—

—
Mutual funds

1,596,539

—

—
Other investments

1,162,480

—

—
Financial liability at fair value

Trade and other payables

—

8,225,508

—

Estimation of fair value
The fair value of marketable securities, mutual funds and US Treasury Bills is calculated using the market approach using quoted prices in active markets for identical assets. The quoted marked price used for financial assets held by the Group is the current bid price. These instruments are included in level 1.
The Group’s financial liabilities, which were not traded in an active market, were determined using valuation techniques that maximize the use of available market information, and thus rely as little as possible on specific estimates of the entity specific estimates. If all significant inputs required to fair value an instrument are observable, the instruments are included in level 2.
If one or more of the significant inputs is not based on observable market data, the instruments are included in level 3.
The Group’s policy is to recognize transfers between different categories of the fair value hierarchy at the time they occur or when there are changes in the circumstances that cause the transfer. There were no transfers between levels of the fair value hierarchy. There were no changes in economic or business circumstances affecting fair value.
Financial instruments not measured at fair value
The financial instruments not measured at fair value include cash and cash equivalents, trade accounts receivable, other accounts receivable, trade payables and other debts, borrowings, financed payments and convertible notes.
The carrying value of financial instruments not measured at fair value does not differ significantly from their fair value, except for borrowings (Note 5.12).
Management estimates that the carrying value of the financial instruments measured at amortized cost approximates their fair value.
Currency risk
Foreign currency risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rate. Currency on foreign exchange risk arises when the Group enters into transactions denominated in a currency other than its functional currency.
The table below sets forth our net exposure to currency risk as of September 30, 2023:

Net foreign currency position

09/30/2023
Amount expressed in US$

(5,353,860)

Considering only this net currency exposure as of September 30, 2023 if an US Dollar revaluation or depreciation in relation to other foreign currencies with the remaining variables remaining constant, would have a positive or a negative impact on comprehensive income as a result of foreign exchange gains or losses. We estimate that a devaluation or an appreciation of the US Dollar other currencies of 10% during the period ended September 30, 2023 would have resulted in a net pre-tax loss or gain of approximately $0.5 million.

X

- Definition
The disclosure of the entity's financial risk management practices and policies.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 10
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_10_e&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfFinancialRiskManagementExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 28 R19.htm IDEA: XBRL DOCUMENT v3.23.3

LEASES
3 Months Ended

Sep. 30, 2023

LEASES

LEASES
14. LEASES

Right-of-use leased asset

09/30/2023

06/30/2023
Book value at the beginning of the period/year

21,163,192

15,828,032
Additions of the period/year

1,072,418

3,154,950
Additions from business combination

—

3,005,000
Disposals

(461,631)

(1,839,921)
Exchange differences

(513,269)

1,015,131
Book value at the end of the period/year

21,260,710

21,163,192

Depreciation

09/30/2023

06/30/2023
Book value at the beginning of the period/year

7,226,617

3,684,006
Depreciation of the period/year

837,199

3,565,894
Disposals

(274,431)

(171,870)
Exchange differences

(47,874)

148,587
Accumulated depreciation at the end of the period/year

7,741,511

7,226,617
Total

13,519,199

13,936,575

Lease liability

09/30/2023

06/30/2023
Book value at the beginning of the period/year

13,889,223

11,751,284
Additions of the period/year

1,072,418

3,154,950
Additions from business combination

—

3,245,000
Interest expenses, exchange differences and inflation effects

(238,851)

(406,494)
Payments of the period/year

(1,170,039)

(3,855,517)
Total

13,552,751

13,889,223

Lease Liabilities

09/30/2023

06/30/2023
Non-current

9,225,862

10,030,524
Current

4,326,889

3,858,699
Total

13,552,751

13,889,223

The recognized right-of-use assets relate to the following types of assets:


09/30/2023

06/30/2023
Machinery and equipment

3,655,741

3,655,741
Vehicles

1,433,616

1,475,581
Equipment and computer software

1,011,490

903,306
Land and buildings

15,159,863

15,128,564

21,260,710

21,163,192

The incremental borrowing rate used was 2.13 %.

X

- Definition
The entire disclosure for leases.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 16
-IssueDate 2023-01-01
-Section Presentation
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS16_g47-50_TI
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 16
-IssueDate 2023-01-01
-Section Disclosure
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS16_g51-60_TI
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfLeasesExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_PresentationOfLeasesForLesseeAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 29 R20.htm IDEA: XBRL DOCUMENT v3.23.3

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS
3 Months Ended

Sep. 30, 2023

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS
15. SHAREHOLDERS AND OTHER RELAED PARTIES BALANCES AND TRANSACTIONS
During the period ended September 30, 2023, and 2022, the transactions between the Group and related parties, and the related balances owed by and to them, are as follows:

Value of transactions for the period ended
Party

Transaction type

09/30/2023

09/30/2022
Joint ventures and associates

Sales and services

6,801,117

17,083,027
Joint ventures and associates

Purchases of goods and services

(20,691,171)

(25,314,814)
Key management personnel

Salaries, social security benefits and other benefits

(6,702,803)

(648,494)
Shareholders and other related parties

Sales of goods and services

1,590,568

261,418
Shareholders and other related parties

Purchases of goods and services

(196,051)

(239,772)
Shareholders and other related parties

In-kind contributions

—

550,183
Shareholders and other related parties

Net loans granted/(cancelled)

—

(1,609)
Shareholders and other related parties

Interest expenses

(23,000)

—
Parent company and related parties to Parent (Note 6.6)

Interest expenses

(97,063)

(149,734)
Total

(19,318,403)

(8,459,795)

Amounts receivable from related parties
Party

Transaction type

09/30/2023

06/30/2023
Shareholders and other related parties

Other receivables

1,368,373

—
Shareholders and other related parties

Other receivables

2,919,431

3,792,429
Joint ventures and associates

Trade debtors

781,451

865,627
Joint ventures and associates

Other receivables

6,699,863

6,334,219
Total

11,769,118

10,992,275

Amounts payable to related parties
Party

Transaction type

09/30/2023

06/30/2022
Parent company and related parties to Parent

Trade creditors

(270,645)

(644,191)
Parent company and related parties to Parent

Net loans payables

(3,565,754)

(3,491,691)
Key management personnel

Salaries, social security benefits and other benefits

(333,616)

(218,068)
Shareholders and other related parties

Trade and other payables

(27,708)

(35,292)
Joint ventures and associates

Trade creditors

(47,282,380)

(41,402,594)
Total

(51,480,103)

(45,791,836)

X

- Definition
The entire disclosure for related parties.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 24
-IssueDate 2023-01-01
-Section Disclosures
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS24_g13-24_TI
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfRelatedPartyExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 30 R21.htm IDEA: XBRL DOCUMENT v3.23.3

KEY MANAGEMENT PERSONNEL COMPENSATION
3 Months Ended

Sep. 30, 2023

KEY MANAGEMENT PERSONNEL COMPENSATION

KEY MANAGEMENT PERSONNEL COMPENSATION
16. KEY MANAGEMENT PERSONNEL COMPENSATION
The compensation of directors and other members of key management personnel, including social contributions and other benefits, were as follows for the period ended September 30, 2023, and 2022.


09/30/2023

09/30/2022

Salaries, social security and other benefits

509,135

421,143
Share-based incentives

6,193,668

227,351
Total

6,702,803

648,494

X

- References
No definition available.
+ Details

Name: biox_KeyManagementPersonnelCompensationAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of information about key management personnel. [Refer: Key management personnel of entity or parent [member]]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 10
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_10_e&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

XML 31 R22.htm IDEA: XBRL DOCUMENT v3.23.3

SHARE-BASED PAYMENT
3 Months Ended

Sep. 30, 2023

SHARE-BASED PAYMENT

SHARE-BASED PAYMENT
17. SHARE-BASED PAYMENT
Pursuant to the 2023 Omnibus Equity Incentive Plan approved on May 12, 2023, in August 2023 the Board has granted the following stock options plan to certain directors, executives and management of the Group.
-
Past Share Option plan: immediately vested options with a strike price between $11.93 and $13.24.
-
Base Share Option plan: to vest and become exercisable in equal installments on June 30, 2023, June 30, 2024, and June 30, 2025, with a strike price of $10.47.
-
Performance Share Option plan: to vest and become exercisable if the Company’s fiscal year 2025 EBITDA reaches at least US$120 million, at 0% of the award, and linearly thereafter up to 100% of the awarded options when reaching at least US$150 million. This option has also a strike price of $10.47.
The fair value of the stock options at the grant date was estimated using the “Black-Scholes” model considering the terms and conditions under which the stock options were granted and adjusted to consider the possible dilutive effect of the future exercise of options. As of September 30, 2023, the expenses associated with share-based incentive plans are included in results within “Share-based incentives” along with the associated increase in net worth.

X

- Definition
The entire disclosure for share-based payment arrangements.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2023-01-01
-Paragraph 44
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_44&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 32 R23.htm IDEA: XBRL DOCUMENT v3.23.3

CONTINGENCIES, COMMITMENTS AND RESTRICTIONS ON THE DISTRIBUTION OF PROFITS
3 Months Ended

Sep. 30, 2023

CONTINGENCIES, COMMITMENTS AND RESTRICTIONS ON THE DISTRIBUTION OF PROFITS

CONTINGENCIES, COMMITMENTS AND RESTRICTIONS ON THE DISTRIBUTION OF PROFITS
18. CONTINGENCIES, COMMITMENTS AND RESTRICTIONS ON THE DISTRIBUTION OF PROFITS
There were no other significant changes to the contingencies, commitments and restrictions on the distribution of profits from the disclosure made in the Consolidated financial statement as of June 30, 2023.

X

- References
No definition available.
+ Details

Name: biox_ContingenciesCommitmentsAndRestrictionsOnDistributionOfProfitsAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of commitments.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 10
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_10_e&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfCommitmentsExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

XML 33 R24.htm IDEA: XBRL DOCUMENT v3.23.3

EVENTS OCCURRING AFTER THE REPORTING PERIOD
3 Months Ended

Sep. 30, 2023

EVENTS OCCURRING AFTER THE REPORTING PERIOD

EVENTS OCCURRING AFTER THE REPORTING PERIOD
19. EVENTS OCCURRING AFTER THE REPORTING PERIOD
Subsequent to September 30, 2023, there have been no other situations or circumstances that may require significant adjustments or further disclosure in these consolidated financial statements that were not mentioned above.

X

- Definition
The entire disclosure for events after the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 10
-IssueDate 2023-01-01
-Section Disclosure
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS10_g17-22_TI
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 34 R25.htm IDEA: XBRL DOCUMENT v3.23.3

ACCOUNTING STANDARDS AND BASIS OF PRESENTATION (Policies)
3 Months Ended

Sep. 30, 2023

ACCOUNTING STANDARDS AND BASIS OF PREPARATION

Basis of measurement
Basis of measurement
The consolidated financial statements of the Group have been prepared using:
● Going concern basis of accounting, considering the conclusion of the assessment made by the Group’s Management about the ability of the Group and its subsidiaries to continue as a going concern, in accordance with the requirements of paragraph 25 of IAS 1, “Presentation of Financial Statements”.
● Accrual basis of accounting (except for cash flows information). Under this basis of accounting, the effects of transactions and other events are recognized as they occur, even when there are no cash flows.

Functional currency
a)
Functional currency
Items included in the financial statements of each of the Group’s entities are measured using the currency of the primary economic market in which the entity operates (i.e., “the functional currency”).

Presentation currency
b)
Presentation currency
The consolidated financial statements of the Group are presented in US dollars.

Foreign currency
c)
Foreign currency
Transactions entered into by Group entities in a currency other than their functional currency are recorded at the relevant exchange rates as of the date upon which such transactions occur. Foreign currency monetary assets and liabilities are translated at the prevailing exchanges rates as of the final day of each reporting period. Exchange differences arising from the retranslation of unsettled monetary assets and liabilities are recognized immediately in profit or loss, except for foreign currency borrowings qualifying as a hedge of a net investment in a foreign operation for which exchange differences are recognized in other comprehensive income and accumulated in the foreign exchange reserve along with the exchange differences arising from the retranslation of the foreign operation. Upon the disposal of a foreign operation, the cumulative exchange differences recognized in the foreign exchange reserve relating to such operation up to the date of disposal are transferred to the consolidated statement of profit or loss and other comprehensive income as part of the gain or loss recognized upon such disposal.

Changes in accounting policies
Changes in accounting policies
The accounting policies adopted in the preparation of these unaudited interim condensed consolidated financial statements are consistent with those adopted for the preparation of the consolidated financial statements as of June 30, 2023.

X

- References
No definition available.
+ Details

Name: biox_AccountingStandardsAndBasisOfPreparationAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The description of the entity's accounting policy for the basis of measurement, preparation, and presentation of the financial statements.
+ References
No definition available.
+ Details

Name: biox_DescriptionOfAccountingPolicyForBasisOfMeasurementTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The description of the entity's changes in accounting policies.
+ References
No definition available.
+ Details

Name: biox_DescriptionOfAccountingPolicyForChangesInAccountingPoliciesTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The description of the entity's accounting policy for the currency used in presenting financial statements to regulatory agencies.
+ References
No definition available.
+ Details

Name: biox_DescriptionOfAccountingPolicyForPresentationCurrencyTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The description of the entity's material accounting policy information for foreign currency translation.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 117
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_117&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The description of the entity's material accounting policy information for the currency of the primary economic environment in which the entity operates.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 117
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_117&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

XML 35 R26.htm IDEA: XBRL DOCUMENT v3.23.3

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Tables)
3 Months Ended

Sep. 30, 2023

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

Schedule of cash and cash equivalents


09/30/2023

06/30/2023
Cash at bank and on hand

25,954,730

48,129,194
Mutual funds

2,419,194

—

28,373,924

48,129,194

Schedule of other financial assets


09/30/2023

06/30/2023
Current


Restricted short-term deposits

—

212,703
US Treasury bills

9,719,486

9,163,298
Mutual funds

3,236,702

1,596,539
Other investments

1,672,014

1,162,480

14,628,202

12,135,020

09/30/2023

06/30/2023
Non-current




Shares of Bioceres S.A.

444,575

444,635
Other investments

58,335

274

502,910

444,909

Schedule of trade receivables


09/30/2023

06/30/2023
Current

Trade debtors

189,222,562

160,269,233
Allowance for impairment of trade debtors

(7,615,433)

(7,425,604)
Shareholders and other related parties (Note 15)

1,368,373

—
Allowance for credit notes to be issued

(2,610,596)

(3,694,019)
Trade debtors - Joint ventures and associates (Note 15)

781,451

865,627
Deferred checks

5,129,962

7,991,237

186,276,319

158,006,474

Schedule of other receivables


09/30/2023

06/30/2023
Current




Taxes

6,009,626

6,113,764
Receivables for PP&E sales

89,715

156,423
Shareholders and other related parties (Note 15)

2,919,431

3,792,429
Other receivables - Joint ventures and associates (Note 15)

6,469,863

6,104,219
Prepayments to suppliers

5,010,022

10,956,831
Reimbursements over exports

10,558

10,558
Prepaid expenses and other receivables

3,657,633

1,302,221
Miscellaneous

735,655

388,553

24,902,503

28,824,998


09/30/2023

06/30/2023
Non-current

Taxes

865,588

873,699
Reimbursements over exports

1,268,928

1,290,227
Loans receivables

230,000

230,000
Miscellaneous

29,423

152,315

2,393,939

2,546,241

Schedule of inventories


09/30/2023

06/30/2023
Seeds

9,293,210

1,542,159
Resale products

71,973,203

58,544,931
Manufactured products

19,604,930

25,881,761
Goods in transit

2,298,136

3,620,606
Supplies

18,709,303

24,893,187
Agricultural products

19,111,345

28,436,830
Allowance for obsolescence

(2,913,305)

(2,492,499)

138,076,822

140,426,975

Net of agricultural products

118,965,477

111,990,145

Schedule of changes in biological assets


Soybean

Corn

Wheat

Barley

Sunflower

Total
Beginning of the period

—

—

87,785

59,057

—

146,842
Initial recognition and changes in the fair value of biological assets at the point of harvest

—

—

276,511

134,402

—

410,913
Costs incurred during the period

374,456

177,601

—

—

31,301

583,358
Period ended September 30, 2023

374,456

177,601

364,296

193,459

31,301

1,141,113


Wheat

Barley

Total
Beginning of the period

44,413

12,900

57,313
Initial recognition and changes in the fair value of biological assets at the point of harvest

365,833

124,173

490,006
Costs incurred during the period

378,631

122,837

501,468
Exchange differences

(16,699)

(5,344)

(22,043)
Period ended September 30, 2022

772,178

254,566

1,026,744

Schedule of property plant and equipment


09/30/2023

06/30/2023
Gross carrying amount

96,833,359

93,634,779
Accumulated depreciation

(26,902,650)

(25,780,944)
Net carrying amount

69,930,709

67,853,835

Schedule of net carrying amount

Net carrying

Net carrying

amount

amount
Class

09/30/2023

06/30/2023
Office equipment

280,905

263,892
Vehicles

1,862,542

2,032,853
Equipment and computer software

167,741

174,399
Fixtures and fittings

2,676,861

2,862,949
Machinery and equipment

13,970,593

14,463,756
Land and buildings

35,640,076

36,144,792
Buildings in progress

15,331,991

11,911,194
Total

69,930,709

67,853,835

Schedule of gross carrying amount
1. Gross carrying amount as of September 30, 2023 is as follows:

Gross carrying amount

As of the

beginning

Foreign

As of the

of the

currency

end of the
Class

period

Additions

Disposals

translation

period
Office equipment

968,088

34,918

—

(2,764)

1,000,242
Vehicles

5,492,319

28,680

(45,062)

(1,498)

5,474,439
Equipment and computer software

974,509

30,188

—

(5,857)

998,840
Fixtures and fittings

7,663,899

—

—

(2,126)

7,661,773
Machinery and equipment

23,513,047

176,837

—

(91,465)

23,598,419
Land and buildings

43,111,723

—

—

(344,068)

42,767,655
Buildings in progress

11,911,194

3,678,037

—

(257,240)

15,331,991
Total

93,634,779

3,948,660

(45,062)

(705,018)

96,833,359
3. Gross carrying amount as of September 30, 2022 is as follows:

Gross carrying amount

As of the

Additions

Foreign

As of the

beginning

from business

currency

end of the
Class

of the period

Additions

combination

Disposals

translation

period
Office equipment

908,004

—

—

—

(15,172)

892,832
Vehicles

5,261,979

226,051

—

(59,744)

(6,243)

5,422,043
Equipment and computer software

925,349

41,658

12,469

—

(6,667)

972,809
Fixtures and fittings

7,606,389

33,869

5,379

—

(5,539)

7,640,098
Machinery and equipment

13,017,830

107,717

7,047,496

—

(24,469)

20,148,574
Land and buildings

40,659,129

—

4,750,136

—

(313,148)

45,096,117
Buildings in progress

3,142,774

1,005,435

1,285,092

—

(17,941)

5,415,360
Total

71,521,454

1,414,730

13,100,572

(59,744)

(389,179)

85,587,833

Schedule of accumulated depreciation
2. Accumulated depreciation as of September 30, 2023 is as follows:

Depreciation

Accumulated

as of the

Foreign

Accumulated

beginning of

currency

as of the end
Class

the period

Disposals

Of the period

translation

of the period
Office equipment

704,196

—

17,004

(1,863)

719,337
Vehicles

3,459,466

(36,049)

188,532

(52)

3,611,897
Equipment and computer software

800,110

—

35,963

(4,974)

831,099
Fixtures and fittings

4,800,950

—

184,877

(915)

4,984,912
Machinery and equipment

9,049,291

—

595,729

(17,194)

9,627,826
Land and buildings

6,966,931

—

221,298

(60,650)

7,127,579
Total

25,780,944

(36,049)

1,243,403

(85,648)

26,902,650
4. Accumulated depreciation as of September 30, 2022 is as follows:

Depreciation

Accumulated

as of the

Foreign

Accumulated

beginning of

Of the

currency

as of the end
Class

the period

Disposals

period

translation

of the period
Office equipment

638,466

—

17,053

(16,931)

638,588
Vehicles

2,596,905

(59,744)

226,899

(3,364)

2,760,696
Equipment and computer software

693,673

—

28,914

(476)

722,111
Fixtures and fittings

4,059,470

—

206,830

(23,814)

4,242,486
Machinery and equipment

7,205,870

—

679,201

(180,089)

7,704,982
Land and buildings

6,418,745

—

223,196

(695)

6,641,246
Total

21,613,129

(59,744)

1,382,093

(225,369)

22,710,109

Schedule of intangible assets


09/30/2023

06/30/2023
Gross carrying amount

204,300,750

202,306,618
Accumulated amortization

(31,266,214)

(28,522,662)
Net carrying amount

173,034,536

173,783,956

Schedule of net carrying amount of intangibles

Net carrying

Net carrying

amount

amount
Class

09/30/2023

06/30/2023
Seed and integrated products

HB4 soy and breeding program

31,476,363

31,679,681
Integrated seed products

2,786,562

2,841,008
Crop nutrition

Microbiological products

50,506,239

49,508,801
Other intangible assets

Trademarks and patents

58,730,415

59,760,753
Software

1,609,367

1,987,690
Customer loyalty

22,925,590

23,006,023
RG/RS/OX Wheat

5,000,000

5,000,000
Total

173,034,536

173,783,956

Schedule of gross carrying amounts of intangibles
1. Gross carrying amount as of September 30, 2023 is as follows:

Gross carrying amount

As of the

Foreign

As of the

beginning of

currency

end of the
Class

the period

Additions

translation

period
Seed and integrated products

HB4 soy and breeding program

34,958,425

224,230

—

35,182,655
Integrated seed products

3,219,808

—

(8,178)

3,211,630
Crop nutrition

Microbiological products

55,645,028

1,723,274

(6,119)

57,362,183
Other intangible assets

Trademarks and patents

67,653,234

62,543

—

67,715,777
Software

5,582,411

1,943

(3,561)

5,580,793
Customer loyalty

30,247,712

—

—

30,247,712
RG/RS/OX Wheat

5,000,000

—

—

5,000,000
Total

202,306,618

2,011,990

(17,858)

204,300,750
3. Gross carrying amount as of September 30, 2022 is as follows:

Gross carrying amount

As of the

Additions from

beginning

business

Foreign currency

As of the end of
Class

of the period

Additions

combination

translation

the period
Seed and integrated products






HB4 soy and breeding program

31,371,088

361,006

—

—

31,732,094
Integrated seed products

3,181,155

—

—

—

3,181,155
Crop nutrition

Microbiological products

8,855,421

2,880,002

39,613,280

(3,945)

51,344,758
Other intangible assets

Trademarks and patents

12,183,045

3,679

55,420,441

—

67,607,165
Software

5,176,373

206,184

—

(1,652)

5,380,905
Customer loyalty

28,462,475

—

1,785,237

—

30,247,712
RG/RS/OX Wheat

5,000,000

—

—

—

5,000,000
Total

94,229,557

3,450,871

96,818,958

(5,597)

194,493,789

Schedule of accumulated amortization of intangibles
2. Accumulated amortization as of September 30, 2023 is as follows:

Amortization

Accumulated

Foreign

Accumulated as

as of beginning

currency

of the end of the
Class

of the period

Of the period

translation

period
Seed and integrated products








HB4 soy and breeding program

3,278,744

427,548

—

3,706,292
Integrated seed products

378,800

47,229

(961)

425,068
Crop nutrition

Microbiological products

6,136,227

719,717

—

6,855,944
Other intangible assets

Trademarks and patents

7,892,481

1,092,881

—

8,985,362
Software

3,594,721

379,398

(2,693)

3,971,426
Customer loyalty

7,241,689

80,433

—

7,322,122
Total

28,522,662

2,747,206

(3,654)

31,266,214
4. Accumulated amortization as of September 30, 2022 is as follows:

Amortization

Accumulated as



Foreign

Accumulated

of beginning of

currency

as of the end
Class

the period

Of the period

translation

of the period
Seed and integrated products

HB4 soy and breeding program

1,568,554

396,701

—

1,965,255
Integrated seed products

43,997

13,019

—

57,016
Crop nutrition

Microbiological products

3,063,073

1,057,149

—

4,120,222
Other intangible assets

Trademarks and patents

3,916,004

542,868

—

4,458,872
Software

3,008,388

141,044

(1,221)

3,148,211
Customer loyalty

5,924,672

326,051

—

6,250,723
Total

17,524,688

2,476,832

(1,221)

20,000,299

Schedule of carrying amount of goodwill


09/30/2023

06/30/2023

Rizobacter Argentina S.A.

28,080,271

28,080,271
Bioceres Crops S.A.

7,523,322

7,523,322
Pro farm Group, Inc.

76,089,749

76,089,749
Insumos Agroquímicos S.A.

470,090

470,090

112,163,432

112,163,432

Summary of investment properties


09/30/2023

06/30/2023

Investment properties

3,675,493

3,589,749

3,675,493

3,589,749

Schedule of trade and other payable


09/30/2023

06/30/2023

Trade creditors

106,222,415

104,211,238
Shareholders and other related parties (Note 15)

27,708

35,292
Trade creditors - Parent company (Note 15)

270,645

644,191
Trade creditors - Joint ventures and associates (Note 15)

47,282,380

41,402,594
Taxes

5,138,674

3,561,058
Miscellaneous

183,536

953,301

159,125,358

150,807,674

Schedule of borrowings


09/30/2023

06/30/2023
Current

Bank borrowings

60,473,023

61,303,952
Corporate bonds

29,745,450

35,547,510
Trust debt securities

6,936,758

7,296,506
Net loans payables- Parents companies and related parties to Parent (Note 15)

3,565,754

3,491,691

100,720,985

107,639,659
Non-current

Bank borrowings

7,586,944

10,663,266
Corporate bonds

41,202,548

50,007,680

48,789,492

60,670,946

Schedule of carrying value of borrowings

09/30/2023

06/30/2023


Amortized cost

Fair value

Amortized cost

Fair value
Current

Bank borrowings

60,473,023

57,553,255

61,303,952

57,209,155
Corporate Bonds

29,745,450

29,389,136

35,547,510

34,725,828

Non-current

Bank borrowings

7,586,944

5,620,759

10,663,266

10,374,646
Corporate Bonds

41,202,548

39,984,876

50,007,680

47,014,542

Schedule of employee benefits and social security


09/30/2023

06/30/2023
Salaries, accrued incentives, vacations and social security

9,685,549

9,388,639
Key management personnel (Note 15)

333,616

218,068

10,019,165

9,606,707

Schedule of deferred revenue and advances from customers


09/30/2023

06/30/2023
Current




Advances from customers

17,019,407

9,216,032
Deferred revenue

15,752,495

15,659,630

32,771,902

24,875,662
Non-current

Advances from customers

272,334

620,893
Deferred revenue

1,930,040

1,436,912

2,202,374

2,057,805

X

- Definition
n/a
+ References
No definition available.
+ Details

Name: biox_ComponentsOfConsolidatedStatementsOfFinancialPositionAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
he disclosure of detailed information about accumulated amortization of intangible assets.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfAccumulatedAmortizationOfIntangibleAssets.TextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The tabular disclosure of salaries and social security payables.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfBenefitsAndSocialSecurityPayablesTableTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of detailed information about carrying value of borrowings.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfCarryingValueOfBorrowingsExplanatory

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of depreciation.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfDepreciationExpenseTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of detailed information about gross carrying amount of intangible assets.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfGrossCarryingAmountOfIntangibleAssetsTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of gross carrying amount of each asset class.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfGrossCarryingAmountTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of detailed information about other intangible assets.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfNetCarryingAmountOfOtherIntangibleAssetsTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of net carrying amount of each asset class.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfNetCarryingAmountTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of other financial assets.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfOtherFinancialAssetsExplanatory

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of detailed information about other receivables.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfOtherReceivablesTableTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Definition: Tabular disclosure of components of trade and other payables.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfTradeAndOtherPayablesComponentsTableTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The tabular disclosure of current and non-current trade receivables.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfTradeReceivablesTableTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.
+ References
No definition available.
+ Details

Name: biox_IfrsScheduleOfInventoryCurrentTableTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of cash and cash equivalents. [Refer: Cash and cash equivalents]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 10
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_10_e&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of detailed information about borrowings. [Refer: Borrowings]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IFRS
-Number 7
-IssueDate 2023-01-01
-Paragraph 7
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_7&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of detailed information about intangible assets. [Refer: Intangible assets other than goodwill]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 38
-IssueDate 2023-01-01
-Paragraph 118
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 16
-IssueDate 2023-01-01
-Paragraph 73
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for investment property.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 40
-IssueDate 2023-01-01
-Section Disclosure
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS40_g74-79_TI
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfInvestmentPropertyExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of performance obligations in contracts with customers. [Refer: Performance obligations [member]]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 15
-IssueDate 2023-01-01
-Paragraph 119
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_119&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfPerformanceObligationsExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of the reconciliation of changes in biological assets. [Refer: Biological assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 41
-IssueDate 2023-01-01
-Paragraph 50
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_50&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of the reconciliation of changes in goodwill. [Refer: Goodwill]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 3
-IssueDate 2023-01-01
-Paragraph B67
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

XML 36 R27.htm IDEA: XBRL DOCUMENT v3.23.3

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Tables)
3 Months Ended

Sep. 30, 2023

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

Schedule of revenue from contracts with customers


09/30/2023

09/30/2022
Sale of goods and services

115,628,792

126,113,636
Royalties

554,013

729,612

116,182,805

126,843,248

Schedule of cost of sales

Item

09/30/2023

09/30/2022
Inventories as of the beginning of the period

111,990,145

78,759,610
Business combination

—

11,064,908
Purchases of the period

71,694,655

79,325,509
Production costs

7,123,255

8,440,830
Foreign currency translation

(226,797)

(236,263)
Subtotal

190,581,258

177,354,594
Inventories as of the end of the period (*)

(118,965,477)

(101,678,716)
Cost of sales

71,615,781

75,675,878
(*)Net of agricultural products.

Schedule of R&D classified by nature


Research and

Research and

development

development

expenses

expenses
Item

09/30/2023

09/30/2022
Amortization of intangible assets

1,164,940

1,511,118
Analysis and storage

—

11,568
Import and export expenses

—

850
Depreciation of property, plant and equipment

157,808

142,373
Freight and haulage

3,917

5,300
Employee benefits and social securities

1,307,126

861,312
Maintenance

206,778

217,066
Energy and fuel

3,628

79,121
Supplies and materials

847,382

559,044
Mobility and travel

13,771

108,694
Share-based incentives

188,250

6,975
Professional fees and outsourced services

491,787

293,776
Office supplies

170,375

21,454
Information technology expenses

4,375

11,996
Insurance

21,049

10,537
Depreciation of leased assets

—

10,650
Miscellaneous

55

180
Total

4,581,241

3,852,014


09/30/2023

09/30/2022
R&D capitalized (Note 5.8)

1,947,504

3,241,008
R&D profit and loss

4,581,241

3,852,014
Total

6,528,745

7,093,022

Schedule of expenses classified by nature and function




Selling,


general and

Production

administrative

Total
Item

costs

expenses

09/30/2023
Amortization of intangible assets

30,478

1,551,788

1,582,266
Analysis and storage

570

153,473

154,043
Commissions and royalties

134,592

794,058

928,650
Import and export expenses

67,228

120,345

187,573
Depreciation of property, plant and equipment

643,006

442,589

1,085,595
Depreciation of leased assets

339,378

497,821

837,199
Impairment of receivables

—

352,920

352,920
Freight and haulage

643,877

2,989,094

3,632,971
Employee benefits and social securities

2,806,939

10,238,931

13,045,870
Maintenance

422,757

568,155

990,912
Energy and fuel

163,122

16,397

179,519
Supplies and materials

260,043

831,454

1,091,497
Mobility and travel

33,407

1,348,563

1,381,970
Publicity and advertising

—

1,161,498

1,161,498
Contingencies

—

27,109

27,109
Share-based incentives

275,432

5,729,986

6,005,418
Professional fees and outsourced services

509,450

1,575,982

2,085,432
Office supplies and registrations fees

149,888

370,770

520,658
Insurance

27,024

473,850

500,874
Information technology expenses

18,361

743,163

761,524
Obsolescence

505,285

—

505,285
Taxes

70,819

3,766,419

3,837,238
Miscellaneous

21,599

178,483

200,082
Total

7,123,255

33,932,848

41,056,103




Selling,


general and

Production

administrative

Total
Item

costs

expenses

09/30/2022
Amortization of intangible assets

43,456

922,258

965,714
Analysis and storage

5,425

113,265

118,690
Commissions and royalties

118,960

623,459

742,419
Import and export expenses

98,186

256,070

354,256
Depreciation of property, plant and equipment

746,609

493,111

1,239,720
Depreciation of leased assets

395,972

269,805

665,777
Impairment of receivables

—

156,053

156,053
Freight and haulage

241,533

3,474,028

3,715,561
Employee benefits and social securities

3,994,761

10,041,033

14,035,794
Maintenance

462,743

980,742

1,443,485
Energy and fuel

500,359

58,400

558,759
Supplies and materials

339,843

491,811

831,654
Mobility and travel

20,940

994,919

1,015,859
Publicity and advertising

—

1,888,497

1,888,497
Contingencies

—

2,448

2,448
Share-based incentives

100,206

120,170

220,376
Professional fees and outsourced services

674,014

4,610,610

5,284,624
Office supplies and registrations fees

32,546

289,467

322,013
Insurance

28,430

760,276

788,706
Information technology expenses

13,243

993,378

1,006,621
Obsolescence

539,382

79,107

618,489
Taxes

45,049

4,130,539

4,175,588
Miscellaneous

39,173

155,465

194,638
Total

8,440,830

31,904,911

40,345,741

Schedule of other income or expenses, net


09/30/2023

09/30/2022
Net result from commercialization of agricultural products

(1,316,393)

6,327
Expenses recovery

87,053

126,061
Other income or expenses, net

(2,295)

345,653

(1,231,635)

478,041

Schedule of net financial cost


09/30/2023

09/30/2022
Financial costs

Interest expenses with the Parents (Note 15)

(97,063)

(149,734)
Interest expenses

(6,935,241)

(5,569,576)
Financial commissions

(629,553)

(1,060,537)

(7,661,857)

(6,779,847)

Other financial results


Exchange differences generated by assets

(9,685,066)

(833,428)
Exchange differences generated by liabilities

10,335,537

6,322
Changes in fair value of financial assets or liabilities and other financial results

(151,646)

(569,032)
Net gain of inflation effect on monetary items

(380,960)

107,832

117,865

(1,288,306)

X

- Definition
The disclosure of the cost of sales. [Refer: Cost of sales]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 10
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_10_e&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfCostOfSalesExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of the disaggregation of revenue from contracts with customers. [Refer: Revenue from contracts with customers]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 15
-IssueDate 2023-01-01
-Paragraph 114
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_114&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of expenses by nature. [Refer: Expenses, by nature]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 10
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_10_e&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfExpensesByNatureExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of finance income (cost). [Refer: Finance income (cost)]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 10
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_10_e&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of other operating income or expense. [Refer: Other operating income (expense)]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 10
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_10_e&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of research and development expense. [Refer: Research and development expense]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 10
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_10_e&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_StatementOfComprehensiveIncomeAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 37 R28.htm IDEA: XBRL DOCUMENT v3.23.3

TAXATION (Tables)
3 Months Ended

Sep. 30, 2023

TAXATION

Schedule of current tax


09/30/2023

09/30/2022
Current tax expense

(6,457,134)

(6,020,201)
Deferred tax

6,028,094

1,007,558
Total

(429,040)

(5,012,643)

Schedule of net deferred tax


09/30/2023

09/30/2022
Beginning of the period deferred tax

(28,472,383)

(24,994,569)
Additions for business combination

—

(16,704,770)
Charge for the period

6,028,094

1,007,558
Conversion difference

(3,718,889)

(261,014)
Total net deferred tax

(26,163,178)

(40,952,795)

Schedule of reconciliation of the statutory tax rate to the effective tax rate


09/30/2023

09/30/2022
Earning before income tax-rate

(2,249,424)

8,924,643
Income tax expense by applying tax rate in force in the respective countries

(1,721,853)

(5,739,069)
Share of profit or loss of subsidiaries, joint ventures and associates

530,177

313,280
Stock options charge

(1,226,796)

(57,818)
Non-deductible expenses

(383,074)

(805,883)
Unrecognized deferred tax

—

(895,896)
Tax inflation adjustment

4,826,023

1,822,594
Result of inflation effect on monetary items and other finance results

(2,352,623)

213,857
Others

(100,894)

136,292
Income tax expenses

(429,040)

(5,012,643)

X

- Definition
Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.
+ References
No definition available.
+ Details

Name: biox_IfrsScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.
+ References
No definition available.
+ Details

Name: biox_IfrsScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of deferred taxes. [Refer: Deferred tax liabilities; Deferred tax assets]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 10
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_10_e&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfDeferredTaxesExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 38 R29.htm IDEA: XBRL DOCUMENT v3.23.3

EARNING PER SHARE (Tables)
3 Months Ended

Sep. 30, 2023

EARNING PER SHARE

Schedule of earnings per share


09/30/2023

09/30/2022
Numerator

(Loss) profit for the period (basic EPS)

(4,591,634)

498,297
(Loss) profit for the period (diluted EPS)

(4,591,634)

498,297
Denominator

Weighted average number of shares (basic EPS)

62,846,690

60,537,110
Weighted average number of shares (diluted EPS)

62,846,690

61,736,679

Basic (loss) profit attributable to ordinary equity holders of the parent

(0.0731)

0.0082
Diluted (loss) profit attributable to ordinary equity holders of the parent

(0.0731)

0.0081

X

- References
No definition available.
+ Details

Name: ifrs-full_EarningsPerShareAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of earnings per share.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 33
-IssueDate 2023-01-01
-Paragraph 66
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_66&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_EarningsPerShareExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

XML 39 R30.htm IDEA: XBRL DOCUMENT v3.23.3

CASH FLOW INFORMATION (Tables)
3 Months Ended

Sep. 30, 2023

CASH FLOW INFORMATION

Schedule of significant non-cash transactions related to investing and financing activities


09/30/2023

09/30/2022
Investment activities

Net assets acquisition by business combination

—

150,510,313
Investment in-kind in other related parties (Note 15)

—

550,183
Capitalization of interest on buildings in progress

36,589

—

36,589

151,060,496

09/30/2023

09/30/2022
Financing activities




Capitalization of convertible notes (Note 5.13)

—

12,211,638
Purchase of own shares

—

(23,915,029)

—

(11,703,391)

X

- Definition
The tabular disclosure of significant non-cash transactions related to investing and financing activities.
+ References
No definition available.
+ Details

Name: biox_ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
It represents the information pertaining to non cash transactions in cash flow.
+ References
No definition available.
+ Details

Name: biox_StatementOfNonCashTransactionsCashFlowsAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 40 R31.htm IDEA: XBRL DOCUMENT v3.23.3

JOINT VENTURES AND ASSOCIATES (Tables)
3 Months Ended

Sep. 30, 2023

JOINT VENTURES AND ASSOCIATES

Schedule of investments in joint ventures and associates


09/30/2023

06/30/2023
Assets




Synertech Industrias S.A.

37,550,684

36,026,710
Alfalfa Technologies S.R.L.

36,502

36,502
Moolec Science S.A.

3,233,598

3,233,598

40,820,784

39,296,810


09/30/2023

06/30/2023
Liabilities




Trigall Genetics S.A.

638,126

622,823

638,126

622,823

Schedule of share of profit or loss of joint ventures and associates


09/30/2023

09/30/2022
Trigall Genetics S.A.

(15,303)

(132,117)
Synertech Industrias S.A.

1,523,974

974,357

1,508,671

842,240

Schedule of changes in joint ventures


09/30/2023

09/30/2022
As of the beginning of the period

38,673,987

37,836,144
Foreign currency translation

—

100,868
Share of profit or loss

1,508,671

842,240
As of the end of the period

40,182,658

38,779,252

X

- Definition
The disclosure of investments in joint ventures and affiliates.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfChangesInInvestmentInJointVenturesAndAffiliatesTableTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Information pertains to disclosure of investments in associates and joint ventures.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of share of profit / (loss) joint ventures and affiliates.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfShareOfProfitOrLossInJointVenturesAndAffiliatesTableTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_InvestmentsAccountedForUsingEquityMethodAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 41 R32.htm IDEA: XBRL DOCUMENT v3.23.3

SEGMENT INFORMATION (Tables)
3 Months Ended

Sep. 30, 2023

SEGMENT INFORMATION

Schedule of operating results group's reporting segments


Seed and






integrated

Crop

Crop

Period ended September 30, 2023

products

protection

nutrition

Consolidated

Revenues from contracts with customers

Sale of goods and services

21,677,053

55,754,360

38,197,379

115,628,792

Royalties

554,013

—

—

554,013

Others

Initial recognition and changes in the fair value of biological assets at the point of harvest

87,844

172,118

150,951

410,913

Total

22,318,910

55,926,478

38,348,330

116,593,718

Cost of sales

(14,110,381)

(36,183,792)

(21,321,608)

(71,615,781)

Gross profit per segment

8,208,529

19,742,686

17,026,722

44,977,937

% Gross margin

37
%
35
%
44
%
39
%


Seed and






integrated

Crop

Crop

Period ended September 30, 2022

products

protection

nutrition

Consolidated

Revenues from contracts with customers

Sale of goods and services

13,073,640

62,986,173

50,053,823

126,113,636

Royalties

729,612

—

—

729,612

Others

Initial recognition and changes in the fair value of biological assets at the point of harvest

51,451

89,573

348,982

490,006

Total

13,854,703

63,075,746

50,402,805

127,333,254

Cost of sales

(5,539,489)

(45,035,250)

(25,101,139)

(75,675,878)

Gross profit per segment

8,315,214

18,040,496

25,301,666

51,657,376

% Gross margin

60
%
29
%
50
%
41
%

X

- References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfOperatingSegmentsAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of operating segments. [Refer: Operating segments [member]]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 23
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfOperatingSegmentsExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

XML 42 R33.htm IDEA: XBRL DOCUMENT v3.23.3

FINANCIAL INSTRUMENTS - RISK MANAGEMENT (Tables)
3 Months Ended

Sep. 30, 2023

FINANCIAL INSTRUMENTS - RISK MANAGEMENT

Schedule of financial assets by category

Mandatorily measured at fair

Amortized cost

value through profit or loss
Financial asset

09/30/2023

06/30/2023

09/30/2023

06/30/2023
Cash and cash equivalents

25,954,730

48,129,194

2,419,194

—
Other financial assets

502,910

657,612

14,628,202

11,922,317
Trade receivables

186,276,319

158,006,474

—

—
Other receivables (*)

11,753,573

12,124,724

—

—
Total

224,487,532

218,918,004

17,047,396

11,922,317
(*)
Advances expenses and tax balances are not included.

Schedule financial liabilities by category

Mandatorily measured at fair

Amortized cost

value through profit or loss
Financial liability

09/30/2023

06/30/2023

09/30/2023

06/30/2023
Trade and other payables

152,753,083

142,582,166

6,372,275

8,225,508
Borrowings

149,510,477

168,310,605

—

—
Secured notes

76,911,874

75,213,146

—

—
Lease liability

13,552,751

13,889,223

—

—
Consideration for acquisition of assets

6,742,570

4,993,256

—

—
Total

399,470,755

404,988,396

6,372,275

8,225,508

Schedule of fair value by hierarchy

Measurement at fair value at 09/30/2023

Level 1

Level 2

Level 3

Financial assets at fair value

US Treasury bills

9,719,486

—

—
Mutual funds

3,236,702

—

—
Other investments

1,672,014

—

—
Financial liability at fair value






Trade and other payables

—

6,372,275

—

Measurement at fair value at 06/30/2023

Level 1

Level 2

Level 3

Financial assets at fair value

US Treasury bills

9,163,298

—

—
Mutual funds

1,596,539

—

—
Other investments

1,162,480

—

—
Financial liability at fair value

Trade and other payables

—

8,225,508

—

Schedule of net exposure

Net foreign currency position

09/30/2023
Amount expressed in US$

(5,353,860)

X

- Definition
The disclosure of the fair value of financial instruments. [Refer: Financial instruments, class [member]; At fair value [member]]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 10
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_10_e&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of financial assets. [Refer: Financial assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 7
-IssueDate 2023-01-01
-Paragraph 7
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_7&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfFinancialAssetsExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of financial liabilities. [Refer: Financial liabilities]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 7
-IssueDate 2023-01-01
-Paragraph 7
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_7&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of information that enables users of financial statements to evaluate the nature and extent of risks arising from financial instruments to which the entity is exposed. [Refer: Financial instruments, class [member]]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 7
-IssueDate 2023-01-01
-Paragraph 31
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_31&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 43 R34.htm IDEA: XBRL DOCUMENT v3.23.3

LEASES (Tables)
3 Months Ended

Sep. 30, 2023

LEASES

Schedule of right of use leased assets and lease liability from beginning of year to end of year

Right-of-use leased asset

09/30/2023

06/30/2023
Book value at the beginning of the period/year

21,163,192

15,828,032
Additions of the period/year

1,072,418

3,154,950
Additions from business combination

—

3,005,000
Disposals

(461,631)

(1,839,921)
Exchange differences

(513,269)

1,015,131
Book value at the end of the period/year

21,260,710

21,163,192

Depreciation

09/30/2023

06/30/2023
Book value at the beginning of the period/year

7,226,617

3,684,006
Depreciation of the period/year

837,199

3,565,894
Disposals

(274,431)

(171,870)
Exchange differences

(47,874)

148,587
Accumulated depreciation at the end of the period/year

7,741,511

7,226,617
Total

13,519,199

13,936,575

Lease liability

09/30/2023

06/30/2023
Book value at the beginning of the period/year

13,889,223

11,751,284
Additions of the period/year

1,072,418

3,154,950
Additions from business combination

—

3,245,000
Interest expenses, exchange differences and inflation effects

(238,851)

(406,494)
Payments of the period/year

(1,170,039)

(3,855,517)
Total

13,552,751

13,889,223

Lease Liabilities

09/30/2023

06/30/2023
Non-current

9,225,862

10,030,524
Current

4,326,889

3,858,699
Total

13,552,751

13,889,223

Schedule of right-of-use leased assets


09/30/2023

06/30/2023
Machinery and equipment

3,655,741

3,655,741
Vehicles

1,433,616

1,475,581
Equipment and computer software

1,011,490

903,306
Land and buildings

15,159,863

15,128,564

21,260,710

21,163,192

X

- Definition
The tabular disclosure of roll forward of right of use leased assets and lease liability
+ References
No definition available.
+ Details

Name: biox_Disclosureofrightofuseleasedassetsandleaseliabilitytabletextblock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of right-of-use leased assets.
+ References
No definition available.
+ Details

Name: biox_RightOfUseLeasedAssetsTableTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_PresentationOfLeasesForLesseeAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 44 R35.htm IDEA: XBRL DOCUMENT v3.23.3

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS (Tables)
3 Months Ended

Sep. 30, 2023

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS

Schedule of transactions between the group and related parties, and the related balances owed

Value of transactions for the period ended
Party

Transaction type

09/30/2023

09/30/2022
Joint ventures and associates

Sales and services

6,801,117

17,083,027
Joint ventures and associates

Purchases of goods and services

(20,691,171)

(25,314,814)
Key management personnel

Salaries, social security benefits and other benefits

(6,702,803)

(648,494)
Shareholders and other related parties

Sales of goods and services

1,590,568

261,418
Shareholders and other related parties

Purchases of goods and services

(196,051)

(239,772)
Shareholders and other related parties

In-kind contributions

—

550,183
Shareholders and other related parties

Net loans granted/(cancelled)

—

(1,609)
Shareholders and other related parties

Interest expenses

(23,000)

—
Parent company and related parties to Parent (Note 6.6)

Interest expenses

(97,063)

(149,734)
Total

(19,318,403)

(8,459,795)

Amounts receivable from related parties
Party

Transaction type

09/30/2023

06/30/2023
Shareholders and other related parties

Other receivables

1,368,373

—
Shareholders and other related parties

Other receivables

2,919,431

3,792,429
Joint ventures and associates

Trade debtors

781,451

865,627
Joint ventures and associates

Other receivables

6,699,863

6,334,219
Total

11,769,118

10,992,275

Amounts payable to related parties
Party

Transaction type

09/30/2023

06/30/2022
Parent company and related parties to Parent

Trade creditors

(270,645)

(644,191)
Parent company and related parties to Parent

Net loans payables

(3,565,754)

(3,491,691)
Key management personnel

Salaries, social security benefits and other benefits

(333,616)

(218,068)
Shareholders and other related parties

Trade and other payables

(27,708)

(35,292)
Joint ventures and associates

Trade creditors

(47,282,380)

(41,402,594)
Total

(51,480,103)

(45,791,836)

X

- References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The disclosure of transactions between the entity and its related parties. [Refer: Related parties [member]]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 24
-IssueDate 2023-01-01
-Paragraph 18
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_18&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory

Namespace Prefix: ifrs-full_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

XML 45 R36.htm IDEA: XBRL DOCUMENT v3.23.3

KEY MANAGEMENT PERSONNEL COMPENSATION (Tables)
3 Months Ended

Sep. 30, 2023

KEY MANAGEMENT PERSONNEL COMPENSATION

Schedule of compensation of directors and other members of key management personnel


09/30/2023

09/30/2022

Salaries, social security and other benefits

509,135

421,143
Share-based incentives

6,193,668

227,351
Total

6,702,803

648,494

X

- Definition
The tabular disclosure of compensation of directors and other members of key management personnel.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock

Namespace Prefix: biox_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: biox_KeyManagementPersonnelCompensationAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 46 R37.htm IDEA: XBRL DOCUMENT v3.23.3

GENERAL INFORMATION - (Details)

Sep. 30, 2023

country

Business information

Number of countries where Group's agricultural inputs are marketed 40

X

- References
No definition available.
+ Details

Name: biox_BusinessInformationAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The minimum number of countries where the entity has marketed agricultural inputs.
+ References
No definition available.
+ Details

Name: biox_MinimumNumberOfCountriesWhereEntityMarketedAgriculturalInputs

Namespace Prefix: biox_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: instant

XML 47 R38.htm IDEA: XBRL DOCUMENT v3.23.3

SEASONALITY (Details)

Sep. 30, 2023

item

SEASONALITY

Some customers and distributers order per year, minimum 1

Some customers and distributers order per year, maximum 2

X

- Definition
The maximum number of bulk orders per year of some customers and distributors of the entity.
+ References
No definition available.
+ Details

Name: biox_CustomersAndDistributorBulkOrdersPerYearMaximum

Namespace Prefix: biox_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: instant

X

- Definition
The minimum number of bulk orders per year of some customers and distributors of the entity.
+ References
No definition available.
+ Details

Name: biox_CustomersAndDistributorBulkOrdersPerYearMinimum

Namespace Prefix: biox_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: instant

X

- Definition
No definition availability.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfSeasonalityAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 48 R39.htm IDEA: XBRL DOCUMENT v3.23.3

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Cash and cash equivalents (Details) - USD ($)

Sep. 30, 2023

Jun. 30, 2023

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

Cash at bank and on hand $ 25,954,730 $ 48,129,194

Mutual funds 2,419,194

Cash and cash equivalents $ 28,373,924 $ 48,129,194

X

- Definition
n/a
+ References
No definition available.
+ Details

Name: biox_ComponentsOfConsolidatedStatementsOfFinancialPositionAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of an investment program funded by shareholders that trades in diversified holdings and is professionally managed.
+ References
No definition available.
+ Details

Name: biox_MutualFundsAtCarryingValue

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of cash on hand and demand deposits. [Refer: Cash on hand]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 45
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_Cash

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 45
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B13
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_i&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CashAndCashEquivalents

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 49 R40.htm IDEA: XBRL DOCUMENT v3.23.3

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Other financial assets (Details) - USD ($)

Sep. 30, 2023

Jun. 30, 2023

Current

Restricted short-term deposit $ 212,703

US Treasury bills $ 9,719,486 9,163,298

Mutual funds 3,236,702 1,596,539

Other investments 1,672,014 1,162,480

Other financial assets 14,628,202 12,135,020

Non-current

Shares of Bioceres S.A. 444,575 444,635

Other investments 58,335 274

Other financial assets $ 502,910 $ 444,909

X

- Definition
The amount of non-current other marketable securities classified as non-current.
+ References
No definition available.
+ Details

Name: biox_OtherMarketableSecuritiesClassifiedAsNonCurrent

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of short-term investments held by the entity that are not classified as cash equivalents.
+ References
No definition available.
+ Details

Name: biox_ShortTermInvestmentsNotClassifiedAsCashEquivalents

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: ifrs-full_CurrentAssetsAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of investments other than investments accounted for using the equity method. [Refer: Investments accounted for using equity method]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: ifrs-full_NoncurrentAssetsAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of non-current financial assets available-for-sale. [Refer: Financial assets available-for-sale; Non-current financial assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Note Expired 2023-01-01
-Name IFRS
-Number 7
-IssueDate 2023-01-01
-Paragraph 8
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_8_d&doctype=Standard&book=b
-URIDate 2023-03-23
+ Details

Name: ifrs-full_NoncurrentFinancialAssetsAvailableforsale

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of current financial assets that the entity does not separately disclose in the same statement or note. [Refer: Other financial assets; Current financial assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_d&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_OtherCurrentFinancialAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of non-current financial assets that the entity does not separately disclose in the same statement or note. [Refer: Other financial assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_d&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_OtherNoncurrentFinancialAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of short-term deposits held by the entity that are not classified as cash equivalents. [Refer: Cash equivalents]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
A classification of cash equivalents representing short-term investments. [Refer: Cash equivalents]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 45
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 50 R41.htm IDEA: XBRL DOCUMENT v3.23.3

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Trade receivables (Details) - USD ($)

Sep. 30, 2023

Jun. 30, 2023

Components of Consolidated Statement of Financial Position

Trade debtors $ 189,222,562 $ 160,269,233

Allowance for impairment of trade debtors (7,615,433) (7,425,604)

Allowance for credit notes to be issued (2,610,596) (3,694,019)

Deferred checks 5,129,962 7,991,237

Trade receivables 186,276,319 158,006,474

Shareholders and other related parties

Components of Consolidated Statement of Financial Position

Shareholders and other related parties 1,368,373

Joint ventures and associates

Components of Consolidated Statement of Financial Position

Trade debtors $ 781,451 $ 865,627

X

- Definition
The amount of allowance for return of goods.
+ References
No definition available.
+ Details

Name: biox_AllowanceForReturnOfGoods

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of trade receivables due from related parties.
+ References
No definition available.
+ Details

Name: biox_TradeReceivablesFromRelatedParties

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of an allowance account used to record impairments to financial assets due to credit losses. [Refer: Financial assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Note Expired 2023-01-01
-Name IFRS
-Number 7
-IssueDate 2023-01-01
-Paragraph 16
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_16&doctype=Standard&book=b
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of current trade receivables. [Refer: Trade receivables]
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_b&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 68
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_68&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CurrentTradeReceivables

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount receivable by the entity that it does not separately disclose in the same statement or note.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_OtherReceivables

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph h
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_h&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_TradeAndOtherCurrentReceivables

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_OtherRelatedPartiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_CategoriesOfRelatedPartiesAxis=biox_JointVenturesAndAssociatesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 51 R42.htm IDEA: XBRL DOCUMENT v3.23.3

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Other receivables (Details) - USD ($)

Sep. 30, 2023

Jun. 30, 2023

Current

Taxes $ 6,009,626 $ 6,113,764

Prepayments to suppliers 5,010,022 10,956,831

Reimbursements over exports 10,558 10,558

Prepaid expenses and other receivables 3,657,633 1,302,221

Miscellaneous 735,655 388,553

Other receivables 24,902,503 28,824,998

Non-current

Taxes 865,588 873,699

Reimbursements over exports 1,268,928 1,290,227

Loan receivables 230,000 230,000

Miscellaneous 29,423 152,315

Other receivables 2,393,939 2,546,241

Receivables for PP&E sales

Current

Other receivables 89,715 156,423

Shareholders and other related parties

Current

Other receivables 2,919,431 3,792,429

Joint ventures and associates

Current

Other receivables $ 6,469,863 $ 6,104,219

X

- Definition
Represents the amount of non-current receivables from advances to suppliers.
+ References
No definition available.
+ Details

Name: biox_AdvancesToSuppliersNonCurrent

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Represents the non current amount of loan receivable.
+ References
No definition available.
+ Details

Name: biox_LoanReceivableNonCurrent

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Represents the amount of other current receivables, other.
+ References
No definition available.
+ Details

Name: biox_OtherCurrentReceivablesOther

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Represents other non-current receivables.
+ References
No definition available.
+ Details

Name: biox_OtherNonCurrentReceivablesOther

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Represents the amount of expenditure that is to be reimbursed.
+ References
No definition available.
+ Details

Name: biox_ReceivablesFromReimbursementOfExpenditureCurrent

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Represents the amount of current tax credit receivables.
+ References
No definition available.
+ Details

Name: biox_ReceivablesFromTaxCreditsCurrent

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Represents the amount of non-current tax credit receivables.
+ References
No definition available.
+ Details

Name: biox_ReceivablesFromTaxCreditsNonCurrent

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of current advances made to suppliers before goods or services are received.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CurrentAdvancesToSuppliers

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: ifrs-full_CurrentAssetsAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CurrentPrepaidExpenses

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: ifrs-full_NoncurrentAssetsAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of current other receivables. [Refer: Other receivables]
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_OtherCurrentReceivables

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of non-current other receivables. [Refer: Other receivables]
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_OtherNoncurrentReceivables

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: ifrs-full_CategoriesOfRelatedPartiesAxis=biox_ReceivablesForPpESalesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_OtherRelatedPartiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_CategoriesOfRelatedPartiesAxis=biox_JointVenturesAndAssociatesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 52 R43.htm IDEA: XBRL DOCUMENT v3.23.3

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Inventories (Details) - USD ($)

Sep. 30, 2023

Jun. 30, 2023

Inventory

Goods in transit $ 2,298,136 $ 3,620,606

Supplies 18,709,303 24,893,187

Agricultural products 19,111,345 28,436,830

Inventories 138,076,822 140,426,975

Net of agricultural products 118,965,477 111,990,145

Seeds

Inventory

Inventories 9,293,210 1,542,159

Resale products

Inventory

Inventories 71,973,203 58,544,931

Manufactured products

Inventory

Inventories 19,604,930 25,881,761

Allowance for obsolescence

Inventory

Inventories $ (2,913,305) $ (2,492,499)

X

- Definition
The amount of current inventories excluding agricultural produce.
+ References
No definition available.
+ Details

Name: biox_InventoriesExcludingAgriculturalProduce

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
A classification of current inventory representing the amount of harvested produce of the entity's biological assets. [Refer: Biological assets; Inventories]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 2
-IssueDate 2023-01-01
-Paragraph 37
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2023-en-r&anchor=para_37&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CurrentAgriculturalProduce

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
A classification of current inventory representing the amount of inventories in transit. [Refer: Inventories]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 2
-IssueDate 2023-01-01
-Paragraph 37
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2023-en-r&anchor=para_37&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CurrentInventoriesInTransit

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
A classification of current inventory representing the amount of materials and supplies to be consumed in a production process or while rendering services. [Refer: Inventories]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 2
-IssueDate 2023-01-01
-Paragraph 37
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2023-en-r&anchor=para_37&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CurrentMaterialsAndSuppliesToBeConsumedInProductionProcessOrRenderingServices

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of current inventories. [Refer: Inventories]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 2
-IssueDate 2023-01-01
-Paragraph 36
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2023-en-r&anchor=para_36_b&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph g
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_g&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 68
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_68&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_Inventories

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: ifrs-full_BiologicalAssetsAxis=biox_SeedsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_BiologicalAssetsAxis=biox_MicrobiologicalResaleProductsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_BiologicalAssetsAxis=biox_MicrobiologicalProductsProducedMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedImpairmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 53 R44.htm IDEA: XBRL DOCUMENT v3.23.3

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Biological assets (Details) - USD ($)
3 Months Ended

Sep. 30, 2023

Sep. 30, 2022

Biological assets

Beginning of the period $ 146,842 $ 57,313

Initial recognition and changes in the fair value of biological assets at the point of harvest 410,913 490,006

Cost incurred during the period 583,358 501,468

Exchange differences (22,043)

End of period 1,141,113 1,026,744

Soybean

Biological assets

Beginning of the period 0

Cost incurred during the period 374,456

End of period 374,456

Corn

Biological assets

Beginning of the period 0

Cost incurred during the period 177,601

End of period 177,601

Wheat

Biological assets

Beginning of the period 87,785 44,413

Initial recognition and changes in the fair value of biological assets at the point of harvest 276,511 365,833

Cost incurred during the period 378,631

Exchange differences (16,699)

End of period 364,296 772,178

Sunflower

Biological assets

Beginning of the period 0

Cost incurred during the period 31,301

End of period 31,301

Barley

Biological assets

Beginning of the period 59,057 12,900

Initial recognition and changes in the fair value of biological assets at the point of harvest 134,402 124,173

Cost incurred during the period 122,837

Exchange differences (5,344)

End of period $ 193,459 $ 254,566

X

- Definition
The amount of additions to biological assets, other than those acquired through business combinations. [Refer: Business combinations [member]; Biological assets]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 41
-IssueDate 2023-01-01
-Paragraph 50
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_50&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of living animals or plants recognised as assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 41
-IssueDate 2023-01-01
-Paragraph 43
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_43&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 41
-IssueDate 2023-01-01
-Paragraph 50
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_50&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph f
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_f&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_BiologicalAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The gains (losses) arising from changes in fair value less costs to sell of biological assets due to both physical and price changes in the market. [Refer: Biological assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 41
-IssueDate 2023-01-01
-Paragraph 50
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_50_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition
The increase (decrease) in biological assets resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Biological assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 41
-IssueDate 2023-01-01
-Paragraph 50
-Subparagraph f
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_50_f&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesBiologicalAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: ifrs-full_BiologicalAssetsAxis=biox_BiologicalAssetsSoybeanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_BiologicalAssetsAxis=biox_BiologicalAssetsCornMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_BiologicalAssetsAxis=biox_BiologicalAssetsWheatMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_BiologicalAssetsAxis=biox_SunflowerMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_BiologicalAssetsAxis=biox_BiologicalAssetsBarleyMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 54 R45.htm IDEA: XBRL DOCUMENT v3.23.3

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment (Details) - USD ($)

Sep. 30, 2023

Jun. 30, 2023

Sep. 30, 2022

Jun. 30, 2022

Property, plant and equipment

Property, plant and equipment $ 69,930,709 $ 67,853,835

Gross carrying amount

Property, plant and equipment

Property, plant and equipment 96,833,359 93,634,779 $ 85,587,833 $ 71,521,454

Accumulated depreciation

Property, plant and equipment

Property, plant and equipment $ (26,902,650) $ (25,780,944) $ (22,710,109) $ (21,613,129)

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 16
-IssueDate 2023-01-01
-Paragraph 73
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_PropertyPlantAndEquipment

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 55 R46.htm IDEA: XBRL DOCUMENT v3.23.3

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment - net carrying amount (Details) - USD ($)

Sep. 30, 2023

Jun. 30, 2023

Property, plant and equipment

Property, plant and equipment $ 69,930,709 $ 67,853,835

Office equipment

Property, plant and equipment

Property, plant and equipment 280,905 263,892

Vehicles

Property, plant and equipment

Property, plant and equipment 1,862,542 2,032,853

Equipment and computer software

Property, plant and equipment

Property, plant and equipment 167,741 174,399

Fixture and fittings

Property, plant and equipment

Property, plant and equipment 2,676,861 2,862,949

Machinery and equipment

Property, plant and equipment

Property, plant and equipment 13,970,593 14,463,756

Land and buildings

Property, plant and equipment

Property, plant and equipment 35,640,076 36,144,792

Buildings in progress

Property, plant and equipment

Property, plant and equipment $ 15,331,991 $ 11,911,194

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 16
-IssueDate 2023-01-01
-Paragraph 73
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_PropertyPlantAndEquipment

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_VehiclesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MachineryMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandAndBuildingsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ConstructionInProgressMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 56 R47.htm IDEA: XBRL DOCUMENT v3.23.3

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment - gross carrying amounts (Details) - USD ($)
3 Months Ended

Sep. 30, 2023

Sep. 30, 2022

Property, plant and equipment

As of the beginning of period $ 67,853,835

Additions from business combination $ 13,100,572

As of the end of period 69,930,709

Office equipment

Property, plant and equipment

As of the beginning of period 263,892

As of the end of period 280,905

Vehicles

Property, plant and equipment

As of the beginning of period 2,032,853

As of the end of period 1,862,542

Equipment and computer software

Property, plant and equipment

As of the beginning of period 174,399

Additions from business combination 12,469

As of the end of period 167,741

Fixture and fittings

Property, plant and equipment

As of the beginning of period 2,862,949

Additions from business combination 5,379

As of the end of period 2,676,861

Machinery and equipment

Property, plant and equipment

As of the beginning of period 14,463,756

Additions from business combination 7,047,496

As of the end of period 13,970,593

Land and buildings

Property, plant and equipment

As of the beginning of period 36,144,792

Additions from business combination 4,750,136

As of the end of period 35,640,076

Buildings in progress

Property, plant and equipment

As of the beginning of period 11,911,194

Additions from business combination 1,285,092

As of the end of period 15,331,991

Gross carrying amount

Property, plant and equipment

As of the beginning of period 93,634,779 71,521,454

Additions 3,948,660 1,414,730

Disposals (45,062) (59,744)

Foreign currency translation (705,018) (389,179)

As of the end of period 96,833,359 85,587,833

Gross carrying amount | Office equipment

Property, plant and equipment

As of the beginning of period 968,088 908,004

Additions 34,918

Foreign currency translation (2,764) (15,172)

As of the end of period 1,000,242 892,832

Gross carrying amount | Vehicles

Property, plant and equipment

As of the beginning of period 5,492,319 5,261,979

Additions 28,680 226,051

Disposals (45,062) (59,744)

Foreign currency translation (1,498) (6,243)

As of the end of period 5,474,439 5,422,043

Gross carrying amount | Equipment and computer software

Property, plant and equipment

As of the beginning of period 974,509 925,349

Additions 30,188 41,658

Foreign currency translation (5,857) (6,667)

As of the end of period 998,840 972,809

Gross carrying amount | Fixture and fittings

Property, plant and equipment

As of the beginning of period 7,663,899 7,606,389

Additions 33,869

Foreign currency translation (2,126) (5,539)

As of the end of period 7,661,773 7,640,098

Gross carrying amount | Machinery and equipment

Property, plant and equipment

As of the beginning of period 23,513,047 13,017,830

Additions 176,837 107,717

Foreign currency translation (91,465) (24,469)

As of the end of period 23,598,419 20,148,574

Gross carrying amount | Land and buildings

Property, plant and equipment

As of the beginning of period 43,111,723 40,659,129

Foreign currency translation (344,068) (313,148)

As of the end of period 42,767,655 45,096,117

Gross carrying amount | Buildings in progress

Property, plant and equipment

As of the beginning of period 11,911,194 3,142,774

Additions 3,678,037 1,005,435

Foreign currency translation (257,240) (17,941)

As of the end of period 15,331,991 5,415,360

Accumulated depreciation

Property, plant and equipment

As of the beginning of period (25,780,944) (21,613,129)

Of the period (1,243,403) (1,382,093)

Disposals 36,049 59,744

Foreign currency translation 85,648 225,369

As of the end of period (26,902,650) (22,710,109)

Accumulated depreciation | Office equipment

Property, plant and equipment

As of the beginning of period (704,196) (638,466)

Of the period (17,004) (17,053)

Foreign currency translation 1,863 16,931

As of the end of period (719,337) (638,588)

Accumulated depreciation | Vehicles

Property, plant and equipment

As of the beginning of period (3,459,466) (2,596,905)

Of the period (188,532) (226,899)

Disposals 36,049 59,744

Foreign currency translation 52 3,364

As of the end of period (3,611,897) (2,760,696)

Accumulated depreciation | Equipment and computer software

Property, plant and equipment

As of the beginning of period (800,110) (693,673)

Of the period (35,963) (28,914)

Foreign currency translation 4,974 476

As of the end of period (831,099) (722,111)

Accumulated depreciation | Fixture and fittings

Property, plant and equipment

As of the beginning of period (4,800,950) (4,059,470)

Of the period (184,877) (206,830)

Foreign currency translation 915 23,814

As of the end of period (4,984,912) (4,242,486)

Accumulated depreciation | Machinery and equipment

Property, plant and equipment

As of the beginning of period (9,049,291) (7,205,870)

Of the period (595,729) (679,201)

Foreign currency translation 17,194 180,089

As of the end of period (9,627,826) (7,704,982)

Accumulated depreciation | Land and buildings

Property, plant and equipment

As of the beginning of period (6,966,931) (6,418,745)

Of the period (221,298) (223,196)

Foreign currency translation 60,650 695

As of the end of period $ (7,127,579) $ (6,641,246)

X

- Definition
The amount of adjustment to opening net book amount for application of IAS 29 on property and equipment.
+ References
No definition available.
+ Details

Name: biox_AdjustmentOfOpeningNetBookAmountForApplicationOfLas29OnPropertyAndEquipment

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase in investment property resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Investment property]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 40
-IssueDate 2023-01-01
-Paragraph 76
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_76_b&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 40
-IssueDate 2023-01-01
-Paragraph 79
-Subparagraph d
-Clause ii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_79_d_ii&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AcquisitionsThroughBusinessCombinationsInvestmentProperty

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 16
-IssueDate 2023-01-01
-Paragraph 73
-Subparagraph e
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_i&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The decrease in property, plant and equipment resulting from disposals. [Refer: Property, plant and equipment]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 16
-IssueDate 2023-01-01
-Paragraph 73
-Subparagraph e
-Clause ii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_ii&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisposalsPropertyPlantAndEquipment

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) in property, plant and equipment resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Property, plant and equipment]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 16
-IssueDate 2023-01-01
-Paragraph 73
-Subparagraph e
-Clause viii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_viii&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 16
-IssueDate 2023-01-01
-Paragraph 73
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_PropertyPlantAndEquipment

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_VehiclesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MachineryMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandAndBuildingsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ConstructionInProgressMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 57 R48.htm IDEA: XBRL DOCUMENT v3.23.3

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment - accumulated depreciation (Details) - USD ($)
3 Months Ended

Sep. 30, 2023

Sep. 30, 2022

Property, plant and equipment

As of the beginning of period $ 67,853,835

As of the end of period 69,930,709

Office equipment

Property, plant and equipment

As of the beginning of period 263,892

As of the end of period 280,905

Vehicles

Property, plant and equipment

As of the beginning of period 2,032,853

As of the end of period 1,862,542

Equipment and computer software

Property, plant and equipment

As of the beginning of period 174,399

As of the end of period 167,741

Fixture and fittings

Property, plant and equipment

As of the beginning of period 2,862,949

As of the end of period 2,676,861

Machinery and equipment

Property, plant and equipment

As of the beginning of period 14,463,756

As of the end of period 13,970,593

Land and buildings

Property, plant and equipment

As of the beginning of period 36,144,792

As of the end of period 35,640,076

Accumulated depreciation

Property, plant and equipment

As of the beginning of period (25,780,944) $ (21,613,129)

Disposals 36,049 59,744

Foreign currency translation 85,648 225,369

As of the end of period (26,902,650) (22,710,109)

Accumulated depreciation | Office equipment

Property, plant and equipment

As of the beginning of period (704,196) (638,466)

Foreign currency translation 1,863 16,931

As of the end of period (719,337) (638,588)

Accumulated depreciation | Vehicles

Property, plant and equipment

As of the beginning of period (3,459,466) (2,596,905)

Disposals 36,049 59,744

Foreign currency translation 52 3,364

As of the end of period (3,611,897) (2,760,696)

Accumulated depreciation | Equipment and computer software

Property, plant and equipment

As of the beginning of period (800,110) (693,673)

Foreign currency translation 4,974 476

As of the end of period (831,099) (722,111)

Accumulated depreciation | Fixture and fittings

Property, plant and equipment

As of the beginning of period (4,800,950) (4,059,470)

Foreign currency translation 915 23,814

As of the end of period (4,984,912) (4,242,486)

Accumulated depreciation | Machinery and equipment

Property, plant and equipment

As of the beginning of period (9,049,291) (7,205,870)

Foreign currency translation 17,194 180,089

As of the end of period (9,627,826) (7,704,982)

Accumulated depreciation | Land and buildings

Property, plant and equipment

As of the beginning of period (6,966,931) (6,418,745)

Foreign currency translation 60,650 695

As of the end of period $ (7,127,579) $ (6,641,246)

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The decrease in property, plant and equipment resulting from disposals. [Refer: Property, plant and equipment]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 16
-IssueDate 2023-01-01
-Paragraph 73
-Subparagraph e
-Clause ii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_ii&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DisposalsPropertyPlantAndEquipment

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) in property, plant and equipment resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Property, plant and equipment]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 16
-IssueDate 2023-01-01
-Paragraph 73
-Subparagraph e
-Clause viii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_viii&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 16
-IssueDate 2023-01-01
-Paragraph 73
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_PropertyPlantAndEquipment

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_OfficeEquipmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_VehiclesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MachineryMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandAndBuildingsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 58 R49.htm IDEA: XBRL DOCUMENT v3.23.3

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets (Details) - USD ($)

Sep. 30, 2023

Jun. 30, 2023

Sep. 30, 2022

Jun. 30, 2022

Intangible assets

Intangible assets $ 173,034,536 $ 173,783,956

Gross carrying amount

Intangible assets

Intangible assets 204,300,750 202,306,618 $ 194,493,789 $ 94,229,557

Accumulated depreciation

Intangible assets

Intangible assets $ (31,266,214) $ (28,522,662) $ (20,000,299) $ (17,524,688)

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfIntangibleAssetsLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 38
-IssueDate 2023-01-01
-Paragraph 118
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_IntangibleAssetsOtherThanGoodwill

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 59 R50.htm IDEA: XBRL DOCUMENT v3.23.3

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets, net carrying amount (Details) - USD ($)

Sep. 30, 2023

Jun. 30, 2023

Intangible assets

Intangible assets $ 173,034,536 $ 173,783,956

HB4 and breeding program

Intangible assets

Intangible assets 31,476,363 31,679,681

Integrated products

Intangible assets

Intangible assets 2,786,562 2,841,008

Microbiology product

Intangible assets

Intangible assets 50,506,239 49,508,801

Trademarks and patents

Intangible assets

Intangible assets 58,730,415 59,760,753

Software

Intangible assets

Intangible assets 1,609,367 1,987,690

Customer loyalty

Intangible assets

Intangible assets 22,925,590 23,006,023

RG/RS/OX Wheat

Intangible assets

Intangible assets $ 5,000,000 $ 5,000,000

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfIntangibleAssetsLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 38
-IssueDate 2023-01-01
-Paragraph 118
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_IntangibleAssetsOtherThanGoodwill

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=biox_SoybeanHb4Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=biox_EcoseedIntegratedProductsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=biox_MicrobiologyProductMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_ComputerSoftwareMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=biox_RgRsOxWheatMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 60 R51.htm IDEA: XBRL DOCUMENT v3.23.3

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets, gross carrying amount (Details) - USD ($)
3 Months Ended

Sep. 30, 2023

Sep. 30, 2022

Intangible assets

Balance at beginning of the period $ 173,783,956

Balance at end of the period 173,034,536

Gross carrying amount

Intangible assets

Balance at beginning of the period 202,306,618 $ 94,229,557

Additions 2,011,990 3,450,871

Additions from business combination 96,818,958

Foreign currency translation (17,858) (5,597)

Balance at end of the period 204,300,750 194,493,789

HB4 and breeding program

Intangible assets

Balance at beginning of the period 31,679,681

Balance at end of the period 31,476,363

HB4 and breeding program | Gross carrying amount

Intangible assets

Balance at beginning of the period 34,958,425 31,371,088

Additions 224,230 361,006

Balance at end of the period 35,182,655 31,732,094

Integrated products

Intangible assets

Balance at beginning of the period 2,841,008

Balance at end of the period 2,786,562

Integrated products | Gross carrying amount

Intangible assets

Balance at beginning of the period 3,219,808 3,181,155

Foreign currency translation (8,178)

Balance at end of the period 3,211,630 3,181,155

Microbiology product

Intangible assets

Balance at beginning of the period 49,508,801

Balance at end of the period 50,506,239

Microbiology product | Gross carrying amount

Intangible assets

Balance at beginning of the period 55,645,028 8,855,421

Additions 1,723,274 2,880,002

Additions from business combination 39,613,280

Foreign currency translation (6,119) (3,945)

Balance at end of the period 57,362,183 51,344,758

Trademarks and patents

Intangible assets

Balance at beginning of the period 59,760,753

Balance at end of the period 58,730,415

Trademarks and patents | Gross carrying amount

Intangible assets

Balance at beginning of the period 67,653,234 12,183,045

Additions 62,543 3,679

Additions from business combination 55,420,441

Balance at end of the period 67,715,777 67,607,165

Software

Intangible assets

Balance at beginning of the period 1,987,690

Balance at end of the period 1,609,367

Software | Gross carrying amount

Intangible assets

Balance at beginning of the period 5,582,411 5,176,373

Additions 1,943 206,184

Foreign currency translation (3,561) (1,652)

Balance at end of the period 5,580,793 5,380,905

Customer loyalty

Intangible assets

Balance at beginning of the period 23,006,023

Balance at end of the period 22,925,590

Customer loyalty | Gross carrying amount

Intangible assets

Balance at beginning of the period 30,247,712 28,462,475

Additions from business combination 1,785,237

Balance at end of the period 30,247,712 30,247,712

RG/RS/OX Wheat

Intangible assets

Balance at beginning of the period 5,000,000

Balance at end of the period 5,000,000

RG/RS/OX Wheat | Gross carrying amount

Intangible assets

Balance at beginning of the period 5,000,000 5,000,000

Balance at end of the period $ 5,000,000 $ 5,000,000

X

- Definition
The increase in intangible assets other than goodwill resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 38
-IssueDate 2023-01-01
-Paragraph 118
-Subparagraph e
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e_i&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 38
-IssueDate 2023-01-01
-Paragraph 118
-Subparagraph e
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e_i&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfIntangibleAssetsLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The increase (decrease) in intangible assets other than goodwill resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Intangible assets other than goodwill]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 38
-IssueDate 2023-01-01
-Paragraph 118
-Subparagraph e
-Clause vii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e_vii&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 38
-IssueDate 2023-01-01
-Paragraph 118
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_IntangibleAssetsOtherThanGoodwill

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=biox_SoybeanHb4Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=biox_EcoseedIntegratedProductsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=biox_MicrobiologyProductMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_ComputerSoftwareMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=biox_RgRsOxWheatMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 61 R52.htm IDEA: XBRL DOCUMENT v3.23.3

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets, accumulated amortization (Details) - USD ($)
3 Months Ended

Sep. 30, 2023

Sep. 30, 2022

Intangible assets

Balance at beginning of the period $ 173,783,956

Balance at end of the period 173,034,536

Accumulated depreciation

Intangible assets

Balance at beginning of the period (28,522,662) $ (17,524,688)

Amortization of the period (2,747,206) (2,476,832)

Foreign currency translation 3,654 1,221

Balance at end of the period (31,266,214) (20,000,299)

HB4 and breeding program

Intangible assets

Balance at beginning of the period 31,679,681

Balance at end of the period 31,476,363

HB4 and breeding program | Accumulated depreciation

Intangible assets

Balance at beginning of the period (3,278,744) (1,568,554)

Amortization of the period (427,548) (396,701)

Balance at end of the period (3,706,292) (1,965,255)

Integrated products

Intangible assets

Balance at beginning of the period 2,841,008

Balance at end of the period 2,786,562

Integrated products | Accumulated depreciation

Intangible assets

Balance at beginning of the period (378,800) (43,997)

Amortization of the period (47,229) (13,019)

Foreign currency translation 961

Balance at end of the period (425,068) (57,016)

Microbiology product

Intangible assets

Balance at beginning of the period 49,508,801

Balance at end of the period 50,506,239

Microbiology product | Accumulated depreciation

Intangible assets

Balance at beginning of the period (6,136,227) (3,063,073)

Amortization of the period (719,717) (1,057,149)

Balance at end of the period (6,855,944) (4,120,222)

Trademarks and patents

Intangible assets

Balance at beginning of the period 59,760,753

Balance at end of the period 58,730,415

Trademarks and patents | Accumulated depreciation

Intangible assets

Balance at beginning of the period (7,892,481) (3,916,004)

Amortization of the period (1,092,881) (542,868)

Balance at end of the period (8,985,362) (4,458,872)

Software

Intangible assets

Balance at beginning of the period 1,987,690

Balance at end of the period 1,609,367

Software | Accumulated depreciation

Intangible assets

Balance at beginning of the period (3,594,721) (3,008,388)

Amortization of the period (379,398) (141,044)

Foreign currency translation 2,693 1,221

Balance at end of the period (3,971,426) (3,148,211)

Customer loyalty

Intangible assets

Balance at beginning of the period 23,006,023

Balance at end of the period 22,925,590

Customer loyalty | Accumulated depreciation

Intangible assets

Balance at beginning of the period (7,241,689) (5,924,672)

Amortization of the period (80,433) (326,051)

Balance at end of the period $ (7,322,122) $ (6,250,723)

X

- Definition
The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 38
-IssueDate 2023-01-01
-Paragraph 118
-Subparagraph e
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e_i&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfIntangibleAssetsLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The increase (decrease) in intangible assets other than goodwill resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Intangible assets other than goodwill]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 38
-IssueDate 2023-01-01
-Paragraph 118
-Subparagraph e
-Clause vii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e_vii&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 38
-IssueDate 2023-01-01
-Paragraph 118
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_IntangibleAssetsOtherThanGoodwill

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=biox_SoybeanHb4Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=biox_EcoseedIntegratedProductsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=biox_MicrobiologyProductMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_ComputerSoftwareMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 62 R53.htm IDEA: XBRL DOCUMENT v3.23.3

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Goodwill (Details) - USD ($)

Sep. 30, 2023

Jun. 30, 2023

Goodwill

Goodwill $ 112,163,432 $ 112,163,432

Rizobacter Argentina S.A.

Goodwill

Goodwill 28,080,271 28,080,271

Bioceres Crops S.A.

Goodwill

Goodwill 7,523,322 7,523,322

Pro farm Group, Inc.

Goodwill

Goodwill 76,089,749 76,089,749

Insumos Agroqumicos S.A.

Goodwill

Goodwill $ 470,090 $ 470,090

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Business combinations [member]]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 36
-IssueDate 2023-01-01
-Paragraph 134
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_134_a&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 36
-IssueDate 2023-01-01
-Paragraph 135
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_135_a&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 3
-IssueDate 2023-01-01
-Paragraph B67
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_Goodwill

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: ifrs-full_SignificantInvestmentsInSubsidiariesAxis=biox_RizobacterArgentinaMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_SignificantInvestmentsInSubsidiariesAxis=biox_BioceresCropsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_SignificantInvestmentsInSubsidiariesAxis=biox_ProFarmGroupInc.Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_SignificantInvestmentsInSubsidiariesAxis=biox_InsumosAgroqumicosMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 63 R54.htm IDEA: XBRL DOCUMENT v3.23.3

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Investment properties (Details) - USD ($)

Sep. 30, 2033

Jun. 30, 2033

Sep. 30, 2023

Jun. 30, 2023

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

Investment properties $ 3,675,493 $ 3,589,749 $ 3,675,493 $ 3,589,749

X

- Definition
n/a
+ References
No definition available.
+ Details

Name: biox_ComponentsOfConsolidatedStatementsOfFinancialPositionAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of property (land or a building - or part of a building - or both) held (by the owner or by the lessee as a right-of-use asset) to earn rentals or for capital appreciation or both, rather than for: (a) use in the production or supply of goods or services or for administrative purposes; or (b) sale in the ordinary course of business.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 40
-IssueDate 2023-01-01
-Paragraph 76
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_76&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 40
-IssueDate 2023-01-01
-Paragraph 79
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_79_d&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_InvestmentProperty

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 64 R55.htm IDEA: XBRL DOCUMENT v3.23.3

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Trade and other payable (Details) - USD ($)

Sep. 30, 2023

Jun. 30, 2023

Current

Trade creditors $ 106,222,415 $ 104,211,238

Taxes 5,138,674 3,561,058

Miscellaneous 183,536 953,301

Trade and other payable 159,125,358 150,807,674

Shareholders and other related parties

Current

Trade payable, related party 27,708 35,292

Parent company

Current

Trade payable, related party 270,645 644,191

Joint ventures and associates

Current

Trade payable, related party $ 47,282,380 $ 41,402,594

X

- Definition
The amount of current payables on social security and taxes other than incomes tax. [Refer: Payables on social security and taxes other than income tax]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of current payables that the entity does not separately disclose in the same statement or note.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_OtherCurrentPayables

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph k
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_k&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_TradeAndOtherCurrentPayables

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: ifrs-full_TradeAndOtherCurrentPayablesAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of current payables due to related parties. [Refer: Related parties [member]; Payables to related parties]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 70
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_70&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_OtherRelatedPartiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_ParentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_CategoriesOfRelatedPartiesAxis=biox_JointVenturesAndAssociatesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 65 R56.htm IDEA: XBRL DOCUMENT v3.23.3

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Borrowings (Details) - USD ($)

Sep. 30, 2023

Jun. 30, 2023

Current

Corporate bonds $ 29,745,450 $ 35,547,510

Borrowings 100,720,985 107,639,659

Non-current

Corporate bonds 41,202,548 50,007,680

Borrowings 48,789,492 60,670,946

Bank borrowings

Current

Borrowings 60,473,023 61,303,952

Non-current

Borrowings 7,586,944 10,663,266

Trust debt securities

Current

Borrowings 6,936,758 7,296,506

Net loans payables - Parents companies and related parties

Current

Borrowings $ 3,565,754 $ 3,491,691

X

- Definition
The amount of bonds issued by the entity.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_BondsIssued

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: ifrs-full_CurrentLiabilitiesAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The non-current portion of non-current borrowings. [Refer: Borrowings]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_LongtermBorrowings

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: ifrs-full_NoncurrentLiabilitiesAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The non-current portion of non-current bonds issued. [Refer: Bonds issued]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_NoncurrentPortionOfNoncurrentBondsIssued

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of current borrowings. [Refer: Borrowings]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ShorttermBorrowings

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: ifrs-full_BorrowingsByNameAxis=biox_BankBorrowingsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_BorrowingsByNameAxis=biox_TrustDebtSecuritiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_CategoriesOfRelatedPartiesAxis=biox_ParentsCompaniesAndRelatedPartiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 66 R57.htm IDEA: XBRL DOCUMENT v3.23.3

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Borrowings, carrying amount (Details) - USD ($)

Sep. 30, 2023

Jun. 30, 2023

Current

Borrowings $ 100,720,985 $ 107,639,659

Corporate bonds 29,745,450 35,547,510

Non-current

Borrowings 48,789,492 60,670,946

Corporate bonds 41,202,548 50,007,680

Amortized cost

Current

Corporate bonds 29,745,450 35,547,510

Non-current

Corporate bonds 41,202,548 50,007,680

Fair value

Current

Corporate bonds 29,389,136 34,725,828

Non-current

Corporate bonds 39,984,876 47,014,542

Bank borrowings

Current

Borrowings 60,473,023 61,303,952

Non-current

Borrowings 7,586,944 10,663,266

Bank borrowings | Amortized cost

Current

Borrowings 60,473,023 61,303,952

Non-current

Borrowings 7,586,944 10,663,266

Bank borrowings | Fair value

Current

Borrowings 57,553,255 57,209,155

Non-current

Borrowings $ 5,620,759 $ 10,374,646

X

- Definition
The amount of bonds issued by the entity.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_BondsIssued

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: ifrs-full_CurrentLiabilitiesAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The non-current portion of non-current borrowings. [Refer: Borrowings]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_LongtermBorrowings

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: ifrs-full_NoncurrentLiabilitiesAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The non-current portion of non-current bonds issued. [Refer: Bonds issued]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_NoncurrentPortionOfNoncurrentBondsIssued

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of current borrowings. [Refer: Borrowings]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ShorttermBorrowings

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: ifrs-full_MeasurementAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_BorrowingsByNameAxis=biox_BankBorrowingsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 67 R58.htm IDEA: XBRL DOCUMENT v3.23.3

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Secured Notes (Details) - USD ($)

Sep. 30, 2033

Sep. 30, 2023

Jun. 30, 2023

Borrowings:

Secured notes $ 76,911,874 $ 75,213,146

Secured Guaranteed Notes | At cost

Borrowings:

Borrowings $ 25,900,000

Secured Guaranteed Notes | Fair value

Borrowings:

Borrowings 26,100,000

Secured Convertible Guaranteed Notes | At cost

Borrowings:

Borrowings 51,000,000.0

Secured Convertible Guaranteed Notes | Fair value

Borrowings:

Borrowings $ 53,300,000

X

- Definition
Amount of secured debt, non-current.
+ References
No definition available.
+ Details

Name: biox_SecuredDebtNonCurrent

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of outstanding funds that the entity is obligated to repay.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_Borrowings

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: ifrs-full_BorrowingsByNameAxis=biox_SecuredGuaranteedNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_MeasurementAxis=ifrs-full_AtCostMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_BorrowingsByNameAxis=biox_SecuredConvertibleGuaranteedNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 68 R59.htm IDEA: XBRL DOCUMENT v3.23.3

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Employee benefits and social security (Details) - USD ($)

Sep. 30, 2023

Jun. 30, 2023

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

Salaries, accrued incentives, vacations and social security $ 9,685,549 $ 9,388,639

Key management personnel 333,616 218,068

Employee benefits and social security $ 10,019,165 $ 9,606,707

X

- Definition
n/a
+ References
No definition available.
+ Details

Name: biox_ComponentsOfConsolidatedStatementsOfFinancialPositionAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of current liability related to key management personnel.
+ References
No definition available.
+ Details

Name: biox_KeyManagementPersonnelBenefitsLiabilityCurrent

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of current provisions for salaries, accrued incentives, vacations and social security.
+ References
No definition available.
+ Details

Name: biox_SalariesAccruedIncentivesVacationsAndSocialSecurityCurrent

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of current provisions for employee benefits. [Refer: Provisions for employee benefits]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_d&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CurrentProvisionsForEmployeeBenefits

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 69 R60.htm IDEA: XBRL DOCUMENT v3.23.3

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Deferred revenue and advances from customers (Details) - USD ($)

Sep. 30, 2023

Jun. 30, 2023

Current

Advances from customers $ 17,019,407 $ 9,216,032

Deferred Revenue 15,752,495 15,659,630

Deferred revenue and advances from customers 32,771,902 24,875,662

Non-current

Advances from customers 272,334 620,893

Deferred Revenue 1,930,040 1,436,912

Deferred revenue and advances from customers $ 2,202,374 $ 2,057,805

X

- References
No definition available.
+ Details

Name: ifrs-full_CurrentAccrualsAndCurrentDeferredIncomeIncludingCurrentContractLiabilitiesAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of current advances received representing current contract liabilities for performance obligations satisfied at a point in time. [Refer: Advances received, representing contract liabilities for performance obligations satisfied at point in time]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CurrentAdvances

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of current contract liabilities for performance obligations satisfied over time. [Refer: Contract liabilities for performance obligations satisfied over time]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of current deferred income including current contract liabilities. [Refer: Deferred income including contract liabilities]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: ifrs-full_NoncurrentAccrualsAndNoncurrentDeferredIncomeIncludingNoncurrentContractLiabilitiesAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of non-current advances received representing non-current contract liabilities for performance obligations satisfied at a point in time. [Refer: Advances received, representing contract liabilities for performance obligations satisfied at point in time]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_NoncurrentAdvances

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of non-current contract liabilities. [Refer: Contract liabilities]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 15
-IssueDate 2023-01-01
-Paragraph 105
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_105&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_NoncurrentContractLiabilities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of non-current contract liabilities for performance obligations satisfied over time. [Refer: Contract liabilities for performance obligations satisfied over time]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 55
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_NoncurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 70 R61.htm IDEA: XBRL DOCUMENT v3.23.3

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Revenue (Details) - USD ($)
3 Months Ended

Sep. 30, 2023

Sep. 30, 2022

Revenue

Revenues from contracts with customers $ 116,182,805 $ 126,843,248

Royalties 554,013 729,612

Sale of goods and services

Revenue

Revenues from contracts with customers $ 115,628,792 $ 126,113,636

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity’s ordinary activities in exchange for consideration.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 15
-IssueDate 2023-01-01
-Paragraph 114
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_114&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 15
-IssueDate 2023-01-01
-Paragraph 113
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_113_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_RevenueFromContractsWithCustomers

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of income arising from royalties.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_RevenueFromRoyalties

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: ifrs-full_ProductsAndServicesAxis=biox_GoodsAndServicesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 71 R62.htm IDEA: XBRL DOCUMENT v3.23.3

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Cost of Sales (Details) - USD ($)
3 Months Ended

Sep. 30, 2023

Sep. 30, 2022

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

Inventories as of the beginning of the period $ 111,990,145 $ 78,759,610

Business combination 11,064,908

Purchases of the period 71,694,655 79,325,509

Production costs 7,123,255 8,440,830

Foreign currency translation (226,797) (236,263)

Subtotal 190,581,258 177,354,594

Inventories as of the end of the period (118,965,477) (101,678,716)

Cost of sales $ 71,615,781 $ 75,675,878

X

- Definition
Amount of foreign currency translation on inventory
+ References
No definition available.
+ Details

Name: biox_ForeignCurrencyTranslationOnInventory

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of inventory before closing inventory (ie., Opening inventory plus purchases).
+ References
No definition available.
+ Details

Name: biox_InventoriesBeforeClosingInventory

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Additions to inventories as results of business combination.
+ References
No definition available.
+ Details

Name: biox_InventoriesFromBusinessCombination

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of manufacturing costs capitalized to inventory during the period.
+ References
No definition available.
+ Details

Name: biox_InventoryProductionCosts

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of inventory purchased during the year.
+ References
No definition available.
+ Details

Name: biox_PurchaseOfInventory

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 99
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_99&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 103
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CostOfSales

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of assets: (a) held for sale in the ordinary course of business; (b) in the process of production for such sale; or (c) in the form of materials or supplies to be consumed in the production process or in the rendering of services. Inventories encompass goods purchased and held for resale including, for example, merchandise purchased by a retailer and held for resale, or land and other property held for resale. Inventories also encompass finished goods produced, or work in progress being produced, by the entity and include materials and supplies awaiting use in the production process. [Refer: Current finished goods; Current merchandise; Current work in progress; Land]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 54
-Subparagraph g
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_g&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_InventoriesTotal

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: ifrs-full_StatementOfComprehensiveIncomeAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 72 R63.htm IDEA: XBRL DOCUMENT v3.23.3

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - R&D classified by nature (Details) - USD ($)
3 Months Ended

Sep. 30, 2023

Sep. 30, 2022

Costs and expenses

Depreciation of leased assets $ 837,199 $ 676,427

Total 4,581,241 3,852,014

R&D capitalized 1,947,504 3,241,008

Total 6,528,745 7,093,022

Research and development expenses

Costs and expenses

Amortization of intangible assets 1,164,940 1,511,118

Analysis and storage 11,568

Import and export expenses 850

Depreciation of property, plant and equipment 157,808 142,373

Freight and haulage 3,917 5,300

Employee benefits and social securities 1,307,126 861,312

Maintenance 206,778 217,066

Energy and fuel 3,628 79,121

Supplies and materials 847,382 559,044

Mobility and travel 13,771 108,694

Share-based incentives 188,250 6,975

Professional fees and outsourced services 491,787 293,776

Office supplies and registrations fees 170,375 21,454

Information technology expenses 4,375 11,996

Insurance 21,049 10,537

Depreciation of leased assets 10,650

Miscellaneous 55 180

Total $ 4,581,241 $ 3,852,014

X

- Definition
Amount of analysis and storage.
+ References
No definition available.
+ Details

Name: biox_AnalysisAndStorage

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: biox_DisclosureOfDetailedInformationAboutResearchAndDevelopmentExpenseLineItems

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of freight and haulage expenses.
+ References
No definition available.
+ Details

Name: biox_FreightAndHaulageExpenses

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of import and export expenses.
+ References
No definition available.
+ Details

Name: biox_ImportAndExportExpenses

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of information technology expenses.
+ References
No definition available.
+ Details

Name: biox_InformationTechnologyExpenses

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of miscellaneous expense of income expense.
+ References
No definition available.
+ Details

Name: biox_MiscellaneousExpenseOfIncomeExpense

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of research and development expense capitalized.
+ References
No definition available.
+ Details

Name: biox_ResearchAndDevelopmentExpenseCapitalized

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of share-based incentives expenses.
+ References
No definition available.
+ Details

Name: biox_ShareBasedIncentivesExpenses

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of current supplies and materials purchased for production.
+ References
No definition available.
+ Details

Name: biox_SuppliesAndMaterials

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of research and development costs that an entity incurs.
+ References
No definition available.
+ Details

Name: biox_TotalResearchAndDevelopmentExpenseIncurred

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of expenses that the entity classifies as being administrative.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 26
-IssueDate 2023-01-01
-Paragraph 35
-Subparagraph b
-Clause vi
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2023-en-r&anchor=para_35_b_vi&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 103
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 99
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_99&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AdministrativeExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 38
-IssueDate 2023-01-01
-Paragraph 118
-Subparagraph e
-Clause vi
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e_vi&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of depreciation of property, plant and equipment. [Refer: Depreciation and amortisation expense; Property, plant and equipment]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 16
-IssueDate 2023-01-01
-Paragraph 73
-Subparagraph e
-Clause vii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_vii&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 16
-IssueDate 2023-01-01
-Paragraph 75
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_75_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DepreciationPropertyPlantAndEquipment

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 16
-IssueDate 2023-01-01
-Paragraph 53
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DepreciationRightofuseAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of expense arising from the consumption of fuel and energy.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_FuelAndEnergyExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of expense arising from purchased insurance.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_InsuranceExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of fees paid or payable for professional services.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ProfessionalFeesExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of expenses incurred for the day-to-day servicing of assets, which may include the cost of labour, consumables or small parts.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 85
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_85&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_RepairsAndMaintenanceExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of expenditure directly attributable to research or development activities, recognised in profit or loss.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 38
-IssueDate 2023-01-01
-Paragraph 126
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_126&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ResearchAndDevelopmentExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of expense from employee benefits (other than termination benefits) that are expected to be settled wholly within twelve months after the end of the annual reporting period in which the employees render the related services.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ShorttermEmployeeBenefitsExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of expense arising from travel.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_TravelExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=biox_IfrsResearchAndDevelopmentExpenseMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 73 R64.htm IDEA: XBRL DOCUMENT v3.23.3

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Expenses classified by nature and functions (Details) - USD ($)
3 Months Ended

Sep. 30, 2023

Sep. 30, 2022

Expenses classified by nature and function

Depreciation of leased assets $ 837,199 $ 676,427

Obsolescence 505,285 618,489

Production costs

Expenses classified by nature and function

Amortization of intangible assets 30,478 43,456

Analysis and storage 570 5,425

Commissions and royalties 134,592 118,960

Import and export expenses 67,228 98,186

Depreciation of property, plant and equipment 643,006 746,609

Depreciation of leased assets 339,378 395,972

Freight and haulage 643,877 241,533

Employee benefits and social securities 2,806,939 3,994,761

Maintenance 422,757 462,743

Energy and fuel 163,122 500,359

Supplies and materials 260,043 339,843

Mobility and travel 33,407 20,940

Share-based incentives 275,432 100,206

Professional fees and outsourced services 509,450 674,014

Office supplies 149,888 32,546

Insurance 27,024 28,430

Information technology expenses 18,361 13,243

Obsolescence 505,285 539,382

Taxes 70,819 45,049

Miscellaneous 21,599 39,173

Total 7,123,255 8,440,830

Selling, general and administrative expenses

Expenses classified by nature and function

Amortization of intangible assets 1,551,788 922,258

Analysis and storage 153,473 113,265

Commissions and royalties 794,058 623,459

Import and export expenses 120,345 256,070

Depreciation of property, plant and equipment 442,589 493,111

Depreciation of leased assets 497,821 269,805

Impairment of receivables 352,920 156,053

Freight and haulage 2,989,094 3,474,028

Employee benefits and social securities 10,238,931 10,041,033

Maintenance 568,155 980,742

Energy and fuel 16,397 58,400

Supplies and materials 831,454 491,811

Mobility and travel 1,348,563 994,919

Publicity and advertising 1,161,498 1,888,497

Contingencies 27,109 2,448

Share-based incentives 5,729,986 120,170

Professional fees and outsourced services 1,575,982 4,610,610

Office supplies 370,770 289,467

Insurance 473,850 760,276

Information technology expenses 743,163 993,378

Obsolescence 79,107

Taxes 3,766,419 4,130,539

Miscellaneous 178,483 155,465

Total 33,932,848 31,904,911

Total

Expenses classified by nature and function

Amortization of intangible assets 1,582,266 965,714

Analysis and storage 154,043 118,690

Commissions and royalties 928,650 742,419

Import and export expenses 187,573 354,256

Depreciation of property, plant and equipment 1,085,595 1,239,720

Depreciation of leased assets 837,199 665,777

Impairment of receivables 352,920 156,053

Freight and haulage 3,632,971 3,715,561

Employee benefits and social securities 13,045,870 14,035,794

Maintenance 990,912 1,443,485

Energy and fuel 179,519 558,759

Supplies and materials 1,091,497 831,654

Mobility and travel 1,381,970 1,015,859

Publicity and advertising 1,161,498 1,888,497

Contingencies 27,109 2,448

Share-based incentives 6,005,418 220,376

Professional fees and outsourced services 2,085,432 5,284,624

Office supplies 520,658 322,013

Insurance 500,874 788,706

Information technology expenses 761,524 1,006,621

Obsolescence 505,285 618,489

Taxes 3,837,238 4,175,588

Miscellaneous 200,082 194,638

Total $ 41,056,103 $ 40,345,741

X

- Definition
Adjustments for obsolescence to reconcile profit (loss) to net cash flow from (used in) operating activities.
+ References
No definition available.
+ Details

Name: biox_AdjustmentsForObsolescence

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of advertising expense relating to production costs and selling general and administrative expenses.
+ References
No definition available.
+ Details

Name: biox_AdvertisingExpenses

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of analysis and storage.
+ References
No definition available.
+ Details

Name: biox_AnalysisAndStorage

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of commissions and royalties.
+ References
No definition available.
+ Details

Name: biox_CommissionsAndRoyalties

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of contingencies.
+ References
No definition available.
+ Details

Name: biox_Contingencies

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of freight and haulage expenses.
+ References
No definition available.
+ Details

Name: biox_FreightAndHaulageExpenses

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of impairment loss recognised in profit or loss, trade receivables relating to production costs selling, general and administrative expenses.
+ References
No definition available.
+ Details

Name: biox_ImpairmentOfReceivables

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of import and export expenses.
+ References
No definition available.
+ Details

Name: biox_ImportAndExportExpenses

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of information technology expenses.
+ References
No definition available.
+ Details

Name: biox_InformationTechnologyExpenses

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of miscellaneous expense of income expense.
+ References
No definition available.
+ Details

Name: biox_MiscellaneousExpenseOfIncomeExpense

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of production cost relating to inventory and selling, general and administrative expenses.
+ References
No definition available.
+ Details

Name: biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of share-based incentives expenses.
+ References
No definition available.
+ Details

Name: biox_ShareBasedIncentivesExpenses

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of current supplies and materials purchased for production.
+ References
No definition available.
+ Details

Name: biox_SuppliesAndMaterials

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of taxes.
+ References
No definition available.
+ Details

Name: biox_Taxes

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of expenses that the entity classifies as being administrative.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 26
-IssueDate 2023-01-01
-Paragraph 35
-Subparagraph b
-Clause vi
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2023-en-r&anchor=para_35_b_vi&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 103
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 99
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_99&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AdministrativeExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 38
-IssueDate 2023-01-01
-Paragraph 118
-Subparagraph e
-Clause vi
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e_vi&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of depreciation of property, plant and equipment. [Refer: Depreciation and amortisation expense; Property, plant and equipment]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 16
-IssueDate 2023-01-01
-Paragraph 73
-Subparagraph e
-Clause vii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_vii&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 16
-IssueDate 2023-01-01
-Paragraph 75
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_75_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DepreciationPropertyPlantAndEquipment

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 16
-IssueDate 2023-01-01
-Paragraph 53
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DepreciationRightofuseAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of expense arising from the consumption of fuel and energy.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_FuelAndEnergyExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of expense arising from purchased insurance.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_InsuranceExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of fees paid or payable for professional services.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ProfessionalFeesExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of expenses incurred for the day-to-day servicing of assets, which may include the cost of labour, consumables or small parts.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 85
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_85&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_RepairsAndMaintenanceExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of expense from employee benefits (other than termination benefits) that are expected to be settled wholly within twelve months after the end of the annual reporting period in which the employees render the related services.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ShorttermEmployeeBenefitsExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of expense arising from travel.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_TravelExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=ifrs-full_CostOfSalesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=ifrs-full_SellingGeneralAndAdministrativeExpenseMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=biox_ProductionCostAndSellingGeneralAndAdministrativeExpenseMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 74 R65.htm IDEA: XBRL DOCUMENT v3.23.3

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Other income or expenses, net (Details) - USD ($)
3 Months Ended

Sep. 30, 2023

Sep. 30, 2022

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

Net result from commercialization of agricultural products $ (1,316,393) $ 6,327

Expenses recovery 87,053 126,061

Other income or expenses, net (2,295) 345,653

Total $ (1,231,635) $ 478,041

X

- Definition
The amount of recovered expenses.
+ References
No definition available.
+ Details

Name: biox_ExpensesRecovery

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of other income or expenses net.
+ References
No definition available.
+ Details

Name: biox_OtherIncomeOrExpensesNet

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of operating income (expense) that the entity does not separately disclose in the same statement or note.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 85
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_85&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_OtherOperatingIncomeExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of revenue arising from the sale of agricultural produce. [Refer: Revenue]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_RevenueFromSaleOfAgriculturalProduce

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_StatementOfComprehensiveIncomeAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 75 R66.htm IDEA: XBRL DOCUMENT v3.23.3

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Finance results (Details) - USD ($)
3 Months Ended

Sep. 30, 2023

Sep. 30, 2022

Financial costs

Interest expenses with the Parents $ (97,063) $ (149,734)

Interest expenses (6,935,241) (5,569,576)

Financial commissions (629,553) (1,060,537)

Financial Costs (7,661,857) (6,779,847)

Other financial results

Exchange differences generated by assets (9,685,066) (833,428)

Exchange differences generated by liabilities 10,335,537 6,322

Changes in fair value of financial assets or liabilities and other financial results (151,646) (569,032)

Net gain of inflation effect on monetary items (380,960) 107,832

Other finance results $ 117,865 $ (1,288,306)

X

- Definition
Amount of changes in fair value of financial assets or liabilities and other financial results
+ References
No definition available.
+ Details

Name: biox_ChangeInFairValueOfFinancialAssetsOrLiabilitiesOrOtherFinancialResults

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
No definition available
+ References
No definition available.
+ Details

Name: biox_FinanceCostsAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of interest expense on liabilities with parent.
+ References
No definition available.
+ Details

Name: biox_InterestExpenseOnLiabilitiesWithParent

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Net gain of inflation effect on monetary items.
+ References
No definition available.
+ Details

Name: biox_NetGainOnInflationEffectOnMonetary

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: biox_OtherFinanceResultsAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of expense relating to fees and commissions.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 85
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_85&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_FeeAndCommissionExpense

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of costs associated with financing activities of the entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 82
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_FinanceCosts

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The gains (losses) on exchange differences, recognised in profit or loss, on the fair value measurement of assets. [Refer: At fair value [member]]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IFRS
-Number 13
-IssueDate 2023-01-01
-Paragraph 93
-Subparagraph e
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_e_i&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition
The gains (losses) on exchange differences, recognised in profit or loss, on the fair value measurement of liabilities. [Refer: At fair value [member]]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IFRS
-Number 13
-IssueDate 2023-01-01
-Paragraph 93
-Subparagraph e
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_e_i&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementLiabilities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of interest expense on other financial liabilities. [Refer: Interest expense; Other financial liabilities]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_InterestExpenseOnOtherFinancialLiabilities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of finance income or cost that the entity does not separately disclose in the same statement or note. [Refer: Finance income (cost)]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 85
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_85&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_OtherFinanceIncomeCost

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 76 R67.htm IDEA: XBRL DOCUMENT v3.23.3

TAXATION - Taxes on income (Details) - USD ($)
3 Months Ended

Sep. 30, 2023

Sep. 30, 2022

TAXATION

Current tax expense $ (6,457,134) $ (6,020,201)

Deferred tax 6,028,094 1,007,558

Income tax expenses $ (429,040) $ (5,012,643)

X

- Definition
The amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 12
-IssueDate 2023-01-01
-Paragraph 80
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_80_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CurrentTaxExpenseIncome

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of tax expense (income) relating to changes in deferred tax liabilities and deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 12
-IssueDate 2023-01-01
-Paragraph 81
-Subparagraph g
-Clause ii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_g_ii&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DeferredTaxExpenseIncome

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 23
-Subparagraph h
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_h&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 26
-IssueDate 2023-01-01
-Paragraph 35
-Subparagraph b
-Clause viii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2023-en-r&anchor=para_35_b_viii&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 12
-IssueDate 2023-01-01
-Paragraph 79
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_79&doctype=Standard
-URIDate 2023-03-23

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 12
-IssueDate 2023-01-01
-Paragraph 81
-Subparagraph c
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_i&doctype=Standard
-URIDate 2023-03-23

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 12
-IssueDate 2023-01-01
-Paragraph 81
-Subparagraph c
-Clause ii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_ii&doctype=Standard
-URIDate 2023-03-23

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B13
-Subparagraph g
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 82
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_d&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_IncomeTaxExpenseContinuingOperations

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 77 R68.htm IDEA: XBRL DOCUMENT v3.23.3

TAXATION - Movement on the deferred income tax (Details) - USD ($)
3 Months Ended

Sep. 30, 2023

Sep. 30, 2022

TAXATION

Beginning of the period deferred tax $ (28,472,383) $ (24,994,569)

Additions for business combination (16,704,770)

Charge for the period 6,028,094 1,007,558

Conversion difference (3,718,889) (261,014)

Total net deferred tax $ (26,163,178) $ (40,952,795)

X

- Definition
The amount of tax expense or income relating to changes in deferred tax liabilities and deferred tax assets, recognised in profit or loss. [Refer: Deferred tax assets; Deferred tax expense (income); Deferred tax liabilities]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 12
-IssueDate 2023-01-01
-Paragraph 81
-Subparagraph g
-Clause ii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_g_ii&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of deferred tax liabilities or assets. [Refer: Deferred tax liabilities; Deferred tax assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 12
-IssueDate 2023-01-01
-Paragraph 81
-Subparagraph g
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_g_i&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DeferredTaxLiabilityAsset

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The increase (decrease) in deferred tax liability (asset) resulting from business combinations. [Refer: Deferred tax liability (asset)]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 12
-IssueDate 2023-01-01
-Paragraph 81
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) in deferred tax liability (asset) resulting from the net exchange differences arising when the financial statements are translated from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Deferred tax liability (asset)]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 12
-IssueDate 2023-01-01
-Paragraph 81
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 78 R69.htm IDEA: XBRL DOCUMENT v3.23.3

TAXATION - Reconciliation of the statutory tax rate (Details) - USD ($)
3 Months Ended

Sep. 30, 2023

Sep. 30, 2022

TAXATION

Earnings before income tax-rate $ (2,249,424) $ 8,924,643

Income tax expense by applying tax rate in force in the respective countries (1,721,853) (5,739,069)

Share of profit or loss of subsidiaries, joint ventures and associates 530,177 313,280

Stock options charge (1,226,796) (57,818)

Non-deductible expenses (383,074) (805,883)

Unrecognized deferred tax (895,896)

Tax inflation adjustment 4,826,023 1,822,594

Result of inflation effect on monetary items and other finance results (2,352,623) 213,857

Others (100,894) 136,292

Income tax expenses $ (429,040) $ (5,012,643)

X

- Definition
The amount that represents the inflation effect on monetary items and other finance results.
+ References
No definition available.
+ Details

Name: biox_ResultForInflationEffectOnMonetaryItemsAndOtherFinanceResults

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to expenses not deductible and revenues that are exempt from taxation in determining taxable profit (tax loss).
+ References
No definition available.
+ Details

Name: biox_TaxEffectOfRevenuesExemptFromTaxationAndExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to share of profit or loss of subsidies, joint ventures and associates.
+ References
No definition available.
+ Details

Name: biox_TaxEffectOfShareOfProfitOrLossOfSubsidiesJointVenturesAndAssociates

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount representing the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to stock option charge.
+ References
No definition available.
+ Details

Name: biox_TaxEffectOfStockOptionCharge

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to unrecognized deferred taxes.
+ References
No definition available.
+ Details

Name: biox_TaxEffectOfUnrecognizedDeferredTax

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of Tax Inflation Adjustment
+ References
No definition available.
+ Details

Name: biox_TaxInflationAdjustment

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of profit (loss) for a period before deducting tax expense. [Refer: Profit (loss)]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 12
-IssueDate 2023-01-01
-Paragraph 81
-Subparagraph c
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_i&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 12
-IssueDate 2023-01-01
-Paragraph 81
-Subparagraph c
-Clause ii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_ii&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AccountingProfit

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 23
-Subparagraph h
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_h&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 26
-IssueDate 2023-01-01
-Paragraph 35
-Subparagraph b
-Clause viii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2023-en-r&anchor=para_35_b_viii&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 12
-IssueDate 2023-01-01
-Paragraph 79
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_79&doctype=Standard
-URIDate 2023-03-23

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 12
-IssueDate 2023-01-01
-Paragraph 81
-Subparagraph c
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_i&doctype=Standard
-URIDate 2023-03-23

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 12
-IssueDate 2023-01-01
-Paragraph 81
-Subparagraph c
-Clause ii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_ii&doctype=Standard
-URIDate 2023-03-23

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B13
-Subparagraph g
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 82
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_d&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_IncomeTaxExpenseContinuingOperations

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that the entity does not separately disclose in the same statement or note. [Refer: Accounting profit; Applicable tax rate]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 12
-IssueDate 2023-01-01
-Paragraph 81
-Subparagraph c
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_i&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The product of the accounting profit multiplied by the applicable tax rate(s). [Refer: Accounting profit; Applicable tax rate]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 12
-IssueDate 2023-01-01
-Paragraph 81
-Subparagraph c
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_i&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_TaxExpenseIncomeAtApplicableTaxRate

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 79 R70.htm IDEA: XBRL DOCUMENT v3.23.3

EARNING PER SHARE (Details)
3 Months Ended

Sep. 30, 2023

USD ($)

$ / shares

shares

Sep. 30, 2022

USD ($)

category

$ / shares

shares

Numerator

(Loss) profit for the period (basic EPS) | $ $ (4,591,634) $ 498,297

(Loss) profit for the period (diluted EPS) | $ $ (4,591,634) $ 498,297

Denominator

Weighted average number of shares (basic EPS) | shares 62,846,690 60,537,110

Weighted average number of shares (diluted EPS) | shares 62,846,690 61,736,679

Basic (loss) profit attributable to ordinary equity holders of the parent | $ / shares $ (0.0731) $ 0.0082

Diluted (loss) profit attributable to ordinary equity holders of the parent | $ / shares $ (0.0731) $ 0.0081

Number of categories of dilutive potential shares | category 2

X

- Definition
The number of categories of dilutive potential shares.
+ References
No definition available.
+ Details

Name: biox_NumberOfCategoriesOfDilutiveShares

Namespace Prefix: biox_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- Definition
The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 33
-IssueDate 2023-01-01
-Paragraph 70
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_70_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AdjustedWeightedAverageShares

Namespace Prefix: ifrs-full_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator).
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 33
-IssueDate 2023-01-01
-Paragraph 66
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_66&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 33
-IssueDate 2023-01-01
-Paragraph 67
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_67&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_BasicEarningsLossPerShare

Namespace Prefix: ifrs-full_

Data Type: dtr-types:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 33
-IssueDate 2023-01-01
-Paragraph 66
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_66&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 33
-IssueDate 2023-01-01
-Paragraph 67
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_67&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DilutedEarningsLossPerShare

Namespace Prefix: ifrs-full_

Data Type: dtr-types:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The profit (loss) attributable to ordinary equity holders of the parent entity. [Refer: Profit (loss)]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 33
-IssueDate 2023-01-01
-Paragraph 70
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_70_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The profit (loss) attributable to ordinary equity holders of the parent entity, adjusted for the effects of all dilutive potential ordinary shares. [Refer: Profit (loss)]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 33
-IssueDate 2023-01-01
-Paragraph 70
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_70_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 33
-IssueDate 2023-01-01
-Paragraph 70
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_70_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_WeightedAverageShares

Namespace Prefix: ifrs-full_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 80 R71.htm IDEA: XBRL DOCUMENT v3.23.3

EQUITY INFORMATION (Details)
3 Months Ended

Sep. 30, 2023

shares

Vote

USD ($)

$ / shares

Disclosure of classes of share capital [line items]

Number of own shares repurchased | $ 2,231,761

Number of votes for each ordinary share | Vote 1

Equity compensation plan

Disclosure of classes of share capital [line items]

Number of total converted options outstanding 3,951,917

Ordinary shares

Disclosure of classes of share capital [line items]

Number of shares authorised 100,000,000

Par value per share | $ / shares $ 0.0001

Number of shares issued 62,849,997

Number of shares outstanding 62,849,997

Preference shares

Disclosure of classes of share capital [line items]

Number of shares authorised 1,000,000

Par value per share | $ / shares $ 0.0001

Number of shares issued 0

Number of shares outstanding 0

X

- Definition
Number of shares that have been repurchased.
+ References
No definition available.
+ Details

Name: biox_IfrsStockRepurchasedDuringPeriodShares

Namespace Prefix: biox_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- Definition
Represents the number of votes for each ordinary share.
+ References
No definition available.
+ Details

Name: biox_VotesPerOrdinaryShare

Namespace Prefix: biox_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfClassesOfShareCapitalLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of share options outstanding in a share-based payment arrangement.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2023-01-01
-Paragraph 45
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_d&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2023-01-01
-Paragraph 45
-Subparagraph b
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_i&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2023-01-01
-Paragraph 45
-Subparagraph b
-Clause vi
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_vi&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_NumberOfOutstandingShareOptions

Namespace Prefix: ifrs-full_

Data Type: xbrli:decimalItemType

Balance Type: na

Period Type: instant

X

- Definition
The number of shares authorised.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 79
-Subparagraph a
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a_i&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_NumberOfSharesAuthorised

Namespace Prefix: ifrs-full_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The number of shares issued by the entity.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 106
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_NumberOfSharesIssued

Namespace Prefix: ifrs-full_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 79
-Subparagraph a
-Clause iv
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a_iv&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_NumberOfSharesOutstanding

Namespace Prefix: ifrs-full_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The nominal value per share.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 79
-Subparagraph a
-Clause iii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a_iii&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ParValuePerShare

Namespace Prefix: ifrs-full_

Data Type: dtr-types:perShareItemType

Balance Type: na

Period Type: instant

X

- Details

Name: ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=biox_EquityCompensationPlanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_PreferenceSharesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 81 R72.htm IDEA: XBRL DOCUMENT v3.23.3

CASH FLOW INFORMATION (Details) - USD ($)
3 Months Ended

Sep. 30, 2023

Sep. 30, 2022

Investment activities

Net assets acquisition by business combination $ 150,510,313

Investment in-kind in other related parties 550,183

Capitalization of interest on buildings in progress $ 36,589

Investing activities $ 36,589 151,060,496

Financing activities

Capitalization of convertible notes 12,211,638

Purchase of own shares (23,915,029)

Financing activities $ (11,703,391)

X

- Definition
The amount of cash inflow effect of capitalization of convertible notes.
+ References
No definition available.
+ Details

Name: biox_CapitalizationOfConvertibleFinancingActivities

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of acquisition of own shares.
+ References
No definition available.
+ Details

Name: biox_IfrsPaymentsToPurchaseOfOwnShares

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of investment in kind in other related parties, non cash transactions investment activities.
+ References
No definition available.
+ Details

Name: biox_InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount recognised as of the acquisition date for net assets acquired or liabilities assumed in a business combination.
+ References
No definition available.
+ Details

Name: biox_NetAssetsAcquisitionByBusinessCombination

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of non cash financing activities.
+ References
No definition available.
+ Details

Name: biox_NonCashFinancingActivities

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: biox_NonCashFinancingActivitiesAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of non cash investing activities.
+ References
No definition available.
+ Details

Name: biox_NonCashInvestingActivities

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: biox_NonCashInvestingActivitiesAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of interest costs that an entity incurs in connection with the borrowing of funds that are directly attributable to the acquisition, construction or production of a qualifying asset and which form part of the cost of that asset.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_InterestCostsCapitalised

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

XML 82 R73.htm IDEA: XBRL DOCUMENT v3.23.3

JOINT VENTURES AND ASSOCIATES (Details) - USD ($)
3 Months Ended

Sep. 30, 2023

Sep. 30, 2022

Jun. 30, 2023

JOINT VENTURES

Assets in joint ventures and associates $ 40,820,784 $ 39,296,810

Liabilities in joint ventures and associates 638,126 622,823

Share of profit or loss of joint ventures and associates 1,508,671 $ 842,240

Trigall Genetics S.A.

JOINT VENTURES

Liabilities in joint ventures and associates 638,126 622,823

Share of profit or loss of joint ventures and associates (15,303) (132,117)

Synertech Industrias S.A.

JOINT VENTURES

Assets in joint ventures and associates 37,550,684 36,026,710

Share of profit or loss of joint ventures and associates 1,523,974 $ 974,357

Alfalfa Technologies S.R.L

JOINT VENTURES

Assets in joint ventures and associates 36,502 36,502

Moolec Science S.A.

JOINT VENTURES

Assets in joint ventures and associates $ 3,233,598 $ 3,233,598

X

- Definition
The amount of investments accounted for using the equity method, asset position.
+ References
No definition available.
+ Details

Name: biox_InvestmentsAccountedForUsingEquityMethodAssets

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of investments accounted for using the equity method, liability position.
+ References
No definition available.
+ Details

Name: biox_InvestmentsAccountedForUsingEquityMethodLiability

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfJointVenturesLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entity's share of the profit (loss) of associates and joint ventures accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Joint ventures [member]; Profit (loss)]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 28
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_e&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 23
-Subparagraph g
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_g&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 82
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: ifrs-full_JointVenturesAxis=biox_TrigallGeneticsS.a.Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_JointVenturesAxis=biox_SynertechIndustriasS.aMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_JointVenturesAxis=biox_AlfalfaTechnologiesS.r.lMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_JointVenturesAxis=biox_MoolecScienceS.a.Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 83 R74.htm IDEA: XBRL DOCUMENT v3.23.3

JOINT VENTURES AND ASSOCIATES - Changes in joint ventures investments (Details) - USD ($)
3 Months Ended

Sep. 30, 2023

Sep. 30, 2022

JOINT VENTURES AND ASSOCIATES

As of the beginning of the period $ 38,673,987 $ 37,836,144

Foreign currency translation 100,868

Share of profit or loss 1,508,671 842,240

As of the end of the period $ 40,182,658 $ 38,779,252

X

- Definition
The amount of investments accounted for using the equity method, including an investee with negative equity.
+ References
No definition available.
+ Details

Name: biox_InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: ifrs-full_InvestmentsAccountedForUsingEquityMethodAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of other comprehensive income, net of tax, related to exchange differences on translation of the financial statements of a parent company or a stand-alone entity to a different presentation currency. [Refer: Other comprehensive income]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 91
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_91_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The entity's share of the profit (loss) of associates and joint ventures accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Joint ventures [member]; Profit (loss)]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 28
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_e&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 23
-Subparagraph g
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_g&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 82
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 84 R75.htm IDEA: XBRL DOCUMENT v3.23.3

SEGMENT INFORMATION - Group's reporting segments (Details) - USD ($)
3 Months Ended

Sep. 30, 2023

Sep. 30, 2022

Revenues from contracts with customers

Sale of goods and services $ 116,182,805 $ 126,843,248

Royalties 554,013 729,612

Initial recognition and changes in the fair value of biological assets at the point of harvest 410,913 490,006

Total 116,593,718 127,333,254

Cost of sales (71,615,781) (75,675,878)

Gross profit per segment $ 44,977,937 $ 51,657,376

% Gross margin 39.00% 41.00%

Seed and integrated products

Revenues from contracts with customers

Royalties $ 554,013 $ 729,612

Initial recognition and changes in the fair value of biological assets at the point of harvest 87,844 51,451

Total 22,318,910 13,854,703

Cost of sales (14,110,381) (5,539,489)

Gross profit per segment $ 8,208,529 $ 8,315,214

% Gross margin 37.00% 60.00%

Crop protection

Revenues from contracts with customers

Initial recognition and changes in the fair value of biological assets at the point of harvest $ 172,118 $ 89,573

Total 55,926,478 63,075,746

Cost of sales (36,183,792) (45,035,250)

Gross profit per segment $ 19,742,686 $ 18,040,496

% Gross margin 35.00% 29.00%

Crop nutrition

Revenues from contracts with customers

Initial recognition and changes in the fair value of biological assets at the point of harvest $ 150,951 $ 348,982

Total 38,348,330 50,402,805

Cost of sales (21,321,608) (25,101,139)

Gross profit per segment $ 17,026,722 $ 25,301,666

% Gross margin 44.00% 50.00%

Sale of goods and services

Revenues from contracts with customers

Sale of goods and services $ 115,628,792 $ 126,113,636

Sale of goods and services | Seed and integrated products

Revenues from contracts with customers

Sale of goods and services 21,677,053 13,073,640

Sale of goods and services | Crop protection

Revenues from contracts with customers

Sale of goods and services 55,754,360 62,986,173

Sale of goods and services | Crop nutrition

Revenues from contracts with customers

Sale of goods and services $ 38,197,379 $ 50,053,823

X

- Definition
Percentage of gross margin and total revenue of the period during the entity.
+ References
No definition available.
+ Details

Name: biox_PercentageOfGrossMarginAndTotalRevenue

Namespace Prefix: biox_

Data Type: dtr-types:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 99
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_99&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 103
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CostOfSales

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The gains (losses) arising from changes in fair value less costs to sell of biological assets due to both physical and price changes in the market. [Refer: Biological assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 41
-IssueDate 2023-01-01
-Paragraph 50
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_50_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 103
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_GrossProfit

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 28
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_a&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 23
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_a&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 32
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_32&doctype=Standard
-URIDate 2023-03-23

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 5
-IssueDate 2023-01-01
-Paragraph 33
-Subparagraph b
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2023-en-r&anchor=para_33_b_i&doctype=Standard
-URIDate 2023-03-23

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 33
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_33_a&doctype=Standard
-URIDate 2023-03-23

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2023-01-01
-Paragraph 34
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_34&doctype=Standard
-URIDate 2023-03-23

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B12
-Subparagraph b
-Clause v
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 12
-IssueDate 2023-01-01
-Paragraph B10
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B
-URIDate 2023-03-23

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 82
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_a&doctype=Standard
-URIDate 2023-03-23

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 103
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard
-URIDate 2023-03-23

Reference 11: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 102
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_102&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_Revenue

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: ifrs-full_RevenueAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity’s ordinary activities in exchange for consideration.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 15
-IssueDate 2023-01-01
-Paragraph 114
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_114&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 15
-IssueDate 2023-01-01
-Paragraph 113
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_113_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_RevenueFromContractsWithCustomers

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of income arising from royalties.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 112
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_RevenueFromRoyalties

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: ifrs-full_SegmentsAxis=biox_SeedAndIntegratedProductsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_SegmentsAxis=biox_CropProtectionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_SegmentsAxis=biox_CropNutritionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ProductsAndServicesAxis=biox_GoodsAndServicesIncludingRightOfUseLicenseMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 85 R76.htm IDEA: XBRL DOCUMENT v3.23.3

FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Financial assets by category (Details) - USD ($)

Sep. 30, 2023

Jun. 30, 2023

Amortized cost

Financial assets by category

Financial assets. $ 224,487,532 $ 218,918,004

Fair value

Financial assets by category

Financial assets. 17,047,396 11,922,317

Cash and cash equivalents | Amortized cost

Financial assets by category

Financial assets. 25,954,730 48,129,194

Cash and cash equivalents | Fair value

Financial assets by category

Financial assets. 2,419,194

Other financial assets | Amortized cost

Financial assets by category

Financial assets. 502,910 657,612

Other financial assets | Fair value

Financial assets by category

Financial assets. 14,628,202 11,922,317

Trade receivables | Amortized cost

Financial assets by category

Financial assets. 186,276,319 158,006,474

Other receivables | Amortized cost

Financial assets by category

Financial assets. $ 11,753,573 $ 12,124,724

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfFinancialAssetsLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity’s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity’s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity’s own equity instruments. For this purpose the entity’s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity’s own equity instruments. [Refer: Financial instruments, class [member]; Financial liabilities]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 7
-IssueDate 2023-01-01
-Paragraph 25
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_25&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 7
-IssueDate 2023-01-01
-Paragraph 35H
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35H&doctype=Standard
-URIDate 2023-03-23

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 7
-IssueDate 2023-01-01
-Paragraph 35M
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35M&doctype=Standard
-URIDate 2023-03-23

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Name IFRS
-Number 7
-IssueDate 2023-01-01
-Paragraph 35N
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35N&doctype=Standard
-URIDate 2023-03-23

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 7
-IssueDate 2023-01-01
-Paragraph 35I
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35I&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_FinancialAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: ifrs-full_MeasurementAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfFinancialAssetsAxis=biox_CashAndEquivalentsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfFinancialAssetsAxis=biox_OtherFinancialAssetsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_TradeReceivablesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfFinancialAssetsAxis=biox_OtherReceivablesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 86 R77.htm IDEA: XBRL DOCUMENT v3.23.3

FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Financial liabilities by category (Details) - USD ($)

Sep. 30, 2023

Jun. 30, 2023

Amortized cost

Financial liabilities by category

Financial liabilities $ 399,470,755 $ 404,988,396

Fair value

Financial liabilities by category

Financial liabilities 6,372,275 8,225,508

Trade and other payables | Amortized cost

Financial liabilities by category

Financial liabilities 152,753,083 142,582,166

Trade and other payables | Fair value

Financial liabilities by category

Financial liabilities 6,372,275 8,225,508

Borrowings | Amortized cost

Financial liabilities by category

Financial liabilities 149,510,477 168,310,605

Convertible notes | Amortized cost

Financial liabilities by category

Financial liabilities 76,911,874 75,213,146

Lease liability | Amortized cost

Financial liabilities by category

Financial liabilities 13,552,751 13,889,223

Consideration for acquisition of assets | Amortized cost

Financial liabilities by category

Financial liabilities $ 6,742,570 $ 4,993,256

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfFinancialLiabilitiesLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity’s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity’s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity’s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity’s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity’s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity’s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Financial instruments, class [member]; Financial assets; Derivatives [member]]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 7
-IssueDate 2023-01-01
-Paragraph 25
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_25&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_FinancialLiabilities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: ifrs-full_MeasurementAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfFinancialLiabilitiesAxis=biox_TradeAndOtherPayablesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfFinancialLiabilitiesAxis=biox_BorrowingMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfFinancialLiabilitiesAxis=biox_ConvertibleNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_LeaseLiabilitiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_ContingentConsiderationMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 87 R78.htm IDEA: XBRL DOCUMENT v3.23.3

FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Fair value by hierarchy (Details) - USD ($)

Sep. 30, 2023

Jun. 30, 2023

Level 2

Fair value by hierarchy

Financial liabilities, at fair value $ 6,372,275 $ 8,225,508

US Treasury bills | Level 1

Fair value by hierarchy

Financial assets at fair value 9,719,486 9,163,298

Mutual funds | Level 1

Fair value by hierarchy

Financial assets at fair value 3,236,702 1,596,539

Other investments | Level 1

Fair value by hierarchy

Financial assets at fair value $ 1,672,014 $ 1,162,480

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The fair value of financial assets. [Refer: At fair value [member]; Financial assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 7
-IssueDate 2023-01-01
-Paragraph 25
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_25&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_FinancialAssetsAtFairValue

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The fair value of financial liabilities. [Refer: At fair value [member]; Financial liabilities]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 7
-IssueDate 2023-01-01
-Paragraph 25
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_25&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_FinancialLiabilitiesAtFairValue

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfFinancialAssetsAxis=biox_USTreasuryBillsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level1OfFairValueHierarchyMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_InvestmentFundsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfFinancialAssetsAxis=biox_OtherInvestmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 88 R79.htm IDEA: XBRL DOCUMENT v3.23.3

FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Currency risk (Details) - Currency risk
3 Months Ended

Sep. 30, 2023

USD ($)

Currency risk

Foreign currency $ (5,353,860)

Percentage of that a devaluation or an appreciation of the US Dollar other currencies 10.00%

Effect in profit and loss due to designate devaluation or appreciation of US dollar $ 500,000

X

- Definition
The effect on profit and loss as a result of an increase in a designated risk component that was reasonably possible at the end of the reporting period. Excludes defined benefit plan obligation
+ References
No definition available.
+ Details

Name: biox_EffectInProfitAndLossDueToDesignateDevaluationOrAppreciationOfUsDollar

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Represent the percentage of that a devaluation or an appreciation of the US Dollar against other currencies.
+ References
No definition available.
+ Details

Name: biox_PercentageOfEstimatedOrAppreciationOfDevaluationOfOtherCurrency

Namespace Prefix: biox_

Data Type: dtr-types:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17LineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of risk exposure associated with financial instruments with a shared characteristic that identifies a concentration of risks. [Refer: Financial instruments, class [member]]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 7
-IssueDate 2023-01-01
-Paragraph B8
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B8_c&doctype=Appendix&subtype=B
-URIDate 2023-03-23
+ Details

Name: ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: instant

X

- Details

Name: ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 89 R80.htm IDEA: XBRL DOCUMENT v3.23.3

LEASES - Right-of-use leased asset (Details) - USD ($)
3 Months Ended 12 Months Ended

Sep. 30, 2023

Sep. 30, 2022

Jun. 30, 2023

Right-of-use leased asset

Book value at the beginning of the period/year $ 13,936,575

Depreciation of the period/year 837,199 $ 676,427

Book value at the end of the period/year 13,519,199 $ 13,936,575

Right-of-use leased asset

Right-of-use leased asset

Book value at the beginning of the period/year 21,163,192 15,828,032 15,828,032

Additions of the period/year 1,072,418 3,154,950

Additions from business combination 3,005,000

Disposals (461,631) (1,839,921)

Exchange differences (513,269) 1,015,131

Book value at the end of the period/year 21,260,710 21,163,192

Depreciation

Right-of-use leased asset

Book value at the beginning of the period/year (7,226,617) $ (3,684,006) (3,684,006)

Disposals (274,431) (171,870)

Exchange differences (47,874) 148,587

Depreciation of the period/year 837,199 3,565,894

Book value at the end of the period/year $ (7,741,511) $ (7,226,617)

X

- Definition
The amount of additions to right of use assets from business combination.
+ References
No definition available.
+ Details

Name: biox_AdditionsToRightOfUseAssetsFromBusinessCombination

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of effect of exchange differences on the deprecation of right of use assets.
+ References
No definition available.
+ Details

Name: biox_DepreciationRightOfUseAssetsExchangeDifferences

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of disposals to right-of-use assets
+ References
No definition available.
+ Details

Name: biox_DisposalsToRightOfUseAssets

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of additions to right-of-use assets. [Refer: Right-of-use assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 16
-IssueDate 2023-01-01
-Paragraph 53
-Subparagraph h
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_h&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AdditionsToRightofuseAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 16
-IssueDate 2023-01-01
-Paragraph 53
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_DepreciationRightofuseAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 16
-IssueDate 2023-01-01
-Paragraph 53
-Subparagraph j
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_j&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 16
-IssueDate 2023-01-01
-Paragraph 47
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_47_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_RightofuseAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 90 R81.htm IDEA: XBRL DOCUMENT v3.23.3

LEASES - Lease liability (Details) - USD ($)
3 Months Ended 12 Months Ended

Sep. 30, 2023

Jun. 30, 2023

LEASES

Book value at the beginning of the period/year $ 13,889,223 $ 11,751,284

Additions of the period/year 1,072,418 3,154,950

Additions from business combination 3,245,000

Interest expenses, exchange differences and inflation effects (238,851) (406,494)

Payment of the period/year (1,170,039) (3,855,517)

Total 13,552,751 13,889,223

Lease Liabilities

Non-current 9,225,862 10,030,524

Current 4,326,889 3,858,699

Total $ 13,552,751 $ 13,889,223

X

- Definition
The amount of additions to lease liability from business combination.
+ References
No definition available.
+ Details

Name: biox_AdditionsToLeaseLiabilityFromBusinessCombination

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Lease liabilities additions from interest expense, exchange differences and inflation effects.
+ References
No definition available.
+ Details

Name: biox_LeaseLiabilitiesInterestExpenseExchangeDifferencesAndInflationEffects

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of additional liabilities during the period.
+ References
No definition available.
+ Details

Name: biox_LeasesLiabilitiesAdditions

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow for payment of lease liabilities.
+ References
No definition available.
+ Details

Name: biox_PaymentsOfLeaseLiabilities

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of current lease liabilities. [Refer: Lease liabilities]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 16
-IssueDate 2023-01-01
-Paragraph 47
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_47_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_CurrentLeaseLiabilities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 16
-IssueDate 2023-01-01
-Paragraph 47
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_47_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_LeaseLiabilities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: ifrs-full_LeaseLiabilitiesAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of non-current lease liabilities. [Refer: Lease liabilities]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 16
-IssueDate 2023-01-01
-Paragraph 47
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_47_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_NoncurrentLeaseLiabilities

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: ifrs-full_PresentationOfLeasesForLesseeAbstract

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 91 R82.htm IDEA: XBRL DOCUMENT v3.23.3

LEASES - Right-of-use asset by type (Details) - USD ($)
3 Months Ended

Sep. 30, 2023

Jun. 30, 2023

Jun. 30, 2022

Right-of-use leased asset

Right of use asset $ 13,519,199 $ 13,936,575

Incremental borrowing rate 2.13%

Right-of-use leased asset

Right-of-use leased asset

Right of use asset $ 21,260,710 21,163,192 $ 15,828,032

Right-of-use leased asset | Machinery and equipment

Right-of-use leased asset

Right of use asset 3,655,741 3,655,741

Right-of-use leased asset | Vehicles

Right-of-use leased asset

Right of use asset 1,433,616 1,475,581

Right-of-use leased asset | Equipment and computer software

Right-of-use leased asset

Right of use asset 1,011,490 903,306

Right-of-use leased asset | Land and buildings

Right-of-use leased asset

Right of use asset $ 15,159,863 $ 15,128,564

X

- Definition
Percentage of incremental borrowing rate.
+ References
No definition available.
+ Details

Name: biox_PercentageOfIncrementalBorrowingRate

Namespace Prefix: biox_

Data Type: dtr-types:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 16
-IssueDate 2023-01-01
-Paragraph 53
-Subparagraph j
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_j&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 16
-IssueDate 2023-01-01
-Paragraph 47
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_47_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_RightofuseAssets

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfAssetsAxis=ifrs-full_MachineryMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfAssetsAxis=ifrs-full_VehiclesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfAssetsAxis=ifrs-full_ComputerEquipmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_ClassesOfAssetsAxis=ifrs-full_LandAndBuildingsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 92 R83.htm IDEA: XBRL DOCUMENT v3.23.3

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS - Transactions (Details) - USD ($)
3 Months Ended

Sep. 30, 2023

Sep. 30, 2022

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS

In-kind contributions $ 550,183

Total $ (19,318,403) (8,459,795)

Joint ventures and associates

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS

Sales of goods and services 6,801,117 17,083,027

Purchases of goods and services (20,691,171) (25,314,814)

Key management personnel

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS

Salaries, social security benefits and other benefits (6,702,803) (648,494)

Shareholders and other related parties

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS

Sales of goods and services 1,590,568 261,418

Purchases of goods and services (196,051) (239,772)

In-kind contributions 550,183

Net loans granted / (cancelled) (1,609)

Interest expenses (23,000)

Parent company and related parties to Parent

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS

Interest expenses $ (97,063) $ (149,734)

X

- Definition
Amount of interest expenses.
+ References
No definition available.
+ Details

Name: biox_InterestExpensesRelatedPartyTransaction

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of investment in kind in other related parties, non cash transactions investment activities.
+ References
No definition available.
+ Details

Name: biox_InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of net loans granted or cancelled by the entity in related party transactions.
+ References
No definition available.
+ Details

Name: biox_NetLoansGrantedOrCancelledRelatedPartyTransactions

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of goods purchased and the amount of services received by the entity in related party transactions.
+ References
No definition available.
+ Details

Name: biox_PurchasesOfGoodsAndServicesReceivedRelatedPartyTransactions

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The total amount of related party transactions.
+ References
No definition available.
+ Details

Name: biox_RelatedPartyTransactions

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of revenue arising from the sale of goods and rendering of services in related party transactions.
+ References
No definition available.
+ Details

Name: biox_RevenueFromSaleOfGoodsAndRenderingOfServicesRelatedPartyTransactions

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of salaries, social security benefits and other benefits.
+ References
No definition available.
+ Details

Name: biox_SalariesSocialSecurityBenefitsAndOtherBenefitsRelatedPartyTransactions

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_JointVenturesWhereEntityIsVenturerMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_KeyManagementPersonnelOfEntityOrParentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_OtherRelatedPartiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_CategoriesOfRelatedPartiesAxis=biox_ParentCompaniesAndRelatedPartiesToParentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 93 R84.htm IDEA: XBRL DOCUMENT v3.23.3

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS - Receivable (Details) - USD ($)

Sep. 30, 2023

Jun. 30, 2023

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS

Other receivables $ 24,902,503 $ 28,824,998

Total 11,769,118 10,992,275

Shareholders and other related parties

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS

Other receivables 2,919,431 3,792,429

Trade debtors 1,368,373

Joint ventures and associates

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS

Other receivables 6,699,863 6,334,219

Trade debtors $ 781,451 $ 865,627

X

- Definition
The amount of trade receivables due from related parties.
+ References
No definition available.
+ Details

Name: biox_TradeReceivablesFromRelatedParties

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amounts receivable resulting from related party transactions. [Refer: Related parties [member]]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 24
-IssueDate 2023-01-01
-Paragraph 20
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_20&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 24
-IssueDate 2023-01-01
-Paragraph 18
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_18_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AmountsReceivableRelatedPartyTransactions

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of current other receivables. [Refer: Other receivables]
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_OtherCurrentReceivables

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_OtherRelatedPartiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_JointVenturesWhereEntityIsVenturerMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 94 R85.htm IDEA: XBRL DOCUMENT v3.23.3

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS - Payables (Details) - USD ($)

Sep. 30, 2023

Jun. 30, 2023

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS

Total $ 51,480,103 $ 45,791,836

Parent company and related parties to Parent

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS

Trade payables/creditors (270,645) (644,191)

Net loans payables (3,565,754) (3,491,691)

Key management personnel

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS

Salaries, social security benefits and other benefits (333,616) (218,068)

Shareholders and other related parties

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS

Trade payables/creditors (27,708) (35,292)

Joint ventures and associates

SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS

Trade payables/creditors $ (47,282,380) $ (41,402,594)

X

- Definition
The amount of loans payables to related party.
+ References
No definition available.
+ Details

Name: biox_LoansPayablesRelatedPartyTransactions

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of payables to related party pertaining to salaries, social security benefits and other.
+ References
No definition available.
+ Details

Name: biox_PayablesSalariesSocialSecurityBenefitsAndOther

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amounts payable resulting from related party transactions. [Refer: Related parties [member]]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 24
-IssueDate 2023-01-01
-Paragraph 20
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_20&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 24
-IssueDate 2023-01-01
-Paragraph 18
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_18_b&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_AmountsPayableRelatedPartyTransactions

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of current payables due to related parties. [Refer: Related parties [member]; Payables to related parties]
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2023-01-01
-Paragraph 78
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: ifrs-full_CategoriesOfRelatedPartiesAxis=biox_ParentCompaniesAndRelatedPartiesToParentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_KeyManagementPersonnelOfEntityOrParentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_OtherRelatedPartiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_JointVenturesWhereEntityIsVenturerMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 95 R86.htm IDEA: XBRL DOCUMENT v3.23.3

KEY MANAGEMENT PERSONNEL COMPENSATION - Summary of compensation of directors and other members (Details) - USD ($)
3 Months Ended

Sep. 30, 2023

Sep. 30, 2022

KEY MANAGEMENT PERSONNEL COMPENSATION

Salaries, social security and other benefits $ 509,135 $ 421,143

Share-based incentives 6,193,668 227,351

Total $ 6,702,803 $ 648,494

X

- References
No definition available.
+ Details

Name: biox_KeyManagementPersonnelCompensationAbstract

Namespace Prefix: biox_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 24
-IssueDate 2023-01-01
-Paragraph 17
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_17&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_KeyManagementPersonnelCompensation

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 24
-IssueDate 2023-01-01
-Paragraph 17
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_17_e&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of compensation to key management personnel in the form of short-term employee benefits. [Refer: Key management personnel of entity or parent [member]]
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 24
-IssueDate 2023-01-01
-Paragraph 17
-Subparagraph a
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_17_a&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits

Namespace Prefix: ifrs-full_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 96 R87.htm IDEA: XBRL DOCUMENT v3.23.3

SHARE-BASED PAYMENT (Details)
$ / shares in Units, $ in Millions
1 Months Ended

Aug. 31, 2023

USD ($)

$ / shares

Past Share Option plan | Minimum

SHARE-BASED PAYMENT

Exercise price $ 11.93

Past Share Option plan | Maximum

SHARE-BASED PAYMENT

Exercise price 13.24

Base Share Option plan

SHARE-BASED PAYMENT

Exercise price 10.47

Performance Share Option plan

SHARE-BASED PAYMENT

Exercise price $ 10.47

Performance Share Option plan | If EBITDA Reaches at Least US$120 Million

SHARE-BASED PAYMENT

Threshold earnings before interest | $ $ 120

Vesting percentage 0.00%

Performance Share Option plan | If EBITDA reaches at least US$150 million

SHARE-BASED PAYMENT

Threshold earnings before interest | $ $ 150

Performance Share Option plan | Maximum | If EBITDA reaches at least US$150 million

SHARE-BASED PAYMENT

Vesting percentage 100.00%

X

- Definition
Percentage of vesting of award under share-based payment arrangement.
+ References
No definition available.
+ Details

Name: biox_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage

Namespace Prefix: biox_

Data Type: dtr-types:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of threshold earnings before interest taxes depreciation and amortization.
+ References
No definition available.
+ Details

Name: biox_ThresholdEarningsBeforeInterestTaxesDepreciationAndAmortization

Namespace Prefix: biox_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.
+ References
No definition available.
+ Details

Name: ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems

Namespace Prefix: ifrs-full_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The exercise price of share options granted.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2023-01-01
-Paragraph 47
-Subparagraph a
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_a_i&doctype=Standard
-URIDate 2023-03-23
+ Details

Name: ifrs-full_ExercisePriceShareOptionsGranted2019

Namespace Prefix: ifrs-full_

Data Type: dtr-types:perShareItemType

Balance Type: na

Period Type: duration

X

- Details

Name: ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=biox_PastShareOptionPlanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=biox_BaseShareOptionPlanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=biox_PerformanceShareOptionPlanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_StatementScenarioAxis=biox_IfEbitdaReachesAtLeastUs120MillionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_StatementScenarioAxis=biox_IfEbitdaReachesAtLeastUs150MillionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 97 biox-20230930x6k_htm.xml IDEA: XBRL DOCUMENT 0001769484 2023-07-01 2023-09-30 0001769484 ifrs-full:ParentMember 2023-09-30 0001769484 ifrs-full:ParentMember 2023-06-30 0001769484 biox:TrustDebtSecuritiesMember 2023-09-30 0001769484 biox:ParentsCompaniesAndRelatedPartiesMember 2023-09-30 0001769484 biox:TrustDebtSecuritiesMember 2023-06-30 0001769484 biox:ParentsCompaniesAndRelatedPartiesMember 2023-06-30 0001769484 biox:TrigallGeneticsS.a.Member 2023-07-01 2023-09-30 0001769484 biox:SynertechIndustriasS.aMember 2023-07-01 2023-09-30 0001769484 biox:TrigallGeneticsS.a.Member 2022-07-01 2022-09-30 0001769484 biox:SynertechIndustriasS.aMember 2022-07-01 2022-09-30 0001769484 ifrs-full:CurrencyRiskMember 2023-09-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:VehiclesMember 2023-09-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:MachineryMember 2023-09-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:LandAndBuildingsMember 2023-09-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerEquipmentMember 2023-09-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:VehiclesMember 2023-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:MachineryMember 2023-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:LandAndBuildingsMember 2023-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerEquipmentMember 2023-06-30 0001769484 biox:GoodsAndServicesIncludingRightOfUseLicenseMember biox:SeedAndIntegratedProductsMember 2023-07-01 2023-09-30 0001769484 biox:GoodsAndServicesIncludingRightOfUseLicenseMember biox:CropProtectionMember 2023-07-01 2023-09-30 0001769484 biox:GoodsAndServicesIncludingRightOfUseLicenseMember biox:CropNutritionMember 2023-07-01 2023-09-30 0001769484 biox:GoodsAndServicesMember 2023-07-01 2023-09-30 0001769484 biox:GoodsAndServicesIncludingRightOfUseLicenseMember 2023-07-01 2023-09-30 0001769484 biox:GoodsAndServicesIncludingRightOfUseLicenseMember biox:SeedAndIntegratedProductsMember 2022-07-01 2022-09-30 0001769484 biox:GoodsAndServicesIncludingRightOfUseLicenseMember biox:CropProtectionMember 2022-07-01 2022-09-30 0001769484 biox:GoodsAndServicesIncludingRightOfUseLicenseMember biox:CropNutritionMember 2022-07-01 2022-09-30 0001769484 biox:GoodsAndServicesMember 2022-07-01 2022-09-30 0001769484 biox:GoodsAndServicesIncludingRightOfUseLicenseMember 2022-07-01 2022-09-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:VehiclesMember 2023-09-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:OfficeEquipmentMember 2023-09-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:MachineryMember 2023-09-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:LandAndBuildingsMember 2023-09-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:FixturesAndFittingsMember 2023-09-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:ConstructionInProgressMember 2023-09-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerEquipmentMember 2023-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:VehiclesMember 2023-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:OfficeEquipmentMember 2023-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:MachineryMember 2023-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:LandAndBuildingsMember 2023-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:FixturesAndFittingsMember 2023-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:ComputerEquipmentMember 2023-09-30 0001769484 ifrs-full:VehiclesMember 2023-09-30 0001769484 ifrs-full:OfficeEquipmentMember 2023-09-30 0001769484 ifrs-full:MachineryMember 2023-09-30 0001769484 ifrs-full:LandAndBuildingsMember 2023-09-30 0001769484 ifrs-full:FixturesAndFittingsMember 2023-09-30 0001769484 ifrs-full:ConstructionInProgressMember 2023-09-30 0001769484 ifrs-full:ComputerEquipmentMember 2023-09-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:VehiclesMember 2023-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:OfficeEquipmentMember 2023-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:MachineryMember 2023-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:LandAndBuildingsMember 2023-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:FixturesAndFittingsMember 2023-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:ConstructionInProgressMember 2023-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerEquipmentMember 2023-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:VehiclesMember 2023-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:OfficeEquipmentMember 2023-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:MachineryMember 2023-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:LandAndBuildingsMember 2023-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:FixturesAndFittingsMember 2023-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:ComputerEquipmentMember 2023-06-30 0001769484 ifrs-full:VehiclesMember 2023-06-30 0001769484 ifrs-full:OfficeEquipmentMember 2023-06-30 0001769484 ifrs-full:MachineryMember 2023-06-30 0001769484 ifrs-full:LandAndBuildingsMember 2023-06-30 0001769484 ifrs-full:FixturesAndFittingsMember 2023-06-30 0001769484 ifrs-full:ConstructionInProgressMember 2023-06-30 0001769484 ifrs-full:ComputerEquipmentMember 2023-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:VehiclesMember 2022-09-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:OfficeEquipmentMember 2022-09-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:MachineryMember 2022-09-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:LandAndBuildingsMember 2022-09-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:FixturesAndFittingsMember 2022-09-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:ConstructionInProgressMember 2022-09-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerEquipmentMember 2022-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:VehiclesMember 2022-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:OfficeEquipmentMember 2022-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:MachineryMember 2022-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:LandAndBuildingsMember 2022-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:FixturesAndFittingsMember 2022-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:ComputerEquipmentMember 2022-09-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:VehiclesMember 2022-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:OfficeEquipmentMember 2022-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:MachineryMember 2022-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:LandAndBuildingsMember 2022-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:FixturesAndFittingsMember 2022-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:ConstructionInProgressMember 2022-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerEquipmentMember 2022-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:VehiclesMember 2022-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:OfficeEquipmentMember 2022-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:MachineryMember 2022-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:LandAndBuildingsMember 2022-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:FixturesAndFittingsMember 2022-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:ComputerEquipmentMember 2022-06-30 0001769484 ifrs-full:RetainedEarningsMember 2023-07-01 2023-09-30 0001769484 ifrs-full:RetainedEarningsMember 2022-07-01 2022-09-30 0001769484 biox:ReceivablesForPpESalesMember 2023-09-30 0001769484 ifrs-full:OtherRelatedPartiesMember 2023-06-30 0001769484 biox:ReceivablesForPpESalesMember 2023-06-30 0001769484 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2023-07-01 2023-09-30 0001769484 ifrs-full:NoncontrollingInterestsMember 2023-07-01 2023-09-30 0001769484 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2022-07-01 2022-09-30 0001769484 ifrs-full:PreferenceSharesMember 2023-09-30 0001769484 ifrs-full:OrdinarySharesMember 2023-09-30 0001769484 biox:EquityCompensationPlanMember 2023-09-30 0001769484 biox:BankBorrowingsMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2023-09-30 0001769484 biox:BankBorrowingsMember ifrs-full:AtFairValueMember 2023-09-30 0001769484 biox:BankBorrowingsMember 2023-09-30 0001769484 biox:BankBorrowingsMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2023-06-30 0001769484 biox:BankBorrowingsMember ifrs-full:AtFairValueMember 2023-06-30 0001769484 biox:BankBorrowingsMember 2023-06-30 0001769484 ifrs-full:ReserveOfEquityComponentOfConvertibleInstrumentsMember 2022-07-01 2022-09-30 0001769484 2033-09-30 0001769484 2033-06-30 0001769484 ifrs-full:AccumulatedImpairmentMember 2023-09-30 0001769484 biox:SeedsMember 2023-09-30 0001769484 biox:MicrobiologicalResaleProductsMember 2023-09-30 0001769484 biox:MicrobiologicalProductsProducedMember 2023-09-30 0001769484 ifrs-full:AccumulatedImpairmentMember 2023-06-30 0001769484 biox:SeedsMember 2023-06-30 0001769484 biox:MicrobiologicalResaleProductsMember 2023-06-30 0001769484 biox:MicrobiologicalProductsProducedMember 2023-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2023-09-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember 2023-09-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerSoftwareMember 2023-09-30 0001769484 ifrs-full:GrossCarryingAmountMember biox:SoybeanHb4Member 2023-09-30 0001769484 ifrs-full:GrossCarryingAmountMember biox:RgRsOxWheatMember 2023-09-30 0001769484 ifrs-full:GrossCarryingAmountMember biox:MicrobiologyProductMember 2023-09-30 0001769484 ifrs-full:GrossCarryingAmountMember biox:EcoseedIntegratedProductsMember 2023-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2023-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember 2023-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:ComputerSoftwareMember 2023-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember biox:SoybeanHb4Member 2023-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember biox:MicrobiologyProductMember 2023-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember biox:EcoseedIntegratedProductsMember 2023-09-30 0001769484 ifrs-full:GrossCarryingAmountMember 2023-09-30 0001769484 ifrs-full:CustomerrelatedIntangibleAssetsMember 2023-09-30 0001769484 ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember 2023-09-30 0001769484 ifrs-full:ComputerSoftwareMember 2023-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember 2023-09-30 0001769484 biox:SoybeanHb4Member 2023-09-30 0001769484 biox:RgRsOxWheatMember 2023-09-30 0001769484 biox:MicrobiologyProductMember 2023-09-30 0001769484 biox:EcoseedIntegratedProductsMember 2023-09-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2023-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember 2023-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerSoftwareMember 2023-06-30 0001769484 ifrs-full:GrossCarryingAmountMember biox:SoybeanHb4Member 2023-06-30 0001769484 ifrs-full:GrossCarryingAmountMember biox:RgRsOxWheatMember 2023-06-30 0001769484 ifrs-full:GrossCarryingAmountMember biox:MicrobiologyProductMember 2023-06-30 0001769484 ifrs-full:GrossCarryingAmountMember biox:EcoseedIntegratedProductsMember 2023-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2023-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember 2023-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:ComputerSoftwareMember 2023-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember biox:SoybeanHb4Member 2023-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember biox:MicrobiologyProductMember 2023-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember biox:EcoseedIntegratedProductsMember 2023-06-30 0001769484 ifrs-full:GrossCarryingAmountMember 2023-06-30 0001769484 ifrs-full:CustomerrelatedIntangibleAssetsMember 2023-06-30 0001769484 ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember 2023-06-30 0001769484 ifrs-full:ComputerSoftwareMember 2023-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember 2023-06-30 0001769484 biox:SoybeanHb4Member 2023-06-30 0001769484 biox:RgRsOxWheatMember 2023-06-30 0001769484 biox:MicrobiologyProductMember 2023-06-30 0001769484 biox:EcoseedIntegratedProductsMember 2023-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2022-09-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember 2022-09-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerSoftwareMember 2022-09-30 0001769484 ifrs-full:GrossCarryingAmountMember biox:SoybeanHb4Member 2022-09-30 0001769484 ifrs-full:GrossCarryingAmountMember biox:RgRsOxWheatMember 2022-09-30 0001769484 ifrs-full:GrossCarryingAmountMember biox:MicrobiologyProductMember 2022-09-30 0001769484 ifrs-full:GrossCarryingAmountMember biox:EcoseedIntegratedProductsMember 2022-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2022-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember 2022-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:ComputerSoftwareMember 2022-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember biox:SoybeanHb4Member 2022-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember biox:MicrobiologyProductMember 2022-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember biox:EcoseedIntegratedProductsMember 2022-09-30 0001769484 ifrs-full:GrossCarryingAmountMember 2022-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember 2022-09-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2022-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember 2022-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerSoftwareMember 2022-06-30 0001769484 ifrs-full:GrossCarryingAmountMember biox:SoybeanHb4Member 2022-06-30 0001769484 ifrs-full:GrossCarryingAmountMember biox:RgRsOxWheatMember 2022-06-30 0001769484 ifrs-full:GrossCarryingAmountMember biox:MicrobiologyProductMember 2022-06-30 0001769484 ifrs-full:GrossCarryingAmountMember biox:EcoseedIntegratedProductsMember 2022-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2022-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember 2022-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:ComputerSoftwareMember 2022-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember biox:SoybeanHb4Member 2022-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember biox:MicrobiologyProductMember 2022-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember biox:EcoseedIntegratedProductsMember 2022-06-30 0001769484 ifrs-full:GrossCarryingAmountMember 2022-06-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember 2022-06-30 0001769484 ifrs-full:TreasurySharesMember 2023-07-01 2023-09-30 0001769484 ifrs-full:TreasurySharesMember 2022-07-01 2022-09-30 0001769484 ifrs-full:EquityAttributableToOwnersOfParentMember 2023-07-01 2023-09-30 0001769484 biox:StockOptionsAndShareBasedIncentivesMember 2023-07-01 2023-09-30 0001769484 biox:OwnSharesTradingPremiumMember 2022-07-01 2022-09-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:LandAndBuildingsMember 2023-07-01 2023-09-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:FixturesAndFittingsMember 2023-07-01 2023-09-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:OfficeEquipmentMember 2022-07-01 2022-09-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:LandAndBuildingsMember 2022-07-01 2022-09-30 0001769484 ifrs-full:GrossCarryingAmountMember biox:EcoseedIntegratedProductsMember 2023-07-01 2023-09-30 0001769484 biox:RizobacterArgentinaMember 2023-09-30 0001769484 biox:ProFarmGroupInc.Member 2023-09-30 0001769484 biox:InsumosAgroqumicosMember 2023-09-30 0001769484 biox:BioceresCropsMember 2023-09-30 0001769484 biox:RizobacterArgentinaMember 2023-06-30 0001769484 biox:ProFarmGroupInc.Member 2023-06-30 0001769484 biox:InsumosAgroqumicosMember 2023-06-30 0001769484 biox:BioceresCropsMember 2023-06-30 0001769484 biox:BiologicalAssetsWheatMember 2023-07-01 2023-09-30 0001769484 biox:BiologicalAssetsBarleyMember 2023-07-01 2023-09-30 0001769484 ifrs-full:Level2OfFairValueHierarchyMember 2023-09-30 0001769484 ifrs-full:Level2OfFairValueHierarchyMember 2023-06-30 0001769484 ifrs-full:LeaseLiabilitiesMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2023-09-30 0001769484 ifrs-full:ContingentConsiderationMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2023-09-30 0001769484 biox:TradeAndOtherPayablesMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2023-09-30 0001769484 biox:TradeAndOtherPayablesMember ifrs-full:AtFairValueMember 2023-09-30 0001769484 biox:ConvertibleNotesMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2023-09-30 0001769484 biox:BorrowingMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2023-09-30 0001769484 ifrs-full:LeaseLiabilitiesMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2023-06-30 0001769484 ifrs-full:ContingentConsiderationMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2023-06-30 0001769484 biox:TradeAndOtherPayablesMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2023-06-30 0001769484 biox:TradeAndOtherPayablesMember ifrs-full:AtFairValueMember 2023-06-30 0001769484 biox:ConvertibleNotesMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2023-06-30 0001769484 biox:BorrowingMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2023-06-30 0001769484 ifrs-full:InvestmentFundsMember ifrs-full:Level1OfFairValueHierarchyMember 2023-09-30 0001769484 biox:USTreasuryBillsMember ifrs-full:Level1OfFairValueHierarchyMember 2023-09-30 0001769484 biox:OtherInvestmentMember ifrs-full:Level1OfFairValueHierarchyMember 2023-09-30 0001769484 ifrs-full:InvestmentFundsMember ifrs-full:Level1OfFairValueHierarchyMember 2023-06-30 0001769484 biox:USTreasuryBillsMember ifrs-full:Level1OfFairValueHierarchyMember 2023-06-30 0001769484 biox:OtherInvestmentMember ifrs-full:Level1OfFairValueHierarchyMember 2023-06-30 0001769484 ifrs-full:TradeReceivablesMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2023-09-30 0001769484 biox:OtherReceivablesMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2023-09-30 0001769484 biox:OtherFinancialAssetsMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2023-09-30 0001769484 biox:OtherFinancialAssetsMember ifrs-full:AtFairValueMember 2023-09-30 0001769484 biox:CashAndEquivalentsMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2023-09-30 0001769484 biox:CashAndEquivalentsMember ifrs-full:AtFairValueMember 2023-09-30 0001769484 ifrs-full:TradeReceivablesMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2023-06-30 0001769484 biox:OtherReceivablesMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2023-06-30 0001769484 biox:OtherFinancialAssetsMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2023-06-30 0001769484 biox:OtherFinancialAssetsMember ifrs-full:AtFairValueMember 2023-06-30 0001769484 biox:CashAndEquivalentsMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2023-06-30 0001769484 ifrs-full:TopOfRangeMember biox:PastShareOptionPlanMember 2023-08-01 2023-08-31 0001769484 ifrs-full:BottomOfRangeMember biox:PastShareOptionPlanMember 2023-08-01 2023-08-31 0001769484 biox:PerformanceShareOptionPlanMember 2023-08-01 2023-08-31 0001769484 biox:BaseShareOptionPlanMember 2023-08-01 2023-08-31 0001769484 ifrs-full:TreasurySharesMember 2023-09-30 0001769484 ifrs-full:SharePremiumMember 2023-09-30 0001769484 ifrs-full:RetainedEarningsMember 2023-09-30 0001769484 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2023-09-30 0001769484 ifrs-full:ReserveOfEquityComponentOfConvertibleInstrumentsMember 2023-09-30 0001769484 ifrs-full:NoncontrollingInterestsMember 2023-09-30 0001769484 ifrs-full:IssuedCapitalMember 2023-09-30 0001769484 ifrs-full:EquityAttributableToOwnersOfParentMember 2023-09-30 0001769484 biox:StockOptionsAndShareBasedIncentivesMember 2023-09-30 0001769484 biox:RevaluationOfPropertyPlantAndEquipmentAndEffectOfTaxRateChangeMember 2023-09-30 0001769484 biox:OwnSharesTradingPremiumMember 2023-09-30 0001769484 biox:ChangesInNonControllingInterestMember 2023-09-30 0001769484 ifrs-full:TreasurySharesMember 2023-06-30 0001769484 ifrs-full:SharePremiumMember 2023-06-30 0001769484 ifrs-full:RetainedEarningsMember 2023-06-30 0001769484 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2023-06-30 0001769484 ifrs-full:ReserveOfEquityComponentOfConvertibleInstrumentsMember 2023-06-30 0001769484 ifrs-full:NoncontrollingInterestsMember 2023-06-30 0001769484 ifrs-full:IssuedCapitalMember 2023-06-30 0001769484 ifrs-full:EquityAttributableToOwnersOfParentMember 2023-06-30 0001769484 biox:StockOptionsAndShareBasedIncentivesMember 2023-06-30 0001769484 biox:RevaluationOfPropertyPlantAndEquipmentAndEffectOfTaxRateChangeMember 2023-06-30 0001769484 biox:OwnSharesTradingPremiumMember 2023-06-30 0001769484 biox:ChangesInNonControllingInterestMember 2023-06-30 0001769484 ifrs-full:TreasurySharesMember 2022-09-30 0001769484 ifrs-full:SharePremiumMember 2022-09-30 0001769484 ifrs-full:RetainedEarningsMember 2022-09-30 0001769484 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2022-09-30 0001769484 ifrs-full:ReserveOfEquityComponentOfConvertibleInstrumentsMember 2022-09-30 0001769484 ifrs-full:NoncontrollingInterestsMember 2022-09-30 0001769484 ifrs-full:IssuedCapitalMember 2022-09-30 0001769484 ifrs-full:EquityAttributableToOwnersOfParentMember 2022-09-30 0001769484 biox:StockOptionsAndShareBasedIncentivesMember 2022-09-30 0001769484 biox:RevaluationOfPropertyPlantAndEquipmentAndEffectOfTaxRateChangeMember 2022-09-30 0001769484 biox:OwnSharesTradingPremiumMember 2022-09-30 0001769484 biox:ChangesInNonControllingInterestMember 2022-09-30 0001769484 ifrs-full:TreasurySharesMember 2022-06-30 0001769484 ifrs-full:SharePremiumMember 2022-06-30 0001769484 ifrs-full:RetainedEarningsMember 2022-06-30 0001769484 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2022-06-30 0001769484 ifrs-full:ReserveOfEquityComponentOfConvertibleInstrumentsMember 2022-06-30 0001769484 ifrs-full:NoncontrollingInterestsMember 2022-06-30 0001769484 ifrs-full:IssuedCapitalMember 2022-06-30 0001769484 ifrs-full:EquityAttributableToOwnersOfParentMember 2022-06-30 0001769484 biox:StockOptionsAndShareBasedIncentivesMember 2022-06-30 0001769484 biox:RevaluationOfPropertyPlantAndEquipmentAndEffectOfTaxRateChangeMember 2022-06-30 0001769484 biox:OwnSharesTradingPremiumMember 2022-06-30 0001769484 biox:ChangesInNonControllingInterestMember 2022-06-30 0001769484 ifrs-full:NoncontrollingInterestsMember 2022-07-01 2022-09-30 0001769484 biox:JointVenturesAndAssociatesMember 2023-09-30 0001769484 biox:JointVenturesAndAssociatesMember 2023-06-30 0001769484 biox:SecuredGuaranteedNotesMember ifrs-full:AtFairValueMember 2033-09-30 0001769484 biox:SecuredGuaranteedNotesMember ifrs-full:AtCostMember 2033-09-30 0001769484 biox:SecuredConvertibleGuaranteedNotesMember ifrs-full:AtFairValueMember 2033-09-30 0001769484 biox:SecuredConvertibleGuaranteedNotesMember ifrs-full:AtCostMember 2033-09-30 0001769484 ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2023-09-30 0001769484 ifrs-full:AtFairValueMember 2023-09-30 0001769484 ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2023-06-30 0001769484 ifrs-full:AtFairValueMember 2023-06-30 0001769484 biox:SunflowerMember 2023-09-30 0001769484 biox:BiologicalAssetsWheatMember 2023-09-30 0001769484 biox:BiologicalAssetsSoybeanMember 2023-09-30 0001769484 biox:BiologicalAssetsCornMember 2023-09-30 0001769484 biox:BiologicalAssetsBarleyMember 2023-09-30 0001769484 biox:SunflowerMember 2023-06-30 0001769484 biox:BiologicalAssetsWheatMember 2023-06-30 0001769484 biox:BiologicalAssetsSoybeanMember 2023-06-30 0001769484 biox:BiologicalAssetsCornMember 2023-06-30 0001769484 biox:BiologicalAssetsBarleyMember 2023-06-30 0001769484 biox:BiologicalAssetsWheatMember 2022-09-30 0001769484 biox:BiologicalAssetsBarleyMember 2022-09-30 0001769484 biox:BiologicalAssetsWheatMember 2022-06-30 0001769484 biox:BiologicalAssetsBarleyMember 2022-06-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:VehiclesMember 2023-07-01 2023-09-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:OfficeEquipmentMember 2023-07-01 2023-09-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:MachineryMember 2023-07-01 2023-09-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:ConstructionInProgressMember 2023-07-01 2023-09-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerEquipmentMember 2023-07-01 2023-09-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:VehiclesMember 2022-07-01 2022-09-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:MachineryMember 2022-07-01 2022-09-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:FixturesAndFittingsMember 2022-07-01 2022-09-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:ConstructionInProgressMember 2022-07-01 2022-09-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerEquipmentMember 2022-07-01 2022-09-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember 2023-07-01 2023-09-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerSoftwareMember 2023-07-01 2023-09-30 0001769484 ifrs-full:GrossCarryingAmountMember biox:SoybeanHb4Member 2023-07-01 2023-09-30 0001769484 ifrs-full:GrossCarryingAmountMember biox:MicrobiologyProductMember 2023-07-01 2023-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2023-07-01 2023-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember 2023-07-01 2023-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:ComputerSoftwareMember 2023-07-01 2023-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember biox:SoybeanHb4Member 2023-07-01 2023-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember biox:MicrobiologyProductMember 2023-07-01 2023-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember biox:EcoseedIntegratedProductsMember 2023-07-01 2023-09-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerSoftwareMember 2022-07-01 2022-09-30 0001769484 ifrs-full:GrossCarryingAmountMember biox:SoybeanHb4Member 2022-07-01 2022-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2022-07-01 2022-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember 2022-07-01 2022-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:ComputerSoftwareMember 2022-07-01 2022-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember biox:SoybeanHb4Member 2022-07-01 2022-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember biox:MicrobiologyProductMember 2022-07-01 2022-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember biox:EcoseedIntegratedProductsMember 2022-07-01 2022-09-30 0001769484 biox:SunflowerMember 2023-07-01 2023-09-30 0001769484 biox:BiologicalAssetsSoybeanMember 2023-07-01 2023-09-30 0001769484 biox:BiologicalAssetsCornMember 2023-07-01 2023-09-30 0001769484 biox:BiologicalAssetsWheatMember 2022-07-01 2022-09-30 0001769484 biox:BiologicalAssetsBarleyMember 2022-07-01 2022-09-30 0001769484 ifrs-full:MachineryMember 2022-07-01 2022-09-30 0001769484 ifrs-full:LandAndBuildingsMember 2022-07-01 2022-09-30 0001769484 ifrs-full:FixturesAndFittingsMember 2022-07-01 2022-09-30 0001769484 ifrs-full:ConstructionInProgressMember 2022-07-01 2022-09-30 0001769484 ifrs-full:ComputerEquipmentMember 2022-07-01 2022-09-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2022-07-01 2022-09-30 0001769484 ifrs-full:GrossCarryingAmountMember ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember 2022-07-01 2022-09-30 0001769484 ifrs-full:GrossCarryingAmountMember biox:MicrobiologyProductMember 2022-07-01 2022-09-30 0001769484 ifrs-full:GrossCarryingAmountMember 2022-07-01 2022-09-30 0001769484 ifrs-full:OtherRelatedPartiesMember 2023-09-30 0001769484 ifrs-full:JointVenturesWhereEntityIsVenturerMember 2023-09-30 0001769484 ifrs-full:JointVenturesWhereEntityIsVenturerMember 2023-06-30 0001769484 biox:IfEbitdaReachesAtLeastUs150MillionMember biox:PerformanceShareOptionPlanMember 2023-08-01 2023-08-31 0001769484 ifrs-full:KeyManagementPersonnelOfEntityOrParentMember 2023-07-01 2023-09-30 0001769484 ifrs-full:KeyManagementPersonnelOfEntityOrParentMember 2022-07-01 2022-09-30 0001769484 ifrs-full:JointVenturesWhereEntityIsVenturerMember 2023-07-01 2023-09-30 0001769484 ifrs-full:JointVenturesWhereEntityIsVenturerMember 2022-07-01 2022-09-30 0001769484 biox:SeedAndIntegratedProductsMember 2023-07-01 2023-09-30 0001769484 biox:CropProtectionMember 2023-07-01 2023-09-30 0001769484 biox:CropNutritionMember 2023-07-01 2023-09-30 0001769484 biox:SeedAndIntegratedProductsMember 2022-07-01 2022-09-30 0001769484 biox:CropProtectionMember 2022-07-01 2022-09-30 0001769484 biox:CropNutritionMember 2022-07-01 2022-09-30 0001769484 ifrs-full:KeyManagementPersonnelOfEntityOrParentMember 2023-09-30 0001769484 ifrs-full:KeyManagementPersonnelOfEntityOrParentMember 2023-06-30 0001769484 biox:ParentCompaniesAndRelatedPartiesToParentMember 2023-09-30 0001769484 biox:ParentCompaniesAndRelatedPartiesToParentMember 2023-06-30 0001769484 biox:TrigallGeneticsS.a.Member 2023-09-30 0001769484 biox:TrigallGeneticsS.a.Member 2023-06-30 0001769484 biox:SynertechIndustriasS.aMember 2023-09-30 0001769484 biox:MoolecScienceS.a.Member 2023-09-30 0001769484 biox:AlfalfaTechnologiesS.r.lMember 2023-09-30 0001769484 biox:SynertechIndustriasS.aMember 2023-06-30 0001769484 biox:MoolecScienceS.a.Member 2023-06-30 0001769484 biox:AlfalfaTechnologiesS.r.lMember 2023-06-30 0001769484 ifrs-full:OtherRelatedPartiesMember 2022-07-01 2022-09-30 0001769484 2022-09-30 0001769484 2022-06-30 0001769484 ifrs-full:OtherRelatedPartiesMember 2023-07-01 2023-09-30 0001769484 biox:ParentCompaniesAndRelatedPartiesToParentMember 2023-07-01 2023-09-30 0001769484 biox:ParentCompaniesAndRelatedPartiesToParentMember 2022-07-01 2022-09-30 0001769484 ifrs-full:SharePremiumMember 2022-07-01 2022-09-30 0001769484 ifrs-full:IssuedCapitalMember 2022-07-01 2022-09-30 0001769484 ifrs-full:EquityAttributableToOwnersOfParentMember 2022-07-01 2022-09-30 0001769484 biox:StockOptionsAndShareBasedIncentivesMember 2022-07-01 2022-09-30 0001769484 biox:IfEbitdaReachesAtLeastUs150MillionMember ifrs-full:TopOfRangeMember biox:PerformanceShareOptionPlanMember 2023-08-01 2023-08-31 0001769484 biox:IfEbitdaReachesAtLeastUs120MillionMember biox:PerformanceShareOptionPlanMember 2023-08-01 2023-08-31 0001769484 biox:IfrsResearchAndDevelopmentExpenseMember 2023-07-01 2023-09-30 0001769484 ifrs-full:CurrencyRiskMember 2023-07-01 2023-09-30 0001769484 ifrs-full:GrossCarryingAmountMember 2023-07-01 2023-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember 2022-07-01 2023-06-30 0001769484 biox:IfrsResearchAndDevelopmentExpenseMember 2022-07-01 2022-09-30 0001769484 ifrs-full:SellingGeneralAndAdministrativeExpenseMember 2023-07-01 2023-09-30 0001769484 2023-09-30 0001769484 2023-06-30 0001769484 ifrs-full:CostOfSalesMember 2023-07-01 2023-09-30 0001769484 biox:ProductionCostAndSellingGeneralAndAdministrativeExpenseMember 2023-07-01 2023-09-30 0001769484 ifrs-full:SellingGeneralAndAdministrativeExpenseMember 2022-07-01 2022-09-30 0001769484 ifrs-full:CostOfSalesMember 2022-07-01 2022-09-30 0001769484 biox:ProductionCostAndSellingGeneralAndAdministrativeExpenseMember 2022-07-01 2022-09-30 0001769484 2022-07-01 2022-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:VehiclesMember 2023-07-01 2023-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:OfficeEquipmentMember 2023-07-01 2023-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:MachineryMember 2023-07-01 2023-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:LandAndBuildingsMember 2023-07-01 2023-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:FixturesAndFittingsMember 2023-07-01 2023-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:ComputerEquipmentMember 2023-07-01 2023-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember 2023-07-01 2023-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:VehiclesMember 2022-07-01 2022-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:OfficeEquipmentMember 2022-07-01 2022-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:MachineryMember 2022-07-01 2022-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:LandAndBuildingsMember 2022-07-01 2022-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:FixturesAndFittingsMember 2022-07-01 2022-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:ComputerEquipmentMember 2022-07-01 2022-09-30 0001769484 ifrs-full:AccumulatedDepreciationAndAmortisationMember 2022-07-01 2022-09-30 0001769484 ifrs-full:GrossCarryingAmountMember 2022-07-01 2023-06-30 0001769484 2022-07-01 2023-06-30 iso4217:USD biox:item pure biox:country biox:category biox:Vote shares iso4217:USD shares Bioceres Crop Solutions Corp. 0001769484 --06-30 2024 Q1 false 2023-09-30 6-K 62849997 0 28373924 48129194 14628202 12135020 186276319 158006474 24902503 28824998 2022328 9444898 138076822 140426975 1141113 146842 395421211 397114401 502910 444909 2393939 2546241 5446 16286 8230402 7312964 40820784 39296810 3675493 3589749 69930709 67853835 173034536 173783956 112163432 112163432 13519199 13936575 424276850 420944757 819698061 818059158 159125358 150807674 100720985 107639659 10019165 9606707 32771902 24875662 536840 509034 4202389 1415099 4326889 3858699 311703528 298712534 48789492 60670946 2202374 2057805 638126 622823 34393580 35785347 668775 891769 2540181 3578157 76911874 75213146 9225862 10030524 175370264 188850517 487073792 487563051 298966341 298594088 33657928 31902019 332624269 330496107 819698061 818059158 116182805 126843248 410913 490006 71615781 75675878 -1446316 -227936 4581241 3852014 33932848 31904911 1508671 842240 -1231635 478041 5294568 16992796 -7661857 -6779847 117865 -1288306 -2249424 8924643 429040 5012643 -2678464 3912000 -4591634 498297 1913170 3413703 -2678464 3912000 -0.0731 0.0082 -0.0731 0.0081 -2678464 3912000 -929957 31025 -929957 31025 100868 -929957 -69843 -3608421 3943025 -5364330 401715 1755909 3541310 -3608421 3943025 4637 158819506 -255893 -916202 3767925 175745 -3530926 -32682893 969402 1007272 127358573 30940275 158298848 6 554999 135361 55892 746258 746258 1640 153357564 1620140 154979344 154979344 153 12211485 12211638 12211638 -24291047 -24291047 -24291047 9109516 9109516 9109516 187977 187977 498297 498297 3413703 3912000 -96582 -96582 127607 31025 6436 324943554 -255893 -780841 5443957 9285261 -27821973 -32184596 872820 1007272 280515997 34293608 314809605 6493 327028559 -255893 -780841 6645442 9285261 -30553591 -13903017 1282377 -160702 298594088 31902019 330496107 6193668 6193668 6193668 -457085 -457085 -457085 -4591634 -4591634 1913170 -2678464 -772696 -772696 -157261 -929957 6493 327028559 -255893 -780841 12839110 9285261 -31010676 -18494651 509681 -160702 298966341 33657928 332624269 -2678464 3912000 429040 5012643 7543992 8068153 1243403 1382093 2747206 2476832 837199 676427 2794339 6193668 227351 1508671 842240 27109 2448 352920 156053 505285 618489 -410913 -490006 -1446316 -227936 -26669 -115942 -31012196 -29709414 3722853 -5665708 7113764 -376576 -197454 -7391556 7499929 -18108556 412458 3226505 8040809 373181 -163205 -1051644 2293676 2125194 321539 69662 14733594 -32402336 35682 115942 5933265 -1609 -509534 2729598 2215965 889342 3985249 1414730 1947504 3241008 64486 209863 -8687056 3025471 26837346 93327748 46865499 47061271 4539455 3016078 -781199 -1717070 457085 376018 1170039 744365 187977 -26975931 40224969 -20929393 10848104 -24266 -12404 48129194 33475266 1198389 3076600 28373924 47387566 1. GENERAL INFORMATIONBioceres Crop Solutions Corp. (NASDAQ:BIOX) is a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change. To do this, Bioceres’ products create economic incentives for farmers and other stakeholders to adopt environmentally friendly production practices. Bioceres has a unique biotech platform with high impact, patented technologies for seeds and microbial ag inputs, as well as next generation crop nutrition and protection solutions.Bioceres is a global company with an extensive geographic footprint. The Group’s agricultural inputs are marketed across more than 40 countries, mainly in Argentina, Brazil, United States, Europe and South Africa.Unless the context otherwise requires, “we”, “us”, “our”, “Bioceres”, “BIOX”, “the Group”, and “Bioceres Crop Solutions” will refer to Bioceres Crop Solutions Corp. and its subsidiaries. 40 2. ACCOUNTING STANDARDS AND BASIS OF PREPARATIONStatement of compliance with IFRS as issued by IASBThese unaudited interim condensed consolidated financial statements for the three-month period ended September 30, 2023, have been prepared in accordance with Accounting Standard IAS 34 Interim Financial Reporting.These unaudited interim condensed consolidated financial statements do not include all notes of the type normally included in an annual financial statement. Accordingly, these unaudited interim condensed consolidated financial statements are to be read in conjunction with the consolidated financial statements for the fiscal year ended June 30, 2023.Authorization for the issue of the consolidated financial statementsThese unaudited interim condensed consolidated financial statements of the Group as of September 30, 2023, June 30, 2023 and for the three-month periods ended September 30, 2023 and 2022 were authorized by the Board of Directors of Bioceres Crop Solutions Corp. on November 29, 2023.Basis of measurementThe consolidated financial statements of the Group have been prepared using:<table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;">Going concern basis of accounting, considering the conclusion of the assessment made by the Group’s Management about the ability of the Group and its subsidiaries to continue as a going concern, in accordance with the requirements of paragraph 25 of IAS 1, “Presentation of Financial Statements”.</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;">Accrual basis of accounting (except for cash flows information). Under this basis of accounting, the effects of transactions and other events are recognized as they occur, even when there are no cash flows.</td></tr></table><div style="margin-top:12pt;"></div>Functional currency and presentation currency<table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">a)</td><td style="padding:0pt;">Functional currency</td></tr></table>Items included in the financial statements of each of the Group’s entities are measured using the currency of the primary economic market in which the entity operates (i.e., “the functional currency”).<table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">b)</td><td style="padding:0pt;">Presentation currency</td></tr></table>The consolidated financial statements of the Group are presented in US dollars. <table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">c)</td><td style="padding:0pt;">Foreign currency</td></tr></table>Transactions entered into by Group entities in a currency other than their functional currency are recorded at the relevant exchange rates as of the date upon which such transactions occur. Foreign currency monetary assets and liabilities are translated at the prevailing exchanges rates as of the final day of each reporting period. Exchange differences arising from the retranslation of unsettled monetary assets and liabilities are recognized immediately in profit or loss, except for foreign currency borrowings qualifying as a hedge of a net investment in a foreign operation for which exchange differences are recognized in other comprehensive income and accumulated in the foreign exchange reserve along with the exchange differences arising from the retranslation of the foreign operation. Upon the disposal of a foreign operation, the cumulative exchange differences recognized in the foreign exchange reserve relating to such operation up to the date of disposal are transferred to the consolidated statement of profit or loss and other comprehensive income as part of the gain or loss recognized upon such disposal.Changes in accounting policiesThe accounting policies adopted in the preparation of these unaudited interim condensed consolidated financial statements are consistent with those adopted for the preparation of the consolidated financial statements as of June 30, 2023. Basis of measurementThe consolidated financial statements of the Group have been prepared using:<table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;">Going concern basis of accounting, considering the conclusion of the assessment made by the Group’s Management about the ability of the Group and its subsidiaries to continue as a going concern, in accordance with the requirements of paragraph 25 of IAS 1, “Presentation of Financial Statements”.</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;">Accrual basis of accounting (except for cash flows information). Under this basis of accounting, the effects of transactions and other events are recognized as they occur, even when there are no cash flows.</td></tr></table><div style="margin-top:12pt;"></div> <table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">a)</td><td style="padding:0pt;">Functional currency</td></tr></table>Items included in the financial statements of each of the Group’s entities are measured using the currency of the primary economic market in which the entity operates (i.e., “the functional currency”). <table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">b)</td><td style="padding:0pt;">Presentation currency</td></tr></table>The consolidated financial statements of the Group are presented in US dollars. <table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">c)</td><td style="padding:0pt;">Foreign currency</td></tr></table>Transactions entered into by Group entities in a currency other than their functional currency are recorded at the relevant exchange rates as of the date upon which such transactions occur. Foreign currency monetary assets and liabilities are translated at the prevailing exchanges rates as of the final day of each reporting period. Exchange differences arising from the retranslation of unsettled monetary assets and liabilities are recognized immediately in profit or loss, except for foreign currency borrowings qualifying as a hedge of a net investment in a foreign operation for which exchange differences are recognized in other comprehensive income and accumulated in the foreign exchange reserve along with the exchange differences arising from the retranslation of the foreign operation. Upon the disposal of a foreign operation, the cumulative exchange differences recognized in the foreign exchange reserve relating to such operation up to the date of disposal are transferred to the consolidated statement of profit or loss and other comprehensive income as part of the gain or loss recognized upon such disposal. Changes in accounting policiesThe accounting policies adopted in the preparation of these unaudited interim condensed consolidated financial statements are consistent with those adopted for the preparation of the consolidated financial statements as of June 30, 2023. 3. NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS ISSUED BY THE IASBa)The following new standards, amendments and interpretations became applicable for the current reporting period and adopted by the Group. <table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:14.4pt;padding:0pt;">-</td><td style="padding:0pt;">Amendment to IAS 12 –Deferred tax related to assets and liabilities arising from a single transaction.</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:14.4pt;padding:0pt;">-</td><td style="padding:0pt;">International Tax Reform—Pillar Two Model Rules (Amendments to IAS 12)</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:14.4pt;padding:0pt;">-</td><td style="padding:0pt;">Amendments to IAS 1 and IFRS Practice Statement 2- Disclosure of Accounting Policies</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:14.4pt;padding:0pt;">-</td><td style="padding:0pt;">Amendments to IAS 8-Definition of Accounting Estimates</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:14.4pt;padding:0pt;">-</td><td style="padding:0pt;">IFRS 17, “Insurance Contracts”</td></tr></table><div style="margin-top:12pt;"></div>These new standards and amendments did not have any material impact on the Group.b)The following new standards are not yet adopted by the Group.<table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:14.4pt;padding:0pt;">-</td><td style="padding:0pt;">Amendments to IFRS 16- Lease Liability in a Sale and Leaseback. The amendments are effective for annual reporting periods beginning on or after 1 January 2024.</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:14.4pt;padding:0pt;">-</td><td style="padding:0pt;">Amendments to IAS1 – Non- current liabilities with covenants. The amendments are effective for annual reporting periods beginning on or after 1 January 2024.</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:14.4pt;padding:0pt;">-</td><td style="padding:0pt;">Amendments to IAS 7- Statement of Cash Flows & to IFRS 7- Financial Instruments: Disclosures. The amendments are effective for annual reporting periods beginning on or after 1 January 2024.</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:14.4pt;padding:0pt;">-</td><td style="padding:0pt;">Amendments to IAS 21- The Effects of Changes in Foreign Exchange Ratestitled Lack of Exchangeability. The amendments are effective for annual reporting periods beginning on or after 1 January 2025.</td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:14.4pt;padding:0pt;">-</td><td style="padding:0pt;">Amendment to IAS 7 and IFRS 7 - Supplier Financing. The amendments are effective for annual periods beginning on or after January 1, 2024.</td></tr></table>These amendments are not expected to have material impact on the Group. 4. SEASONALITYOur revenues fluctuate depending on the timing of orders from our distributors and customers and on prevailing market prices, which influence the purchase decisions of growers, the end users of our seed and integrated products, crop protection products and crop nutrition products. Given the cyclicality of crop planting and harvesting, as well as growing seasons, which vary from year to year, our business is highly seasonal. This results in substantial fluctuations in quarterly sales and profitability. Our portfolio is highly oriented to crop planting. Generally, our sales are concentrated in the third and fourth quarters of each calendar year, when demand for our seed and integrated products, crop protection products and crop nutrition products increases as growers begin planting their summer crops in South America, while winter crop season occurs in the Northern hemisphere. With our seed and integrated products business, we contract with growers and seed suppliers based upon our anticipated market demand. Generally, in our seed and integrated products business we stock the seed during the harvest season and ship from inventory throughout the year, with the objective of selling most of the inventory from the current year’s harvest before the next year’s, with our crop protection and our crop nutrition business following a similar cycle to the seed cycle. Milestone, royalty, and license revenues are also likely to fluctuate from period to period given the seasonality of agriculture and time required to progress from one milestone to the next.Our seed and integrated products, crop protection and crop nutrition businesses are also affected by unpredictable weather conditions such as heavy rains, hail, floods, freezing conditions, windstorms, drought or fire, as well as other hazardous situations beyond our control, which may cause our sales and operating results to fluctuate significantly. In addition, disruptions that cause delays by growers in harvesting or planting can result in the movement of orders to a future quarter, which also causes fluctuations in our quarterly operating results. Finally, some of our customers and distributors order in bulk only one or two times a year, which may further cause our seed product revenues to fluctuate from period to period. 1 2 5. INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION5.1. Cash and cash equivalents<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Cash at bank and on hand</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 25,954,730</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 48,129,194</td></tr><tr><td style="vertical-align:middle;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;">Mutual funds</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 2,419,194</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 28,373,924</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 48,129,194</td></tr></table>5.2. Other financial assets<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Restricted short-term deposits</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 212,703</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">US Treasury bills</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 9,719,486</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 9,163,298</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Mutual funds</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 3,236,702</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 1,596,539</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Other investments</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,672,014</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,162,480</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 14,628,202</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 12,135,020</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Non-current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Shares of Bioceres S.A.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 444,575</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 444,635</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Other investments</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 58,335</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 274</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 502,910</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 444,909</td></tr></table>5.3. Trade receivables<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Trade debtors</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 189,222,562</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 160,269,233</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Allowance for impairment of trade debtors</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (7,615,433)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (7,425,604)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Shareholders and other related parties (Note 15)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 1,368,373</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Allowance for credit notes to be issued</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (2,610,596)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (3,694,019)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Trade debtors - Joint ventures and associates (Note 15)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 781,451</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 865,627</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Deferred checks</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 5,129,962</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 7,991,237</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 186,276,319</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 158,006,474</td></tr></table>The book value is reasonably approximate to the fair value given its short-term nature.5.4. Other receivables<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Taxes</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 6,009,626</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 6,113,764</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Receivables for PP&E sales</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 89,715</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 156,423</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Shareholders and other related parties (Note 15)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 2,919,431</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 3,792,429</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Other receivables - Joint ventures and associates (Note 15)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 6,469,863</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 6,104,219</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Prepayments to suppliers</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 5,010,022</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 10,956,831</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Reimbursements over exports</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 10,558</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 10,558</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Prepaid expenses and other receivables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 3,657,633</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 1,302,221</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Miscellaneous</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 735,655</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 388,553</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 24,902,503</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 28,824,998</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Non-current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Taxes</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 865,588</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 873,699</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Reimbursements over exports</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 1,268,928</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 1,290,227</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Loans receivables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 230,000</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 230,000</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Miscellaneous</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 29,423</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 152,315</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 2,393,939</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 2,546,241</td></tr></table>5.5. Inventories<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 09/30/2023 </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 06/30/2023 </td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Seeds</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 9,293,210</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 1,542,159</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Resale products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 71,973,203</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 58,544,931</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Manufactured products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 19,604,930</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 25,881,761</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Goods in transit</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 2,298,136</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 3,620,606</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Supplies</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 18,709,303</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 24,893,187</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Agricultural products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 19,111,345</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 28,436,830</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Allowance for obsolescence</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (2,913,305)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (2,492,499)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 138,076,822</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 140,426,975</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Net of agricultural products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 118,965,477</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 111,990,145</td></tr></table>5.6. Biological assetsChanges in Biological assets:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:34.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:34.56%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Soybean</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Corn</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Wheat</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Barley</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Sunflower</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Total</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:34.56%;background:#cceeff;margin:0pt;padding:0pt;">Beginning of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"> 87,785</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"> 59,057</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;background:#cceeff;margin:0pt;padding:0pt;"> 146,842</td></tr><tr><td style="vertical-align:bottom;width:34.56%;margin:0pt;padding:0pt;">Initial recognition and changes in the fair value of biological assets at the point of harvest</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"> 276,511</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"> 134,402</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;margin:0pt;padding:0pt;"> 410,913</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:34.56%;background:#cceeff;margin:0pt;padding:0pt;">Costs incurred during the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 374,456</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 177,601</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 31,301</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 583,358</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:34.56%;margin:0pt;padding:0pt;">Period ended September 30, 2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"> 374,456</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"> 177,601</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"> 364,296</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"> 193,459</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"> 31,301</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,141,113</td></tr></table><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:51.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:51.38%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Wheat</td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Barley</td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Total</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.38%;background:#cceeff;margin:0pt;padding:0pt;">Beginning of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 44,413</td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 12,900</td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 57,313</td></tr><tr><td style="vertical-align:bottom;width:51.38%;margin:0pt;padding:0pt;">Initial recognition and changes in the fair value of biological assets at the point of harvest</td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 365,833</td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 124,173</td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 490,006</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.38%;background:#cceeff;margin:0pt;padding:0pt;">Costs incurred during the period</td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 378,631</td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 122,837</td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 501,468</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.38%;margin:0pt;padding:0pt;">Exchange differences</td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (16,699)</td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (5,344)</td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (22,043)</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.38%;background:#cceeff;margin:0pt;padding:0pt;">Period ended September 30, 2022</td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"> 772,178</td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"> 254,566</td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"> 1,026,744</td></tr></table>5.7. Property, plant and equipmentProperty, plant and equipment as of September 30, 2023 and June 30, 2023 included the following:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Gross carrying amount</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 96,833,359</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 93,634,779</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Accumulated depreciation</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (26,902,650)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (25,780,944)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Net carrying amount</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 69,930,709</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 67,853,835</td></tr></table>Net carrying amount for each class of assets is as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">Net carrying</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">Net carrying</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">amount</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> amount</td></tr><tr><td style="vertical-align:bottom;width:68.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Class</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Office equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 280,905</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 263,892</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Vehicles</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 1,862,542</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 2,032,853</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Equipment and computer software</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 167,741</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 174,399</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Fixtures and fittings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 2,676,861</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 2,862,949</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Machinery and equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 13,970,593</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 14,463,756</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Land and buildings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 35,640,076</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 36,144,792</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Buildings in progress</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 15,331,991</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 11,911,194</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 69,930,709</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 67,853,835</td></tr></table>1. Gross carrying amount as of September 30, 2023 is as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:57.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Gross carrying amount</td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">As of the</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">beginning</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">Foreign </td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">As of the</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:40.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">of the</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">currency</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">end of the</td></tr><tr><td style="vertical-align:bottom;width:40.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Class</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Additions</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Disposals</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">translation</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">period</td></tr><tr><td style="vertical-align:middle;width:40.5%;background:#cceeff;margin:0pt;padding:0pt;">Office equipment</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 968,088</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 34,918</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> (2,764)</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 1,000,242</td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;">Vehicles</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> 5,492,319</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> 28,680</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> (45,062)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> (1,498)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> 5,474,439</td></tr><tr><td style="vertical-align:bottom;width:40.5%;background:#cceeff;margin:0pt;padding:0pt;">Equipment and computer software</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 974,509</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 30,188</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> (5,857)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 998,840</td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;">Fixtures and fittings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> 7,663,899</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> (2,126)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> 7,661,773</td></tr><tr><td style="vertical-align:bottom;width:40.5%;background:#cceeff;margin:0pt;padding:0pt;">Machinery and equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 23,513,047</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 176,837</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> (91,465)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 23,598,419</td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;">Land and buildings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> 43,111,723</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> (344,068)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> 42,767,655</td></tr><tr><td style="vertical-align:bottom;width:40.5%;background:#cceeff;margin:0pt;padding:0pt;">Buildings in progress</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 11,911,194</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 3,678,037</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (257,240)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 15,331,991</td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 93,634,779</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 3,948,660</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (45,062)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (705,018)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 96,833,359</td></tr></table>2. Accumulated depreciation as of September 30, 2023 is as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:57.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Depreciation</td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">Accumulated</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">as of the</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">Foreign</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">Accumulated</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:40.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">beginning of</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">currency</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">as of the end</td></tr><tr><td style="vertical-align:bottom;width:40.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Class</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Disposals</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> translation</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">of the period</td></tr><tr><td style="vertical-align:middle;width:40.5%;background:#cceeff;margin:0pt;padding:0pt;">Office equipment</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 704,196</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 17,004</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> (1,863)</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 719,337</td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;">Vehicles</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> 3,459,466</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;margin:0pt;padding:0pt;"> (36,049)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;margin:0pt;padding:0pt;"> 188,532</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;margin:0pt;padding:0pt;"> (52)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;margin:0pt;padding:0pt;"> 3,611,897</td></tr><tr><td style="vertical-align:bottom;width:40.5%;background:#cceeff;margin:0pt;padding:0pt;">Equipment and computer software</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 800,110</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 35,963</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> (4,974)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 831,099</td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;">Fixtures and fittings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> 4,800,950</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;margin:0pt;padding:0pt;"> 184,877</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;margin:0pt;padding:0pt;"> (915)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;margin:0pt;padding:0pt;"> 4,984,912</td></tr><tr><td style="vertical-align:bottom;width:40.5%;background:#cceeff;margin:0pt;padding:0pt;">Machinery and equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 9,049,291</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 595,729</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> (17,194)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 9,627,826</td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;">Land and buildings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 6,966,931</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 221,298</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (60,650)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 7,127,579</td></tr><tr><td style="vertical-align:bottom;width:40.5%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 25,780,944</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (36,049)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 1,243,403</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (85,648)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 26,902,650</td></tr></table>3. Gross carrying amount as of September 30, 2022 is as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:33%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:65.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Gross carrying amount</td></tr><tr><td style="vertical-align:bottom;width:33%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;">As of the</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;">Additions</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;">Foreign</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;">As of the</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:33%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;">beginning</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> from business </td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;">currency</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> end of the</td></tr><tr><td style="vertical-align:bottom;width:33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Class</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Additions</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">combination</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Disposals</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">translation</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> period</td></tr><tr><td style="vertical-align:bottom;width:33%;background:#cceeff;margin:0pt;padding:0pt;">Office equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 908,004</td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:middle;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:middle;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:middle;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"> (15,172)</td><td style="vertical-align:middle;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 892,832</td></tr><tr><td style="vertical-align:bottom;width:33%;margin:0pt;padding:0pt;">Vehicles</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;">5,261,979</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"> 226,051</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"> (59,744)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"> (6,243)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> 5,422,043</td></tr><tr><td style="vertical-align:bottom;width:33%;background:#cceeff;margin:0pt;padding:0pt;">Equipment and computer software</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 925,349</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"> 41,658</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 12,469</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"> (6,667)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 972,809</td></tr><tr><td style="vertical-align:bottom;width:33%;margin:0pt;padding:0pt;">Fixtures and fittings</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> 7,606,389</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"> 33,869</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> 5,379</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"> (5,539)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> 7,640,098</td></tr><tr><td style="vertical-align:bottom;width:33%;background:#cceeff;margin:0pt;padding:0pt;">Machinery and equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 13,017,830</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"> 107,717</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 7,047,496</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"> (24,469)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 20,148,574</td></tr><tr><td style="vertical-align:bottom;width:33%;margin:0pt;padding:0pt;">Land and buildings</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> 40,659,129</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> 4,750,136</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"> (313,148)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> 45,096,117</td></tr><tr><td style="vertical-align:bottom;width:33%;background:#cceeff;margin:0pt;padding:0pt;">Buildings in progress</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 3,142,774</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,005,435</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,285,092</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (17,941)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 5,415,360</td></tr><tr><td style="vertical-align:bottom;width:33%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 71,521,454</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 1,414,730</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 13,100,572</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (59,744)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (389,179)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 85,587,833</td></tr></table>4. Accumulated depreciation as of September 30, 2022 is as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:57.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Depreciation</td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">Accumulated</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">as of the</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">Foreign</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">Accumulated</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:40.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">beginning of</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">Of the</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">currency</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">as of the end</td></tr><tr><td style="vertical-align:bottom;width:40.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Class</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Disposals </td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">translation</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">of the period</td></tr><tr><td style="vertical-align:bottom;width:40.5%;background:#cceeff;margin:0pt;padding:0pt;">Office equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 638,466</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 17,053</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> (16,931)</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 638,588</td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;">Vehicles</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> 2,596,905</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;margin:0pt;padding:0pt;"> (59,744)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;margin:0pt;padding:0pt;"> 226,899</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;margin:0pt;padding:0pt;"> (3,364)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;margin:0pt;padding:0pt;"> 2,760,696</td></tr><tr><td style="vertical-align:bottom;width:40.5%;background:#cceeff;margin:0pt;padding:0pt;">Equipment and computer software</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 693,673</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 28,914</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> (476)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 722,111</td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;">Fixtures and fittings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> 4,059,470</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;margin:0pt;padding:0pt;"> 206,830</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;margin:0pt;padding:0pt;"> (23,814)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;margin:0pt;padding:0pt;"> 4,242,486</td></tr><tr><td style="vertical-align:bottom;width:40.5%;background:#cceeff;margin:0pt;padding:0pt;">Machinery and equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 7,205,870</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 679,201</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> (180,089)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 7,704,982</td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;">Land and buildings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 6,418,745</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 223,196</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (695)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 6,641,246</td></tr><tr><td style="vertical-align:bottom;width:40.5%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 21,613,129</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (59,744)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 1,382,093</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (225,369)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 22,710,109</td></tr></table>The depreciation charge is included in Notes 6.3 and 6.4. The Group has no commitments to purchase property, plant and equipment items.5.8. Intangible assetsIntangible assets as of September 30, 2023 and June 30, 2023 included the following:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Gross carrying amount</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 204,300,750</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 202,306,618</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Accumulated amortization</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (31,266,214)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (28,522,662)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Net carrying amount</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 173,034,536</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 173,783,956</td></tr></table>Net carrying amount of each class of intangible assets is as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">Net carrying</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">Net carrying</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">amount</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">amount</td></tr><tr><td style="vertical-align:bottom;width:68.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Class</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Seed and integrated products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;">HB4 soy and breeding program</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 31,476,363</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 31,679,681</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Integrated seed products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 2,786,562</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 2,841,008</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;">Crop nutrition</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Microbiological products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 50,506,239</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 49,508,801</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;">Other intangible assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Trademarks and patents</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 58,730,415</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 59,760,753</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;">Software</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 1,609,367</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 1,987,690</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Customer loyalty</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 22,925,590</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 23,006,023</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;">RG/RS/OX Wheat</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 5,000,000</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 5,000,000</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 173,034,536</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 173,783,956</td></tr></table>1. Gross carrying amount as of September 30, 2023 is as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:50.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Gross carrying amount</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;">As of the</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;">Foreign</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;">As of the</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:47.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;">beginning of</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;">currency</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> end of the</td></tr><tr><td style="vertical-align:bottom;width:47.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Class</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Additions</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">translation</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">period</td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Seed and integrated products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">HB4 soy and breeding program</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"> 34,958,425</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 224,230</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 35,182,655</td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Integrated seed products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"> 3,219,808</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> (8,178)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 3,211,630</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">Crop nutrition</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Microbiological products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"> 55,645,028</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 1,723,274</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> (6,119)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 57,362,183</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">Other intangible assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Trademarks and patents</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"> 67,653,234</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 62,543</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 67,715,777</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">Software</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"> 5,582,411</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 1,943</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> (3,561)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 5,580,793</td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Customer loyalty</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"> 30,247,712</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 30,247,712</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">RG/RS/OX Wheat</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 5,000,000</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 5,000,000</td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 202,306,618</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 2,011,990</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (17,858)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 204,300,750</td></tr></table>2. Accumulated amortization as of September 30, 2023 is as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:50.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Amortization</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;">Accumulated</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;">Foreign</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;">Accumulated as</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:47.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;">as of beginning </td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;">currency</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;">of the end of the</td></tr><tr><td style="vertical-align:middle;width:47.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Class</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">translation</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">period</td></tr><tr><td style="vertical-align:middle;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Seed and integrated products</td><td style="vertical-align:middle;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">HB4 soy and breeding program</td><td style="vertical-align:middle;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"> 3,278,744</td><td style="vertical-align:middle;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 427,548</td><td style="vertical-align:middle;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:middle;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 3,706,292</td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Integrated seed products</td><td style="vertical-align:middle;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"> 378,800</td><td style="vertical-align:middle;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 47,229</td><td style="vertical-align:middle;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> (961)</td><td style="vertical-align:middle;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 425,068</td></tr><tr><td style="vertical-align:middle;width:47.43%;margin:0pt;padding:0pt;">Crop nutrition</td><td style="vertical-align:middle;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:middle;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Microbiological products</td><td style="vertical-align:middle;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"> 6,136,227</td><td style="vertical-align:middle;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 719,717</td><td style="vertical-align:middle;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:middle;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 6,855,944</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">Other intangible assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Trademarks and patents</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"> 7,892,481</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 1,092,881</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 8,985,362</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">Software</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"> 3,594,721</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 379,398</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> (2,693)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 3,971,426</td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Customer loyalty</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 7,241,689</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 80,433</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 7,322,122</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 28,522,662</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 2,747,206</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (3,654)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 31,266,214</td></tr></table>3. Gross carrying amount as of September 30, 2022 is as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:43.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:43.87%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:54.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Gross carrying amount</td></tr><tr><td style="vertical-align:bottom;width:43.87%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;">As of the</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;">Additions from</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:43.87%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;">beginning </td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;">business</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;margin:0pt;padding:0pt;">Foreign currency</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;">As of the end of</td></tr><tr><td style="vertical-align:middle;width:43.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Class</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Additions</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">combination</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">translation</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">the period</td></tr><tr><td style="vertical-align:bottom;width:43.87%;background:#cceeff;margin:0pt;padding:0pt;">Seed and integrated products</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:43.87%;margin:0pt;padding:0pt;">HB4 soy and breeding program</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> 31,371,088</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"> 361,006</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"> 31,732,094</td></tr><tr><td style="vertical-align:bottom;width:43.87%;background:#cceeff;margin:0pt;padding:0pt;">Integrated seed products </td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 3,181,155</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"> 3,181,155</td></tr><tr><td style="vertical-align:bottom;width:43.87%;margin:0pt;padding:0pt;">Crop nutrition</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:43.87%;background:#cceeff;margin:0pt;padding:0pt;">Microbiological products</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 8,855,421</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"> 2,880,002</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;background:#cceeff;margin:0pt;padding:0pt;"> 39,613,280</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;background:#cceeff;margin:0pt;padding:0pt;"> (3,945)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"> 51,344,758</td></tr><tr><td style="vertical-align:bottom;width:43.87%;margin:0pt;padding:0pt;">Other intangible assets</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:43.87%;background:#cceeff;margin:0pt;padding:0pt;">Trademarks and patents</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 12,183,045</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"> 3,679</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;background:#cceeff;margin:0pt;padding:0pt;"> 55,420,441</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"> 67,607,165</td></tr><tr><td style="vertical-align:bottom;width:43.87%;margin:0pt;padding:0pt;">Software</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> 5,176,373</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"> 206,184</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;margin:0pt;padding:0pt;"> (1,652)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"> 5,380,905</td></tr><tr><td style="vertical-align:bottom;width:43.87%;background:#cceeff;margin:0pt;padding:0pt;">Customer loyalty</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 28,462,475</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;background:#cceeff;margin:0pt;padding:0pt;"> 1,785,237</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"> 30,247,712</td></tr><tr><td style="vertical-align:bottom;width:43.87%;margin:0pt;padding:0pt;">RG/RS/OX Wheat</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 5,000,000</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 5,000,000</td></tr><tr><td style="vertical-align:bottom;width:43.87%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 94,229,557</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 3,450,871</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 96,818,958</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (5,597)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 194,493,789</td></tr></table>4. Accumulated amortization as of September 30, 2022 is as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:47.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:50.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Amortization</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:47.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;">Accumulated as</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;">Foreign</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;">Accumulated </td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:47.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;">of beginning of</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;">currency</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;">as of the end</td></tr><tr><td style="vertical-align:middle;width:47.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Class</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">translation</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">of the period</td></tr><tr><td style="vertical-align:middle;width:47.43%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;">Seed and integrated products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:47.43%;margin:0pt;padding:0pt;">HB4 soy and breeding program</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"> 1,568,554</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 396,701</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 1,965,255</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Integrated seed products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"> 43,997</td><td style="vertical-align:middle;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 13,019</td><td style="vertical-align:middle;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:middle;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 57,016</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">Crop nutrition </td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Microbiological products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"> 3,063,073</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 1,057,149</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 4,120,222</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">Other intangible assets </td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Trademarks and patents </td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;">3,916,004</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 542,868</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 4,458,872</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">Software </td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"> 3,008,388</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 141,044</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> (1,221)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 3,148,211</td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Customer loyalty </td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">5,924,672</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">326,051</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">6,250,723</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">Total </td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;">17,524,688</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;">2,476,832</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"> (1,221)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;">20,000,299</td></tr></table>The amortization charge is included in Notes 6.3 and 6.4.5.9. Goodwill<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Rizobacter Argentina S.A.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 28,080,271</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 28,080,271</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Bioceres Crops S.A. </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 7,523,322</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 7,523,322</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Pro farm Group, Inc.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 76,089,749</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 76,089,749</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Insumos Agroquímicos S.A.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 470,090</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 470,090</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 112,163,432</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 112,163,432</td></tr></table>There were no indicators of goodwill impairment. 5.10. Investment properties<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Investment properties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 3,675,493</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 3,589,749</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 3,675,493</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 3,589,749</td></tr></table>5.11. Trade and other payables<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Trade creditors</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 106,222,415</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 104,211,238</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Shareholders and other related parties (Note 15)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 27,708</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 35,292</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Trade creditors - Parent company (Note 15)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 270,645</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 644,191</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Trade creditors - Joint ventures and associates (Note 15)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 47,282,380</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 41,402,594</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Taxes</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 5,138,674</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 3,561,058</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Miscellaneous</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 183,536</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 953,301</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 159,125,358</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 150,807,674</td></tr></table>5.12. Borrowings<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Bank borrowings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 60,473,023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 61,303,952</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Corporate bonds</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 29,745,450</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 35,547,510</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Trust debt securities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 6,936,758</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 7,296,506</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Net loans payables- Parents companies and related parties to Parent (Note 15)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 3,565,754</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 3,491,691</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 100,720,985</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 107,639,659</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Non-current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Bank borrowings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 7,586,944</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 10,663,266</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Corporate bonds</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 41,202,548</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 50,007,680</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">48,789,492</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">60,670,946</td></tr></table>The carrying value of some borrowings as of September 30, 2023 are measured at amortized cost differ from their fair value. The following fair values measured are based on discounted cash flows (Level 3) due to the use of unobservable inputs, including own credit risk.<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:26.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:26.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Amortized cost</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Fair value</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Amortized cost</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Fair value</td></tr><tr><td style="vertical-align:bottom;width:42.55%;background:#cceeff;margin:0pt;padding:0pt;">Current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;">Bank borrowings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 60,473,023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 57,553,255</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 61,303,952</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 57,209,155</td></tr><tr><td style="vertical-align:bottom;width:42.55%;background:#cceeff;margin:0pt;padding:0pt;">Corporate Bonds</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 29,745,450</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 29,389,136</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 35,547,510</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 34,725,828</td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:42.55%;background:#cceeff;margin:0pt;padding:0pt;">Non-current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;">Bank borrowings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 7,586,944</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 5,620,759</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 10,663,266</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 10,374,646</td></tr><tr><td style="vertical-align:bottom;width:42.55%;background:#cceeff;margin:0pt;padding:0pt;">Corporate Bonds</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 41,202,548</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 39,984,876</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 50,007,680</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 47,014,542</td></tr></table>5.13. Secured NotesSecured Guaranteed NotesThe carrying value of $25.9 million of the Secured Guaranteed Notes as of September 30, 2023 are measured at amortized cost. Its fair value based on discounted cash flows, using a fair interest rate, would amount to $26.1 million.Secured Convertible Guaranteed Notes The carrying value of $51.0 million of the Secured Convertible Guaranteed Notes as of September 30, 2023 are measured at amortized cost. Its fair value based on discounted cash flows, using a fair interest rate, would amount to $53.3 million.Under the terms of the Secured Convertible Guaranteed Notes, the Group is in compliance with covenants.5.14. Employee benefits and social security<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Salaries, accrued incentives, vacations and social security</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 9,685,549</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 9,388,639</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Key management personnel (Note 15)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 333,616</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 218,068</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 10,019,165</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 9,606,707</td></tr></table>5.15. Deferred revenue and advances from customers<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Advances from customers</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 17,019,407</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 9,216,032</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Deferred revenue</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 15,752,495</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 15,659,630</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 32,771,902</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 24,875,662</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Non-current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Advances from customers</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 272,334</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 620,893</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Deferred revenue</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,930,040</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,436,912</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">2,202,374</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 2,057,805</td></tr></table> <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Cash at bank and on hand</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 25,954,730</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 48,129,194</td></tr><tr><td style="vertical-align:middle;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;">Mutual funds</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 2,419,194</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 28,373,924</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 48,129,194</td></tr></table> 25954730 48129194 2419194 28373924 48129194 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Restricted short-term deposits</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 212,703</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">US Treasury bills</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 9,719,486</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 9,163,298</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Mutual funds</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 3,236,702</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 1,596,539</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Other investments</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,672,014</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,162,480</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 14,628,202</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 12,135,020</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Non-current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Shares of Bioceres S.A.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 444,575</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 444,635</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Other investments</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 58,335</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 274</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 502,910</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 444,909</td></tr></table> 212703 9719486 9163298 3236702 1596539 1672014 1162480 14628202 12135020 444575 444635 58335 274 502910 444909 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Trade debtors</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 189,222,562</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 160,269,233</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Allowance for impairment of trade debtors</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (7,615,433)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (7,425,604)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Shareholders and other related parties (Note 15)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 1,368,373</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Allowance for credit notes to be issued</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (2,610,596)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (3,694,019)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Trade debtors - Joint ventures and associates (Note 15)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 781,451</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 865,627</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Deferred checks</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 5,129,962</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 7,991,237</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 186,276,319</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 158,006,474</td></tr></table> 189222562 160269233 7615433 7425604 1368373 2610596 3694019 781451 865627 5129962 7991237 186276319 158006474 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Taxes</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 6,009,626</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 6,113,764</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Receivables for PP&E sales</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 89,715</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 156,423</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Shareholders and other related parties (Note 15)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 2,919,431</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 3,792,429</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Other receivables - Joint ventures and associates (Note 15)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 6,469,863</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 6,104,219</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Prepayments to suppliers</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 5,010,022</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 10,956,831</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Reimbursements over exports</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 10,558</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 10,558</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Prepaid expenses and other receivables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 3,657,633</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 1,302,221</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Miscellaneous</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 735,655</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 388,553</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 24,902,503</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 28,824,998</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Non-current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Taxes</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 865,588</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 873,699</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Reimbursements over exports</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 1,268,928</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 1,290,227</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Loans receivables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 230,000</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 230,000</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Miscellaneous</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 29,423</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 152,315</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 2,393,939</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 2,546,241</td></tr></table> 6009626 6113764 89715 156423 2919431 3792429 6469863 6104219 5010022 10956831 10558 10558 3657633 1302221 735655 388553 24902503 28824998 865588 873699 1268928 1290227 230000 230000 29423 152315 2393939 2546241 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 09/30/2023 </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 06/30/2023 </td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Seeds</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 9,293,210</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 1,542,159</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Resale products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 71,973,203</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 58,544,931</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Manufactured products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 19,604,930</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 25,881,761</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Goods in transit</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 2,298,136</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 3,620,606</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Supplies</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 18,709,303</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 24,893,187</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Agricultural products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 19,111,345</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 28,436,830</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Allowance for obsolescence</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (2,913,305)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (2,492,499)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 138,076,822</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 140,426,975</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Net of agricultural products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 118,965,477</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 111,990,145</td></tr></table> 9293210 1542159 71973203 58544931 19604930 25881761 2298136 3620606 18709303 24893187 19111345 28436830 -2913305 -2492499 138076822 140426975 118965477 111990145 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:34.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:34.56%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Soybean</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Corn</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Wheat</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Barley</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Sunflower</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Total</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:34.56%;background:#cceeff;margin:0pt;padding:0pt;">Beginning of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"> 87,785</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"> 59,057</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;background:#cceeff;margin:0pt;padding:0pt;"> 146,842</td></tr><tr><td style="vertical-align:bottom;width:34.56%;margin:0pt;padding:0pt;">Initial recognition and changes in the fair value of biological assets at the point of harvest</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"> 276,511</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"> 134,402</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;margin:0pt;padding:0pt;"> 410,913</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:34.56%;background:#cceeff;margin:0pt;padding:0pt;">Costs incurred during the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 374,456</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 177,601</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 31,301</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 583,358</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:34.56%;margin:0pt;padding:0pt;">Period ended September 30, 2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.87%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"> 374,456</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"> 177,601</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"> 364,296</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"> 193,459</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.86%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"> 31,301</td><td style="vertical-align:bottom;white-space:nowrap;width:2.05%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,141,113</td></tr></table><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:51.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:51.38%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Wheat</td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Barley</td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Total</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.38%;background:#cceeff;margin:0pt;padding:0pt;">Beginning of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 44,413</td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 12,900</td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 57,313</td></tr><tr><td style="vertical-align:bottom;width:51.38%;margin:0pt;padding:0pt;">Initial recognition and changes in the fair value of biological assets at the point of harvest</td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 365,833</td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 124,173</td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 490,006</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.38%;background:#cceeff;margin:0pt;padding:0pt;">Costs incurred during the period</td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 378,631</td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 122,837</td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 501,468</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.38%;margin:0pt;padding:0pt;">Exchange differences</td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (16,699)</td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (5,344)</td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (22,043)</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.38%;background:#cceeff;margin:0pt;padding:0pt;">Period ended September 30, 2022</td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"> 772,178</td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"> 254,566</td><td style="vertical-align:bottom;white-space:nowrap;width:3.04%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"> 1,026,744</td></tr></table> 0 0 87785 59057 0 146842 276511 134402 410913 374456 177601 31301 583358 374456 177601 364296 193459 31301 1141113 44413 12900 57313 365833 124173 490006 378631 122837 501468 -16699 -5344 -22043 772178 254566 1026744 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Gross carrying amount</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 96,833,359</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 93,634,779</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Accumulated depreciation</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (26,902,650)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (25,780,944)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Net carrying amount</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 69,930,709</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 67,853,835</td></tr></table> 96833359 93634779 -26902650 -25780944 69930709 67853835 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">Net carrying</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">Net carrying</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">amount</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> amount</td></tr><tr><td style="vertical-align:bottom;width:68.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Class</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Office equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 280,905</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 263,892</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Vehicles</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 1,862,542</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 2,032,853</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Equipment and computer software</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 167,741</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 174,399</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Fixtures and fittings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 2,676,861</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 2,862,949</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Machinery and equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 13,970,593</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 14,463,756</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Land and buildings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 35,640,076</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 36,144,792</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Buildings in progress</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 15,331,991</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 11,911,194</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 69,930,709</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 67,853,835</td></tr></table> 280905 263892 1862542 2032853 167741 174399 2676861 2862949 13970593 14463756 35640076 36144792 15331991 11911194 69930709 67853835 1. Gross carrying amount as of September 30, 2023 is as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:57.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Gross carrying amount</td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">As of the</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">beginning</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">Foreign </td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">As of the</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:40.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">of the</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">currency</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">end of the</td></tr><tr><td style="vertical-align:bottom;width:40.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Class</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Additions</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Disposals</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">translation</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">period</td></tr><tr><td style="vertical-align:middle;width:40.5%;background:#cceeff;margin:0pt;padding:0pt;">Office equipment</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 968,088</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 34,918</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> (2,764)</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 1,000,242</td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;">Vehicles</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> 5,492,319</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> 28,680</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> (45,062)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> (1,498)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> 5,474,439</td></tr><tr><td style="vertical-align:bottom;width:40.5%;background:#cceeff;margin:0pt;padding:0pt;">Equipment and computer software</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 974,509</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 30,188</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> (5,857)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 998,840</td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;">Fixtures and fittings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> 7,663,899</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> (2,126)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> 7,661,773</td></tr><tr><td style="vertical-align:bottom;width:40.5%;background:#cceeff;margin:0pt;padding:0pt;">Machinery and equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 23,513,047</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 176,837</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> (91,465)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 23,598,419</td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;">Land and buildings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> 43,111,723</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> (344,068)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> 42,767,655</td></tr><tr><td style="vertical-align:bottom;width:40.5%;background:#cceeff;margin:0pt;padding:0pt;">Buildings in progress</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 11,911,194</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 3,678,037</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (257,240)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 15,331,991</td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 93,634,779</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 3,948,660</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (45,062)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (705,018)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 96,833,359</td></tr></table>3. Gross carrying amount as of September 30, 2022 is as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:33%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td colspan="11" style="vertical-align:bottom;white-space:nowrap;width:65.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Gross carrying amount</td></tr><tr><td style="vertical-align:bottom;width:33%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;">As of the</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;">Additions</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;">Foreign</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;">As of the</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:33%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;">beginning</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> from business </td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;">currency</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> end of the</td></tr><tr><td style="vertical-align:bottom;width:33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Class</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Additions</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">combination</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Disposals</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">translation</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> period</td></tr><tr><td style="vertical-align:bottom;width:33%;background:#cceeff;margin:0pt;padding:0pt;">Office equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 908,004</td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:middle;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:middle;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:middle;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"> (15,172)</td><td style="vertical-align:middle;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 892,832</td></tr><tr><td style="vertical-align:bottom;width:33%;margin:0pt;padding:0pt;">Vehicles</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;">5,261,979</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"> 226,051</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"> (59,744)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"> (6,243)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> 5,422,043</td></tr><tr><td style="vertical-align:bottom;width:33%;background:#cceeff;margin:0pt;padding:0pt;">Equipment and computer software</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 925,349</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"> 41,658</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 12,469</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"> (6,667)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 972,809</td></tr><tr><td style="vertical-align:bottom;width:33%;margin:0pt;padding:0pt;">Fixtures and fittings</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> 7,606,389</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"> 33,869</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> 5,379</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"> (5,539)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> 7,640,098</td></tr><tr><td style="vertical-align:bottom;width:33%;background:#cceeff;margin:0pt;padding:0pt;">Machinery and equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 13,017,830</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;margin:0pt;padding:0pt;"> 107,717</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 7,047,496</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;margin:0pt;padding:0pt;"> (24,469)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 20,148,574</td></tr><tr><td style="vertical-align:bottom;width:33%;margin:0pt;padding:0pt;">Land and buildings</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> 40,659,129</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> 4,750,136</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;margin:0pt;padding:0pt;"> (313,148)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> 45,096,117</td></tr><tr><td style="vertical-align:bottom;width:33%;background:#cceeff;margin:0pt;padding:0pt;">Buildings in progress</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 3,142,774</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,005,435</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,285,092</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (17,941)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 5,415,360</td></tr><tr><td style="vertical-align:bottom;width:33%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 71,521,454</td><td style="vertical-align:bottom;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.14%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 1,414,730</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 13,100,572</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (59,744)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (389,179)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.91%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 85,587,833</td></tr></table> 968088 34918 -2764 1000242 5492319 28680 45062 -1498 5474439 974509 30188 -5857 998840 7663899 -2126 7661773 23513047 176837 -91465 23598419 43111723 -344068 42767655 11911194 3678037 -257240 15331991 93634779 3948660 45062 -705018 96833359 2. Accumulated depreciation as of September 30, 2023 is as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:57.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Depreciation</td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">Accumulated</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">as of the</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">Foreign</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">Accumulated</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:40.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">beginning of</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">currency</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">as of the end</td></tr><tr><td style="vertical-align:bottom;width:40.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Class</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Disposals</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> translation</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">of the period</td></tr><tr><td style="vertical-align:middle;width:40.5%;background:#cceeff;margin:0pt;padding:0pt;">Office equipment</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 704,196</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 17,004</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> (1,863)</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 719,337</td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;">Vehicles</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> 3,459,466</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;margin:0pt;padding:0pt;"> (36,049)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;margin:0pt;padding:0pt;"> 188,532</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;margin:0pt;padding:0pt;"> (52)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;margin:0pt;padding:0pt;"> 3,611,897</td></tr><tr><td style="vertical-align:bottom;width:40.5%;background:#cceeff;margin:0pt;padding:0pt;">Equipment and computer software</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 800,110</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 35,963</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> (4,974)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 831,099</td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;">Fixtures and fittings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> 4,800,950</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;margin:0pt;padding:0pt;"> 184,877</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;margin:0pt;padding:0pt;"> (915)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;margin:0pt;padding:0pt;"> 4,984,912</td></tr><tr><td style="vertical-align:bottom;width:40.5%;background:#cceeff;margin:0pt;padding:0pt;">Machinery and equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 9,049,291</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 595,729</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> (17,194)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 9,627,826</td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;">Land and buildings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 6,966,931</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 221,298</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (60,650)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 7,127,579</td></tr><tr><td style="vertical-align:bottom;width:40.5%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 25,780,944</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (36,049)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 1,243,403</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (85,648)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 26,902,650</td></tr></table>4. Accumulated depreciation as of September 30, 2022 is as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:57.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Depreciation</td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">Accumulated</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">as of the</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">Foreign</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">Accumulated</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:40.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">beginning of</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">Of the</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">currency</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;">as of the end</td></tr><tr><td style="vertical-align:bottom;width:40.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Class</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Disposals </td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">translation</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">of the period</td></tr><tr><td style="vertical-align:bottom;width:40.5%;background:#cceeff;margin:0pt;padding:0pt;">Office equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 638,466</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 17,053</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> (16,931)</td><td style="vertical-align:middle;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 638,588</td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;">Vehicles</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> 2,596,905</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;margin:0pt;padding:0pt;"> (59,744)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;margin:0pt;padding:0pt;"> 226,899</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;margin:0pt;padding:0pt;"> (3,364)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;margin:0pt;padding:0pt;"> 2,760,696</td></tr><tr><td style="vertical-align:bottom;width:40.5%;background:#cceeff;margin:0pt;padding:0pt;">Equipment and computer software</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 693,673</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 28,914</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> (476)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 722,111</td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;">Fixtures and fittings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> 4,059,470</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;margin:0pt;padding:0pt;"> 206,830</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;margin:0pt;padding:0pt;"> (23,814)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;width:9.5%;margin:0pt;padding:0pt;"> 4,242,486</td></tr><tr><td style="vertical-align:bottom;width:40.5%;background:#cceeff;margin:0pt;padding:0pt;">Machinery and equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 7,205,870</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 679,201</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> (180,089)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;background:#cceeff;margin:0pt;padding:0pt;"> 7,704,982</td></tr><tr><td style="vertical-align:bottom;width:40.5%;margin:0pt;padding:0pt;">Land and buildings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 6,418,745</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 223,196</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (695)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 6,641,246</td></tr><tr><td style="vertical-align:bottom;width:40.5%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 21,613,129</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;width:9.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (59,744)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 1,382,093</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (225,369)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.5%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 22,710,109</td></tr></table> -704196 -17004 1863 -719337 -3459466 -36049 -188532 52 -3611897 -800110 -35963 4974 -831099 -4800950 -184877 915 -4984912 -9049291 -595729 17194 -9627826 -6966931 -221298 60650 -7127579 -25780944 -36049 -1243403 85648 -26902650 908004 -15172 892832 5261979 226051 59744 -6243 5422043 925349 41658 12469 -6667 972809 7606389 33869 5379 -5539 7640098 13017830 107717 7047496 -24469 20148574 40659129 4750136 -313148 45096117 3142774 1005435 1285092 -17941 5415360 71521454 1414730 13100572 59744 -389179 85587833 -638466 -17053 16931 -638588 -2596905 -59744 -226899 3364 -2760696 -693673 -28914 476 -722111 -4059470 -206830 23814 -4242486 -7205870 -679201 180089 -7704982 -6418745 -223196 695 -6641246 -21613129 -59744 -1382093 225369 -22710109 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Gross carrying amount</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 204,300,750</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 202,306,618</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Accumulated amortization</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (31,266,214)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (28,522,662)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Net carrying amount</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 173,034,536</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 173,783,956</td></tr></table> 204300750 202306618 -31266214 -28522662 173034536 173783956 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">Net carrying</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">Net carrying</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">amount</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">amount</td></tr><tr><td style="vertical-align:bottom;width:68.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Class</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Seed and integrated products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;">HB4 soy and breeding program</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 31,476,363</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 31,679,681</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Integrated seed products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 2,786,562</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 2,841,008</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;">Crop nutrition</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Microbiological products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 50,506,239</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 49,508,801</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;">Other intangible assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Trademarks and patents</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 58,730,415</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 59,760,753</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;">Software</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 1,609,367</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 1,987,690</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Customer loyalty</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 22,925,590</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 23,006,023</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;">RG/RS/OX Wheat</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 5,000,000</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 5,000,000</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 173,034,536</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 173,783,956</td></tr></table> 31476363 31679681 2786562 2841008 50506239 49508801 58730415 59760753 1609367 1987690 22925590 23006023 5000000 5000000 173034536 173783956 1. Gross carrying amount as of September 30, 2023 is as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:50.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Gross carrying amount</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;">As of the</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;">Foreign</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;">As of the</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:47.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;">beginning of</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;">currency</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> end of the</td></tr><tr><td style="vertical-align:bottom;width:47.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Class</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Additions</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">translation</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">period</td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Seed and integrated products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">HB4 soy and breeding program</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"> 34,958,425</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 224,230</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 35,182,655</td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Integrated seed products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"> 3,219,808</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> (8,178)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 3,211,630</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">Crop nutrition</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Microbiological products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"> 55,645,028</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 1,723,274</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> (6,119)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 57,362,183</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">Other intangible assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Trademarks and patents</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"> 67,653,234</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 62,543</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 67,715,777</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">Software</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"> 5,582,411</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 1,943</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> (3,561)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 5,580,793</td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Customer loyalty</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"> 30,247,712</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 30,247,712</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">RG/RS/OX Wheat</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 5,000,000</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 5,000,000</td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 202,306,618</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 2,011,990</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (17,858)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 204,300,750</td></tr></table>3. Gross carrying amount as of September 30, 2022 is as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:43.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:43.87%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td colspan="9" style="vertical-align:bottom;white-space:nowrap;width:54.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Gross carrying amount</td></tr><tr><td style="vertical-align:bottom;width:43.87%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;">As of the</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;">Additions from</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:43.87%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;">beginning </td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;">business</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;margin:0pt;padding:0pt;">Foreign currency</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;">As of the end of</td></tr><tr><td style="vertical-align:middle;width:43.87%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Class</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Additions</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">combination</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">translation</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">the period</td></tr><tr><td style="vertical-align:bottom;width:43.87%;background:#cceeff;margin:0pt;padding:0pt;">Seed and integrated products</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:43.87%;margin:0pt;padding:0pt;">HB4 soy and breeding program</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> 31,371,088</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"> 361,006</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"> 31,732,094</td></tr><tr><td style="vertical-align:bottom;width:43.87%;background:#cceeff;margin:0pt;padding:0pt;">Integrated seed products </td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 3,181,155</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"> 3,181,155</td></tr><tr><td style="vertical-align:bottom;width:43.87%;margin:0pt;padding:0pt;">Crop nutrition</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:43.87%;background:#cceeff;margin:0pt;padding:0pt;">Microbiological products</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 8,855,421</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"> 2,880,002</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;background:#cceeff;margin:0pt;padding:0pt;"> 39,613,280</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;background:#cceeff;margin:0pt;padding:0pt;"> (3,945)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"> 51,344,758</td></tr><tr><td style="vertical-align:bottom;width:43.87%;margin:0pt;padding:0pt;">Other intangible assets</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:43.87%;background:#cceeff;margin:0pt;padding:0pt;">Trademarks and patents</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 12,183,045</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"> 3,679</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;background:#cceeff;margin:0pt;padding:0pt;"> 55,420,441</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"> 67,607,165</td></tr><tr><td style="vertical-align:bottom;width:43.87%;margin:0pt;padding:0pt;">Software</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> 5,176,373</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;margin:0pt;padding:0pt;"> 206,184</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;margin:0pt;padding:0pt;"> (1,652)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"> 5,380,905</td></tr><tr><td style="vertical-align:bottom;width:43.87%;background:#cceeff;margin:0pt;padding:0pt;">Customer loyalty</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 28,462,475</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;background:#cceeff;margin:0pt;padding:0pt;"> 1,785,237</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"> 30,247,712</td></tr><tr><td style="vertical-align:bottom;width:43.87%;margin:0pt;padding:0pt;">RG/RS/OX Wheat</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 5,000,000</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 5,000,000</td></tr><tr><td style="vertical-align:bottom;width:43.87%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 94,229,557</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:8.42%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 3,450,871</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 96,818,958</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.99%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (5,597)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 194,493,789</td></tr></table> 34958425 224230 35182655 3219808 -8178 3211630 55645028 1723274 -6119 57362183 67653234 62543 67715777 5582411 1943 -3561 5580793 30247712 30247712 5000000 5000000 202306618 2011990 -17858 204300750 2. Accumulated amortization as of September 30, 2023 is as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:50.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Amortization</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;">Accumulated</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;">Foreign</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;">Accumulated as</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:47.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;">as of beginning </td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;">currency</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;">of the end of the</td></tr><tr><td style="vertical-align:middle;width:47.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Class</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">translation</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">period</td></tr><tr><td style="vertical-align:middle;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Seed and integrated products</td><td style="vertical-align:middle;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">HB4 soy and breeding program</td><td style="vertical-align:middle;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"> 3,278,744</td><td style="vertical-align:middle;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 427,548</td><td style="vertical-align:middle;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:middle;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 3,706,292</td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Integrated seed products</td><td style="vertical-align:middle;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"> 378,800</td><td style="vertical-align:middle;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 47,229</td><td style="vertical-align:middle;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> (961)</td><td style="vertical-align:middle;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 425,068</td></tr><tr><td style="vertical-align:middle;width:47.43%;margin:0pt;padding:0pt;">Crop nutrition</td><td style="vertical-align:middle;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:middle;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:middle;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Microbiological products</td><td style="vertical-align:middle;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"> 6,136,227</td><td style="vertical-align:middle;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 719,717</td><td style="vertical-align:middle;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:middle;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 6,855,944</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">Other intangible assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Trademarks and patents</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"> 7,892,481</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 1,092,881</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 8,985,362</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">Software</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"> 3,594,721</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 379,398</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> (2,693)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 3,971,426</td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Customer loyalty</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 7,241,689</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 80,433</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 7,322,122</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 28,522,662</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 2,747,206</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (3,654)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 31,266,214</td></tr></table>4. Accumulated amortization as of September 30, 2022 is as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:47.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td colspan="7" style="vertical-align:bottom;white-space:nowrap;width:50.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Amortization</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:47.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;">Accumulated as</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;">Foreign</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;">Accumulated </td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:47.43%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;">of beginning of</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;">currency</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;">as of the end</td></tr><tr><td style="vertical-align:middle;width:47.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Class</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">translation</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">of the period</td></tr><tr><td style="vertical-align:middle;width:47.43%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;">Seed and integrated products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;border-top:1px solid #000000;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:47.43%;margin:0pt;padding:0pt;">HB4 soy and breeding program</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"> 1,568,554</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 396,701</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 1,965,255</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Integrated seed products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"> 43,997</td><td style="vertical-align:middle;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 13,019</td><td style="vertical-align:middle;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:middle;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:middle;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 57,016</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">Crop nutrition </td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Microbiological products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;"> 3,063,073</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 1,057,149</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 4,120,222</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">Other intangible assets </td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Trademarks and patents </td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;margin:0pt;padding:0pt;">3,916,004</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 542,868</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;margin:0pt;padding:0pt;"> 4,458,872</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">Software </td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;margin:0pt;padding:0pt;"> 3,008,388</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 141,044</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> (1,221)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;margin:0pt;padding:0pt;"> 3,148,211</td></tr><tr><td style="vertical-align:bottom;width:47.43%;background:#cceeff;margin:0pt;padding:0pt;">Customer loyalty </td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">5,924,672</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">326,051</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">6,250,723</td></tr><tr><td style="vertical-align:bottom;width:47.43%;margin:0pt;padding:0pt;">Total </td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.81%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;">17,524,688</td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;">2,476,832</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"> (1,221)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.82%;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;">20,000,299</td></tr></table> -3278744 -427548 -3706292 -378800 -47229 961 -425068 -6136227 -719717 -6855944 -7892481 -1092881 -8985362 -3594721 -379398 2693 -3971426 -7241689 -80433 -7322122 -28522662 -2747206 3654 -31266214 31371088 361006 31732094 3181155 3181155 8855421 2880002 39613280 -3945 51344758 12183045 3679 55420441 67607165 5176373 206184 -1652 5380905 28462475 1785237 30247712 5000000 5000000 94229557 3450871 96818958 -5597 194493789 -1568554 -396701 -1965255 -43997 -13019 -57016 -3063073 -1057149 -4120222 -3916004 -542868 -4458872 -3008388 -141044 1221 -3148211 -5924672 -326051 -6250723 -17524688 -2476832 1221 -20000299 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Rizobacter Argentina S.A.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 28,080,271</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 28,080,271</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Bioceres Crops S.A. </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 7,523,322</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 7,523,322</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Pro farm Group, Inc.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 76,089,749</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 76,089,749</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Insumos Agroquímicos S.A.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 470,090</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 470,090</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 112,163,432</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 112,163,432</td></tr></table> 28080271 28080271 7523322 7523322 76089749 76089749 470090 470090 112163432 112163432 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Investment properties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 3,675,493</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 3,589,749</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 3,675,493</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 3,589,749</td></tr></table> 3675493 3589749 3675493 3589749 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Trade creditors</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 106,222,415</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 104,211,238</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Shareholders and other related parties (Note 15)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 27,708</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 35,292</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Trade creditors - Parent company (Note 15)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 270,645</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 644,191</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Trade creditors - Joint ventures and associates (Note 15)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 47,282,380</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 41,402,594</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Taxes</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 5,138,674</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 3,561,058</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Miscellaneous</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 183,536</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 953,301</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 159,125,358</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 150,807,674</td></tr></table> 106222415 104211238 27708 35292 270645 644191 47282380 41402594 5138674 3561058 183536 953301 159125358 150807674 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Bank borrowings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 60,473,023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 61,303,952</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Corporate bonds</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 29,745,450</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 35,547,510</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Trust debt securities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 6,936,758</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 7,296,506</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Net loans payables- Parents companies and related parties to Parent (Note 15)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 3,565,754</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 3,491,691</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 100,720,985</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 107,639,659</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Non-current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Bank borrowings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 7,586,944</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 10,663,266</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Corporate bonds</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 41,202,548</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 50,007,680</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">48,789,492</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">60,670,946</td></tr></table> 60473023 61303952 29745450 35547510 6936758 7296506 3565754 3491691 100720985 107639659 7586944 10663266 41202548 50007680 48789492 60670946 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:26.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:26.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Amortized cost</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Fair value</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Amortized cost</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Fair value</td></tr><tr><td style="vertical-align:bottom;width:42.55%;background:#cceeff;margin:0pt;padding:0pt;">Current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;">Bank borrowings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 60,473,023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 57,553,255</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 61,303,952</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 57,209,155</td></tr><tr><td style="vertical-align:bottom;width:42.55%;background:#cceeff;margin:0pt;padding:0pt;">Corporate Bonds</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 29,745,450</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 29,389,136</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 35,547,510</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 34,725,828</td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:42.55%;background:#cceeff;margin:0pt;padding:0pt;">Non-current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;">Bank borrowings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 7,586,944</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 5,620,759</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 10,663,266</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 10,374,646</td></tr><tr><td style="vertical-align:bottom;width:42.55%;background:#cceeff;margin:0pt;padding:0pt;">Corporate Bonds</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 41,202,548</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 39,984,876</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 50,007,680</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 47,014,542</td></tr></table> 60473023 57553255 61303952 57209155 29745450 29389136 35547510 34725828 7586944 5620759 10663266 10374646 41202548 39984876 50007680 47014542 25900000 26100000 51000000.0 53300000 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Salaries, accrued incentives, vacations and social security</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 9,685,549</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 9,388,639</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Key management personnel (Note 15)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 333,616</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 218,068</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 10,019,165</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 9,606,707</td></tr></table> 9685549 9388639 333616 218068 10019165 9606707 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Advances from customers</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 17,019,407</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 9,216,032</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Deferred revenue</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 15,752,495</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 15,659,630</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 32,771,902</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 24,875,662</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Non-current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Advances from customers</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 272,334</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 620,893</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Deferred revenue</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,930,040</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,436,912</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">2,202,374</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 2,057,805</td></tr></table> 17019407 9216032 15752495 15659630 32771902 24875662 272334 620893 1930040 1436912 2202374 2057805 6. INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME6.1. Revenue from contracts with customers<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2022</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Sale of goods and services</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 115,628,792</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 126,113,636</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Royalties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 554,013</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 729,612</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 116,182,805</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 126,843,248</td></tr></table>Transactions of sales of goods and services with joint ventures and with shareholders and other related parties are reported in Note 15.6.2. Cost of sales<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:67.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Item</td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2022</td></tr><tr><td style="vertical-align:bottom;width:67.67%;background:#cceeff;margin:0pt;padding:0pt;">Inventories as of the beginning of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;margin:0pt;padding:0pt;"> 111,990,145</td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;margin:0pt;padding:0pt;"> 78,759,610</td></tr><tr><td style="vertical-align:bottom;width:67.67%;margin:0pt;padding:0pt;">Business combination</td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"> 11,064,908</td></tr><tr><td style="vertical-align:bottom;width:67.67%;background:#cceeff;margin:0pt;padding:0pt;">Purchases of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;margin:0pt;padding:0pt;"> 71,694,655</td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;margin:0pt;padding:0pt;"> 79,325,509</td></tr><tr><td style="vertical-align:bottom;width:67.67%;margin:0pt;padding:0pt;">Production costs</td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"> 7,123,255</td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"> 8,440,830</td></tr><tr><td style="vertical-align:bottom;width:67.67%;background:#cceeff;margin:0pt;padding:0pt;">Foreign currency translation</td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (226,797)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (236,263)</td></tr><tr><td style="vertical-align:bottom;width:67.67%;margin:0pt;padding:0pt;">Subtotal</td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"> 190,581,258</td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"> 177,354,594</td></tr><tr><td style="vertical-align:bottom;width:67.67%;background:#cceeff;margin:0pt;padding:0pt;">Inventories as of the end of the period (*)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (118,965,477)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (101,678,716)</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:67.67%;margin:0pt;padding:0pt;">Cost of sales </td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">71,615,781</td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 75,675,878</td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div>(*)Net of agricultural products.6.3. R&D classified by nature<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">Research and</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">Research and</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">development</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">development</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">expenses</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Item</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2022</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Amortization of intangible assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 1,164,940</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 1,511,118</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Analysis and storage </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 11,568</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Import and export expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 850</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Depreciation of property, plant and equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 157,808</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 142,373</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Freight and haulage</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 3,917</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 5,300</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Employee benefits and social securities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 1,307,126</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 861,312</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Maintenance</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 206,778</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 217,066</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Energy and fuel</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 3,628</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 79,121</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Supplies and materials</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 847,382</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 559,044</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Mobility and travel</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 13,771</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 108,694</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Share-based incentives</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 188,250</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 6,975</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Professional fees and outsourced services</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 491,787</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 293,776</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Office supplies</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 170,375</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 21,454</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Information technology expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 4,375</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 11,996</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Insurance</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 21,049</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 10,537</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Depreciation of leased assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 10,650</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Miscellaneous</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 55</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 180</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 4,581,241</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 3,852,014</td></tr></table><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2022</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">R&D capitalized (Note 5.8)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 1,947,504</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 3,241,008</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">R&D profit and loss</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 4,581,241</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 3,852,014</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 6,528,745</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 7,093,022</td></tr></table>6.4. Expenses classified by nature and function<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:58.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.68%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;">Selling, </td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;">general and</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;">Production </td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;">administrative</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;">Total</td></tr><tr><td style="vertical-align:bottom;width:58.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Item</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">costs</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Amortization of intangible assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 30,478</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 1,551,788</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 1,582,266</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Analysis and storage</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 570</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 153,473</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 154,043</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Commissions and royalties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 134,592</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 794,058</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 928,650</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Import and export expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 67,228</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 120,345</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 187,573</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Depreciation of property, plant and equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 643,006</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 442,589</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 1,085,595</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Depreciation of leased assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 339,378</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 497,821</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 837,199</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Impairment of receivables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 352,920</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 352,920</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Freight and haulage</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 643,877</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 2,989,094</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 3,632,971</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Employee benefits and social securities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 2,806,939</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 10,238,931</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 13,045,870</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Maintenance</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 422,757</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 568,155</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 990,912</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Energy and fuel</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 163,122</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 16,397</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 179,519</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Supplies and materials</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 260,043</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 831,454</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 1,091,497</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Mobility and travel</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 33,407</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 1,348,563</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 1,381,970</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Publicity and advertising</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 1,161,498</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 1,161,498</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Contingencies</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 27,109</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 27,109</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Share-based incentives</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 275,432</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 5,729,986</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 6,005,418</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Professional fees and outsourced services</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 509,450</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 1,575,982</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 2,085,432</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Office supplies and registrations fees</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 149,888</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 370,770</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 520,658</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Insurance</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 27,024</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 473,850</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 500,874</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Information technology expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 18,361</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 743,163</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 761,524</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Obsolescence</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 505,285</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 505,285</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Taxes</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 70,819</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 3,766,419</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 3,837,238</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Miscellaneous</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 21,599</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 178,483</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 200,082</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Total </td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 7,123,255</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 33,932,848</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 41,056,103</td></tr></table><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:58.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.68%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;">Selling, </td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;">general and</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;">Production </td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;">administrative</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;">Total</td></tr><tr><td style="vertical-align:bottom;width:58.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Item</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">costs</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2022</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Amortization of intangible assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 43,456</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 922,258</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 965,714</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Analysis and storage</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 5,425</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 113,265</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 118,690</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Commissions and royalties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 118,960</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 623,459</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 742,419</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Import and export expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 98,186</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 256,070</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 354,256</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Depreciation of property, plant and equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 746,609</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 493,111</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 1,239,720</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Depreciation of leased assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 395,972</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 269,805</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 665,777</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Impairment of receivables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 156,053</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 156,053</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Freight and haulage</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 241,533</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 3,474,028</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 3,715,561</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Employee benefits and social securities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 3,994,761</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 10,041,033</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 14,035,794</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Maintenance</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 462,743</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 980,742</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 1,443,485</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Energy and fuel</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 500,359</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 58,400</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 558,759</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Supplies and materials</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 339,843</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 491,811</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 831,654</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Mobility and travel</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 20,940</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 994,919</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 1,015,859</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Publicity and advertising</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 1,888,497</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 1,888,497</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Contingencies</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 2,448</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 2,448</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Share-based incentives</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 100,206</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 120,170</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 220,376</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Professional fees and outsourced services</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 674,014</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 4,610,610</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 5,284,624</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Office supplies and registrations fees</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 32,546</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 289,467</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 322,013</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Insurance</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 28,430</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 760,276</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 788,706</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Information technology expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 13,243</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 993,378</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 1,006,621</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Obsolescence</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 539,382</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 79,107</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 618,489</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Taxes</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 45,049</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 4,130,539</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 4,175,588</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Miscellaneous</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 39,173</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 155,465</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 194,638</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Total </td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 8,440,830</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 31,904,911</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 40,345,741</td></tr></table>6.5. Other income or expenses, net<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.54%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2022</td></tr><tr><td style="vertical-align:bottom;width:73.54%;background:#cceeff;margin:0pt;padding:0pt;">Net result from commercialization of agricultural products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;"> (1,316,393)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;"> 6,327</td></tr><tr><td style="vertical-align:bottom;width:73.54%;margin:0pt;padding:0pt;">Expenses recovery</td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"> 87,053</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"> 126,061</td></tr><tr><td style="vertical-align:bottom;width:73.54%;background:#cceeff;margin:0pt;padding:0pt;">Other income or expenses, net</td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (2,295)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 345,653</td></tr><tr><td style="vertical-align:bottom;width:73.54%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (1,231,635)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 478,041</td></tr></table>6.6. Finance results<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2022</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Financial costs</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Interest expenses with the Parents (Note 15)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (97,063)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (149,734)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Interest expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (6,935,241)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (5,569,576)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Financial commissions</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (629,553)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (1,060,537)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (7,661,857)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (6,779,847)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Other financial results</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Exchange differences generated by assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (9,685,066)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (833,428)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Exchange differences generated by liabilities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 10,335,537</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 6,322</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Changes in fair value of financial assets or liabilities and other financial results</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (151,646)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (569,032)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Net gain of inflation effect on monetary items</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (380,960)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 107,832</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 117,865</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (1,288,306)</td></tr></table> <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2022</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Sale of goods and services</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 115,628,792</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 126,113,636</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Royalties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 554,013</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 729,612</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 116,182,805</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 126,843,248</td></tr></table> 115628792 126113636 554013 729612 116182805 126843248 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:67.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Item</td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2022</td></tr><tr><td style="vertical-align:bottom;width:67.67%;background:#cceeff;margin:0pt;padding:0pt;">Inventories as of the beginning of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;margin:0pt;padding:0pt;"> 111,990,145</td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;margin:0pt;padding:0pt;"> 78,759,610</td></tr><tr><td style="vertical-align:bottom;width:67.67%;margin:0pt;padding:0pt;">Business combination</td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"> 11,064,908</td></tr><tr><td style="vertical-align:bottom;width:67.67%;background:#cceeff;margin:0pt;padding:0pt;">Purchases of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;margin:0pt;padding:0pt;"> 71,694,655</td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;margin:0pt;padding:0pt;"> 79,325,509</td></tr><tr><td style="vertical-align:bottom;width:67.67%;margin:0pt;padding:0pt;">Production costs</td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"> 7,123,255</td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"> 8,440,830</td></tr><tr><td style="vertical-align:bottom;width:67.67%;background:#cceeff;margin:0pt;padding:0pt;">Foreign currency translation</td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (226,797)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (236,263)</td></tr><tr><td style="vertical-align:bottom;width:67.67%;margin:0pt;padding:0pt;">Subtotal</td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"> 190,581,258</td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;margin:0pt;padding:0pt;"> 177,354,594</td></tr><tr><td style="vertical-align:bottom;width:67.67%;background:#cceeff;margin:0pt;padding:0pt;">Inventories as of the end of the period (*)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (118,965,477)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (101,678,716)</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:67.67%;margin:0pt;padding:0pt;">Cost of sales </td><td style="vertical-align:bottom;white-space:nowrap;width:2.45%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;border-bottom:3px double #000000;margin:0pt;padding:0pt;">71,615,781</td><td style="vertical-align:bottom;white-space:nowrap;width:2.46%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.7%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 75,675,878</td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div>(*)Net of agricultural products. 111990145 78759610 11064908 71694655 79325509 7123255 8440830 226797 236263 190581258 177354594 118965477 101678716 71615781 75675878 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">Research and</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">Research and</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">development</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">development</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;">expenses</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Item</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2022</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Amortization of intangible assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 1,164,940</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 1,511,118</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Analysis and storage </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 11,568</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Import and export expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 850</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Depreciation of property, plant and equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 157,808</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 142,373</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Freight and haulage</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 3,917</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 5,300</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Employee benefits and social securities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 1,307,126</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 861,312</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Maintenance</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 206,778</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 217,066</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Energy and fuel</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 3,628</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 79,121</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Supplies and materials</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 847,382</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 559,044</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Mobility and travel</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 13,771</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 108,694</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Share-based incentives</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 188,250</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 6,975</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Professional fees and outsourced services</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 491,787</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 293,776</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Office supplies</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 170,375</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 21,454</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Information technology expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 4,375</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 11,996</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Insurance</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 21,049</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 10,537</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Depreciation of leased assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 10,650</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Miscellaneous</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 55</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 180</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 4,581,241</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 3,852,014</td></tr></table><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2022</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">R&D capitalized (Note 5.8)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 1,947,504</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 3,241,008</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">R&D profit and loss</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 4,581,241</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 3,852,014</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 6,528,745</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 7,093,022</td></tr></table> 1164940 1511118 11568 850 157808 142373 3917 5300 1307126 861312 206778 217066 3628 79121 847382 559044 13771 108694 188250 6975 491787 293776 170375 21454 4375 11996 21049 10537 10650 55 180 4581241 3852014 1947504 3241008 4581241 3852014 6528745 7093022 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:58.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.68%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;">Selling, </td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;">general and</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;">Production </td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;">administrative</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;">Total</td></tr><tr><td style="vertical-align:bottom;width:58.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Item</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">costs</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Amortization of intangible assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 30,478</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 1,551,788</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 1,582,266</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Analysis and storage</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 570</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 153,473</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 154,043</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Commissions and royalties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 134,592</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 794,058</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 928,650</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Import and export expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 67,228</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 120,345</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 187,573</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Depreciation of property, plant and equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 643,006</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 442,589</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 1,085,595</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Depreciation of leased assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 339,378</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 497,821</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 837,199</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Impairment of receivables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 352,920</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 352,920</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Freight and haulage</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 643,877</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 2,989,094</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 3,632,971</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Employee benefits and social securities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 2,806,939</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 10,238,931</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 13,045,870</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Maintenance</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 422,757</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 568,155</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 990,912</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Energy and fuel</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 163,122</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 16,397</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 179,519</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Supplies and materials</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 260,043</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 831,454</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 1,091,497</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Mobility and travel</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 33,407</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 1,348,563</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 1,381,970</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Publicity and advertising</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 1,161,498</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 1,161,498</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Contingencies</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 27,109</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 27,109</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Share-based incentives</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 275,432</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 5,729,986</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 6,005,418</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Professional fees and outsourced services</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 509,450</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 1,575,982</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 2,085,432</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Office supplies and registrations fees</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 149,888</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 370,770</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 520,658</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Insurance</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 27,024</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 473,850</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 500,874</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Information technology expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 18,361</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 743,163</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 761,524</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Obsolescence</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 505,285</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 505,285</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Taxes</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 70,819</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 3,766,419</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 3,837,238</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Miscellaneous</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 21,599</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 178,483</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 200,082</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Total </td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 7,123,255</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 33,932,848</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 41,056,103</td></tr></table><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:58.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.68%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;">Selling, </td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;">general and</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;">Production </td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;">administrative</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;">Total</td></tr><tr><td style="vertical-align:bottom;width:58.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Item</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">costs</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2022</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Amortization of intangible assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 43,456</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 922,258</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 965,714</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Analysis and storage</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 5,425</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 113,265</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 118,690</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Commissions and royalties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 118,960</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 623,459</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 742,419</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Import and export expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 98,186</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 256,070</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 354,256</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Depreciation of property, plant and equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 746,609</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 493,111</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 1,239,720</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Depreciation of leased assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 395,972</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 269,805</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 665,777</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Impairment of receivables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 156,053</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 156,053</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Freight and haulage</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 241,533</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 3,474,028</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 3,715,561</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Employee benefits and social securities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 3,994,761</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 10,041,033</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 14,035,794</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Maintenance</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 462,743</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 980,742</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 1,443,485</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Energy and fuel</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 500,359</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 58,400</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 558,759</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Supplies and materials</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 339,843</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 491,811</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 831,654</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Mobility and travel</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 20,940</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 994,919</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 1,015,859</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Publicity and advertising</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 1,888,497</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 1,888,497</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Contingencies</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 2,448</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 2,448</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Share-based incentives</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 100,206</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 120,170</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 220,376</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Professional fees and outsourced services</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 674,014</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 4,610,610</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 5,284,624</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Office supplies and registrations fees</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 32,546</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 289,467</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 322,013</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Insurance</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 28,430</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 760,276</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 788,706</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Information technology expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 13,243</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 993,378</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 1,006,621</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Obsolescence</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 539,382</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 79,107</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> 618,489</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Taxes</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 45,049</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 4,130,539</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> 4,175,588</td></tr><tr><td style="vertical-align:bottom;width:58.68%;background:#cceeff;margin:0pt;padding:0pt;">Miscellaneous</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 39,173</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 155,465</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 194,638</td></tr><tr><td style="vertical-align:bottom;width:58.68%;margin:0pt;padding:0pt;">Total </td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 8,440,830</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 31,904,911</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 40,345,741</td></tr></table> 30478 1551788 1582266 570 153473 154043 134592 794058 928650 67228 120345 187573 643006 442589 1085595 339378 497821 837199 352920 352920 643877 2989094 3632971 2806939 10238931 13045870 422757 568155 990912 163122 16397 179519 260043 831454 1091497 33407 1348563 1381970 1161498 1161498 27109 27109 275432 5729986 6005418 509450 1575982 2085432 149888 370770 520658 27024 473850 500874 18361 743163 761524 505285 505285 70819 3766419 3837238 21599 178483 200082 7123255 33932848 41056103 43456 922258 965714 5425 113265 118690 118960 623459 742419 98186 256070 354256 746609 493111 1239720 395972 269805 665777 156053 156053 241533 3474028 3715561 3994761 10041033 14035794 462743 980742 1443485 500359 58400 558759 339843 491811 831654 20940 994919 1015859 1888497 1888497 2448 2448 100206 120170 220376 674014 4610610 5284624 32546 289467 322013 28430 760276 788706 13243 993378 1006621 539382 79107 618489 45049 4130539 4175588 39173 155465 194638 8440830 31904911 40345741 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.54%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2022</td></tr><tr><td style="vertical-align:bottom;width:73.54%;background:#cceeff;margin:0pt;padding:0pt;">Net result from commercialization of agricultural products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;"> (1,316,393)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;margin:0pt;padding:0pt;"> 6,327</td></tr><tr><td style="vertical-align:bottom;width:73.54%;margin:0pt;padding:0pt;">Expenses recovery</td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"> 87,053</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;margin:0pt;padding:0pt;"> 126,061</td></tr><tr><td style="vertical-align:bottom;width:73.54%;background:#cceeff;margin:0pt;padding:0pt;">Other income or expenses, net</td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (2,295)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 345,653</td></tr><tr><td style="vertical-align:bottom;width:73.54%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.33%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (1,231,635)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.32%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.89%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 478,041</td></tr></table> -1316393 6327 87053 126061 -2295 345653 -1231635 478041 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2022</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Financial costs</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Interest expenses with the Parents (Note 15)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (97,063)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (149,734)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Interest expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (6,935,241)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (5,569,576)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Financial commissions</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (629,553)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (1,060,537)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (7,661,857)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (6,779,847)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Other financial results</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Exchange differences generated by assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (9,685,066)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (833,428)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Exchange differences generated by liabilities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 10,335,537</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 6,322</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Changes in fair value of financial assets or liabilities and other financial results</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (151,646)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (569,032)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Net gain of inflation effect on monetary items</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (380,960)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 107,832</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 117,865</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (1,288,306)</td></tr></table> 97063 149734 6935241 5569576 629553 1060537 7661857 6779847 -9685066 -833428 10335537 6322 -151646 -569032 -380960 107832 117865 -1288306 7. TAXATIONTaxes on income in the interim periods are accrued using the tax rate that would be applicable to expected total annual earnings.<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2022</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Current tax expense</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (6,457,134)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (6,020,201)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Deferred tax</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 6,028,094</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,007,558</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (429,040)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (5,012,643)</td></tr></table><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2022</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Beginning of the period deferred tax</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (28,472,383)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (24,994,569)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Additions for business combination</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (16,704,770)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Charge for the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 6,028,094</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 1,007,558</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Conversion difference</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (3,718,889)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (261,014)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Total net deferred tax</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (26,163,178)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (40,952,795)</td></tr></table>The tax on the Group’s profit before tax differs from the theoretical amount that would arise using the weighted average tax rate applicable to profits of the consolidated entities as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2022</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Earning before income tax-rate</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (2,249,424)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 8,924,643</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Income tax expense by applying tax rate in force in the respective countries</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (1,721,853)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (5,739,069)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Share of profit or loss of subsidiaries, joint ventures and associates</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 530,177</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 313,280</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Stock options charge</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (1,226,796)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (57,818)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Non-deductible expenses </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (383,074)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (805,883)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Unrecognized deferred tax</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (895,896)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Tax inflation adjustment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 4,826,023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 1,822,594</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Result of inflation effect on monetary items and other finance results</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (2,352,623)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 213,857</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Others</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (100,894)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 136,292</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Income tax expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (429,040)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (5,012,643)</td></tr></table> <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2022</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Current tax expense</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (6,457,134)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (6,020,201)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Deferred tax</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 6,028,094</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,007,558</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (429,040)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (5,012,643)</td></tr></table> 6457134 6020201 -6028094 -1007558 429040 5012643 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2022</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Beginning of the period deferred tax</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (28,472,383)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (24,994,569)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Additions for business combination</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (16,704,770)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Charge for the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 6,028,094</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 1,007,558</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Conversion difference</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (3,718,889)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (261,014)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Total net deferred tax</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (26,163,178)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (40,952,795)</td></tr></table> -28472383 -24994569 -16704770 6028094 1007558 -3718889 -261014 -26163178 -40952795 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2022</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Earning before income tax-rate</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (2,249,424)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 8,924,643</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Income tax expense by applying tax rate in force in the respective countries</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (1,721,853)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (5,739,069)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Share of profit or loss of subsidiaries, joint ventures and associates</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 530,177</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 313,280</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Stock options charge</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (1,226,796)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (57,818)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Non-deductible expenses </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (383,074)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (805,883)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Unrecognized deferred tax</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (895,896)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Tax inflation adjustment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 4,826,023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 1,822,594</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Result of inflation effect on monetary items and other finance results</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (2,352,623)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 213,857</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Others</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (100,894)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 136,292</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Income tax expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (429,040)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (5,012,643)</td></tr></table> -2249424 8924643 1721853 5739069 -530177 -313280 1226796 57818 383074 805883 895896 -4826023 -1822594 2352623 -213857 100894 -136292 429040 5012643 8. EARNING PER SHAREThe numerators and denominators used in the calculation of basic EPS and diluted EPS are presented below:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2022</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Numerator</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">(Loss) profit for the period (basic EPS)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (4,591,634)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 498,297</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">(Loss) profit for the period (diluted EPS)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (4,591,634)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 498,297</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Denominator</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Weighted average number of shares (basic EPS)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 62,846,690</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 60,537,110</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Weighted average number of shares (diluted EPS)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 62,846,690</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 61,736,679</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Basic (loss) profit attributable to ordinary equity holders of the parent</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (0.0731)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 0.0082</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Diluted (loss) profit attributable to ordinary equity holders of the parent</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (0.0731)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 0.0081</td></tr></table>For the three-month period ended September 30, 2023 diluted EPS was equal to basic EPS as the effect of potential ordinary shares would be antidilutive.For the three-month period ended September 30, 2022, diluted earnings per share was calculated by adjusting the weighted average number of shares outstanding to assume conversion of all dilutive potential shares. The Group had two categories of dilutive potential shares, share-based incentives and the convertible notes.The stock options were included in the diluted EPS calculation for the period ended September 30, 2022 only for the tranches in which the average market price of ordinary shares during the periods was higher than the assumed proceeds per option. Convertible notes outstanding were not included in the diluted EPS calculations for the period ended September 30, 2022 because the interest (net of tax and other changes in income or expense) per ordinary share obtainable on conversion exceeds basic earnings per share. <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2022</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Numerator</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">(Loss) profit for the period (basic EPS)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (4,591,634)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 498,297</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">(Loss) profit for the period (diluted EPS)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (4,591,634)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 498,297</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Denominator</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Weighted average number of shares (basic EPS)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 62,846,690</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 60,537,110</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Weighted average number of shares (diluted EPS)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 62,846,690</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 61,736,679</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Basic (loss) profit attributable to ordinary equity holders of the parent</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (0.0731)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 0.0082</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Diluted (loss) profit attributable to ordinary equity holders of the parent</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (0.0731)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 0.0081</td></tr></table> -4591634 498297 -4591634 498297 62846690 60537110 62846690 61736679 -0.0731 0.0082 -0.0731 0.0081 2 9. EQUITY INFORMATIONCapital issuedAs of September 30, 2023, we had (i) 100,000,000 ordinary shares ($0.0001 par value) authorized, (ii) 62,849,997 ordinary shares issued and outstanding, (iii) 1,000,000 preferred shares ($0.0001 par value) authorized, (iv) no preferred shares issued and outstanding, (v) 3,951,917 ordinary shares reserved for our equity compensation plans. Of the total issued shares, we have repurchased 2,231,761 shares of our own.Holders of the ordinary shares are entitled to one vote for each ordinary share. 100000000 0.0001 62849997 1000000 0.0001 0 3951917 2231761 1 10. CASH FLOW INFORMATIONSignificant non-cash transactions related to investing and financing activities are as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2022</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Investment activities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Net assets acquisition by business combination</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 150,510,313</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Investment in-kind in other related parties (Note 15)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 550,183</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Capitalization of interest on buildings in progress</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 36,589</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 36,589</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 151,060,496</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2022</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Financing activities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Capitalization of convertible notes (Note 5.13)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 12,211,638</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Purchase of own shares</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (23,915,029)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"> (11,703,391)</td></tr></table> <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2022</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Investment activities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Net assets acquisition by business combination</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 150,510,313</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Investment in-kind in other related parties (Note 15)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 550,183</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Capitalization of interest on buildings in progress</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 36,589</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 36,589</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 151,060,496</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2022</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Financing activities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Capitalization of convertible notes (Note 5.13)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 12,211,638</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Purchase of own shares</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (23,915,029)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"> (11,703,391)</td></tr></table> -150510313 550183 36589 36589 151060496 12211638 23915029 -11703391 11. JOINT VENTURES AND ASSOCIATES<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Synertech Industrias S.A.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 37,550,684</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 36,026,710</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Alfalfa Technologies S.R.L.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 36,502</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 36,502</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Moolec Science S.A.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 3,233,598</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 3,233,598</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 40,820,784</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 39,296,810</td></tr></table><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Liabilities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Trigall Genetics S.A.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 638,126</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 622,823</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 638,126</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 622,823</td></tr></table>Changes in joint ventures investments and affiliates:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2022</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">As of the beginning of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 38,673,987</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 37,836,144</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Foreign currency translation</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 100,868</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Share of profit or loss</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,508,671</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 842,240</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">As of the end of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 40,182,658</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 38,779,252</td></tr></table>Share of profit or loss of joint ventures and affiliates:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2022</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Trigall Genetics S.A.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (15,303)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (132,117)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Synertech Industrias S.A.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,523,974</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 974,357</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"> 1,508,671</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"> 842,240</td></tr></table> <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Synertech Industrias S.A.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 37,550,684</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 36,026,710</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Alfalfa Technologies S.R.L.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 36,502</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 36,502</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Moolec Science S.A.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 3,233,598</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 3,233,598</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 40,820,784</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 39,296,810</td></tr></table><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Liabilities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Trigall Genetics S.A.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 638,126</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 622,823</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 638,126</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 622,823</td></tr></table> 37550684 36026710 36502 36502 3233598 3233598 40820784 39296810 638126 622823 638126 622823 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2022</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">As of the beginning of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 38,673,987</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 37,836,144</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Foreign currency translation</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 100,868</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Share of profit or loss</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,508,671</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 842,240</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">As of the end of the period</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 40,182,658</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 38,779,252</td></tr></table> 38673987 37836144 100868 1508671 842240 40182658 38779252 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2022</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Trigall Genetics S.A.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (15,303)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (132,117)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Synertech Industrias S.A.</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,523,974</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 974,357</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"> 1,508,671</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;border-top:1px solid #000000;margin:0pt;padding:0pt;"> 842,240</td></tr></table> -15303 -132117 1523974 974357 1508671 842240 12. SEGMENT INFORMATIONThe tables present information with respect to the Group´s reporting segments:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:49.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:49.25%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;">Seed and</td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:49.25%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;">integrated</td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;">Crop</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;">Crop</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:49.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Period ended September 30, 2023</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">protection</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">nutrition</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Consolidated</td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:49.25%;background:#cceeff;margin:0pt;padding:0pt;">Revenues from contracts with customers</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:49.25%;margin:0pt;padding:0pt;">Sale of goods and services</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"> 21,677,053</td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"> 55,754,360</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"> 38,197,379</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"> 115,628,792</td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:49.25%;background:#cceeff;margin:0pt;padding:0pt;">Royalties</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"> 554,013</td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"> 554,013</td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:49.25%;margin:0pt;padding:0pt;">Others</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:49.25%;background:#cceeff;margin:0pt;padding:0pt;">Initial recognition and changes in the fair value of biological assets at the point of harvest</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 87,844</td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 172,118</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 150,951</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 410,913</td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:49.25%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 22,318,910</td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 55,926,478</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 38,348,330</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 116,593,718</td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:49.25%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:49.25%;margin:0pt;padding:0pt;">Cost of sales</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (14,110,381)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (36,183,792)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (21,321,608)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (71,615,781)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:49.25%;background:#cceeff;margin:0pt;padding:0pt;">Gross profit per segment </td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 8,208,529</td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 19,742,686</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 17,026,722</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 44,977,937</td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:49.25%;margin:0pt;padding:0pt;">% Gross margin</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"> 37</td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"> 35</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"> 44</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"> 39</td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;">%</td></tr></table><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:49.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:49.93%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;">Seed and</td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:49.93%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;">integrated</td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;">Crop</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;">Crop</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:top;width:49.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Period ended September 30, 2022</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">protection</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">nutrition</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Consolidated</td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:49.93%;background:#cceeff;margin:0pt;padding:0pt;">Revenues from contracts with customers</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:49.93%;margin:0pt;padding:0pt;">Sale of goods and services</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> 13,073,640</td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"> 62,986,173</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"> 50,053,823</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"> 126,113,636</td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:49.93%;background:#cceeff;margin:0pt;padding:0pt;">Royalties</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 729,612</td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"> 729,612</td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:49.93%;margin:0pt;padding:0pt;">Others</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:49.93%;background:#cceeff;margin:0pt;padding:0pt;">Initial recognition and changes in the fair value of biological assets at the point of harvest</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 51,451</td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 89,573</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 348,982</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 490,006</td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:49.93%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 13,854,703</td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 63,075,746</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 50,402,805</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 127,333,254</td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:49.93%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:49.93%;margin:0pt;padding:0pt;">Cost of sales</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (5,539,489)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (45,035,250)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (25,101,139)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (75,675,878)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:49.93%;background:#cceeff;margin:0pt;padding:0pt;">Gross profit per segment</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 8,315,214</td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 18,040,496</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 25,301,666</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 51,657,376</td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:49.93%;margin:0pt;padding:0pt;">% Gross margin</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> 60</td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"> 29</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"> 50</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"> 41</td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;">%</td></tr></table>As of the current period, changes in the net realizable value of agricultural products after harvest have been excluded from segment information since those results depend on market fluctuations which are beyond the Group’s operating control. The company has recast the comparative amounts. <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:49.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:49.25%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;">Seed and</td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:49.25%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;">integrated</td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;">Crop</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;">Crop</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:49.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Period ended September 30, 2023</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">protection</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">nutrition</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Consolidated</td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:49.25%;background:#cceeff;margin:0pt;padding:0pt;">Revenues from contracts with customers</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:49.25%;margin:0pt;padding:0pt;">Sale of goods and services</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"> 21,677,053</td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"> 55,754,360</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"> 38,197,379</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"> 115,628,792</td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:49.25%;background:#cceeff;margin:0pt;padding:0pt;">Royalties</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"> 554,013</td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"> 554,013</td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:49.25%;margin:0pt;padding:0pt;">Others</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:49.25%;background:#cceeff;margin:0pt;padding:0pt;">Initial recognition and changes in the fair value of biological assets at the point of harvest</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 87,844</td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 172,118</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 150,951</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 410,913</td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:49.25%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 22,318,910</td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 55,926,478</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 38,348,330</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 116,593,718</td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:49.25%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:49.25%;margin:0pt;padding:0pt;">Cost of sales</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (14,110,381)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (36,183,792)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (21,321,608)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (71,615,781)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:49.25%;background:#cceeff;margin:0pt;padding:0pt;">Gross profit per segment </td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 8,208,529</td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 19,742,686</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 17,026,722</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 44,977,937</td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:49.25%;margin:0pt;padding:0pt;">% Gross margin</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"> 37</td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"> 35</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"> 44</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"> 39</td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;">%</td></tr></table><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:49.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:49.93%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;">Seed and</td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"> </td></tr><tr><td style="vertical-align:bottom;width:49.93%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;">integrated</td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;">Crop</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;">Crop</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:top;width:49.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Period ended September 30, 2022</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">products</td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">protection</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">nutrition</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Consolidated</td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:49.93%;background:#cceeff;margin:0pt;padding:0pt;">Revenues from contracts with customers</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:49.93%;margin:0pt;padding:0pt;">Sale of goods and services</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> 13,073,640</td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"> 62,986,173</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"> 50,053,823</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"> 126,113,636</td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:49.93%;background:#cceeff;margin:0pt;padding:0pt;">Royalties</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"> 729,612</td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"> 729,612</td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:49.93%;margin:0pt;padding:0pt;">Others</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:49.93%;background:#cceeff;margin:0pt;padding:0pt;">Initial recognition and changes in the fair value of biological assets at the point of harvest</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 51,451</td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 89,573</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 348,982</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 490,006</td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:49.93%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 13,854,703</td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 63,075,746</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 50,402,805</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 127,333,254</td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:49.93%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:49.93%;margin:0pt;padding:0pt;">Cost of sales</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (5,539,489)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (45,035,250)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (25,101,139)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (75,675,878)</td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:49.93%;background:#cceeff;margin:0pt;padding:0pt;">Gross profit per segment</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 8,315,214</td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 18,040,496</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 25,301,666</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 51,657,376</td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:49.93%;margin:0pt;padding:0pt;">% Gross margin</td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:9.35%;margin:0pt;padding:0pt;"> 60</td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"> 29</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"> 50</td><td style="vertical-align:bottom;white-space:nowrap;width:2.47%;margin:0pt;padding:0pt;">% </td><td style="vertical-align:bottom;white-space:nowrap;width:10.27%;margin:0pt;padding:0pt;"> 41</td><td style="vertical-align:bottom;white-space:nowrap;width:1.54%;margin:0pt;padding:0pt;">%</td></tr></table> 21677053 55754360 38197379 115628792 554013 554013 87844 172118 150951 410913 22318910 55926478 38348330 116593718 14110381 36183792 21321608 71615781 8208529 19742686 17026722 44977937 0.37 0.35 0.44 0.39 13073640 62986173 50053823 126113636 729612 729612 51451 89573 348982 490006 13854703 63075746 50402805 127333254 5539489 45035250 25101139 75675878 8315214 18040496 25301666 51657376 0.60 0.29 0.50 0.41 13. FINANCIAL INSTRUMENTS – RISK MANAGEMENTFinancial instruments by categoryThe following tables show additional information required under IFRS 7 on the financial assets and liabilities recorded as of September 30, 2023, and June 30, 2023.Financial assets by category<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:26.2%;margin:0pt;padding:0pt;">Mandatorily measured at fair</td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:26.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Amortized cost</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:26.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">value through profit or loss</td></tr><tr><td style="vertical-align:bottom;width:42.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Financial asset</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:42.55%;background:#cceeff;margin:0pt;padding:0pt;">Cash and cash equivalents</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 25,954,730</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 48,129,194</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 2,419,194</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;">Other financial assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 502,910</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 657,612</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 14,628,202</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 11,922,317</td></tr><tr><td style="vertical-align:bottom;width:42.55%;background:#cceeff;margin:0pt;padding:0pt;">Trade receivables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 186,276,319</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 158,006,474</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;">Other receivables (*)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 11,753,573</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 12,124,724</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:42.55%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 224,487,532</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 218,918,004</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 17,047,396</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 11,922,317</td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(*)</td><td style="padding:0pt;">Advances expenses and tax balances are not included.</td></tr></table>Financial liabilities by category<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:26.2%;margin:0pt;padding:0pt;">Mandatorily measured at fair</td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:26.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Amortized cost</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:26.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">value through profit or loss</td></tr><tr><td style="vertical-align:bottom;width:42.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Financial liability</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:42.55%;background:#cceeff;margin:0pt;padding:0pt;">Trade and other payables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 152,753,083</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 142,582,166</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 6,372,275</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 8,225,508</td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;">Borrowings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 149,510,477</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 168,310,605</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:42.55%;background:#cceeff;margin:0pt;padding:0pt;">Secured notes</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 76,911,874</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 75,213,146</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;">Lease liability</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 13,552,751</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 13,889,223</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:42.55%;background:#cceeff;margin:0pt;padding:0pt;">Consideration for acquisition of assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 6,742,570</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 4,993,256</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 399,470,755</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 404,988,396</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 6,372,275</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 8,225,508</td></tr></table>Financial instruments measured at fair value<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Measurement at fair value at 09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 1</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 2</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 3</td></tr><tr><td style="vertical-align:bottom;width:58.66%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:58.66%;background:#cceeff;margin:0pt;padding:0pt;">Financial assets at fair value</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:58.66%;margin:0pt;padding:0pt;">US Treasury bills</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 9,719,486</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:58.66%;background:#cceeff;margin:0pt;padding:0pt;">Mutual funds</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 3,236,702</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:58.66%;margin:0pt;padding:0pt;">Other investments</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 1,672,014</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:58.66%;background:#cceeff;margin:0pt;padding:0pt;">Financial liability at fair value</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.66%;margin:0pt;padding:0pt;">Trade and other payables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 6,372,275</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.66%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:58.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Measurement at fair value at 06/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 1</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 2</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 3</td></tr><tr><td style="vertical-align:bottom;width:58.66%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:58.66%;background:#cceeff;margin:0pt;padding:0pt;">Financial assets at fair value</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:58.66%;margin:0pt;padding:0pt;">US Treasury bills</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 9,163,298</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:58.66%;background:#cceeff;margin:0pt;padding:0pt;">Mutual funds</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 1,596,539</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:58.66%;margin:0pt;padding:0pt;">Other investments</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 1,162,480</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:58.66%;background:#cceeff;margin:0pt;padding:0pt;">Financial liability at fair value</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.66%;margin:0pt;padding:0pt;">Trade and other payables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 8,225,508</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> —</td></tr></table>Estimation of fair valueThe fair value of marketable securities, mutual funds and US Treasury Bills is calculated using the market approach using quoted prices in active markets for identical assets. The quoted marked price used for financial assets held by the Group is the current bid price. These instruments are included in level 1.The Group’s financial liabilities, which were not traded in an active market, were determined using valuation techniques that maximize the use of available market information, and thus rely as little as possible on specific estimates of the entity specific estimates. If all significant inputs required to fair value an instrument are observable, the instruments are included in level 2.If one or more of the significant inputs is not based on observable market data, the instruments are included in level 3.The Group’s policy is to recognize transfers between different categories of the fair value hierarchy at the time they occur or when there are changes in the circumstances that cause the transfer. There were no transfers between levels of the fair value hierarchy. There were no changes in economic or business circumstances affecting fair value.Financial instruments not measured at fair valueThe financial instruments not measured at fair value include cash and cash equivalents, trade accounts receivable, other accounts receivable, trade payables and other debts, borrowings, financed payments and convertible notes.The carrying value of financial instruments not measured at fair value does not differ significantly from their fair value, except for borrowings (Note 5.12).Management estimates that the carrying value of the financial instruments measured at amortized cost approximates their fair value.Currency riskForeign currency risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rate. Currency on foreign exchange risk arises when the Group enters into transactions denominated in a currency other than its functional currency. The table below sets forth our net exposure to currency risk as of September 30, 2023:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:86.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:86.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Net foreign currency position</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td></tr><tr><td style="vertical-align:bottom;width:86.4%;background:#cceeff;margin:0pt;padding:0pt;">Amount expressed in US$</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;background:#cceeff;margin:0pt;padding:0pt;"> (5,353,860)</td></tr></table>Considering only this net currency exposure as of September 30, 2023 if an US Dollar revaluation or depreciation in relation to other foreign currencies with the remaining variables remaining constant, would have a positive or a negative impact on comprehensive income as a result of foreign exchange gains or losses. We estimate that a devaluation or an appreciation of the US Dollar other currencies of 10% during the period ended September 30, 2023 would have resulted in a net pre-tax loss or gain of approximately $0.5 million. <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:26.2%;margin:0pt;padding:0pt;">Mandatorily measured at fair</td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:26.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Amortized cost</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:26.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">value through profit or loss</td></tr><tr><td style="vertical-align:bottom;width:42.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Financial asset</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:42.55%;background:#cceeff;margin:0pt;padding:0pt;">Cash and cash equivalents</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 25,954,730</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 48,129,194</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 2,419,194</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;">Other financial assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 502,910</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 657,612</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 14,628,202</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 11,922,317</td></tr><tr><td style="vertical-align:bottom;width:42.55%;background:#cceeff;margin:0pt;padding:0pt;">Trade receivables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 186,276,319</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 158,006,474</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;">Other receivables (*)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 11,753,573</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 12,124,724</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:42.55%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 224,487,532</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 218,918,004</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 17,047,396</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 11,922,317</td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(*)</td><td style="padding:0pt;">Advances expenses and tax balances are not included.</td></tr></table> 25954730 48129194 2419194 502910 657612 14628202 11922317 186276319 158006474 11753573 12124724 224487532 218918004 17047396 11922317 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:26.2%;margin:0pt;padding:0pt;">Mandatorily measured at fair</td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:26.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Amortized cost</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:26.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">value through profit or loss</td></tr><tr><td style="vertical-align:bottom;width:42.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Financial liability</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:42.55%;background:#cceeff;margin:0pt;padding:0pt;">Trade and other payables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 152,753,083</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 142,582,166</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 6,372,275</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 8,225,508</td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;">Borrowings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 149,510,477</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 168,310,605</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:42.55%;background:#cceeff;margin:0pt;padding:0pt;">Secured notes</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 76,911,874</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> 75,213,146</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;">Lease liability</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 13,552,751</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> 13,889,223</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:42.55%;background:#cceeff;margin:0pt;padding:0pt;">Consideration for acquisition of assets</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 6,742,570</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 4,993,256</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:42.55%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 399,470,755</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 404,988,396</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 6,372,275</td><td style="vertical-align:bottom;white-space:nowrap;width:2.51%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.84%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 8,225,508</td></tr></table> 152753083 142582166 6372275 8225508 149510477 168310605 76911874 75213146 13552751 13889223 6742570 4993256 399470755 404988396 6372275 8225508 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Measurement at fair value at 09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 1</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 2</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 3</td></tr><tr><td style="vertical-align:bottom;width:58.66%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:58.66%;background:#cceeff;margin:0pt;padding:0pt;">Financial assets at fair value</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:58.66%;margin:0pt;padding:0pt;">US Treasury bills</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 9,719,486</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:58.66%;background:#cceeff;margin:0pt;padding:0pt;">Mutual funds</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 3,236,702</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:58.66%;margin:0pt;padding:0pt;">Other investments</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 1,672,014</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:58.66%;background:#cceeff;margin:0pt;padding:0pt;">Financial liability at fair value</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.66%;margin:0pt;padding:0pt;">Trade and other payables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 6,372,275</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.66%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:58.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Measurement at fair value at 06/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 1</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 2</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Level 3</td></tr><tr><td style="vertical-align:bottom;width:58.66%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:58.66%;background:#cceeff;margin:0pt;padding:0pt;">Financial assets at fair value</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:58.66%;margin:0pt;padding:0pt;">US Treasury bills</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 9,163,298</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:58.66%;background:#cceeff;margin:0pt;padding:0pt;">Mutual funds</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> 1,596,539</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:58.66%;margin:0pt;padding:0pt;">Other investments</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 1,162,480</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:58.66%;background:#cceeff;margin:0pt;padding:0pt;">Financial liability at fair value</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;background:#cceeff;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.66%;margin:0pt;padding:0pt;">Trade and other payables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.36%;margin:0pt;padding:0pt;"> 8,225,508</td><td style="vertical-align:bottom;white-space:nowrap;width:2.41%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:11.34%;margin:0pt;padding:0pt;"> —</td></tr></table> 9719486 3236702 1672014 6372275 9163298 1596539 1162480 8225508 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:86.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:86.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Net foreign currency position</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td></tr><tr><td style="vertical-align:bottom;width:86.4%;background:#cceeff;margin:0pt;padding:0pt;">Amount expressed in US$</td><td style="vertical-align:bottom;white-space:nowrap;width:2.21%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;background:#cceeff;margin:0pt;padding:0pt;"> (5,353,860)</td></tr></table> -5353860 0.10 500000 14. LEASES<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Right-of-use leased asset</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Book value at the beginning of the period/year</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 21,163,192</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 15,828,032</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Additions of the period/year</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 1,072,418</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 3,154,950</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Additions from business combination</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 3,005,000</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Disposals</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (461,631)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (1,839,921)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Exchange differences</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (513,269)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,015,131</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Book value at the end of the period/year</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 21,260,710</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 21,163,192</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Depreciation</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Book value at the beginning of the period/year</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 7,226,617</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 3,684,006</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Depreciation of the period/year</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 837,199</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 3,565,894</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Disposals</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (274,431)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (171,870)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Exchange differences</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (47,874)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 148,587</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Accumulated depreciation at the end of the period/year</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 7,741,511</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 7,226,617</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 13,519,199</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 13,936,575</td></tr></table><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Lease liability</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Book value at the beginning of the period/year</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 13,889,223</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 11,751,284</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Additions of the period/year</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 1,072,418</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 3,154,950</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Additions from business combination</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 3,245,000</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Interest expenses, exchange differences and inflation effects</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (238,851)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (406,494)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Payments of the period/year</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (1,170,039)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (3,855,517)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 13,552,751</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 13,889,223</td></tr></table><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Lease Liabilities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Non-current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 9,225,862</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 10,030,524</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 4,326,889</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 3,858,699</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 13,552,751</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 13,889,223</td></tr></table>The recognized right-of-use assets relate to the following types of assets:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Machinery and equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 3,655,741</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 3,655,741</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Vehicles</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 1,433,616</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 1,475,581</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Equipment and computer software</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 1,011,490</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 903,306</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Land and buildings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 15,159,863</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 15,128,564</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 21,260,710</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 21,163,192</td></tr></table>The incremental borrowing rate used was 2.13 %. <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Right-of-use leased asset</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Book value at the beginning of the period/year</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 21,163,192</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 15,828,032</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Additions of the period/year</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 1,072,418</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 3,154,950</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Additions from business combination</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 3,005,000</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Disposals</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (461,631)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (1,839,921)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Exchange differences</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (513,269)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 1,015,131</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Book value at the end of the period/year</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 21,260,710</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 21,163,192</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Depreciation</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Book value at the beginning of the period/year</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 7,226,617</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 3,684,006</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Depreciation of the period/year</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 837,199</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 3,565,894</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Disposals</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (274,431)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> (171,870)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Exchange differences</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (47,874)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 148,587</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Accumulated depreciation at the end of the period/year</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 7,741,511</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 7,226,617</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 13,519,199</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 13,936,575</td></tr></table><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Lease liability</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Book value at the beginning of the period/year</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 13,889,223</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 11,751,284</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Additions of the period/year</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 1,072,418</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 3,154,950</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Additions from business combination</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 3,245,000</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Interest expenses, exchange differences and inflation effects</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (238,851)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> (406,494)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Payments of the period/year</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (1,170,039)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (3,855,517)</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 13,552,751</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 13,889,223</td></tr></table><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Lease Liabilities</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Non-current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 9,225,862</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 10,030,524</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Current</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 4,326,889</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 3,858,699</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 13,552,751</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 13,889,223</td></tr></table> 21163192 15828032 1072418 3154950 3005000 -461631 -1839921 -513269 1015131 21260710 21163192 -7226617 -3684006 837199 3565894 -274431 -171870 -47874 148587 -7741511 -7226617 13519199 13936575 13889223 11751284 1072418 3154950 3245000 -238851 -406494 -1170039 -3855517 13552751 13889223 9225862 10030524 4326889 3858699 13552751 13889223 <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Machinery and equipment</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 3,655,741</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 3,655,741</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Vehicles</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 1,433,616</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"> 1,475,581</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Equipment and computer software</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 1,011,490</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 903,306</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Land and buildings</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 15,159,863</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 15,128,564</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 21,260,710</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 21,163,192</td></tr></table> 3655741 3655741 1433616 1475581 1011490 903306 15159863 15128564 21260710 21163192 0.0213 15. SHAREHOLDERS AND OTHER RELAED PARTIES BALANCES AND TRANSACTIONSDuring the period ended September 30, 2023, and 2022, the transactions between the Group and related parties, and the related balances owed by and to them, are as follows:<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:36.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:36.04%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:31.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Value of transactions for the period ended</td></tr><tr><td style="vertical-align:bottom;width:36.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Party</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Transaction type</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2022</td></tr><tr><td style="vertical-align:top;width:36.04%;background:#cceeff;margin:0pt;padding:0pt;">Joint ventures and associates</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;width:27.17%;background:#cceeff;margin:0pt;padding:0pt;">Sales and services</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;margin:0pt;padding:0pt;"> 6,801,117</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;background:#cceeff;margin:0pt;padding:0pt;"> 17,083,027</td></tr><tr><td style="vertical-align:top;width:36.04%;margin:0pt;padding:0pt;">Joint ventures and associates</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;width:27.17%;margin:0pt;padding:0pt;">Purchases of goods and services</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"> (20,691,171)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;margin:0pt;padding:0pt;"> (25,314,814)</td></tr><tr><td style="vertical-align:top;width:36.04%;background:#cceeff;margin:0pt;padding:0pt;">Key management personnel</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;width:27.17%;background:#cceeff;margin:0pt;padding:0pt;">Salaries, social security benefits and other benefits</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;margin:0pt;padding:0pt;"> (6,702,803)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;background:#cceeff;margin:0pt;padding:0pt;"> (648,494)</td></tr><tr><td style="vertical-align:top;width:36.04%;margin:0pt;padding:0pt;">Shareholders and other related parties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;width:27.17%;margin:0pt;padding:0pt;">Sales of goods and services</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"> 1,590,568</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;margin:0pt;padding:0pt;"> 261,418</td></tr><tr><td style="vertical-align:top;width:36.04%;background:#cceeff;margin:0pt;padding:0pt;">Shareholders and other related parties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:27.17%;background:#cceeff;margin:0pt;padding:0pt;">Purchases of goods and services</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;margin:0pt;padding:0pt;"> (196,051)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;background:#cceeff;margin:0pt;padding:0pt;"> (239,772)</td></tr><tr><td style="vertical-align:top;width:36.04%;margin:0pt;padding:0pt;">Shareholders and other related parties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:27.17%;margin:0pt;padding:0pt;">In-kind contributions</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;margin:0pt;padding:0pt;"> 550,183</td></tr><tr><td style="vertical-align:top;width:36.04%;background:#cceeff;margin:0pt;padding:0pt;">Shareholders and other related parties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:27.17%;background:#cceeff;margin:0pt;padding:0pt;">Net loans granted/(cancelled)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;background:#cceeff;margin:0pt;padding:0pt;"> (1,609)</td></tr><tr><td style="vertical-align:top;width:36.04%;margin:0pt;padding:0pt;">Shareholders and other related parties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:27.17%;margin:0pt;padding:0pt;">Interest expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"> (23,000)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:top;width:36.04%;background:#cceeff;margin:0pt;padding:0pt;">Parent company and related parties to Parent (Note 6.6)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;width:27.17%;background:#cceeff;margin:0pt;padding:0pt;">Interest expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (97,063)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (149,734)</td></tr><tr><td style="vertical-align:top;width:36.04%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;width:27.17%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (19,318,403)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (8,459,795)</td></tr></table><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:36.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:36.04%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:31.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Amounts receivable from related parties</td></tr><tr><td style="vertical-align:bottom;width:36.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Party</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Transaction type</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:36.04%;background:#cceeff;margin:0pt;padding:0pt;">Shareholders and other related parties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;background:#cceeff;margin:0pt;padding:0pt;">Other receivables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;margin:0pt;padding:0pt;"> 1,368,373</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;background:#cceeff;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:36.04%;margin:0pt;padding:0pt;">Shareholders and other related parties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;">Other receivables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"> 2,919,431</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;margin:0pt;padding:0pt;"> 3,792,429</td></tr><tr><td style="vertical-align:bottom;width:36.04%;background:#cceeff;margin:0pt;padding:0pt;">Joint ventures and associates</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;background:#cceeff;margin:0pt;padding:0pt;">Trade debtors</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;margin:0pt;padding:0pt;"> 781,451</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;background:#cceeff;margin:0pt;padding:0pt;"> 865,627</td></tr><tr><td style="vertical-align:bottom;width:36.04%;margin:0pt;padding:0pt;">Joint ventures and associates</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;">Other receivables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 6,699,863</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 6,334,219</td></tr><tr><td style="vertical-align:bottom;width:36.04%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 11,769,118</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 10,992,275</td></tr></table><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:36.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:36.04%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:31.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Amounts payable to related parties</td></tr><tr><td style="vertical-align:bottom;width:36.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Party</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Transaction type</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2022</td></tr><tr><td style="vertical-align:top;width:36.04%;background:#cceeff;margin:0pt;padding:0pt;">Parent company and related parties to Parent</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;background:#cceeff;margin:0pt;padding:0pt;">Trade creditors</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;margin:0pt;padding:0pt;"> (270,645)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;background:#cceeff;margin:0pt;padding:0pt;"> (644,191)</td></tr><tr><td style="vertical-align:top;width:36.04%;margin:0pt;padding:0pt;">Parent company and related parties to Parent</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;">Net loans payables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"> (3,565,754)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;margin:0pt;padding:0pt;"> (3,491,691)</td></tr><tr><td style="vertical-align:top;width:36.04%;background:#cceeff;margin:0pt;padding:0pt;">Key management personnel</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;width:27.17%;background:#cceeff;margin:0pt;padding:0pt;">Salaries, social security benefits and other benefits</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;margin:0pt;padding:0pt;"> (333,616)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;background:#cceeff;margin:0pt;padding:0pt;"> (218,068)</td></tr><tr><td style="vertical-align:top;width:36.04%;margin:0pt;padding:0pt;">Shareholders and other related parties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;">Trade and other payables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"> (27,708)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;margin:0pt;padding:0pt;"> (35,292)</td></tr><tr><td style="vertical-align:top;width:36.04%;background:#cceeff;margin:0pt;padding:0pt;">Joint ventures and associates</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;background:#cceeff;margin:0pt;padding:0pt;">Trade creditors</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (47,282,380)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (41,402,594)</td></tr><tr><td style="vertical-align:top;width:36.04%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (51,480,103)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (45,791,836)</td></tr></table> <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:36.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:36.04%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:31.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Value of transactions for the period ended</td></tr><tr><td style="vertical-align:bottom;width:36.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Party</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Transaction type</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2022</td></tr><tr><td style="vertical-align:top;width:36.04%;background:#cceeff;margin:0pt;padding:0pt;">Joint ventures and associates</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;width:27.17%;background:#cceeff;margin:0pt;padding:0pt;">Sales and services</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;margin:0pt;padding:0pt;"> 6,801,117</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;background:#cceeff;margin:0pt;padding:0pt;"> 17,083,027</td></tr><tr><td style="vertical-align:top;width:36.04%;margin:0pt;padding:0pt;">Joint ventures and associates</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;width:27.17%;margin:0pt;padding:0pt;">Purchases of goods and services</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"> (20,691,171)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;margin:0pt;padding:0pt;"> (25,314,814)</td></tr><tr><td style="vertical-align:top;width:36.04%;background:#cceeff;margin:0pt;padding:0pt;">Key management personnel</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;width:27.17%;background:#cceeff;margin:0pt;padding:0pt;">Salaries, social security benefits and other benefits</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;margin:0pt;padding:0pt;"> (6,702,803)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;background:#cceeff;margin:0pt;padding:0pt;"> (648,494)</td></tr><tr><td style="vertical-align:top;width:36.04%;margin:0pt;padding:0pt;">Shareholders and other related parties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;width:27.17%;margin:0pt;padding:0pt;">Sales of goods and services</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"> 1,590,568</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;margin:0pt;padding:0pt;"> 261,418</td></tr><tr><td style="vertical-align:top;width:36.04%;background:#cceeff;margin:0pt;padding:0pt;">Shareholders and other related parties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:27.17%;background:#cceeff;margin:0pt;padding:0pt;">Purchases of goods and services</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;margin:0pt;padding:0pt;"> (196,051)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;background:#cceeff;margin:0pt;padding:0pt;"> (239,772)</td></tr><tr><td style="vertical-align:top;width:36.04%;margin:0pt;padding:0pt;">Shareholders and other related parties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:27.17%;margin:0pt;padding:0pt;">In-kind contributions</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;margin:0pt;padding:0pt;"> 550,183</td></tr><tr><td style="vertical-align:top;width:36.04%;background:#cceeff;margin:0pt;padding:0pt;">Shareholders and other related parties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:27.17%;background:#cceeff;margin:0pt;padding:0pt;">Net loans granted/(cancelled)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;margin:0pt;padding:0pt;"> —</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;background:#cceeff;margin:0pt;padding:0pt;"> (1,609)</td></tr><tr><td style="vertical-align:top;width:36.04%;margin:0pt;padding:0pt;">Shareholders and other related parties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:27.17%;margin:0pt;padding:0pt;">Interest expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"> (23,000)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:top;width:36.04%;background:#cceeff;margin:0pt;padding:0pt;">Parent company and related parties to Parent (Note 6.6)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;width:27.17%;background:#cceeff;margin:0pt;padding:0pt;">Interest expenses</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (97,063)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (149,734)</td></tr><tr><td style="vertical-align:top;width:36.04%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;width:27.17%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (19,318,403)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (8,459,795)</td></tr></table><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:36.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:36.04%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:31.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Amounts receivable from related parties</td></tr><tr><td style="vertical-align:bottom;width:36.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Party</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Transaction type</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2023</td></tr><tr><td style="vertical-align:bottom;width:36.04%;background:#cceeff;margin:0pt;padding:0pt;">Shareholders and other related parties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;background:#cceeff;margin:0pt;padding:0pt;">Other receivables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;margin:0pt;padding:0pt;"> 1,368,373</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;background:#cceeff;margin:0pt;padding:0pt;"> —</td></tr><tr><td style="vertical-align:bottom;width:36.04%;margin:0pt;padding:0pt;">Shareholders and other related parties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;">Other receivables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"> 2,919,431</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;margin:0pt;padding:0pt;"> 3,792,429</td></tr><tr><td style="vertical-align:bottom;width:36.04%;background:#cceeff;margin:0pt;padding:0pt;">Joint ventures and associates</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;background:#cceeff;margin:0pt;padding:0pt;">Trade debtors</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;margin:0pt;padding:0pt;"> 781,451</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;background:#cceeff;margin:0pt;padding:0pt;"> 865,627</td></tr><tr><td style="vertical-align:bottom;width:36.04%;margin:0pt;padding:0pt;">Joint ventures and associates</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;">Other receivables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 6,699,863</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 6,334,219</td></tr><tr><td style="vertical-align:bottom;width:36.04%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 11,769,118</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 10,992,275</td></tr></table><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:36.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:36.04%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:31.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Amounts payable to related parties</td></tr><tr><td style="vertical-align:bottom;width:36.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Party</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">Transaction type</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">06/30/2022</td></tr><tr><td style="vertical-align:top;width:36.04%;background:#cceeff;margin:0pt;padding:0pt;">Parent company and related parties to Parent</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;background:#cceeff;margin:0pt;padding:0pt;">Trade creditors</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;margin:0pt;padding:0pt;"> (270,645)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;background:#cceeff;margin:0pt;padding:0pt;"> (644,191)</td></tr><tr><td style="vertical-align:top;width:36.04%;margin:0pt;padding:0pt;">Parent company and related parties to Parent</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;">Net loans payables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"> (3,565,754)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;margin:0pt;padding:0pt;"> (3,491,691)</td></tr><tr><td style="vertical-align:top;width:36.04%;background:#cceeff;margin:0pt;padding:0pt;">Key management personnel</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;width:27.17%;background:#cceeff;margin:0pt;padding:0pt;">Salaries, social security benefits and other benefits</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;margin:0pt;padding:0pt;"> (333,616)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;background:#cceeff;margin:0pt;padding:0pt;"> (218,068)</td></tr><tr><td style="vertical-align:top;width:36.04%;margin:0pt;padding:0pt;">Shareholders and other related parties</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;">Trade and other payables</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;margin:0pt;padding:0pt;"> (27,708)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;margin:0pt;padding:0pt;"> (35,292)</td></tr><tr><td style="vertical-align:top;width:36.04%;background:#cceeff;margin:0pt;padding:0pt;">Joint ventures and associates</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;background:#cceeff;margin:0pt;padding:0pt;">Trade creditors</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (47,282,380)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> (41,402,594)</td></tr><tr><td style="vertical-align:top;width:36.04%;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.4%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:27.17%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (51,480,103)</td><td style="vertical-align:bottom;white-space:nowrap;width:2.39%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:14.77%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> (45,791,836)</td></tr></table> 6801117 17083027 20691171 25314814 6702803 648494 1590568 261418 196051 239772 550183 -1609 -23000 -97063 -149734 -19318403 -8459795 1368373 2919431 3792429 781451 865627 6699863 6334219 11769118 10992275 270645 644191 3565754 3491691 333616 218068 27708 35292 47282380 41402594 51480103 45791836 16. KEY MANAGEMENT PERSONNEL COMPENSATIONThe compensation of directors and other members of key management personnel, including social contributions and other benefits, were as follows for the period ended September 30, 2023, and 2022.<table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2022</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Salaries, social security and other benefits</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 509,135</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 421,143</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Share-based incentives</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 6,193,668</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 227,351</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 6,702,803</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 648,494</td></tr></table> <table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2023</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;">09/30/2022</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Salaries, social security and other benefits</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 509,135</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;margin:0pt;padding:0pt;"> 421,143</td></tr><tr><td style="vertical-align:bottom;width:68.03%;margin:0pt;padding:0pt;">Share-based incentives</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 6,193,668</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"> 227,351</td></tr><tr><td style="vertical-align:bottom;width:68.03%;background:#cceeff;margin:0pt;padding:0pt;">Total</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 6,702,803</td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"> </td><td style="vertical-align:bottom;white-space:nowrap;width:13.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"> 648,494</td></tr></table> 509135 421143 6193668 227351 6702803 648494 17. SHARE-BASED PAYMENTPursuant to the 2023 Omnibus Equity Incentive Plan approved on May 12, 2023, in August 2023 the Board has granted the following stock options plan to certain directors, executives and management of the Group. <table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">-</td><td style="padding:0pt;">Past Share Option plan: immediately vested options with a strike price between $11.93 and $13.24.</td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">-</td><td style="padding:0pt;">Base Share Option plan: to vest and become exercisable in equal installments on June 30, 2023, June 30, 2024, and June 30, 2025, with a strike price of $10.47.</td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">-</td><td style="padding:0pt;">Performance Share Option plan: to vest and become exercisable if the Company’s fiscal year 2025 EBITDA reaches at least US$120 million, at 0% of the award, and linearly thereafter up to 100% of the awarded options when reaching at least US$150 million. This option has also a strike price of $10.47.</td></tr></table>The fair value of the stock options at the grant date was estimated using the “Black-Scholes” model considering the terms and conditions under which the stock options were granted and adjusted to consider the possible dilutive effect of the future exercise of options. As of September 30, 2023, the expenses associated with share-based incentive plans are included in results within “Share-based incentives” along with the associated increase in net worth. 11.93 13.24 10.47 120000000 0 1 150000000 10.47 18. CONTINGENCIES, COMMITMENTS AND RESTRICTIONS ON THE DISTRIBUTION OF PROFITSThere were no other significant changes to the contingencies, commitments and restrictions on the distribution of profits from the disclosure made in the Consolidated financial statement as of June 30, 2023. 19. EVENTS OCCURRING AFTER THE REPORTING PERIODSubsequent to September 30, 2023, there have been no other situations or circumstances that may require significant adjustments or further disclosure in these consolidated financial statements that were not mentioned above. EXCEL 98 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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
G6 0!?&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-0 M2P$"% ,4 " "[@7U7(=OYL3$" #-,0 $P @ '>X $ I6T-O;G1E;G1?5'EP97-=+GAM;%!+!08 7P!? ! : ! XP$ ! end XML 99 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 100 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 101 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 436 360 1 false 98 0 false 8 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.biocerescrops.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00100 - Statement - UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION Sheet http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION Statements 2 false false R3.htm 00200 - Statement - UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Sheet http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Statements 3 false false R4.htm 00300 - Statement - UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY Sheet http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY Statements 4 false false R5.htm 00400 - Statement - UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 5 false false R6.htm 10101 - Disclosure - GENERAL INFORMATION Sheet http://www.biocerescrops.com/role/DisclosureGeneralInformation GENERAL INFORMATION Notes 6 false false R7.htm 10201 - Disclosure - ACCOUNTING STANDARDS AND BASIS OF PREPARATION Sheet http://www.biocerescrops.com/role/DisclosureAccountingStandardsAndBasisOfPreparation ACCOUNTING STANDARDS AND BASIS OF PREPARATION Notes 7 false false R8.htm 10301 - Disclosure - NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS ISSUED BY THE IASB Sheet http://www.biocerescrops.com/role/DisclosureNewStandardsAmendmentsAndInterpretationsIssuedByIasb NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS ISSUED BY THE IASB Notes 8 false false R9.htm 10401 - Disclosure - SEASONALITY Sheet http://www.biocerescrops.com/role/DisclosureSeasonality SEASONALITY Notes 9 false false R10.htm 10501 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPosition INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION Notes 10 false false R11.htm 10601 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncome INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Notes 11 false false R12.htm 10701 - Disclosure - TAXATION Sheet http://www.biocerescrops.com/role/DisclosureTaxation TAXATION Notes 12 false false R13.htm 10801 - Disclosure - EARNING PER SHARE Sheet http://www.biocerescrops.com/role/DisclosureEarningPerShare EARNING PER SHARE Notes 13 false false R14.htm 10901 - Disclosure - EQUITY INFORMATION Sheet http://www.biocerescrops.com/role/DisclosureEquityInformation EQUITY INFORMATION Notes 14 false false R15.htm 11001 - Disclosure - CASH FLOW INFORMATION Sheet http://www.biocerescrops.com/role/DisclosureCashFlowInformation CASH FLOW INFORMATION Notes 15 false false R16.htm 11101 - Disclosure - JOINT VENTURES AND ASSOCIATES Sheet http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociates JOINT VENTURES AND ASSOCIATES Notes 16 false false R17.htm 11201 - Disclosure - SEGMENT INFORMATION Sheet http://www.biocerescrops.com/role/DisclosureSegmentInformation SEGMENT INFORMATION Notes 17 false false R18.htm 11301 - Disclosure - FINANCIAL INSTRUMENTS - RISK MANAGEMENT Sheet http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagement FINANCIAL INSTRUMENTS - RISK MANAGEMENT Notes 18 false false R19.htm 11401 - Disclosure - LEASES Sheet http://www.biocerescrops.com/role/DisclosureLeases LEASES Notes 19 false false R20.htm 11501 - Disclosure - SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS Sheet http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactions SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS Notes 20 false false R21.htm 11601 - Disclosure - KEY MANAGEMENT PERSONNEL COMPENSATION Sheet http://www.biocerescrops.com/role/DisclosureKeyManagementPersonnelCompensation KEY MANAGEMENT PERSONNEL COMPENSATION Notes 21 false false R22.htm 11701 - Disclosure - SHARE-BASED PAYMENT Sheet http://www.biocerescrops.com/role/DisclosureShareBasedPayment SHARE-BASED PAYMENT Notes 22 false false R23.htm 11801 - Disclosure - CONTINGENCIES, COMMITMENTS AND RESTRICTIONS ON THE DISTRIBUTION OF PROFITS Sheet http://www.biocerescrops.com/role/DisclosureContingenciesCommitmentsAndRestrictionsOnDistributionOfProfits CONTINGENCIES, COMMITMENTS AND RESTRICTIONS ON THE DISTRIBUTION OF PROFITS Notes 23 false false R24.htm 11901 - Disclosure - EVENTS OCCURRING AFTER THE REPORTING PERIOD Sheet http://www.biocerescrops.com/role/DisclosureEventsOccurringAfterReportingPeriod EVENTS OCCURRING AFTER THE REPORTING PERIOD Notes 24 false false R25.htm 20102 - Disclosure - ACCOUNTING STANDARDS AND BASIS OF PRESENTATION (Policies) Sheet http://www.biocerescrops.com/role/DisclosureAccountingStandardsAndBasisOfPresentationPolicies ACCOUNTING STANDARDS AND BASIS OF PRESENTATION (Policies) Policies 25 false false R26.htm 30503 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Tables) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Tables) Tables http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPosition 26 false false R27.htm 30603 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Tables) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTables INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Tables) Tables http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncome 27 false false R28.htm 30703 - Disclosure - TAXATION (Tables) Sheet http://www.biocerescrops.com/role/DisclosureTaxationTables TAXATION (Tables) Tables http://www.biocerescrops.com/role/DisclosureTaxation 28 false false R29.htm 30803 - Disclosure - EARNING PER SHARE (Tables) Sheet http://www.biocerescrops.com/role/DisclosureEarningPerShareTables EARNING PER SHARE (Tables) Tables http://www.biocerescrops.com/role/DisclosureEarningPerShare 29 false false R30.htm 31003 - Disclosure - CASH FLOW INFORMATION (Tables) Sheet http://www.biocerescrops.com/role/DisclosureCashFlowInformationTables CASH FLOW INFORMATION (Tables) Tables http://www.biocerescrops.com/role/DisclosureCashFlowInformation 30 false false R31.htm 31103 - Disclosure - JOINT VENTURES AND ASSOCIATES (Tables) Sheet http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesTables JOINT VENTURES AND ASSOCIATES (Tables) Tables http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociates 31 false false R32.htm 31203 - Disclosure - SEGMENT INFORMATION (Tables) Sheet http://www.biocerescrops.com/role/DisclosureSegmentInformationTables SEGMENT INFORMATION (Tables) Tables http://www.biocerescrops.com/role/DisclosureSegmentInformation 32 false false R33.htm 31303 - Disclosure - FINANCIAL INSTRUMENTS - RISK MANAGEMENT (Tables) Sheet http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementTables FINANCIAL INSTRUMENTS - RISK MANAGEMENT (Tables) Tables http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagement 33 false false R34.htm 31403 - Disclosure - LEASES (Tables) Sheet http://www.biocerescrops.com/role/DisclosureLeasesTables LEASES (Tables) Tables http://www.biocerescrops.com/role/DisclosureLeases 34 false false R35.htm 31503 - Disclosure - SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS (Tables) Sheet http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTables SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS (Tables) Tables http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactions 35 false false R36.htm 31603 - Disclosure - KEY MANAGEMENT PERSONNEL COMPENSATION (Tables) Sheet http://www.biocerescrops.com/role/DisclosureKeyManagementPersonnelCompensationTables KEY MANAGEMENT PERSONNEL COMPENSATION (Tables) Tables http://www.biocerescrops.com/role/DisclosureKeyManagementPersonnelCompensation 36 false false R37.htm 40101 - Disclosure - GENERAL INFORMATION - (Details) Sheet http://www.biocerescrops.com/role/DisclosureGeneralInformationDetails GENERAL INFORMATION - (Details) Details http://www.biocerescrops.com/role/DisclosureGeneralInformation 37 false false R38.htm 40401 - Disclosure - SEASONALITY (Details) Sheet http://www.biocerescrops.com/role/DisclosureSeasonalityDetails SEASONALITY (Details) Details http://www.biocerescrops.com/role/DisclosureSeasonality 38 false false R39.htm 40501 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Cash and cash equivalents (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionCashAndCashEquivalentsDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Cash and cash equivalents (Details) Details 39 false false R40.htm 40502 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Other financial assets (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Other financial assets (Details) Details 40 false false R41.htm 40503 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Trade receivables (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Trade receivables (Details) Details 41 false false R42.htm 40504 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Other receivables (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Other receivables (Details) Details 42 false false R43.htm 40505 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Inventories (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Inventories (Details) Details http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables 43 false false R44.htm 40506 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Biological assets (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBiologicalAssetsDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Biological assets (Details) Details 44 false false R45.htm 40507 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment (Details) Details 45 false false R46.htm 40508 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment - net carrying amount (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentNetCarryingAmountDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment - net carrying amount (Details) Details 46 false false R47.htm 40509 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment - gross carrying amounts (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentGrossCarryingAmountsDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment - gross carrying amounts (Details) Details 47 false false R48.htm 40510 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment - accumulated depreciation (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentAccumulatedDepreciationDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment - accumulated depreciation (Details) Details 48 false false R49.htm 40511 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets (Details) Details 49 false false R50.htm 40512 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets, net carrying amount (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsNetCarryingAmountDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets, net carrying amount (Details) Details 50 false false R51.htm 40513 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets, gross carrying amount (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsGrossCarryingAmountDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets, gross carrying amount (Details) Details 51 false false R52.htm 40514 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets, accumulated amortization (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsAccumulatedAmortizationDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets, accumulated amortization (Details) Details 52 false false R53.htm 40515 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Goodwill (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionGoodwillDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Goodwill (Details) Details http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables 53 false false R54.htm 40516 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Investment properties (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInvestmentPropertiesDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Investment properties (Details) Details 54 false false R55.htm 40517 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Trade and other payable (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayableDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Trade and other payable (Details) Details 55 false false R56.htm 40518 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Borrowings (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Borrowings (Details) Details http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables 56 false false R57.htm 40519 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Borrowings, carrying amount (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Borrowings, carrying amount (Details) Details 57 false false R58.htm 40521 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Secured Notes (Details) Notes http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionSecuredNotesDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Secured Notes (Details) Details http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables 58 false false R59.htm 40522 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Employee benefits and social security (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionEmployeeBenefitsAndSocialSecurityDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Employee benefits and social security (Details) Details 59 false false R60.htm 40523 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Deferred revenue and advances from customers (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionDeferredRevenueAndAdvancesFromCustomersDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Deferred revenue and advances from customers (Details) Details 60 false false R61.htm 40601 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Revenue (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRevenueDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Revenue (Details) Details http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTables 61 false false R62.htm 40602 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Cost of Sales (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeCostOfSalesDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Cost of Sales (Details) Details http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTables 62 false false R63.htm 40603 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - R&D classified by nature (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - R&D classified by nature (Details) Details 63 false false R64.htm 40604 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Expenses classified by nature and functions (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Expenses classified by nature and functions (Details) Details 64 false false R65.htm 40605 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Other income or expenses, net (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeOtherIncomeOrExpensesNetDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Other income or expenses, net (Details) Details 65 false false R66.htm 40606 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Finance results (Details) Sheet http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Finance results (Details) Details http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTables 66 false false R67.htm 40701 - Disclosure - TAXATION - Taxes on income (Details) Sheet http://www.biocerescrops.com/role/DisclosureTaxationTaxesOnIncomeDetails TAXATION - Taxes on income (Details) Details 67 false false R68.htm 40702 - Disclosure - TAXATION - Movement on the deferred income tax (Details) Sheet http://www.biocerescrops.com/role/DisclosureTaxationMovementOnDeferredIncomeTaxDetails TAXATION - Movement on the deferred income tax (Details) Details 68 false false R69.htm 40703 - Disclosure - TAXATION - Reconciliation of the statutory tax rate (Details) Sheet http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails TAXATION - Reconciliation of the statutory tax rate (Details) Details 69 false false R70.htm 40801 - Disclosure - EARNING PER SHARE (Details) Sheet http://www.biocerescrops.com/role/DisclosureEarningPerShareDetails EARNING PER SHARE (Details) Details http://www.biocerescrops.com/role/DisclosureEarningPerShareTables 70 false false R71.htm 40901 - Disclosure - EQUITY INFORMATION (Details) Sheet http://www.biocerescrops.com/role/DisclosureEquityInformationDetails EQUITY INFORMATION (Details) Details http://www.biocerescrops.com/role/DisclosureEquityInformation 71 false false R72.htm 41001 - Disclosure - CASH FLOW INFORMATION (Details) Sheet http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails CASH FLOW INFORMATION (Details) Details http://www.biocerescrops.com/role/DisclosureCashFlowInformationTables 72 false false R73.htm 41101 - Disclosure - JOINT VENTURES AND ASSOCIATES (Details) Sheet http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesDetails JOINT VENTURES AND ASSOCIATES (Details) Details http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesTables 73 false false R74.htm 41102 - Disclosure - JOINT VENTURES AND ASSOCIATES - Changes in joint ventures investments (Details) Sheet http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesChangesInJointVenturesInvestmentsDetails JOINT VENTURES AND ASSOCIATES - Changes in joint ventures investments (Details) Details 74 false false R75.htm 41201 - Disclosure - SEGMENT INFORMATION - Group's reporting segments (Details) Sheet http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails SEGMENT INFORMATION - Group's reporting segments (Details) Details 75 false false R76.htm 41301 - Disclosure - FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Financial assets by category (Details) Sheet http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialAssetsByCategoryDetails FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Financial assets by category (Details) Details 76 false false R77.htm 41302 - Disclosure - FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Financial liabilities by category (Details) Sheet http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Financial liabilities by category (Details) Details 77 false false R78.htm 41303 - Disclosure - FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Fair value by hierarchy (Details) Sheet http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Fair value by hierarchy (Details) Details 78 false false R79.htm 41304 - Disclosure - FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Currency risk (Details) Sheet http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementCurrencyRiskDetails FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Currency risk (Details) Details 79 false false R80.htm 41401 - Disclosure - LEASES - Right-of-use leased asset (Details) Sheet http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseLeasedAssetDetails LEASES - Right-of-use leased asset (Details) Details 80 false false R81.htm 41402 - Disclosure - LEASES - Lease liability (Details) Sheet http://www.biocerescrops.com/role/DisclosureLeasesLeaseLiabilityDetails LEASES - Lease liability (Details) Details 81 false false R82.htm 41403 - Disclosure - LEASES - Right-of-use asset by type (Details) Sheet http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails LEASES - Right-of-use asset by type (Details) Details 82 false false R83.htm 41501 - Disclosure - SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS - Transactions (Details) Sheet http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS - Transactions (Details) Details http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTables 83 false false R84.htm 41502 - Disclosure - SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS - Receivable (Details) Sheet http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsReceivableDetails SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS - Receivable (Details) Details http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTables 84 false false R85.htm 41503 - Disclosure - SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS - Payables (Details) Sheet http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsPayablesDetails SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS - Payables (Details) Details http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTables 85 false false R86.htm 41601 - Disclosure - KEY MANAGEMENT PERSONNEL COMPENSATION - Summary of compensation of directors and other members (Details) Sheet http://www.biocerescrops.com/role/DisclosureKeyManagementPersonnelCompensationSummaryOfCompensationOfDirectorsAndOtherMembersDetails KEY MANAGEMENT PERSONNEL COMPENSATION - Summary of compensation of directors and other members (Details) Details 86 false false R87.htm 41701 - Disclosure - SHARE-BASED PAYMENT (Details) Sheet http://www.biocerescrops.com/role/DisclosureShareBasedPaymentDetails SHARE-BASED PAYMENT (Details) Details http://www.biocerescrops.com/role/DisclosureShareBasedPayment 87 false false All Reports Book All Reports biox-20230930.xsd biox-20230930_cal.xml biox-20230930_def.xml biox-20230930_lab.xml biox-20230930_pre.xml biox-20230930x6k.htm biox-20230930xex99d1.htm biox-20230930xex99d1001.jpg biox-20230930xex99d1002.jpg http://xbrl.sec.gov/dei/2023 https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full true true JSON 104 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "biox-20230930x6k.htm biox-20230930xex99d1.htm": { "nsprefix": "biox", "nsuri": "http://www.biocerescrops.com/20230930", "dts": { "schema": { "local": [ "biox-20230930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "calculationLink": { "local": [ "biox-20230930_cal.xml" ] }, "definitionLink": { "local": [ "biox-20230930_def.xml" ] }, "labelLink": { "local": [ "biox-20230930_lab.xml" ] }, "presentationLink": { "local": [ "biox-20230930_pre.xml" ] }, "inline": { "local": [ "biox-20230930x6k.htm", "biox-20230930xex99d1.htm" ] } }, "keyStandard": 229, "keyCustom": 131, "axisStandard": 22, "axisCustom": 0, "memberStandard": 41, "memberCustom": 53, "hidden": { "total": 9, "http://xbrl.sec.gov/dei/2023": 7, "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full": 2 }, "contextCount": 436, "entityCount": 1, "segmentCount": 98, "elementCount": 587, "unitCount": 8, "baseTaxonomies": { "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full": 1059, "http://xbrl.sec.gov/dei/2023": 8 }, "report": { "R1": { "role": "http://www.biocerescrops.com/role/DocumentDocumentAndEntityInformation", "longName": "00090 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930x6k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930x6k.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition", "longName": "00100 - Statement - UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION", "shortName": "UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "As_Of_9_30_2023_A1Jt0YXvEkmbf8yUk2thqg", "name": "ifrs-full:CashAndCashEquivalents", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_9_30_2023_A1Jt0YXvEkmbf8yUk2thqg", "name": "ifrs-full:CurrentTaxAssets", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "unique": true } }, "R3": { "role": "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome", "longName": "00200 - Statement - UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME", "shortName": "UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:RevenueFromContractsWithCustomers", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "biox:ChangeInNetRealizableValueOfAgricultural", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "unique": true } }, "R4": { "role": "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity", "longName": "00300 - Statement - UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY", "shortName": "UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "As_Of_6_30_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_7n8Nro9YBUy9hXkm7kCB4w", "name": "ifrs-full:Equity", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_6_30_2022_ifrs-full_ComponentsOfEquityAxis_ifrs-full_EquityAttributableToOwnersOfParentMember_7n8Nro9YBUy9hXkm7kCB4w", "name": "ifrs-full:Equity", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R5": { "role": "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows", "longName": "00400 - Statement - UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS", "shortName": "UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:ProfitLoss", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:AdjustmentsForIncomeTaxExpense", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "unique": true } }, "R6": { "role": "http://www.biocerescrops.com/role/DisclosureGeneralInformation", "longName": "10101 - Disclosure - GENERAL INFORMATION", "shortName": "GENERAL INFORMATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "6", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R7": { "role": "http://www.biocerescrops.com/role/DisclosureAccountingStandardsAndBasisOfPreparation", "longName": "10201 - Disclosure - ACCOUNTING STANDARDS AND BASIS OF PREPARATION", "shortName": "ACCOUNTING STANDARDS AND BASIS OF PREPARATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "biox:DisclosureOfAccountingStandardsAndBasisOfPresentationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "biox:DisclosureOfAccountingStandardsAndBasisOfPresentationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R8": { "role": "http://www.biocerescrops.com/role/DisclosureNewStandardsAmendmentsAndInterpretationsIssuedByIasb", "longName": "10301 - Disclosure - NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS ISSUED BY THE IASB", "shortName": "NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS ISSUED BY THE IASB", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R9": { "role": "http://www.biocerescrops.com/role/DisclosureSeasonality", "longName": "10401 - Disclosure - SEASONALITY", "shortName": "SEASONALITY", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "biox:DisclosureOfSeasonalityTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "biox:DisclosureOfSeasonalityTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPosition", "longName": "10501 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "biox:DisclosureOfComponentsOfConsolidatedStatementsOfFinancialPosition", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "biox:DisclosureOfComponentsOfConsolidatedStatementsOfFinancialPosition", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncome", "longName": "10601 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "biox:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "biox:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.biocerescrops.com/role/DisclosureTaxation", "longName": "10701 - Disclosure - TAXATION", "shortName": "TAXATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.biocerescrops.com/role/DisclosureEarningPerShare", "longName": "10801 - Disclosure - EARNING PER SHARE", "shortName": "EARNING PER SHARE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.biocerescrops.com/role/DisclosureEquityInformation", "longName": "10901 - Disclosure - EQUITY INFORMATION", "shortName": "EQUITY INFORMATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.biocerescrops.com/role/DisclosureCashFlowInformation", "longName": "11001 - Disclosure - CASH FLOW INFORMATION", "shortName": "CASH FLOW INFORMATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociates", "longName": "11101 - Disclosure - JOINT VENTURES AND ASSOCIATES", "shortName": "JOINT VENTURES AND ASSOCIATES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "biox:InvestmentsInJointVenturesAndAssociatesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "biox:InvestmentsInJointVenturesAndAssociatesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.biocerescrops.com/role/DisclosureSegmentInformation", "longName": "11201 - Disclosure - SEGMENT INFORMATION", "shortName": "SEGMENT INFORMATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagement", "longName": "11301 - Disclosure - FINANCIAL INSTRUMENTS - RISK MANAGEMENT", "shortName": "FINANCIAL INSTRUMENTS - RISK MANAGEMENT", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.biocerescrops.com/role/DisclosureLeases", "longName": "11401 - Disclosure - LEASES", "shortName": "LEASES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:DisclosureOfLeasesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:DisclosureOfLeasesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactions", "longName": "11501 - Disclosure - SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS", "shortName": "SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.biocerescrops.com/role/DisclosureKeyManagementPersonnelCompensation", "longName": "11601 - Disclosure - KEY MANAGEMENT PERSONNEL COMPENSATION", "shortName": "KEY MANAGEMENT PERSONNEL COMPENSATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R22": { "role": "http://www.biocerescrops.com/role/DisclosureShareBasedPayment", "longName": "11701 - Disclosure - SHARE-BASED PAYMENT", "shortName": "SHARE-BASED PAYMENT", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.biocerescrops.com/role/DisclosureContingenciesCommitmentsAndRestrictionsOnDistributionOfProfits", "longName": "11801 - Disclosure - CONTINGENCIES, COMMITMENTS AND RESTRICTIONS ON THE DISTRIBUTION OF PROFITS", "shortName": "CONTINGENCIES, COMMITMENTS AND RESTRICTIONS ON THE DISTRIBUTION OF PROFITS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:DisclosureOfCommitmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:DisclosureOfCommitmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.biocerescrops.com/role/DisclosureEventsOccurringAfterReportingPeriod", "longName": "11901 - Disclosure - EVENTS OCCURRING AFTER THE REPORTING PERIOD", "shortName": "EVENTS OCCURRING AFTER THE REPORTING PERIOD", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.biocerescrops.com/role/DisclosureAccountingStandardsAndBasisOfPresentationPolicies", "longName": "20102 - Disclosure - ACCOUNTING STANDARDS AND BASIS OF PRESENTATION (Policies)", "shortName": "ACCOUNTING STANDARDS AND BASIS OF PRESENTATION (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "25", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "biox:DescriptionOfAccountingPolicyForBasisOfMeasurementTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "biox:DisclosureOfAccountingStandardsAndBasisOfPresentationTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "biox:DescriptionOfAccountingPolicyForBasisOfMeasurementTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "biox:DisclosureOfAccountingStandardsAndBasisOfPresentationTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R26": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables", "longName": "30503 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Tables)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "biox:DisclosureOfComponentsOfConsolidatedStatementsOfFinancialPosition", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "biox:DisclosureOfComponentsOfConsolidatedStatementsOfFinancialPosition", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R27": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTables", "longName": "30603 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Tables)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "biox:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "biox:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.biocerescrops.com/role/DisclosureTaxationTables", "longName": "30703 - Disclosure - TAXATION (Tables)", "shortName": "TAXATION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "biox:IfrsScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "biox:IfrsScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.biocerescrops.com/role/DisclosureEarningPerShareTables", "longName": "30803 - Disclosure - EARNING PER SHARE (Tables)", "shortName": "EARNING PER SHARE (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:EarningsPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:EarningsPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.biocerescrops.com/role/DisclosureCashFlowInformationTables", "longName": "31003 - Disclosure - CASH FLOW INFORMATION (Tables)", "shortName": "CASH FLOW INFORMATION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "biox:ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "biox:ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R31": { "role": "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesTables", "longName": "31103 - Disclosure - JOINT VENTURES AND ASSOCIATES (Tables)", "shortName": "JOINT VENTURES AND ASSOCIATES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "biox:DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "biox:InvestmentsInJointVenturesAndAssociatesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "biox:DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "biox:InvestmentsInJointVenturesAndAssociatesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R32": { "role": "http://www.biocerescrops.com/role/DisclosureSegmentInformationTables", "longName": "31203 - Disclosure - SEGMENT INFORMATION (Tables)", "shortName": "SEGMENT INFORMATION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R33": { "role": "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementTables", "longName": "31303 - Disclosure - FINANCIAL INSTRUMENTS - RISK MANAGEMENT (Tables)", "shortName": "FINANCIAL INSTRUMENTS - RISK MANAGEMENT (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:DisclosureOfFinancialAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:DisclosureOfFinancialAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.biocerescrops.com/role/DisclosureLeasesTables", "longName": "31403 - Disclosure - LEASES (Tables)", "shortName": "LEASES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "biox:Disclosureofrightofuseleasedassetsandleaseliabilitytabletextblock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfLeasesExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "biox:Disclosureofrightofuseleasedassetsandleaseliabilitytabletextblock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfLeasesExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R35": { "role": "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTables", "longName": "31503 - Disclosure - SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS (Tables)", "shortName": "SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "35", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfRelatedPartyExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfRelatedPartyExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R36": { "role": "http://www.biocerescrops.com/role/DisclosureKeyManagementPersonnelCompensationTables", "longName": "31603 - Disclosure - KEY MANAGEMENT PERSONNEL COMPENSATION (Tables)", "shortName": "KEY MANAGEMENT PERSONNEL COMPENSATION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "36", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "biox:DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "biox:DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R37": { "role": "http://www.biocerescrops.com/role/DisclosureGeneralInformationDetails", "longName": "40101 - Disclosure - GENERAL INFORMATION - (Details)", "shortName": "GENERAL INFORMATION - (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "As_Of_9_30_2023_A1Jt0YXvEkmbf8yUk2thqg", "name": "biox:MinimumNumberOfCountriesWhereEntityMarketedAgriculturalInputs", "unitRef": "Unit_Standard_country_EhSDQugu-EaRj1x3vP4eKw", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_9_30_2023_A1Jt0YXvEkmbf8yUk2thqg", "name": "biox:MinimumNumberOfCountriesWhereEntityMarketedAgriculturalInputs", "unitRef": "Unit_Standard_country_EhSDQugu-EaRj1x3vP4eKw", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R38": { "role": "http://www.biocerescrops.com/role/DisclosureSeasonalityDetails", "longName": "40401 - Disclosure - SEASONALITY (Details)", "shortName": "SEASONALITY (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "As_Of_9_30_2023_A1Jt0YXvEkmbf8yUk2thqg", "name": "biox:CustomersAndDistributorBulkOrdersPerYearMinimum", "unitRef": "Unit_Standard_item_dmGRIhrl6kWp2KJwZGqXKA", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "biox:DisclosureOfSeasonalityTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_9_30_2023_A1Jt0YXvEkmbf8yUk2thqg", "name": "biox:CustomersAndDistributorBulkOrdersPerYearMinimum", "unitRef": "Unit_Standard_item_dmGRIhrl6kWp2KJwZGqXKA", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "biox:DisclosureOfSeasonalityTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R39": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionCashAndCashEquivalentsDetails", "longName": "40501 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Cash and cash equivalents (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Cash and cash equivalents (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "As_Of_9_30_2023_A1Jt0YXvEkmbf8yUk2thqg", "name": "ifrs-full:Cash", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "biox:DisclosureOfComponentsOfConsolidatedStatementsOfFinancialPosition", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_9_30_2023_A1Jt0YXvEkmbf8yUk2thqg", "name": "ifrs-full:Cash", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "biox:DisclosureOfComponentsOfConsolidatedStatementsOfFinancialPosition", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R40": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails", "longName": "40502 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Other financial assets (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Other financial assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "As_Of_6_30_2023_endvF4nifEeyldOjgWPdsg", "name": "ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfOtherFinancialAssetsExplanatory", "biox:DisclosureOfComponentsOfConsolidatedStatementsOfFinancialPosition", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_6_30_2023_endvF4nifEeyldOjgWPdsg", "name": "ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfOtherFinancialAssetsExplanatory", "biox:DisclosureOfComponentsOfConsolidatedStatementsOfFinancialPosition", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R41": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails", "longName": "40503 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Trade receivables (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Trade receivables (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "As_Of_9_30_2023_A1Jt0YXvEkmbf8yUk2thqg", "name": "ifrs-full:CurrentTradeReceivables", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfTradeReceivablesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_9_30_2023_A1Jt0YXvEkmbf8yUk2thqg", "name": "ifrs-full:CurrentTradeReceivables", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfTradeReceivablesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R42": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails", "longName": "40504 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Other receivables (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Other receivables (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "As_Of_9_30_2023_A1Jt0YXvEkmbf8yUk2thqg", "name": "biox:ReceivablesFromTaxCreditsCurrent", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfOtherReceivablesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_9_30_2023_A1Jt0YXvEkmbf8yUk2thqg", "name": "biox:ReceivablesFromTaxCreditsCurrent", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfOtherReceivablesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R43": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails", "longName": "40505 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Inventories (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Inventories (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "As_Of_9_30_2023_A1Jt0YXvEkmbf8yUk2thqg", "name": "ifrs-full:CurrentInventoriesInTransit", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:IfrsScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_9_30_2023_A1Jt0YXvEkmbf8yUk2thqg", "name": "ifrs-full:CurrentInventoriesInTransit", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:IfrsScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R44": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBiologicalAssetsDetails", "longName": "40506 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Biological assets (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Biological assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "As_Of_6_30_2023_endvF4nifEeyldOjgWPdsg", "name": "ifrs-full:BiologicalAssets", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_6_30_2022_5CwYqx4BMEyk95x4ycrWtQ", "name": "ifrs-full:BiologicalAssets", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "p", "td", "tr", "table", "ifrs-full:DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "unique": true } }, "R45": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentDetails", "longName": "40507 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "As_Of_9_30_2023_A1Jt0YXvEkmbf8yUk2thqg", "name": "ifrs-full:PropertyPlantAndEquipment", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true }, "uniqueAnchor": null }, "R46": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentNetCarryingAmountDetails", "longName": "40508 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment - net carrying amount (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment - net carrying amount (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "As_Of_9_30_2023_A1Jt0YXvEkmbf8yUk2thqg", "name": "ifrs-full:PropertyPlantAndEquipment", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true }, "uniqueAnchor": null }, "R47": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentGrossCarryingAmountsDetails", "longName": "40509 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment - gross carrying amounts (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment - gross carrying amounts (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "As_Of_6_30_2023_endvF4nifEeyldOjgWPdsg", "name": "ifrs-full:PropertyPlantAndEquipment", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2022_To_9_30_2022_Ka1qcpRM_kuqKmjkVI5d8A", "name": "ifrs-full:AcquisitionsThroughBusinessCombinationsInvestmentProperty", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "unique": true } }, "R48": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentAccumulatedDepreciationDetails", "longName": "40510 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment - accumulated depreciation (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment - accumulated depreciation (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "As_Of_6_30_2023_endvF4nifEeyldOjgWPdsg", "name": "ifrs-full:PropertyPlantAndEquipment", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true }, "uniqueAnchor": null }, "R49": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsDetails", "longName": "40511 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "As_Of_9_30_2023_A1Jt0YXvEkmbf8yUk2thqg", "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true }, "uniqueAnchor": null }, "R50": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsNetCarryingAmountDetails", "longName": "40512 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets, net carrying amount (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets, net carrying amount (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "As_Of_9_30_2023_A1Jt0YXvEkmbf8yUk2thqg", "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true }, "uniqueAnchor": null }, "R51": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsGrossCarryingAmountDetails", "longName": "40513 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets, gross carrying amount (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets, gross carrying amount (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "As_Of_6_30_2023_endvF4nifEeyldOjgWPdsg", "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_nhgckKn6x0qBa8PM4GroUw", "name": "ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfGrossCarryingAmountOfIntangibleAssetsTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "unique": true } }, "R52": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsAccumulatedAmortizationDetails", "longName": "40514 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets, accumulated amortization (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets, accumulated amortization (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "As_Of_6_30_2023_endvF4nifEeyldOjgWPdsg", "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_AccumulatedDepreciationAndAmortisationMember_6cYV8cmfQ0m4RPlR2DQpgQ", "name": "ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfAccumulatedAmortizationOfIntangibleAssets.TextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "unique": true } }, "R53": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionGoodwillDetails", "longName": "40515 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Goodwill (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Goodwill (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "As_Of_9_30_2023_A1Jt0YXvEkmbf8yUk2thqg", "name": "ifrs-full:Goodwill", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_9_30_2023_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_biox_RizobacterArgentinaMember_l9zFW6gF6UW_-6sAF2bXhw", "name": "ifrs-full:Goodwill", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfReconciliationOfChangesInGoodwillExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "unique": true } }, "R54": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInvestmentPropertiesDetails", "longName": "40516 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Investment properties (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Investment properties (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "As_Of_9_30_2033_B7M932_QXEC-hlPnUVILRQ", "name": "ifrs-full:InvestmentProperty", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfInvestmentPropertyExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_9_30_2033_B7M932_QXEC-hlPnUVILRQ", "name": "ifrs-full:InvestmentProperty", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfInvestmentPropertyExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R55": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayableDetails", "longName": "40517 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Trade and other payable (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Trade and other payable (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "As_Of_9_30_2023_A1Jt0YXvEkmbf8yUk2thqg", "name": "ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfTradeAndOtherPayablesComponentsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_9_30_2023_A1Jt0YXvEkmbf8yUk2thqg", "name": "ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfTradeAndOtherPayablesComponentsTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R56": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails", "longName": "40518 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Borrowings (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Borrowings (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "As_Of_9_30_2023_A1Jt0YXvEkmbf8yUk2thqg", "name": "ifrs-full:BondsIssued", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_9_30_2023_ifrs-full_BorrowingsByNameAxis_biox_TrustDebtSecuritiesMember_yEGFGbHIA0i_eyHoqh-Pbg", "name": "ifrs-full:ShorttermBorrowings", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "unique": true } }, "R57": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails", "longName": "40519 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Borrowings, carrying amount (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Borrowings, carrying amount (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "As_Of_9_30_2023_A1Jt0YXvEkmbf8yUk2thqg", "name": "ifrs-full:ShorttermBorrowings", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_9_30_2023_ifrs-full_MeasurementAxis_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember_OtdtUd4Dk0iU6T9CrMooTA", "name": "ifrs-full:BondsIssued", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfCarryingValueOfBorrowingsExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "unique": true } }, "R58": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionSecuredNotesDetails", "longName": "40521 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Secured Notes (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Secured Notes (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "As_Of_9_30_2023_A1Jt0YXvEkmbf8yUk2thqg", "name": "biox:SecuredDebtNonCurrent", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_9_30_2033_ifrs-full_BorrowingsByNameAxis_biox_SecuredGuaranteedNotesMember_ifrs-full_MeasurementAxis_ifrs-full_AtCostMember_9M_wFNv1Ek2LYRAbUMlMhg", "name": "ifrs-full:Borrowings", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "unique": true } }, "R59": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionEmployeeBenefitsAndSocialSecurityDetails", "longName": "40522 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Employee benefits and social security (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Employee benefits and social security (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "As_Of_9_30_2023_A1Jt0YXvEkmbf8yUk2thqg", "name": "biox:SalariesAccruedIncentivesVacationsAndSocialSecurityCurrent", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfBenefitsAndSocialSecurityPayablesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_9_30_2023_A1Jt0YXvEkmbf8yUk2thqg", "name": "biox:SalariesAccruedIncentivesVacationsAndSocialSecurityCurrent", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfBenefitsAndSocialSecurityPayablesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R60": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionDeferredRevenueAndAdvancesFromCustomersDetails", "longName": "40523 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Deferred revenue and advances from customers (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Deferred revenue and advances from customers (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "As_Of_9_30_2023_A1Jt0YXvEkmbf8yUk2thqg", "name": "ifrs-full:CurrentAdvances", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfPerformanceObligationsExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_9_30_2023_A1Jt0YXvEkmbf8yUk2thqg", "name": "ifrs-full:CurrentAdvances", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfPerformanceObligationsExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R61": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRevenueDetails", "longName": "40601 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Revenue (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Revenue (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:RevenueFromContractsWithCustomers", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_ifrs-full_ProductsAndServicesAxis_biox_GoodsAndServicesMember_SAW3cFEsHka2FQC2caI4yA", "name": "ifrs-full:RevenueFromContractsWithCustomers", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory", "biox:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "unique": true } }, "R62": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeCostOfSalesDetails", "longName": "40602 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Cost of Sales (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Cost of Sales (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "As_Of_6_30_2023_endvF4nifEeyldOjgWPdsg", "name": "ifrs-full:InventoriesTotal", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfCostOfSalesExplanatory", "biox:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_6_30_2023_endvF4nifEeyldOjgWPdsg", "name": "ifrs-full:InventoriesTotal", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfCostOfSalesExplanatory", "biox:DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R63": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails", "longName": "40603 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - R&D classified by nature (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - R&D classified by nature (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:DepreciationRightofuseAssets", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "biox:ResearchAndDevelopmentExpenseCapitalized", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "unique": true } }, "R64": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "longName": "40604 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Expenses classified by nature and functions (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Expenses classified by nature and functions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:DepreciationRightofuseAssets", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_ifrs-full_CostOfSalesMember_YCpZIZ7B-kePh84JDihFzg", "name": "ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfExpensesByNatureExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "unique": true } }, "R65": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeOtherIncomeOrExpensesNetDetails", "longName": "40605 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Other income or expenses, net (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Other income or expenses, net (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:RevenueFromSaleOfAgriculturalProduce", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:RevenueFromSaleOfAgriculturalProduce", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R66": { "role": "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails", "longName": "40606 - Disclosure - INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Finance results (Details)", "shortName": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Finance results (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "biox:InterestExpenseOnLiabilitiesWithParent", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "biox:InterestExpenseOnLiabilitiesWithParent", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R67": { "role": "http://www.biocerescrops.com/role/DisclosureTaxationTaxesOnIncomeDetails", "longName": "40701 - Disclosure - TAXATION - Taxes on income (Details)", "shortName": "TAXATION - Taxes on income (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:CurrentTaxExpenseIncome", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:IfrsScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:CurrentTaxExpenseIncome", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:IfrsScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R68": { "role": "http://www.biocerescrops.com/role/DisclosureTaxationMovementOnDeferredIncomeTaxDetails", "longName": "40702 - Disclosure - TAXATION - Movement on the deferred income tax (Details)", "shortName": "TAXATION - Movement on the deferred income tax (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "As_Of_6_30_2023_endvF4nifEeyldOjgWPdsg", "name": "ifrs-full:DeferredTaxLiabilityAsset", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfDeferredTaxesExplanatory", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_6_30_2023_endvF4nifEeyldOjgWPdsg", "name": "ifrs-full:DeferredTaxLiabilityAsset", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfDeferredTaxesExplanatory", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R69": { "role": "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails", "longName": "40703 - Disclosure - TAXATION - Reconciliation of the statutory tax rate (Details)", "shortName": "TAXATION - Reconciliation of the statutory tax rate (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:AccountingProfit", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:IfrsScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:AccountingProfit", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:IfrsScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R70": { "role": "http://www.biocerescrops.com/role/DisclosureEarningPerShareDetails", "longName": "40801 - Disclosure - EARNING PER SHARE (Details)", "shortName": "EARNING PER SHARE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:EarningsPerShareExplanatory", "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:EarningsPerShareExplanatory", "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R71": { "role": "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails", "longName": "40901 - Disclosure - EQUITY INFORMATION (Details)", "shortName": "EQUITY INFORMATION (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "71", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "biox:IfrsStockRepurchasedDuringPeriodShares", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "biox:IfrsStockRepurchasedDuringPeriodShares", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R72": { "role": "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails", "longName": "41001 - Disclosure - CASH FLOW INFORMATION (Details)", "shortName": "CASH FLOW INFORMATION (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "72", "firstAnchor": { "contextRef": "Duration_7_1_2022_To_9_30_2022_Ka1qcpRM_kuqKmjkVI5d8A", "name": "biox:NetAssetsAcquisitionByBusinessCombination", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities", "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2022_To_9_30_2022_Ka1qcpRM_kuqKmjkVI5d8A", "name": "biox:NetAssetsAcquisitionByBusinessCombination", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities", "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R73": { "role": "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesDetails", "longName": "41101 - Disclosure - JOINT VENTURES AND ASSOCIATES (Details)", "shortName": "JOINT VENTURES AND ASSOCIATES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "73", "firstAnchor": { "contextRef": "As_Of_9_30_2023_A1Jt0YXvEkmbf8yUk2thqg", "name": "biox:InvestmentsAccountedForUsingEquityMethodAssets", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_9_30_2023_ifrs-full_JointVenturesAxis_biox_TrigallGeneticsS.a.Member_BzDJq4TQFUOO5FmyQGLkng", "name": "biox:InvestmentsAccountedForUsingEquityMethodLiability", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock", "biox:InvestmentsInJointVenturesAndAssociatesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "unique": true } }, "R74": { "role": "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesChangesInJointVenturesInvestmentsDetails", "longName": "41102 - Disclosure - JOINT VENTURES AND ASSOCIATES - Changes in joint ventures investments (Details)", "shortName": "JOINT VENTURES AND ASSOCIATES - Changes in joint ventures investments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "74", "firstAnchor": { "contextRef": "As_Of_6_30_2023_endvF4nifEeyldOjgWPdsg", "name": "biox:InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfChangesInInvestmentInJointVenturesAndAffiliatesTableTextBlock", "biox:InvestmentsInJointVenturesAndAssociatesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_6_30_2023_endvF4nifEeyldOjgWPdsg", "name": "biox:InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfChangesInInvestmentInJointVenturesAndAffiliatesTableTextBlock", "biox:InvestmentsInJointVenturesAndAssociatesTextBlock", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R75": { "role": "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails", "longName": "41201 - Disclosure - SEGMENT INFORMATION - Group's reporting segments (Details)", "shortName": "SEGMENT INFORMATION - Group's reporting segments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "75", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:RevenueFromContractsWithCustomers", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:Revenue", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "p", "td", "tr", "table", "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "unique": true } }, "R76": { "role": "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialAssetsByCategoryDetails", "longName": "41301 - Disclosure - FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Financial assets by category (Details)", "shortName": "FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Financial assets by category (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "76", "firstAnchor": { "contextRef": "As_Of_9_30_2023_ifrs-full_MeasurementAxis_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember_OtdtUd4Dk0iU6T9CrMooTA", "name": "ifrs-full:FinancialAssets", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "p", "td", "tr", "table", "ifrs-full:DisclosureOfFinancialAssetsExplanatory", "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_9_30_2023_ifrs-full_MeasurementAxis_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember_OtdtUd4Dk0iU6T9CrMooTA", "name": "ifrs-full:FinancialAssets", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "p", "td", "tr", "table", "ifrs-full:DisclosureOfFinancialAssetsExplanatory", "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R77": { "role": "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails", "longName": "41302 - Disclosure - FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Financial liabilities by category (Details)", "shortName": "FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Financial liabilities by category (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "77", "firstAnchor": { "contextRef": "As_Of_9_30_2023_ifrs-full_MeasurementAxis_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember_OtdtUd4Dk0iU6T9CrMooTA", "name": "ifrs-full:FinancialLiabilities", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "p", "td", "tr", "table", "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory", "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_9_30_2023_ifrs-full_MeasurementAxis_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember_OtdtUd4Dk0iU6T9CrMooTA", "name": "ifrs-full:FinancialLiabilities", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "p", "td", "tr", "table", "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory", "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R78": { "role": "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails", "longName": "41303 - Disclosure - FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Fair value by hierarchy (Details)", "shortName": "FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Fair value by hierarchy (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "78", "firstAnchor": { "contextRef": "As_Of_9_30_2023_ifrs-full_LevelsOfFairValueHierarchyAxis_ifrs-full_Level2OfFairValueHierarchyMember_w7J_KbT44061BoHMGfqaag", "name": "ifrs-full:FinancialLiabilitiesAtFairValue", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfFairValueOfFinancialInstrumentsExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_9_30_2023_ifrs-full_LevelsOfFairValueHierarchyAxis_ifrs-full_Level2OfFairValueHierarchyMember_w7J_KbT44061BoHMGfqaag", "name": "ifrs-full:FinancialLiabilitiesAtFairValue", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfFairValueOfFinancialInstrumentsExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R79": { "role": "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementCurrencyRiskDetails", "longName": "41304 - Disclosure - FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Currency risk (Details)", "shortName": "FINANCIAL INSTRUMENTS - RISK MANAGEMENT - Currency risk (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "79", "firstAnchor": { "contextRef": "As_Of_9_30_2023_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_QMTD9NtHbku46GkDD1csdQ", "name": "ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_9_30_2023_ifrs-full_TypesOfRisksAxis_ifrs-full_CurrencyRiskMember_QMTD9NtHbku46GkDD1csdQ", "name": "ifrs-full:RiskExposureAssociatedWithInstrumentsSharingCharacteristic", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R80": { "role": "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseLeasedAssetDetails", "longName": "41401 - Disclosure - LEASES - Right-of-use leased asset (Details)", "shortName": "LEASES - Right-of-use leased asset (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "80", "firstAnchor": { "contextRef": "As_Of_6_30_2023_endvF4nifEeyldOjgWPdsg", "name": "ifrs-full:RightofuseAssets", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrs-full_GrossCarryingAmountMember_nhgckKn6x0qBa8PM4GroUw", "name": "ifrs-full:AdditionsToRightofuseAssets", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:Disclosureofrightofuseleasedassetsandleaseliabilitytabletextblock", "ifrs-full:DisclosureOfLeasesExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "unique": true } }, "R81": { "role": "http://www.biocerescrops.com/role/DisclosureLeasesLeaseLiabilityDetails", "longName": "41402 - Disclosure - LEASES - Lease liability (Details)", "shortName": "LEASES - Lease liability (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "81", "firstAnchor": { "contextRef": "As_Of_6_30_2023_endvF4nifEeyldOjgWPdsg", "name": "ifrs-full:LeaseLiabilities", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "p", "td", "tr", "table", "biox:Disclosureofrightofuseleasedassetsandleaseliabilitytabletextblock", "ifrs-full:DisclosureOfLeasesExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_6_30_2022_5CwYqx4BMEyk95x4ycrWtQ", "name": "ifrs-full:LeaseLiabilities", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:Disclosureofrightofuseleasedassetsandleaseliabilitytabletextblock", "ifrs-full:DisclosureOfLeasesExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "unique": true } }, "R82": { "role": "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails", "longName": "41403 - Disclosure - LEASES - Right-of-use asset by type (Details)", "shortName": "LEASES - Right-of-use asset by type (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "82", "firstAnchor": { "contextRef": "As_Of_9_30_2023_A1Jt0YXvEkmbf8yUk2thqg", "name": "ifrs-full:RightofuseAssets", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "biox:PercentageOfIncrementalBorrowingRate", "unitRef": "Unit_Standard_pure_TAuG1nKeh0CMOLXkRoAc7g", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "unique": true } }, "R83": { "role": "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails", "longName": "41501 - Disclosure - SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS - Transactions (Details)", "shortName": "SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS - Transactions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "83", "firstAnchor": { "contextRef": "Duration_7_1_2022_To_9_30_2022_Ka1qcpRM_kuqKmjkVI5d8A", "name": "biox:InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities", "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "biox:RelatedPartyTransactions", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "unique": true } }, "R84": { "role": "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsReceivableDetails", "longName": "41502 - Disclosure - SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS - Receivable (Details)", "shortName": "SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS - Receivable (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "84", "firstAnchor": { "contextRef": "As_Of_9_30_2023_A1Jt0YXvEkmbf8yUk2thqg", "name": "ifrs-full:OtherCurrentReceivables", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true }, "uniqueAnchor": { "contextRef": "As_Of_9_30_2023_A1Jt0YXvEkmbf8yUk2thqg", "name": "ifrs-full:AmountsReceivableRelatedPartyTransactions", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "unique": true } }, "R85": { "role": "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsPayablesDetails", "longName": "41503 - Disclosure - SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS - Payables (Details)", "shortName": "SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS - Payables (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "85", "firstAnchor": { "contextRef": "As_Of_9_30_2023_A1Jt0YXvEkmbf8yUk2thqg", "name": "ifrs-full:AmountsPayableRelatedPartyTransactions", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "As_Of_9_30_2023_A1Jt0YXvEkmbf8yUk2thqg", "name": "ifrs-full:AmountsPayableRelatedPartyTransactions", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R86": { "role": "http://www.biocerescrops.com/role/DisclosureKeyManagementPersonnelCompensationSummaryOfCompensationOfDirectorsAndOtherMembersDetails", "longName": "41601 - Disclosure - KEY MANAGEMENT PERSONNEL COMPENSATION - Summary of compensation of directors and other members (Details)", "shortName": "KEY MANAGEMENT PERSONNEL COMPENSATION - Summary of compensation of directors and other members (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "86", "firstAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock", "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_7_1_2023_To_9_30_2023_O4-Uva0ZLU6--B3b87yV-w", "name": "ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits", "unitRef": "Unit_Standard_USD_Xu4YRecv0kulv6V5fb64IQ", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "td", "tr", "table", "biox:DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock", "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } }, "R87": { "role": "http://www.biocerescrops.com/role/DisclosureShareBasedPaymentDetails", "longName": "41701 - Disclosure - SHARE-BASED PAYMENT (Details)", "shortName": "SHARE-BASED PAYMENT (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "87", "firstAnchor": { "contextRef": "Duration_8_1_2023_To_8_31_2023_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_biox_PastShareOptionPlanMember_11XcSX-WyUqmCh_uaZaang", "name": "ifrs-full:ExercisePriceShareOptionsGranted2019", "unitRef": "Unit_Divide_USD_shares_X-OK1yhkQ0--MuzfYb8-ZA", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_8_1_2023_To_8_31_2023_ifrs-full_RangeAxis_ifrs-full_BottomOfRangeMember_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_biox_PastShareOptionPlanMember_11XcSX-WyUqmCh_uaZaang", "name": "ifrs-full:ExercisePriceShareOptionsGranted2019", "unitRef": "Unit_Divide_USD_shares_X-OK1yhkQ0--MuzfYb8-ZA", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "biox-20230930xex99d1.htm", "first": true, "unique": true } } }, "tag": { "biox_FinanceCostsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "FinanceCostsAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails" ], "lang": { "en-us": { "role": { "documentation": "No definition available", "label": "Finance Costs [Abstract]", "terseLabel": "Financial costs" } } }, "auth_ref": [] }, "biox_InterestExpenseOnLiabilitiesWithParent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "InterestExpenseOnLiabilitiesWithParent", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails": { "parentTag": "ifrs-full_FinanceCosts", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of interest expense on liabilities with parent.", "label": "Interest Expense on Liabilities with Parent", "negatedLabel": "Interest expenses with the Parents" } } }, "auth_ref": [] }, "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of production cost relating to inventory and selling, general and administrative expenses.", "label": "Production Costs and Selling General and Administrative Expenses", "totalLabel": "Total" } } }, "auth_ref": [] }, "ifrs-full_NumberOfSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfSharesOutstanding", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails" ], "lang": { "en-us": { "role": { "label": "Number of shares outstanding", "terseLabel": "Number of shares outstanding" } }, "en": { "role": { "documentation": "The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]" } } }, "auth_ref": [ "r31" ] }, "ifrs-full_CurrentAdvancesToSuppliers": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentAdvancesToSuppliers", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails": { "parentTag": "ifrs-full_OtherCurrentReceivables", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Current advances to suppliers", "terseLabel": "Prepayments to suppliers" } }, "en": { "role": { "documentation": "The amount of current advances made to suppliers before goods or services are received." } } }, "auth_ref": [ "r252" ] }, "ifrs-full_CurrentAccrualsAndCurrentDeferredIncomeIncludingCurrentContractLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentAccrualsAndCurrentDeferredIncomeIncludingCurrentContractLiabilitiesAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionDeferredRevenueAndAdvancesFromCustomersDetails" ], "lang": { "en-us": { "role": { "label": "Current accruals and current deferred income including current contract liabilities [abstract]", "terseLabel": "Current" } } }, "auth_ref": [] }, "biox_DisclosureOfGrossCarryingAmountTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "DisclosureOfGrossCarryingAmountTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "documentation": "The disclosure of gross carrying amount of each asset class.", "label": "Disclosure of gross carrying amount [text block]", "terseLabel": "Schedule of gross carrying amount" } } }, "auth_ref": [] }, "biox_DisclosureOfNetCarryingAmountOfOtherIntangibleAssetsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "DisclosureOfNetCarryingAmountOfOtherIntangibleAssetsTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "documentation": "The disclosure of detailed information about other intangible assets.", "label": "Disclosure of net carrying amount of other intangible assets [Text block]", "terseLabel": "Schedule of net carrying amount of intangibles" } } }, "auth_ref": [] }, "ifrs-full_OrdinarySharesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OrdinarySharesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails" ], "lang": { "en-us": { "role": { "label": "Ordinary shares [member]", "terseLabel": "Ordinary shares" } }, "en": { "role": { "documentation": "This member stands for equity instruments that are subordinate to all other classes of equity instruments. It also represents the standard value for the 'Classes of ordinary shares' axis if no other member is used." } } }, "auth_ref": [ "r82", "r256" ] }, "biox_DisclosureOfAccumulatedAmortizationOfIntangibleAssets.TextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "DisclosureOfAccumulatedAmortizationOfIntangibleAssets.TextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "documentation": "he disclosure of detailed information about accumulated amortization of intangible assets.", "label": "Disclosure of accumulated amortization of intangible assets. [text block]", "terseLabel": "Schedule of accumulated amortization of intangibles" } } }, "auth_ref": [] }, "biox_DisclosureOfGrossCarryingAmountOfIntangibleAssetsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "DisclosureOfGrossCarryingAmountOfIntangibleAssetsTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "documentation": "The disclosure of detailed information about gross carrying amount of intangible assets.", "label": "Disclosure of gross carrying amount of intangible assets [text block]", "terseLabel": "Schedule of gross carrying amounts of intangibles" } } }, "auth_ref": [] }, "ifrs-full_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EarningsPerShareAbstract", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "EARNING PER SHARE", "terseLabel": "(Loss) profit per share" } } }, "auth_ref": [] }, "biox_DisclosureOfDepreciationExpenseTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "DisclosureOfDepreciationExpenseTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "documentation": "The disclosure of depreciation.", "label": "Disclosure of depreciation expense [text block]", "terseLabel": "Schedule of accumulated depreciation" } } }, "auth_ref": [] }, "ifrs-full_OfficeEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OfficeEquipmentMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentAccumulatedDepreciationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentGrossCarryingAmountsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentNetCarryingAmountDetails" ], "lang": { "en-us": { "role": { "label": "Office equipment", "terseLabel": "Office equipment" } }, "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing equipment used to support office functions, not specifically used in the production process. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r219" ] }, "biox_DisclosureOfNetCarryingAmountTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "DisclosureOfNetCarryingAmountTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "documentation": "The disclosure of net carrying amount of each asset class.", "label": "Disclosure of net carrying amount [text block]", "terseLabel": "Schedule of net carrying amount" } } }, "auth_ref": [] }, "biox_NetGainOnInflationEffectOnMonetary": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "NetGainOnInflationEffectOnMonetary", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails": { "parentTag": "ifrs-full_OtherFinanceIncomeCost", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails" ], "lang": { "en-us": { "role": { "documentation": "Net gain of inflation effect on monetary items.", "label": "Net Gain on Inflation Effect on Monetary", "terseLabel": "Net gain of inflation effect on monetary items" } } }, "auth_ref": [] }, "ifrs-full_CurrentAdvances": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentAdvances", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionDeferredRevenueAndAdvancesFromCustomersDetails": { "parentTag": "ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionDeferredRevenueAndAdvancesFromCustomersDetails" ], "lang": { "en-us": { "role": { "label": "Current advances received, representing current contract liabilities for performance obligations satisfied at point in time", "terseLabel": "Advances from customers" } }, "en": { "role": { "documentation": "The amount of current advances received representing current contract liabilities for performance obligations satisfied at a point in time. [Refer: Advances received, representing contract liabilities for performance obligations satisfied at point in time]" } } }, "auth_ref": [ "r254", "r255" ] }, "biox_OtherFinanceResultsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "OtherFinanceResultsAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails" ], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Other Finance Results [Abstract]", "terseLabel": "Other financial results" } } }, "auth_ref": [] }, "ifrs-full_EarningsPerShareExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EarningsPerShareExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEarningPerShareTables" ], "lang": { "en-us": { "role": { "label": "Earnings per share [text block]", "terseLabel": "Schedule of earnings per share" } }, "en": { "role": { "documentation": "The disclosure of earnings per share." } } }, "auth_ref": [ "r82" ] }, "ifrs-full_CashFlowsFromUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from (used in) financing activities", "totalLabel": "Net cash flows (used) generated by financing activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity." } } }, "auth_ref": [ "r111", "r119" ] }, "ifrs-full_CurrentAgriculturalProduce": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentAgriculturalProduce", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Current agricultural produce", "terseLabel": "Agricultural products" } }, "en": { "role": { "documentation": "A classification of current inventory representing the amount of harvested produce of the entity's biological assets. [Refer: Biological assets; Inventories]" } } }, "auth_ref": [ "r261" ] }, "biox_OtherMarketableSecuritiesClassifiedAsNonCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "OtherMarketableSecuritiesClassifiedAsNonCurrent", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails": { "parentTag": "ifrs-full_OtherNoncurrentFinancialAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of non-current other marketable securities classified as non-current.", "label": "Other marketable securities classified as non current", "verboseLabel": "Other investments" } } }, "auth_ref": [] }, "ifrs-full_CurrentAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentAssetsAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "CURRENT ASSETS", "terseLabel": "Current" } } }, "auth_ref": [] }, "ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "FINANCING ACTIVITIES" } } }, "auth_ref": [] }, "biox_DisclosureOfTradeReceivablesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "DisclosureOfTradeReceivablesTableTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "documentation": "The tabular disclosure of current and non-current trade receivables.", "label": "Disclosure of Trade Receivables [Table Text Block]", "terseLabel": "Schedule of trade receivables" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfReconciliationOfChangesInBiologicalAssetsExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of reconciliation of changes in biological assets [text block]", "terseLabel": "Schedule of changes in biological assets" } }, "en": { "role": { "documentation": "The disclosure of the reconciliation of changes in biological assets. [Refer: Biological assets]" } } }, "auth_ref": [ "r108" ] }, "biox_AllowanceForReturnOfGoods": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "AllowanceForReturnOfGoods", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails": { "parentTag": "ifrs-full_TradeAndOtherCurrentReceivables", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of allowance for return of goods.", "label": "Allowance for return of goods", "negatedTerseLabel": "Allowance for credit notes to be issued" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfReconciliationOfChangesInBiologicalAssetsLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBiologicalAssetsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of reconciliation of changes in biological assets [line items]", "terseLabel": "Inventory", "verboseLabel": "Biological assets" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfReconciliationOfChangesInBiologicalAssetsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfReconciliationOfChangesInBiologicalAssetsTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBiologicalAssetsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of reconciliation of changes in biological assets [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the reconciliation of changes in biological assets." } } }, "auth_ref": [ "r108" ] }, "ifrs-full_CurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentAssets", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Total current assets", "totalLabel": "Total current assets" } }, "en": { "role": { "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]" } } }, "auth_ref": [ "r24", "r129", "r236" ] }, "ifrs-full_CashFlowsFromUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from (used in) investing activities", "totalLabel": "Net cash flows (used) generated by investing activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents." } } }, "auth_ref": [ "r111", "r119" ] }, "biox_ReceivablesFromTaxCreditsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "ReceivablesFromTaxCreditsCurrent", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails": { "parentTag": "ifrs-full_OtherCurrentReceivables", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the amount of current tax credit receivables.", "label": "Receivables from Tax Credits, Current", "terseLabel": "Taxes" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfReconciliationOfChangesInGoodwillExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of reconciliation of changes in goodwill [text block]", "terseLabel": "Schedule of carrying amount of goodwill" } }, "en": { "role": { "documentation": "The disclosure of the reconciliation of changes in goodwill. [Refer: Goodwill]" } } }, "auth_ref": [ "r171" ] }, "biox_DisclosureOfOtherReceivablesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "DisclosureOfOtherReceivablesTableTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "documentation": "The disclosure of detailed information about other receivables.", "label": "Disclosure of Other Receivables [Table Text Block]", "terseLabel": "Schedule of other receivables" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfReconciliationOfChangesInGoodwillLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionGoodwillDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of reconciliation of changes in goodwill [line items]", "terseLabel": "Goodwill" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInInvestingActivitiesAbstract", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "INVESTMENT ACTIVITIES" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfReconciliationOfChangesInGoodwillTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionGoodwillDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of reconciliation of changes in goodwill [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the reconciliation of changes in goodwill." } } }, "auth_ref": [ "r171" ] }, "biox_ReceivablesFromTaxCreditsNonCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "ReceivablesFromTaxCreditsNonCurrent", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails": { "parentTag": "ifrs-full_OtherNoncurrentReceivables", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the amount of non-current tax credit receivables.", "label": "Receivables from Tax Credits, Non-Current", "terseLabel": "Taxes" } } }, "auth_ref": [] }, "ifrs-full_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RetainedEarningsMember", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Retained deficit" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit." } } }, "auth_ref": [ "r6", "r209" ] }, "biox_ReceivablesFromReimbursementOfExpenditureCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "ReceivablesFromReimbursementOfExpenditureCurrent", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails": { "parentTag": "ifrs-full_OtherCurrentReceivables", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the amount of expenditure that is to be reimbursed.", "label": "Receivables from Reimbursement of Expenditure, Current", "terseLabel": "Reimbursements over exports" } } }, "auth_ref": [] }, "ifrs-full_CashFlowsFromUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInOperatingActivities", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from (used in) operating activities", "totalLabel": "Net cash flows generated (used) by operating activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]" } } }, "auth_ref": [ "r111", "r119" ] }, "biox_AdvancesToSuppliersNonCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "AdvancesToSuppliersNonCurrent", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails": { "parentTag": "ifrs-full_OtherNoncurrentReceivables", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the amount of non-current receivables from advances to suppliers.", "label": "Advances to suppliers, Non Current", "terseLabel": "Reimbursements over exports" } } }, "auth_ref": [] }, "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Effect of exchange rate changes on cash and cash equivalents", "terseLabel": "Effect of exchange rate changes on cash and equivalents" } }, "en": { "role": { "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]" } } }, "auth_ref": [ "r114", "r115" ] }, "ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "OPERATING ACTIVITIES" } } }, "auth_ref": [] }, "biox_OtherCurrentReceivablesOther": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "OtherCurrentReceivablesOther", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails": { "parentTag": "ifrs-full_OtherCurrentReceivables", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the amount of other current receivables, other.", "label": "Other Current Receivables, Other", "terseLabel": "Miscellaneous" } } }, "auth_ref": [] }, "biox_WorkingCapitalAdjustmentsOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "WorkingCapitalAdjustmentsOperatingActivitiesAbstract", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Working capital adjustments" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of attribution of expenses by nature to their function [line items]", "terseLabel": "Expenses classified by nature and function" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of attribution of expenses by nature to their function [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to attribution of expenses by nature to analysis of expenses by function in the statement of profit or loss." } } }, "auth_ref": [ "r249", "r252" ] }, "biox_OtherNonCurrentReceivablesOther": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "OtherNonCurrentReceivablesOther", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails": { "parentTag": "ifrs-full_OtherNoncurrentReceivables", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents other non-current receivables.", "label": "Other Non-Current Receivables Other", "terseLabel": "Miscellaneous" } } }, "auth_ref": [] }, "srt_StatementScenarioAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementScenarioAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareBasedPaymentDetails" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "auth_ref": [] }, "biox_GoodsAndServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "GoodsAndServicesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRevenueDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for goods and services.", "label": "Goods And Services [Member]", "terseLabel": "Sale of goods and services" } } }, "auth_ref": [] }, "biox_IfrsScheduleOfInventoryCurrentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "IfrsScheduleOfInventoryCurrentTableTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Ifrs Schedule of Inventory Current Table Text Block", "terseLabel": "Schedule of inventories" } } }, "auth_ref": [] }, "srt_ScenarioUnspecifiedDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScenarioUnspecifiedDomain", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareBasedPaymentDetails" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]" } } }, "auth_ref": [] }, "biox_PurchaseOfInventory": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "PurchaseOfInventory", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeCostOfSalesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of inventory purchased during the year.", "label": "Purchase of inventory", "terseLabel": "Purchases of the period" } } }, "auth_ref": [] }, "ifrs-full_OtherComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherComprehensiveIncome", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Other comprehensive income", "totalLabel": "Other comprehensive (loss) income", "verboseLabel": "Other comprehensive income (loss)" } }, "en": { "role": { "documentation": "The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]" } } }, "auth_ref": [ "r3", "r35", "r45", "r135" ] }, "biox_ChangeInFairValueOfFinancialAssetsOrLiabilitiesOrOtherFinancialResults": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "ChangeInFairValueOfFinancialAssetsOrLiabilitiesOrOtherFinancialResults", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails": { "parentTag": "ifrs-full_OtherFinanceIncomeCost", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of changes in fair value of financial assets or liabilities and other financial results", "label": "Change in Fair Value of Financial Assets or Liabilities or Other Financial Results", "terseLabel": "Changes in fair value of financial assets or liabilities and other financial results" } } }, "auth_ref": [] }, "biox_InventoriesBeforeClosingInventory": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "InventoriesBeforeClosingInventory", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeCostOfSalesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of inventory before closing inventory (ie., Opening inventory plus purchases).", "label": "Inventories Before Closing Inventory", "terseLabel": "Subtotal" } } }, "auth_ref": [] }, "biox_ForeignCurrencyTranslationOnInventory": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "ForeignCurrencyTranslationOnInventory", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeCostOfSalesDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation on inventory", "label": "Foreign Currency Translation on Inventory", "negatedLabel": "Foreign currency translation" } } }, "auth_ref": [] }, "biox_ResearchAndDevelopmentExpenseCapitalized": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "ResearchAndDevelopmentExpenseCapitalized", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "biox_TotalResearchAndDevelopmentExpenseIncurred", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of research and development expense capitalized.", "label": "Research and Development Expense Capitalized", "terseLabel": "R&D capitalized" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfCashAndCashEquivalentsExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of cash and cash equivalents [text block]", "terseLabel": "Schedule of cash and cash equivalents" } }, "en": { "role": { "documentation": "The disclosure of cash and cash equivalents. [Refer: Cash and cash equivalents]" } } }, "auth_ref": [ "r248" ] }, "biox_DisclosureOfDetailedInformationAboutResearchAndDevelopmentExpenseTable": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "DisclosureOfDetailedInformationAboutResearchAndDevelopmentExpenseTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "documentation": "Schedule disclosing information related to details of research and development expense.", "label": "Disclosure of Detailed Information about Research and Development Expense [Table]" } } }, "auth_ref": [] }, "biox_AdjustmentsForDecreaseIncreaseInIncomeAndMinimumPresumedIncomeTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "AdjustmentsForDecreaseIncreaseInIncomeAndMinimumPresumedIncomeTaxes", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Adjustments for decrease (increase) in income and minimum presumed income taxes to reconcile profit (loss) to net cash flow from (used in) operating activities.", "label": "Adjustments for Decrease (Increase) in Income and Minimum Presumed Income Taxes", "terseLabel": "Income and minimum presumed income taxes payable" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfCashFlowStatementExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfCashFlowStatementExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureCashFlowInformation" ], "lang": { "en-us": { "role": { "label": "Disclosure of cash flow statement [text block]", "terseLabel": "CASH FLOW INFORMATION" } }, "en": { "role": { "documentation": "The entire disclosure for a statement of cash flows." } } }, "auth_ref": [ "r120" ] }, "biox_DisclosureOfDetailedInformationAboutResearchAndDevelopmentExpenseLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "DisclosureOfDetailedInformationAboutResearchAndDevelopmentExpenseLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.", "label": "Disclosure of Detailed Information about Research and Development Expense [Line Items]", "terseLabel": "Costs and expenses" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureGeneralInformation" ], "lang": { "en-us": { "role": { "label": "Disclosure of general information about financial statements [text block]", "terseLabel": "GENERAL INFORMATION" } }, "en": { "role": { "documentation": "The entire disclosure for general information about financial statements." } } }, "auth_ref": [ "r8" ] }, "biox_KeyManagementPersonnelBenefitsLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "KeyManagementPersonnelBenefitsLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionEmployeeBenefitsAndSocialSecurityDetails": { "parentTag": "ifrs-full_CurrentProvisionsForEmployeeBenefits", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionEmployeeBenefitsAndSocialSecurityDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of current liability related to key management personnel.", "label": "Key Management Personnel Benefits Liability, Current", "terseLabel": "Key management personnel" } } }, "auth_ref": [] }, "biox_InvestmentsInJointVenturesAndAssociatesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "InvestmentsInJointVenturesAndAssociatesTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociates" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure on investments in joint ventures and associates.", "label": "Investments In Joint Ventures And Associates [Text Block]", "terseLabel": "JOINT VENTURES AND ASSOCIATES" } } }, "auth_ref": [] }, "ifrs-full_OtherOperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherOperatingIncomeExpense", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": 1.0, "order": 10.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeOtherIncomeOrExpensesNetDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeOtherIncomeOrExpensesNetDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Other operating income (expense)", "terseLabel": "Other income or expenses, net", "totalLabel": "Total" } }, "en": { "role": { "documentation": "The amount of operating income (expense) that the entity does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r257" ] }, "biox_ComponentsOfConsolidatedStatementsOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "ComponentsOfConsolidatedStatementsOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "documentation": "n/a", "label": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION" } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.biocerescrops.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r247" ] }, "biox_ResultForInflationEffectOnMonetaryItemsAndOtherFinanceResults": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "ResultForInflationEffectOnMonetaryItemsAndOtherFinanceResults", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount that represents the inflation effect on monetary items and other finance results.", "label": "Result for Inflation Effect on Monetary Items And Other Finance Results", "negatedLabel": "Result of inflation effect on monetary items and other finance results" } } }, "auth_ref": [] }, "biox_DisclosureOfOtherFinancialAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "DisclosureOfOtherFinancialAssetsExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "documentation": "The disclosure of other financial assets.", "label": "Disclosure of other financial assets explanatory", "terseLabel": "Schedule of other financial assets" } } }, "auth_ref": [] }, "biox_FreightAndHaulageExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "FreightAndHaulageExpenses", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 5.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of freight and haulage expenses.", "label": "Freight and Haulage Expenses", "terseLabel": "Freight and haulage" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfFinancialAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinancialAssetsExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of financial assets [text block]", "terseLabel": "Schedule of financial assets by category" } }, "en": { "role": { "documentation": "The disclosure of financial assets. [Refer: Financial assets]" } } }, "auth_ref": [ "r185" ] }, "ifrs-full_BottomOfRangeMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BottomOfRangeMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareBasedPaymentDetails" ], "lang": { "en-us": { "role": { "label": "Bottom of range [Member]", "terseLabel": "Minimum" } }, "en": { "role": { "documentation": "This member stands for the bottom of a range." } } }, "auth_ref": [ "r144", "r158", "r168", "r238", "r239", "r277" ] }, "biox_IfrsScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "IfrsScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationTables" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Ifrs Schedule Of Components Of Income Tax Expense Benefit [Table Text Block]", "terseLabel": "Schedule of current tax" } } }, "auth_ref": [] }, "biox_LeasesLiabilitiesAdditions": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "LeasesLiabilitiesAdditions", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of additional liabilities during the period.", "label": "Leases Liabilities Additions", "terseLabel": "Additions of the period/year" } } }, "auth_ref": [] }, "biox_SalariesAccruedIncentivesVacationsAndSocialSecurityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "SalariesAccruedIncentivesVacationsAndSocialSecurityCurrent", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionEmployeeBenefitsAndSocialSecurityDetails": { "parentTag": "ifrs-full_CurrentProvisionsForEmployeeBenefits", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionEmployeeBenefitsAndSocialSecurityDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of current provisions for salaries, accrued incentives, vacations and social security.", "label": "Salaries, Accrued Incentives, Vacations and Social Security, Current", "terseLabel": "Salaries, accrued incentives, vacations and social security" } } }, "auth_ref": [] }, "biox_DocumentAndEntityInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "DocumentAndEntityInformationAbstract", "lang": { "en-us": { "role": { "label": "Document and Entity Information [Abstract]" } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.biocerescrops.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "biox_USTreasuryBillsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "USTreasuryBillsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for US Treasury bills.", "label": "US Treasury bills" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfFinancialAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinancialAssetsLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialAssetsByCategoryDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of financial assets [line items]", "terseLabel": "Financial assets by category" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "biox_IfrsScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "IfrsScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationTables" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "IFRS Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "terseLabel": "Schedule of reconciliation of the statutory tax rate to the effective tax rate" } } }, "auth_ref": [] }, "ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromBorrowingsClassifiedAsFinancingActivities", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from borrowings, classified as financing activities", "terseLabel": "Proceeds from borrowings" } }, "en": { "role": { "documentation": "The cash inflow from borrowings obtained. [Refer: Borrowings]" } } }, "auth_ref": [ "r231" ] }, "biox_TotalResearchAndDevelopmentExpenseIncurred": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "TotalResearchAndDevelopmentExpenseIncurred", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of research and development costs that an entity incurs.", "label": "Total Research And Development Expense Incurred", "totalLabel": "Total" } } }, "auth_ref": [] }, "biox_DisclosureOfCarryingValueOfBorrowingsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "DisclosureOfCarryingValueOfBorrowingsExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "documentation": "The disclosure of detailed information about carrying value of borrowings.", "label": "Disclosure of carrying value of borrowings explanatory", "terseLabel": "Schedule of carrying value of borrowings" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfFinancialAssetsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinancialAssetsTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialAssetsByCategoryDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of financial assets [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to financial assets." } } }, "auth_ref": [ "r185" ] }, "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsAccumulatedAmortizationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsGrossCarryingAmountDetails" ], "lang": { "en-us": { "role": { "label": "Additions other than through business combinations, intangible assets other than goodwill", "terseLabel": "Additions", "verboseLabel": "Amortization of the period" } }, "en": { "role": { "documentation": "The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]" } } }, "auth_ref": [ "r92" ] }, "biox_PayablesSalariesSocialSecurityBenefitsAndOther": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "PayablesSalariesSocialSecurityBenefitsAndOther", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsPayablesDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of payables to related party pertaining to salaries, social security benefits and other.", "label": "Payables, Salaries, Social Security Benefits And Other", "negatedLabel": "Salaries, social security benefits and other benefits" } } }, "auth_ref": [] }, "biox_BankBorrowingsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "BankBorrowingsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for bank borrowings.", "label": "Bank borrowings", "terseLabel": "Bank borrowings" } } }, "auth_ref": [] }, "biox_RelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "RelatedPartyTransactions", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "The total amount of related party transactions.", "label": "Related Party Transactions", "totalLabel": "Total" } } }, "auth_ref": [] }, "biox_Taxes": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "Taxes", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 22.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of taxes.", "label": "Taxes", "terseLabel": "Taxes" } } }, "auth_ref": [] }, "biox_LoansPayablesRelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "LoansPayablesRelatedPartyTransactions", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsPayablesDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of loans payables to related party.", "label": "Loans Payables, Related Party Transactions", "negatedLabel": "Net loans payables" } } }, "auth_ref": [] }, "biox_BiologicalAssetsBarleyMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "BiologicalAssetsBarleyMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBiologicalAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for barley biological assets.", "label": "Barley", "terseLabel": "Barley" } } }, "auth_ref": [] }, "biox_Contingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "Contingencies", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of contingencies.", "label": "Contingencies", "terseLabel": "Contingencies" } } }, "auth_ref": [] }, "biox_CommissionsAndRoyalties": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "CommissionsAndRoyalties", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of commissions and royalties.", "label": "Commissions and Royalties", "terseLabel": "Commissions and royalties" } } }, "auth_ref": [] }, "ifrs-full_PaymentsForDevelopmentProjectExpenditure": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PaymentsForDevelopmentProjectExpenditure", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments for development project expenditure", "negatedLabel": "Capitalized development expenditures" } }, "en": { "role": { "documentation": "The cash outflow for expenditure related to development projects." } } }, "auth_ref": [ "r268" ] }, "ifrs-full_FinancialLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialLiabilities", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails" ], "lang": { "en-us": { "role": { "label": "Financial liabilities.", "verboseLabel": "Financial liabilities" } }, "en": { "role": { "documentation": "The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity\u2019s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity\u2019s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Financial instruments, class [member]; Financial assets; Derivatives [member]]" } } }, "auth_ref": [ "r174" ] }, "biox_SoybeanHb4Member": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "SoybeanHb4Member", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsAccumulatedAmortizationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsGrossCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsNetCarryingAmountDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for information pertaining to Soybeans HB4.", "label": "Soybean HB4 and breeding program", "terseLabel": "HB4 and breeding program" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseLeasedAssetDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of quantitative information about right-of-use assets [line items]", "terseLabel": "Right-of-use leased asset" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "biox_BiologicalAssetsWheatMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "BiologicalAssetsWheatMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBiologicalAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for wheat biological assets.", "label": "Wheat", "terseLabel": "Wheat" } } }, "auth_ref": [] }, "biox_TaxEffectOfStockOptionCharge": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "TaxEffectOfStockOptionCharge", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount representing the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to stock option charge.", "label": "Tax Effect Of Stock Option Charge", "negatedLabel": "Stock options charge" } } }, "auth_ref": [] }, "biox_DisclosureOfBenefitsAndSocialSecurityPayablesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "DisclosureOfBenefitsAndSocialSecurityPayablesTableTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "documentation": "The tabular disclosure of salaries and social security payables.", "label": "Disclosure of Benefits and Social Security Payables [Table Text Block]", "terseLabel": "Schedule of employee benefits and social security" } } }, "auth_ref": [] }, "biox_OtherFinancialAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "OtherFinancialAssetsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialAssetsByCategoryDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for financial assets that the entity does not separately disclose in the same statement or note.", "label": "Other financial assets" } } }, "auth_ref": [] }, "biox_EcoseedIntegratedProductsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "EcoseedIntegratedProductsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsAccumulatedAmortizationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsGrossCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsNetCarryingAmountDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for information pertaining to Eco seed integrated products.", "label": "Eco seed integrated products", "terseLabel": "Integrated products" } } }, "auth_ref": [] }, "ifrs-full_FinancialLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialLiabilitiesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails" ], "lang": { "en-us": { "role": { "label": "Financial liabilities" } }, "en": { "role": { "documentation": "This member stands for aggregated classes financial liabilities. It also represents the standard value for the 'Classes of financial liabilities' axis if no other member is used. [Refer: Financial liabilities]" } } }, "auth_ref": [ "r183", "r184", "r203", "r204" ] }, "ifrs-full_OtherReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherReceivables", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails": { "parentTag": "ifrs-full_TradeAndOtherCurrentReceivables", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Other receivables", "verboseLabel": "Deferred checks" } }, "en": { "role": { "documentation": "The amount receivable by the entity that it does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r212" ] }, "biox_DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "DisclosureOfInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of information about components of consolidated statement of comprehensive income.", "label": "Disclosure of Information About Components of Consolidated Statements of Comprehensive Income [Text Block]", "terseLabel": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME" } } }, "auth_ref": [] }, "biox_MicrobiologyProductMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "MicrobiologyProductMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsAccumulatedAmortizationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsGrossCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsNetCarryingAmountDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for information pertaining to microbiology products.", "label": "Microbiology product", "terseLabel": "Microbiology product" } } }, "auth_ref": [] }, "biox_NewStandardsAmendmentsAndInterpretationsIssuedByIasbAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "NewStandardsAmendmentsAndInterpretationsIssuedByIasbAbstract", "lang": { "en-us": { "role": { "documentation": "n/a", "label": "NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS ISSUED BY THE IASB" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfIntangibleAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfIntangibleAssetsLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsAccumulatedAmortizationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsGrossCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsNetCarryingAmountDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about intangible assets [line items]", "terseLabel": "Intangible assets" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "biox_OtherReceivablesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "OtherReceivablesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialAssetsByCategoryDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for receivables that the entity does not separately disclose in the same statement or note.", "label": "Other receivables [member]", "terseLabel": "Other receivables" } } }, "auth_ref": [] }, "biox_TaxEffectOfRevenuesExemptFromTaxationAndExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "TaxEffectOfRevenuesExemptFromTaxationAndExpensesNotDeductibleInDeterminingTaxableProfitTaxLoss", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to expenses not deductible and revenues that are exempt from taxation in determining taxable profit (tax loss).", "label": "Tax Effect of Revenues Exempt from Taxation and Expenses Not Deductible in Determining Taxable Profit (Tax Loss)", "negatedLabel": "Non-deductible expenses" } } }, "auth_ref": [] }, "biox_TradeReceivablesFromRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "TradeReceivablesFromRelatedParties", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails": { "parentTag": "ifrs-full_TradeAndOtherCurrentReceivables", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsReceivableDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of trade receivables due from related parties.", "label": "Trade Receivables From Related Parties", "terseLabel": "Trade debtors", "verboseLabel": "Shareholders and other related parties" } } }, "auth_ref": [] }, "ifrs-full_RepairsAndMaintenanceExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RepairsAndMaintenanceExpense", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 7.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "label": "Repairs and maintenance expense", "terseLabel": "Maintenance" } }, "en": { "role": { "documentation": "The amount of expenses incurred for the day-to-day servicing of assets, which may include the cost of labour, consumables or small parts." } } }, "auth_ref": [ "r257" ] }, "biox_InventoryProductionCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "InventoryProductionCosts", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeCostOfSalesDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of manufacturing costs capitalized to inventory during the period.", "label": "Inventory Production Costs", "terseLabel": "Production costs" } } }, "auth_ref": [] }, "biox_DisclosureOfTradeAndOtherPayablesComponentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "DisclosureOfTradeAndOtherPayablesComponentsTableTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "documentation": "Definition: Tabular disclosure of components of trade and other payables.", "label": "Disclosure Of Trade And Other Payables Components [Table Text Block]", "terseLabel": "Schedule of trade and other payable" } } }, "auth_ref": [] }, "ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RepaymentsOfBorrowingsClassifiedAsFinancingActivities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Repayments of borrowings, classified as financing activities", "negatedLabel": "Repayment of borrowings and financed payments" } }, "en": { "role": { "documentation": "The cash outflow to settle borrowings, classified as financing activities. [Refer: Borrowings]" } } }, "auth_ref": [ "r232" ] }, "ifrs-full_OtherRelatedPartiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherRelatedPartiesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayableDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsPayablesDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsReceivableDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Other related parties [member]", "terseLabel": "Shareholders and other related parties" } }, "en": { "role": { "documentation": "This member stands for related parties that the entity does not separately disclose in the same statement or note. [Refer: Related parties [member]]" } } }, "auth_ref": [ "r74" ] }, "biox_TradeAndOtherPayablesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "TradeAndOtherPayablesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for trade and other payables.", "label": "Trade and other payables" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfIntangibleAssetsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfIntangibleAssetsTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsAccumulatedAmortizationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsGrossCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsNetCarryingAmountDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about intangible assets [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of intangible assets." } } }, "auth_ref": [ "r96" ] }, "biox_DisclosureOfAccountingStandardsAndBasisOfPresentationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "DisclosureOfAccountingStandardsAndBasisOfPresentationTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureAccountingStandardsAndBasisOfPreparation" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure on accounting standards and basis of presentation.", "label": "Disclosure Of Accounting Standards And Basis Of Presentation [Text Block]", "terseLabel": "ACCOUNTING STANDARDS AND BASIS OF PREPARATION" } } }, "auth_ref": [] }, "biox_MicrobiologicalResaleProductsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "MicrobiologicalResaleProductsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for information pertaining to Microbiological resale products.", "label": "Resale products", "terseLabel": "Resale products" } } }, "auth_ref": [] }, "ifrs-full_TravelExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TravelExpense", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 10.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "label": "Travel expense", "terseLabel": "Mobility and travel" } }, "en": { "role": { "documentation": "The amount of expense arising from travel." } } }, "auth_ref": [ "r252" ] }, "biox_DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "DisclosureOfInvestmentsInJointVenturesAndAffiliatesTableTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesTables" ], "lang": { "en-us": { "role": { "documentation": "Information pertains to disclosure of investments in associates and joint ventures.", "label": "Disclosure of Investments in Joint Ventures and Affiliates [Table Text Block]", "terseLabel": "Schedule of investments in joint ventures and associates" } } }, "auth_ref": [] }, "biox_TaxEffectOfShareOfProfitOrLossOfSubsidiesJointVenturesAndAssociates": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "TaxEffectOfShareOfProfitOrLossOfSubsidiesJointVenturesAndAssociates", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to share of profit or loss of subsidies, joint ventures and associates.", "label": "Tax Effect of Share Of Profit Or Loss Of Subsidies, Joint Ventures And Associates", "negatedLabel": "Share of profit or loss of subsidiaries, joint ventures and associates" } } }, "auth_ref": [] }, "biox_DisclosureOfChangesInInvestmentInJointVenturesAndAffiliatesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "DisclosureOfChangesInInvestmentInJointVenturesAndAffiliatesTableTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesTables" ], "lang": { "en-us": { "role": { "documentation": "The disclosure of investments in joint ventures and affiliates.", "label": "Disclosure of Changes in Investment in Joint Ventures and Affiliates [Table Text Block]", "terseLabel": "Schedule of changes in joint ventures" } } }, "auth_ref": [] }, "ifrs-full_FinancialLiabilitiesAtAmortisedCostMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialLiabilitiesAtAmortisedCostMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialAssetsByCategoryDetails", "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails" ], "lang": { "en-us": { "role": { "label": "Amortized cost", "terseLabel": "Amortized cost" } }, "en": { "role": { "documentation": "This member stands for the financial liabilities measured at amortised cost class. [Refer: Financial liabilities at amortised cost]" } } }, "auth_ref": [ "r186" ] }, "biox_SeedAndIntegratedProductsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "SeedAndIntegratedProductsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsAccumulatedAmortizationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsGrossCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsNetCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Seed and integrated products.", "label": "Seed and integrated products" } } }, "auth_ref": [] }, "ifrs-full_FinancialLiabilitiesAtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialLiabilitiesAtFairValue", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails" ], "lang": { "en-us": { "role": { "label": "Financial liabilities, at fair value" } }, "en": { "role": { "documentation": "The fair value of financial liabilities. [Refer: At fair value [member]; Financial liabilities]" } } }, "auth_ref": [ "r174" ] }, "biox_DisclosureOfShareOfProfitOrLossInJointVenturesAndAffiliatesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "DisclosureOfShareOfProfitOrLossInJointVenturesAndAffiliatesTableTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesTables" ], "lang": { "en-us": { "role": { "documentation": "The disclosure of share of profit / (loss) joint ventures and affiliates.", "label": "Disclosure of Share of Profit or Loss in Joint Ventures and Affiliates [Table Text Block]", "terseLabel": "Schedule of share of profit or loss of joint ventures and associates" } } }, "auth_ref": [] }, "ifrs-full_TreasurySharesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TreasurySharesMember", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Cost of own shares held" } }, "en": { "role": { "documentation": "This member stands for the entity\u2019s own equity instruments, held by the entity or other members of the consolidated group." } } }, "auth_ref": [ "r6" ] }, "biox_MicrobiologicalProductsProducedMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "MicrobiologicalProductsProducedMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for information pertaining to microbiological products produced.", "label": "Manufactured products", "terseLabel": "Manufactured products" } } }, "auth_ref": [] }, "biox_InflationEffectsOnCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "InflationEffectsOnCashAndCashEquivalents", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "The effect of inflation effects on cash and cash equivalents.", "label": "Inflation Effects on Cash and Cash Equivalents", "terseLabel": "Inflation effects on cash and cash equivalents" } } }, "auth_ref": [] }, "biox_SynertechIndustriasS.aMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "SynertechIndustriasS.aMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Synertech Industrias S.A.", "label": "Synertech Industrias S.A." } } }, "auth_ref": [] }, "biox_PercentageOfGrossMarginAndTotalRevenue": { "xbrltype": "percentItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "PercentageOfGrossMarginAndTotalRevenue", "presentation": [ "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "Percentage of gross margin and total revenue of the period during the entity.", "label": "Percentage Of Gross Margin And Total Revenue", "terseLabel": "% Gross margin" } } }, "auth_ref": [] }, "biox_CropProtectionMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "CropProtectionMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Crop protection.", "label": "Crop protection" } } }, "auth_ref": [] }, "biox_ParentsCompaniesAndRelatedPartiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "ParentsCompaniesAndRelatedPartiesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for parent companies and related parties to parents.", "label": "Parents companies and related parties", "terseLabel": "Net loans payables - Parents companies and related parties" } } }, "auth_ref": [] }, "biox_DisclosureOfComponentsOfConsolidatedStatementsOfFinancialPosition": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "DisclosureOfComponentsOfConsolidatedStatementsOfFinancialPosition", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "documentation": "The disclosure of components of Consolidated Statements of Financial Position.", "label": "Disclosure Of Components Of Consolidated Statements Of Financial Position", "terseLabel": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION" } } }, "auth_ref": [] }, "biox_TrigallGeneticsS.a.Member": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "TrigallGeneticsS.a.Member", "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Trigall Genetics S.A.", "label": "Trigall Genetics S.A." } } }, "auth_ref": [] }, "biox_JointVenturesAndAssociatesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "JointVenturesAndAssociatesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayableDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for information pertaining to Joint Ventures and Associates.", "label": "Joint ventures and associates", "terseLabel": "Joint ventures and associates" } } }, "auth_ref": [] }, "biox_PurchasesOfGoodsAndServicesReceivedRelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "PurchasesOfGoodsAndServicesReceivedRelatedPartyTransactions", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails": { "parentTag": "biox_RelatedPartyTransactions", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of goods purchased and the amount of services received by the entity in related party transactions.", "label": "Purchases of Goods and Services Received Related Party Transactions", "negatedLabel": "Purchases of goods and services" } } }, "auth_ref": [] }, "biox_CropNutritionMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "CropNutritionMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsAccumulatedAmortizationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsGrossCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsNetCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Crop nutrition.", "label": "Crop nutrition" } } }, "auth_ref": [] }, "biox_InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "InvestmentAccountedForUsingEquityMethodIncludingNegativeEquity", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesChangesInJointVenturesInvestmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of investments accounted for using the equity method, including an investee with negative equity.", "label": "Investment Accounted For Using Equity Method, Including Negative Equity", "periodEndLabel": "As of the end of the period", "periodStartLabel": "As of the beginning of the period" } } }, "auth_ref": [] }, "biox_ImportAndExportExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "ImportAndExportExpenses", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 3.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of import and export expenses.", "label": "Import and Export Expenses", "terseLabel": "Import and export expenses" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinancialLiabilitiesExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of financial liabilities [text block]", "terseLabel": "Schedule financial liabilities by category" } }, "en": { "role": { "documentation": "The disclosure of financial liabilities. [Refer: Financial liabilities]" } } }, "auth_ref": [ "r185" ] }, "ifrs-full_AtCostMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AtCostMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionSecuredNotesDetails" ], "lang": { "en-us": { "role": { "label": "At cost" } }, "en": { "role": { "documentation": "This member stands for measurement based on cost. Cost is the amount of cash or cash equivalents paid or the fair value of the other consideration given to acquire an asset at the time of its acquisition or construction, or, when applicable, the amount attributed to that asset when initially recognised in accordance with the specific requirements of other IFRSs." } } }, "auth_ref": [ "r98", "r108", "r110" ] }, "biox_DisclosureOfSeasonalityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "DisclosureOfSeasonalityAbstract", "lang": { "en-us": { "role": { "documentation": "No definition availability.", "label": "SEASONALITY" } } }, "auth_ref": [] }, "ifrs-full_NoncontrollingInterests": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncontrollingInterests", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Equity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Non-controlling interests.", "terseLabel": "Non-controlling interest" } }, "en": { "role": { "documentation": "The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Subsidiaries [member]]" } } }, "auth_ref": [ "r20", "r126", "r128" ] }, "biox_BiologicalAssetsSoybeanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "BiologicalAssetsSoybeanMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBiologicalAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for soybean biological assets.", "label": "Soybean", "terseLabel": "Soybean" } } }, "auth_ref": [] }, "biox_GeneralInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "GeneralInformationAbstract", "lang": { "en-us": { "role": { "documentation": "No Definition Available", "label": "GENERAL INFORMATION" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfFinancialLiabilitiesLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinancialLiabilitiesLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of financial liabilities [line items]", "terseLabel": "Financial liabilities by category" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "biox_SuppliesAndMaterials": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "SuppliesAndMaterials", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 9.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of current supplies and materials purchased for production.", "label": "Supplies and Materials", "terseLabel": "Supplies and materials" } } }, "auth_ref": [] }, "ifrs-full_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "biox_TotalResearchAndDevelopmentExpenseIncurred", "weight": 1.0, "order": 1.0 }, "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Research and development expense", "negatedLabel": "Research and development expenses", "totalLabel": "Total" } }, "en": { "role": { "documentation": "The amount of expenditure directly attributable to research or development activities, recognised in profit or loss." } } }, "auth_ref": [ "r97" ] }, "biox_DisclosureOfSeasonalityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "DisclosureOfSeasonalityTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureSeasonality" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of the seasonality of the entity's business.", "label": "Disclosure of Seasonality [Text Block]", "terseLabel": "SEASONALITY" } } }, "auth_ref": [] }, "ifrs-full_AtFairValueMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AtFairValueMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialAssetsByCategoryDetails", "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionSecuredNotesDetails" ], "lang": { "en-us": { "role": { "label": "Fair value", "terseLabel": "Fair value" } }, "en": { "role": { "documentation": "This member stands for measurement based on fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date." } } }, "auth_ref": [ "r98", "r108", "r140" ] }, "ifrs-full_DisclosureOfFinancialLiabilitiesTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinancialLiabilitiesTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of financial liabilities [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to financial liabilities." } } }, "auth_ref": [ "r185" ] }, "ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from sales of property, plant and equipment, classified as investing activities", "terseLabel": "Proceeds from sale of property, plant and equipment" } }, "en": { "role": { "documentation": "The cash inflow from sales of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r229" ] }, "ifrs-full_DisclosureOfFinancialRiskManagementExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinancialRiskManagementExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagement" ], "lang": { "en-us": { "role": { "label": "Disclosure of financial risk management [text block]", "terseLabel": "FINANCIAL INSTRUMENTS - RISK MANAGEMENT" } }, "en": { "role": { "documentation": "The disclosure of the entity's financial risk management practices and policies." } } }, "auth_ref": [ "r248" ] }, "biox_IfrsResearchAndDevelopmentExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "IfrsResearchAndDevelopmentExpenseMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.", "label": "Research And Development Expense [Member]", "terseLabel": "Research and development expenses" } } }, "auth_ref": [] }, "ifrs-full_NoncontrollingInterestsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncontrollingInterestsMember", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Non-controlling Interests" } }, "en": { "role": { "documentation": "This member stands for equity in a subsidiary not attributable, directly or indirectly, to the parent." } } }, "auth_ref": [ "r6" ] }, "ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails" ], "lang": { "en-us": { "role": { "label": "Other tax effects for reconciliation between accounting profit and tax expense (income)", "negatedLabel": "Others" } }, "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that the entity does not separately disclose in the same statement or note. [Refer: Accounting profit; Applicable tax rate]" } } }, "auth_ref": [ "r49" ] }, "biox_RizobacterArgentinaMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "RizobacterArgentinaMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionGoodwillDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Rizobacter Argentina S.A.", "label": "Rizobacter Argentina S.A.", "verboseLabel": "Rizobacter Argentina S.A." } } }, "auth_ref": [] }, "ifrs-full_NoncurrentAccrualsAndNoncurrentDeferredIncomeIncludingNoncurrentContractLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentAccrualsAndNoncurrentDeferredIncomeIncludingNoncurrentContractLiabilitiesAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionDeferredRevenueAndAdvancesFromCustomersDetails" ], "lang": { "en-us": { "role": { "label": "Non-current accruals and non-current deferred income including non-current contract liabilities [abstract]", "terseLabel": "Non-current" } } }, "auth_ref": [] }, "biox_AnalysisAndStorage": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "AnalysisAndStorage", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 2.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of analysis and storage.", "label": "Analysis and Storage", "terseLabel": "Analysis and storage" } } }, "auth_ref": [] }, "ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AttributionOfExpensesByNatureToTheirFunctionAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "label": "Attribution of expenses by nature to their function [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r249", "r252" ] }, "biox_BiologicalAssetsCornMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "BiologicalAssetsCornMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBiologicalAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for corn biological assets.", "label": "Corn", "terseLabel": "Corn" } } }, "auth_ref": [] }, "ifrs-full_CurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionDeferredRevenueAndAdvancesFromCustomersDetails": { "parentTag": "ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionDeferredRevenueAndAdvancesFromCustomersDetails" ], "lang": { "en-us": { "role": { "label": "Current contract liabilities for performance obligations satisfied over time", "terseLabel": "Deferred Revenue" } }, "en": { "role": { "documentation": "The amount of current contract liabilities for performance obligations satisfied over time. [Refer: Contract liabilities for performance obligations satisfied over time]" } } }, "auth_ref": [ "r254", "r255" ] }, "ifrs-full_LiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LiabilitiesAbstract", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "LIABILITIES.", "terseLabel": "LIABILITIES" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17LineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17LineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementCurrencyRiskDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of sensitivity analysis to changes in risk variables that arise from contracts within scope of IFRS 17 [line items]", "terseLabel": "Currency risk" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_InsuranceExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InsuranceExpense", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 16.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 19.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "label": "Insurance expense", "terseLabel": "Insurance" } }, "en": { "role": { "documentation": "The amount of expense arising from purchased insurance." } } }, "auth_ref": [ "r252" ] }, "ifrs-full_WeightedAverageShares": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageShares", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEarningPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average number of ordinary shares outstanding", "verboseLabel": "Weighted average number of shares (basic EPS)" } }, "en": { "role": { "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor." } } }, "auth_ref": [ "r85" ] }, "ifrs-full_AmountsPayableRelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AmountsPayableRelatedPartyTransactions", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Amounts payable, related party transactions", "terseLabel": "Total" } }, "en": { "role": { "documentation": "The amounts payable resulting from related party transactions. [Refer: Related parties [member]]" } } }, "auth_ref": [ "r69", "r76" ] }, "ifrs-full_RevenueAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RevenueAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Revenue [abstract]", "verboseLabel": "Revenues from contracts with customers" } } }, "auth_ref": [] }, "ifrs-full_LeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LeaseLiabilities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureLeasesLeaseLiabilityDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Lease liabilities", "periodEndLabel": "Total", "periodStartLabel": "Book value at the beginning of the period/year", "totalLabel": "Total" } }, "en": { "role": { "documentation": "The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration." } } }, "auth_ref": [ "r151" ] }, "ifrs-full_Revenue": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Revenue", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails": { "parentTag": "ifrs-full_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Revenues", "terseLabel": "Total" } }, "en": { "role": { "documentation": "The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims." } } }, "auth_ref": [ "r41", "r134", "r172", "r189", "r193", "r199", "r200", "r201", "r207", "r208", "r236" ] }, "ifrs-full_AmountsReceivableRelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AmountsReceivableRelatedPartyTransactions", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsReceivableDetails" ], "lang": { "en-us": { "role": { "label": "Amounts receivable, related party transactions", "terseLabel": "Total" } }, "en": { "role": { "documentation": "The amounts receivable resulting from related party transactions. [Refer: Related parties [member]]" } } }, "auth_ref": [ "r69", "r76" ] }, "biox_AdjustmentsForObsolescence": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "AdjustmentsForObsolescence", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 12.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 21.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Adjustments for obsolescence to reconcile profit (loss) to net cash flow from (used in) operating activities.", "label": "Adjustments for Obsolescence", "terseLabel": "Allowance for obsolescence", "verboseLabel": "Obsolescence" } } }, "auth_ref": [] }, "ifrs-full_WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEarningPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average number of shares", "terseLabel": "Denominator" } } }, "auth_ref": [] }, "ifrs-full_FinanceIncomeReceivedClassifiedAsOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinanceIncomeReceivedClassifiedAsOperatingActivities", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 18.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Finance income received, classified as operating activities", "terseLabel": "Interest collected" } }, "en": { "role": { "documentation": "The cash inflow from finance income received, classified as operating activities. [Refer: Finance income]" } } }, "auth_ref": [ "r273" ] }, "ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentDeferredIncomeIncludingCurrentContractLiabilities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 3.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionDeferredRevenueAndAdvancesFromCustomersDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionDeferredRevenueAndAdvancesFromCustomersDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current deferred income including current contract liabilities", "terseLabel": "Deferred revenue and advances from customers", "totalLabel": "Deferred revenue and advances from customers" } }, "en": { "role": { "documentation": "The amount of current deferred income including current contract liabilities. [Refer: Deferred income including contract liabilities]" } } }, "auth_ref": [ "r254", "r255" ] }, "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Purchase of property, plant and equipment, classified as investing activities", "negatedLabel": "Purchase of property, plant and equipment" } }, "en": { "role": { "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r228" ] }, "ifrs-full_LeaseLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LeaseLiabilitiesAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Lease liabilities [abstract]", "terseLabel": "Lease Liabilities" } } }, "auth_ref": [] }, "ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments of lease liabilities, classified as financing activities", "negatedLabel": "Leased assets payments" } }, "en": { "role": { "documentation": "The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r233" ] }, "ifrs-full_AccountingProfit": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AccountingProfit", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails" ], "lang": { "en-us": { "role": { "label": "Accounting profit", "terseLabel": "Earnings before income tax-rate" } }, "en": { "role": { "documentation": "The amount of profit (loss) for a period before deducting tax expense. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r49", "r50" ] }, "ifrs-full_RevenueFromContractsWithCustomers": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RevenueFromContractsWithCustomers", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRevenueDetails", "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Revenue from contracts with customers", "terseLabel": "Revenues from contracts with customers", "verboseLabel": "Sale of goods and services" } }, "en": { "role": { "documentation": "The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity\u2019s ordinary activities in exchange for consideration." } } }, "auth_ref": [ "r146", "r147" ] }, "ifrs-full_FinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialAssets", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialAssetsByCategoryDetails" ], "lang": { "en-us": { "role": { "label": "Financial assets." } }, "en": { "role": { "documentation": "The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose the entity\u2019s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. [Refer: Financial instruments, class [member]; Financial liabilities]" } } }, "auth_ref": [ "r174", "r179", "r180", "r182", "r244" ] }, "ifrs-full_PaymentsToAcquireOrRedeemEntitysShares": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PaymentsToAcquireOrRedeemEntitysShares", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Payments to acquire or redeem entity's shares", "negatedLabel": "Purchase of own shares" } }, "en": { "role": { "documentation": "The cash outflow to acquire or redeem entity's shares." } } }, "auth_ref": [ "r230" ] }, "ifrs-full_LeaseLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LeaseLiabilitiesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails" ], "lang": { "en-us": { "role": { "label": "Lease liability" } }, "en": { "role": { "documentation": "This member stands for lease liabilities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r234", "r235" ] }, "ifrs-full_ComponentsOfEquityAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComponentsOfEquityAxis", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Components of equity [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r6" ] }, "biox_DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "DisclosureOfCompensationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTableTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureKeyManagementPersonnelCompensationTables" ], "lang": { "en-us": { "role": { "documentation": "The tabular disclosure of compensation of directors and other members of key management personnel.", "label": "Disclosure of Compensation of Directors and Other Members of Key Management Personnel [Table Text Block]", "verboseLabel": "Schedule of compensation of directors and other members of key management personnel" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfRelatedPartyExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfRelatedPartyExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactions" ], "lang": { "en-us": { "role": { "label": "Disclosure of related party [text block]", "verboseLabel": "SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS" } }, "en": { "role": { "documentation": "The entire disclosure for related parties." } } }, "auth_ref": [ "r77" ] }, "ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfResearchAndDevelopmentExpenseExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of research and development expense [text block]", "terseLabel": "Schedule of R&D classified by nature" } }, "en": { "role": { "documentation": "The disclosure of research and development expense. [Refer: Research and development expense]" } } }, "auth_ref": [ "r248" ] }, "ifrs-full_ReserveOfEquityComponentOfConvertibleInstrumentsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ReserveOfEquityComponentOfConvertibleInstrumentsMember", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Convertible instruments" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing components of convertible instruments classified as equity." } } }, "auth_ref": [ "r251" ] }, "ifrs-full_FuelAndEnergyExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FuelAndEnergyExpense", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 8.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "label": "Fuel and energy expense", "terseLabel": "Energy and fuel" } }, "en": { "role": { "documentation": "The amount of expense arising from the consumption of fuel and energy." } } }, "auth_ref": [ "r252" ] }, "ifrs-full_GrossCarryingAmountMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GrossCarryingAmountMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsGrossCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentGrossCarryingAmountsDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseLeasedAssetDetails" ], "lang": { "en-us": { "role": { "label": "Gross carrying amount [member]", "terseLabel": "Gross carrying amount", "verboseLabel": "Right-of-use leased asset" } }, "en": { "role": { "documentation": "This member stands for the amount at which an asset is recognised before deducting any accumulated depreciation (amortisation) and accumulated impairment losses thereon. [Refer: Depreciation and amortisation expense; Impairment loss]" } } }, "auth_ref": [ "r54", "r91", "r101", "r109", "r171", "r180", "r182", "r244" ] }, "ifrs-full_OtherLongtermProvisions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherLongtermProvisions", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Non-current provisions", "terseLabel": "Provisions" } }, "en": { "role": { "documentation": "The amount of non-current provisions other than provisions for employee benefits. [Refer: Non-current provisions]" } } }, "auth_ref": [ "r27" ] }, "ifrs-full_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityAbstract", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "EQUITY.", "verboseLabel": "EQUITY" } } }, "auth_ref": [] }, "ifrs-full_ComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComprehensiveIncome", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementInterimCondensedConsolidatedStatementsOfComprehensiveIncomeCalc2": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Comprehensive income", "totalLabel": "Total comprehensive (loss) profit" } }, "en": { "role": { "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners." } } }, "auth_ref": [ "r1", "r36", "r123", "r125", "r133", "r236" ] }, "ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ReserveOfExchangeDifferencesOnTranslationMember", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Foreign currency translation reserve" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing accumulated exchange differences on the translation of financial statements recognised in other comprehensive income. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r65", "r209" ] }, "ifrs-full_GainsLossesOnChangeInFairValueEstimatesOfBiologicalAssetsForCurrentPeriod": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GainsLossesOnChangeInFairValueEstimatesOfBiologicalAssetsForCurrentPeriod", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Gains (losses) on change in fair value less costs to sell of biological assets for current period", "negatedLabel": "Changes in the net realizable value of agricultural products after harvest" } }, "en": { "role": { "documentation": "The gains (losses) arising during the current period on the change in fair value less costs to sell of biological assets. [Refer: Biological assets]" } } }, "auth_ref": [ "r105" ] }, "ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract", "lang": { "en-us": { "role": { "label": "FINANCIAL INSTRUMENTS - RISK MANAGEMENT" } } }, "auth_ref": [] }, "ifrs-full_EntitysTotalForJointVenturesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EntitysTotalForJointVenturesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesDetails" ], "lang": { "en-us": { "role": { "label": "Entity's total for joint ventures [member]" } }, "en": { "role": { "documentation": "This member stands for the standard value for the 'Joint ventures' axis if no other member is used." } } }, "auth_ref": [ "r80", "r81", "r139" ] }, "ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComprehensiveIncomeAttributableToNoncontrollingInterests", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementInterimCondensedConsolidatedStatementsOfComprehensiveIncomeCalc2": { "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Comprehensive income, attributable to non-controlling interests", "terseLabel": "Non-controlling interests" } }, "en": { "role": { "documentation": "The amount of comprehensive income attributable to non-controlling interests. [Refer: Comprehensive income; Non-controlling interests]" } } }, "auth_ref": [ "r1", "r39" ] }, "ifrs-full_ComprehensiveIncomeAttributableToAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComprehensiveIncomeAttributableToAbstract", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Total comprehensive (Loss) profit attributable to:" } } }, "auth_ref": [] }, "ifrs-full_EntitysTotalForRelatedPartiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EntitysTotalForRelatedPartiesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayableDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsPayablesDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsReceivableDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Entity's total for related parties [member]" } }, "en": { "role": { "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used." } } }, "auth_ref": [ "r75" ] }, "ifrs-full_EntitysTotalForSubsidiariesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EntitysTotalForSubsidiariesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionGoodwillDetails" ], "lang": { "en-us": { "role": { "label": "Entity's total for subsidiaries [member]" } }, "en": { "role": { "documentation": "This member stands for the standard value for the 'Subsidiaries' axis if no other member is used." } } }, "auth_ref": [ "r80", "r81", "r138" ] }, "ifrs-full_FinancialAssetsAtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialAssetsAtFairValue", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails" ], "lang": { "en-us": { "role": { "label": "Financial assets, at fair value", "terseLabel": "Financial assets at fair value" } }, "en": { "role": { "documentation": "The fair value of financial assets. [Refer: At fair value [member]; Financial assets]" } } }, "auth_ref": [ "r174" ] }, "ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComprehensiveIncomeAttributableToOwnersOfParent", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementInterimCondensedConsolidatedStatementsOfComprehensiveIncomeCalc2": { "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Comprehensive income, attributable to owners of parent", "terseLabel": "Equity holders of the parent" } }, "en": { "role": { "documentation": "The amount of comprehensive income attributable to owners of the parent. [Refer: Comprehensive income]" } } }, "auth_ref": [ "r1", "r40" ] }, "ifrs-full_OtherNoncurrentFinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherNoncurrentFinancialAssets", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 10.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Other non-current financial assets", "terseLabel": "Other financial assets", "totalLabel": "Other financial assets" } }, "en": { "role": { "documentation": "The amount of non-current financial assets that the entity does not separately disclose in the same statement or note. [Refer: Other financial assets]" } } }, "auth_ref": [ "r12" ] }, "ifrs-full_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RangeAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareBasedPaymentDetails" ], "lang": { "en-us": { "role": { "label": "Range [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r144", "r158", "r168", "r238", "r239", "r277" ] }, "ifrs-full_FixturesAndFittingsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FixturesAndFittingsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentAccumulatedDepreciationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentGrossCarryingAmountsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentNetCarryingAmountDetails" ], "lang": { "en-us": { "role": { "label": "Fixture and fittings", "terseLabel": "Fixture and fittings" } }, "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing fixtures and fittings that are not permanently attached to real property. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r218" ] }, "ifrs-full_Equity": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Equity", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Equity", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "Total equity" } }, "en": { "role": { "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities." } } }, "auth_ref": [ "r22", "r28", "r122", "r124", "r140", "r141", "r142" ] }, "biox_RevenueFromSaleOfGoodsAndRenderingOfServicesRelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "RevenueFromSaleOfGoodsAndRenderingOfServicesRelatedPartyTransactions", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails": { "parentTag": "biox_RelatedPartyTransactions", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of revenue arising from the sale of goods and rendering of services in related party transactions.", "label": "Revenue from Sale of Goods and Rendering of Services, Related Party Transactions", "verboseLabel": "Sales of goods and services" } } }, "auth_ref": [] }, "ifrs-full_AccumulatedDepreciationAndAmortisationMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AccumulatedDepreciationAndAmortisationMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsAccumulatedAmortizationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentAccumulatedDepreciationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentGrossCarryingAmountsDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseLeasedAssetDetails" ], "lang": { "en-us": { "role": { "label": "Accumulated depreciation and amortisation [member]", "terseLabel": "Accumulated depreciation", "verboseLabel": "Depreciation" } }, "en": { "role": { "documentation": "This member stands for accumulated depreciation and amortisation. [Refer: Depreciation and amortisation expense]" } } }, "auth_ref": [ "r62", "r260", "r262", "r264", "r266" ] }, "ifrs-full_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Gross profit", "totalLabel": "Gross profit per segment" } }, "en": { "role": { "documentation": "The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]" } } }, "auth_ref": [ "r208" ] }, "ifrs-full_EquityAndLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityAndLiabilities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Equity and liabilities", "totalLabel": "Total equity and liabilities" } }, "en": { "role": { "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]" } } }, "auth_ref": [ "r22" ] }, "ifrs-full_RangesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RangesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareBasedPaymentDetails" ], "lang": { "en-us": { "role": { "label": "Ranges [member]" } }, "en": { "role": { "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used." } } }, "auth_ref": [ "r144", "r158", "r168", "r238", "r239", "r277" ] }, "ifrs-full_PurchaseOfAvailableforsaleFinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PurchaseOfAvailableforsaleFinancialAssets", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Purchase of available-for-sale financial assets", "negatedLabel": "Investment in financial assets" } }, "en": { "role": { "documentation": "The cash outflow for the purchase of available-for-sale financial assets. [Refer: Financial assets available-for-sale]" } } }, "auth_ref": [ "r278" ] }, "ifrs-full_Level1OfFairValueHierarchyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Level1OfFairValueHierarchyMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails" ], "lang": { "en-us": { "role": { "label": "Level 1" } }, "en": { "role": { "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date." } } }, "auth_ref": [ "r63", "r141" ] }, "ifrs-full_AccumulatedImpairmentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AccumulatedImpairmentMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Allowance for obsolescence", "terseLabel": "Allowance for obsolescence" } }, "en": { "role": { "documentation": "This member stands for accumulated impairment. [Refer: Impairment loss]" } } }, "auth_ref": [ "r171", "r179", "r244", "r260", "r262", "r264", "r266" ] }, "ifrs-full_ComputerEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComputerEquipmentMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentAccumulatedDepreciationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentGrossCarryingAmountsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentNetCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails" ], "lang": { "en-us": { "role": { "label": "Equipment and computer software [member]", "terseLabel": "Equipment and computer software" } }, "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing computer equipment. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r259" ] }, "ifrs-full_Level2OfFairValueHierarchyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Level2OfFairValueHierarchyMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails" ], "lang": { "en-us": { "role": { "label": "Level 2" } }, "en": { "role": { "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly." } } }, "auth_ref": [ "r141" ] }, "ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsGrossCarryingAmountDetails" ], "lang": { "en-us": { "role": { "label": "Acquisitions through business combinations, intangible assets other than goodwill", "terseLabel": "Additions from business combination" } }, "en": { "role": { "documentation": "The increase in intangible assets other than goodwill resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]" } } }, "auth_ref": [ "r92" ] }, "ifrs-full_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AssetsAbstract", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "ASSETS.", "terseLabel": "ASSETS" } } }, "auth_ref": [] }, "ifrs-full_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME" } } }, "auth_ref": [] }, "ifrs-full_OtherNoncurrentReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherNoncurrentReceivables", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 9.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Other non-current receivables", "terseLabel": "Other receivables", "totalLabel": "Other receivables" } }, "en": { "role": { "documentation": "The amount of non-current other receivables. [Refer: Other receivables]" } } }, "auth_ref": [ "r212" ] }, "ifrs-full_ClassesOfAssetsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfAssetsAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails" ], "lang": { "en-us": { "role": { "label": "Classes of assets [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r87", "r88", "r143", "r155" ] }, "ifrs-full_EquityAttributableToOwnersOfParentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityAttributableToOwnersOfParentMember", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Equity / (deficit) attributable to owners of the parent" } }, "en": { "role": { "documentation": "This member stands for equity attributable to the owners of the parent." } } }, "auth_ref": [ "r6" ] }, "ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Purchase of intangible assets, classified as investing activities", "negatedLabel": "Purchase of intangible assets" } }, "en": { "role": { "documentation": "The cash outflow for the purchases of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r228" ] }, "ifrs-full_EquityAttributableToOwnersOfParent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityAttributableToOwnersOfParent", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Equity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Equity attributable to owners of parent", "terseLabel": "Equity attributable to owners of the parent" } }, "en": { "role": { "documentation": "The amount of equity attributable to the owners of the parent. This specifically excludes non-controlling interest." } } }, "auth_ref": [ "r21" ] }, "ifrs-full_AdjustmentsForDecreaseIncreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForDecreaseIncreaseInInventories", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments for decrease (increase) in inventories", "terseLabel": "Inventories and biological assets" } }, "en": { "role": { "documentation": "Adjustments for decrease (increase) in inventories to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Inventories; Profit (loss)]" } } }, "auth_ref": [ "r269" ] }, "ifrs-full_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Liabilities", "totalLabel": "Total liabilities" } }, "en": { "role": { "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } } }, "auth_ref": [ "r22", "r140", "r141", "r142", "r192", "r196" ] }, "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GainsLossesOnExchangeDifferencesOnTranslationNetOfTax", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Gains (losses) on exchange differences on translation, net of tax", "terseLabel": "Foreign exchange differences on translation of foreign operations" } }, "en": { "role": { "documentation": "The gains (losses) recognised in other comprehensive income on exchange differences on the translation of financial statements of foreign operations, net of tax, before reclassification adjustments. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r45" ] }, "ifrs-full_Assets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Assets", "totalLabel": "Total assets" } }, "en": { "role": { "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } } }, "auth_ref": [ "r22", "r140", "r141", "r142", "r192", "r195" ] }, "ifrs-full_LevelsOfFairValueHierarchyAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LevelsOfFairValueHierarchyAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails" ], "lang": { "en-us": { "role": { "label": "Levels of fair value hierarchy [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r63", "r141" ] }, "biox_AdjustmentsForDecreaseIncreaseInInflationEffectsOnWorkingCapitalAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "AdjustmentsForDecreaseIncreaseInInflationEffectsOnWorkingCapitalAdjustments", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Adjustments for decrease (increase) in Inflation effects on working capital adjustments to reconcile profit (loss) to net cash flow from (used in) operating activities.", "label": "Adjustments for Decrease (Increase) in Inflation Effects on Working Capital Adjustments", "terseLabel": "Inflation effects on working capital adjustments" } } }, "auth_ref": [] }, "ifrs-full_ComputerSoftwareMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComputerSoftwareMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsAccumulatedAmortizationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsGrossCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsNetCarryingAmountDetails" ], "lang": { "en-us": { "role": { "label": "Software", "terseLabel": "Software" } }, "en": { "role": { "documentation": "This member stands for a class of intangible assets representing computer software. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r223" ] }, "ifrs-full_ClassesOfAssetsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfAssetsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails" ], "lang": { "en-us": { "role": { "label": "Assets [member]" } }, "en": { "role": { "documentation": "This member stands for a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits. It also represents the standard value for the 'Classes of assets' axis if no other member is used." } } }, "auth_ref": [ "r87", "r143", "r155" ] }, "ifrs-full_GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GainsLossesOnFairValueAdjustmentAttributableToPriceChangesBiologicalAssets", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Gains (losses) on fair value adjustment attributable to price changes, biological assets", "terseLabel": "Initial recognition and changes in the fair value of biological assets" } }, "en": { "role": { "documentation": "The gains (losses) arising from changes in fair value less costs to sell of biological assets due to price changes in the market. [Refer: Biological assets]" } } }, "auth_ref": [ "r226", "r227" ] }, "ifrs-full_GainsLossesOnFairValueAdjustmentBiologicalAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GainsLossesOnFairValueAdjustmentBiologicalAssets", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBiologicalAssetsDetails", "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Gains (losses) on fair value adjustment, biological assets", "terseLabel": "Initial recognition and changes in the fair value of biological assets at the point of harvest", "verboseLabel": "Initial recognition and changes in the fair value of biological assets at the point of harvest" } }, "en": { "role": { "documentation": "The gains (losses) arising from changes in fair value less costs to sell of biological assets due to both physical and price changes in the market. [Refer: Biological assets]" } } }, "auth_ref": [ "r106" ] }, "ifrs-full_LineItemsByFunctionMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LineItemsByFunctionMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "label": "Line items by function [member]" } }, "en": { "role": { "documentation": "This member stands for the standard value of the \u2018Attribution of expenses by nature to their function' axis if no other member is used." } } }, "auth_ref": [ "r249", "r252" ] }, "biox_ContingenciesCommitmentsAndRestrictionsOnDistributionOfProfitsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "ContingenciesCommitmentsAndRestrictionsOnDistributionOfProfitsAbstract", "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "CONTINGENCIES, COMMITMENTS AND RESTRICTIONS ON THE DISTRIBUTION OF PROFITS" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfInvestmentPropertyExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfInvestmentPropertyExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of investment property [text block]", "terseLabel": "Summary of investment properties" } }, "en": { "role": { "documentation": "The entire disclosure for investment property." } } }, "auth_ref": [ "r104" ] }, "biox_EquityCompensationPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "EquityCompensationPlanMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Member stands for equity compensation plan.", "label": "Equity Compensation Plan [Member]", "terseLabel": "Equity compensation plan" } } }, "auth_ref": [] }, "biox_NonCashFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "NonCashFinancingActivities", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of non cash financing activities.", "label": "Non Cash Financing Activities", "totalLabel": "Financing activities" } } }, "auth_ref": [] }, "ifrs-full_NoncurrentLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentLiabilitiesAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "NON-CURRENT LIABILITIES.", "terseLabel": "Non-current", "verboseLabel": "NON-CURRENT LIABILITIES" } } }, "auth_ref": [] }, "ifrs-full_BiologicalAssetsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BiologicalAssetsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBiologicalAssetsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Biological assets [member]" } }, "en": { "role": { "documentation": "This member stands for living animals or plants. It also represents the standard value for the 'Biological assets' axis if no other member is used." } } }, "auth_ref": [ "r265" ] }, "ifrs-full_BasicEarningsLossPerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BasicEarningsLossPerShare", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEarningPerShareDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Basic earnings (loss) per share", "terseLabel": "Basic (loss) profit attributable to ordinary equity holders of the parent" } }, "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator)." } } }, "auth_ref": [ "r82", "r83" ] }, "ifrs-full_TaxExpenseIncomeAtApplicableTaxRate": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TaxExpenseIncomeAtApplicableTaxRate", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails" ], "lang": { "en-us": { "role": { "label": "Tax expense (income) at applicable tax rate", "negatedLabel": "Income tax expense by applying tax rate in force in the respective countries" } }, "en": { "role": { "documentation": "The product of the accounting profit multiplied by the applicable tax rate(s). [Refer: Accounting profit; Applicable tax rate]" } } }, "auth_ref": [ "r49" ] }, "biox_DisposalsToRightOfUseAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "DisposalsToRightOfUseAssets", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseLeasedAssetDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of disposals to right-of-use assets", "label": "Disposals To Right-of-use Assets", "terseLabel": "Disposals" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfClassesOfShareCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfClassesOfShareCapitalAbstract", "lang": { "en-us": { "role": { "label": "EQUITY INFORMATION" } } }, "auth_ref": [] }, "ifrs-full_EquityMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityMember", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Equity [member]" } }, "en": { "role": { "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used." } } }, "auth_ref": [ "r6" ] }, "biox_TaxInflationAdjustment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "TaxInflationAdjustment", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of Tax Inflation Adjustment", "label": "Tax Inflation Adjustment", "negatedLabel": "Tax inflation adjustment" } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForFinanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForFinanceCosts", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 23.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments for finance costs", "terseLabel": "Financial results" } }, "en": { "role": { "documentation": "Adjustments for finance costs to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Finance costs; Profit (loss)]" } } }, "auth_ref": [ "r271" ] }, "biox_NonCashInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "NonCashInvestingActivities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of non cash investing activities.", "label": "Non Cash Investing Activities", "totalLabel": "Investing activities" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfClassesOfShareCapitalLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfClassesOfShareCapitalLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of classes of share capital [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfClassesOfShareCapitalTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfClassesOfShareCapitalTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of classes of share capital [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to classes of share capital." } } }, "auth_ref": [ "r32" ] }, "ifrs-full_BondsIssued": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BondsIssued", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails" ], "lang": { "en-us": { "role": { "label": "Bonds issued", "verboseLabel": "Corporate bonds" } }, "en": { "role": { "documentation": "The amount of bonds issued by the entity." } } }, "auth_ref": [ "r252" ] }, "biox_InventoriesExcludingAgriculturalProduce": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "InventoriesExcludingAgriculturalProduce", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of current inventories excluding agricultural produce.", "label": "Inventories, Excluding Agricultural Produce", "terseLabel": "Net of agricultural products" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfCommitmentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfCommitmentsExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureContingenciesCommitmentsAndRestrictionsOnDistributionOfProfits" ], "lang": { "en-us": { "role": { "label": "Disclosure of commitments [text block]", "verboseLabel": "CONTINGENCIES, COMMITMENTS AND RESTRICTIONS ON THE DISTRIBUTION OF PROFITS" } }, "en": { "role": { "documentation": "The disclosure of commitments." } } }, "auth_ref": [ "r248" ] }, "ifrs-full_DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfNatureAndExtentOfRisksArisingFromFinancialInstrumentsExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of nature and extent of risks arising from financial instruments [text block]", "terseLabel": "Schedule of net exposure" } }, "en": { "role": { "documentation": "The disclosure of information that enables users of financial statements to evaluate the nature and extent of risks arising from financial instruments to which the entity is exposed. [Refer: Financial instruments, class [member]]" } } }, "auth_ref": [ "r175" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.biocerescrops.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations", "presentation": [ "http://www.biocerescrops.com/role/DisclosureNewStandardsAmendmentsAndInterpretationsIssuedByIasb" ], "lang": { "en-us": { "role": { "label": "Disclosure of expected impact of initial application of new standards or interpretations [text block]", "terseLabel": "NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS ISSUED BY THE IASB" } }, "en": { "role": { "documentation": "The disclosure of the known or reasonably estimable information relevant to assessing the possible impact that the application of a new IFRS, that has been issued but is not yet effective, will have." } } }, "auth_ref": [ "r121" ] }, "ifrs-full_DisclosureOfJointVenturesLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfJointVenturesLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of joint ventures [line items]", "terseLabel": "JOINT VENTURES" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfJointVenturesTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfJointVenturesTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of joint ventures [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to joint ventures." } } }, "auth_ref": [ "r80", "r81", "r139" ] }, "ifrs-full_DisclosureOfLeasesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfLeasesExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeases" ], "lang": { "en-us": { "role": { "label": "Disclosure of leases [text block]", "terseLabel": "LEASES" } }, "en": { "role": { "documentation": "The entire disclosure for leases." } } }, "auth_ref": [ "r156", "r157" ] }, "biox_ConvertibleNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "ConvertibleNotesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for convertible notes.", "label": "Convertible notes" } } }, "auth_ref": [] }, "ifrs-full_TopOfRangeMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TopOfRangeMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareBasedPaymentDetails" ], "lang": { "en-us": { "role": { "label": "Top of range [member]", "terseLabel": "Maximum" } }, "en": { "role": { "documentation": "This member stands for top of a range." } } }, "auth_ref": [ "r144", "r158", "r168", "r238", "r239", "r277" ] }, "ifrs-full_AdjustmentsForDepreciationExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForDepreciationExpense", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 22.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments for depreciation expense", "terseLabel": "Depreciation of property, plant and equipment" } }, "en": { "role": { "documentation": "Adjustments for depreciation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r272" ] }, "biox_RightOfUseLeasedAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "RightOfUseLeasedAssetsTableTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesTables" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of right-of-use leased assets.", "label": "Right Of Use Leased Assets [Table Text Block]", "terseLabel": "Schedule of right-of-use leased assets" } } }, "auth_ref": [] }, "biox_LeaseLiabilitiesInterestExpenseExchangeDifferencesAndInflationEffects": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "LeaseLiabilitiesInterestExpenseExchangeDifferencesAndInflationEffects", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "documentation": "Lease liabilities additions from interest expense, exchange differences and inflation effects.", "label": "Lease Liabilities, Interest Expense, Exchange Differences And Inflation Effects", "terseLabel": "Interest expenses, exchange differences and inflation effects" } } }, "auth_ref": [] }, "biox_BusinessInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "BusinessInformationAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureGeneralInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Business Information [Abstract]", "terseLabel": "Business information" } } }, "auth_ref": [] }, "ifrs-full_Borrowings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Borrowings", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionSecuredNotesDetails" ], "lang": { "en-us": { "role": { "label": "Borrowings" } }, "en": { "role": { "documentation": "The amount of outstanding funds that the entity is obligated to repay." } } }, "auth_ref": [ "r254" ] }, "biox_Disclosureofrightofuseleasedassetsandleaseliabilitytabletextblock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "Disclosureofrightofuseleasedassetsandleaseliabilitytabletextblock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesTables" ], "lang": { "en-us": { "role": { "documentation": "The tabular disclosure of roll forward of right of use leased assets and lease liability", "label": "Disclosure Of Right Of Use Leased Assets And Lease Liability [Table Text Block]", "terseLabel": "Schedule of right of use leased assets and lease liability from beginning of year to end of year" } } }, "auth_ref": [] }, "biox_ShortTermInvestmentsNotClassifiedAsCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "ShortTermInvestmentsNotClassifiedAsCashEquivalents", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails": { "parentTag": "ifrs-full_OtherCurrentFinancialAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of short-term investments held by the entity that are not classified as cash equivalents.", "label": "Short Term Investments Not Classified As Cash Equivalents", "terseLabel": "US Treasury bills" } } }, "auth_ref": [] }, "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesBiologicalAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughNetExchangeDifferencesBiologicalAssets", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBiologicalAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) through net exchange differences, biological assets", "terseLabel": "Exchange differences" } }, "en": { "role": { "documentation": "The increase (decrease) in biological assets resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Biological assets]" } } }, "auth_ref": [ "r107" ] }, "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract", "lang": { "en-us": { "role": { "label": "EVENTS OCCURRING AFTER THE REPORTING PERIOD" } } }, "auth_ref": [] }, "ifrs-full_NoncurrentPortionOfNoncurrentBondsIssued": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentPortionOfNoncurrentBondsIssued", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails" ], "lang": { "en-us": { "role": { "label": "Non-current portion of non-current bonds issued", "terseLabel": "Corporate bonds" } }, "en": { "role": { "documentation": "The non-current portion of non-current bonds issued. [Refer: Bonds issued]" } } }, "auth_ref": [ "r252" ] }, "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationMovementOnDeferredIncomeTaxDetails" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) through net exchange differences, deferred tax liability (asset)", "terseLabel": "Conversion difference" } }, "en": { "role": { "documentation": "The increase (decrease) in deferred tax liability (asset) resulting from the net exchange differences arising when the financial statements are translated from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Deferred tax liability (asset)]" } } }, "auth_ref": [ "r258" ] }, "biox_StockOptionsAndShareBasedIncentivesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "StockOptionsAndShareBasedIncentivesMember", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Stock Options And Share Based Incentives.", "label": "Stock options and share based incentives" } } }, "auth_ref": [] }, "biox_DepreciationRightOfUseAssetsExchangeDifferences": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "DepreciationRightOfUseAssetsExchangeDifferences", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseLeasedAssetDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of effect of exchange differences on the deprecation of right of use assets.", "label": "Depreciation right of use assets, exchange differences", "terseLabel": "Exchange differences" } } }, "auth_ref": [] }, "ifrs-full_BiologicalAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BiologicalAssets", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBiologicalAssetsDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Biological assets", "periodEndLabel": "End of period", "periodStartLabel": "Beginning of the period", "terseLabel": "Biological assets" } }, "en": { "role": { "documentation": "The amount of living animals or plants recognised as assets." } } }, "auth_ref": [ "r13", "r108", "r225" ] }, "biox_ConsiderationForAcquisitionOfAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "ConsiderationForAcquisitionOfAssetsCurrent", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "documentation": "The amount of consideration for acquisition of assets recognised as of balance sheet date, classified as current.", "label": "Consideration for Acquisition of Assets, Current", "terseLabel": "Consideration for acquisition" } } }, "auth_ref": [] }, "ifrs-full_SellingGeneralAndAdministrativeExpenseMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SellingGeneralAndAdministrativeExpenseMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails" ], "lang": { "en-us": { "role": { "label": "Selling, general and administrative expense [member]", "terseLabel": "Selling, general and administrative expenses" } }, "en": { "role": { "documentation": "This member stands for the amount of expense relating to selling, general and administrative activities of the entity. This member is used to attribute an expense by nature to a functional line item in the statement of profit or loss." } } }, "auth_ref": [ "r249", "r252" ] }, "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsAccumulatedAmortizationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsGrossCarryingAmountDetails" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) through net exchange differences, intangible assets other than goodwill", "terseLabel": "Foreign currency translation" } }, "en": { "role": { "documentation": "The increase (decrease) in intangible assets other than goodwill resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r94" ] }, "biox_ConsiderationForAcquisitionOfAssetsNonCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "ConsiderationForAcquisitionOfAssetsNonCurrent", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "documentation": "The amount of consideration for acquisition of assets recognised as of balance sheet date, classified as non-current.", "label": "Consideration for Acquisition of Assets, Non Current", "terseLabel": "Consideration for acquisition" } } }, "auth_ref": [] }, "ifrs-full_BorrowingsByNameAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BorrowingsByNameAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionSecuredNotesDetails" ], "lang": { "en-us": { "role": { "label": "Borrowings by name [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r277" ] }, "biox_OwnSharesTradingPremiumMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "OwnSharesTradingPremiumMember", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "documentation": "The member stands for the own shares trading premium.", "label": "Own shares trading premium" } } }, "auth_ref": [] }, "biox_CashAndEquivalentsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "CashAndEquivalentsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialAssetsByCategoryDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for cash and cash equivalents.", "label": "Cash and cash equivalents [member]", "terseLabel": "Cash and cash equivalents" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfCostOfSalesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfCostOfSalesExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of cost of sales [text block]", "terseLabel": "Schedule of cost of sales" } }, "en": { "role": { "documentation": "The disclosure of the cost of sales. [Refer: Cost of sales]" } } }, "auth_ref": [ "r248" ] }, "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentAccumulatedDepreciationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentGrossCarryingAmountsDetails" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) through net exchange differences, property, plant and equipment", "terseLabel": "Foreign currency translation" } }, "en": { "role": { "documentation": "The increase (decrease) in property, plant and equipment resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r58" ] }, "biox_InformationTechnologyExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "InformationTechnologyExpenses", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 15.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 20.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of information technology expenses.", "label": "Information Technology Expenses", "terseLabel": "Information technology expenses" } } }, "auth_ref": [] }, "ifrs-full_ExercisePriceShareOptionsGranted2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ExercisePriceShareOptionsGranted2019", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareBasedPaymentDetails" ], "lang": { "en-us": { "role": { "label": "Exercise price, share options granted", "terseLabel": "Exercise price" } }, "en": { "role": { "documentation": "The exercise price of share options granted." } } }, "auth_ref": [ "r170" ] }, "biox_KeyManagementPersonnelCompensationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "KeyManagementPersonnelCompensationAbstract", "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "KEY MANAGEMENT PERSONNEL COMPENSATION" } } }, "auth_ref": [] }, "ifrs-full_BorrowingsByNameMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BorrowingsByNameMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionSecuredNotesDetails" ], "lang": { "en-us": { "role": { "label": "Borrowings by name [member]" } }, "en": { "role": { "documentation": "This member stands for all borrowings when disaggregated by name. It also represents the standard value for the 'Borrowings by name' axis if no other member is used. [Refer: Borrowings]" } } }, "auth_ref": [ "r277" ] }, "biox_NonCashFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "NonCashFinancingActivitiesAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Non Cash Financing Activities [Abstract]", "terseLabel": "Financing activities" } } }, "auth_ref": [] }, "biox_VotesPerOrdinaryShare": { "xbrltype": "integerItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "VotesPerOrdinaryShare", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the number of votes for each ordinary share.", "label": "Votes Per Ordinary Share", "terseLabel": "Number of votes for each ordinary share" } } }, "auth_ref": [] }, "ifrs-full_BiologicalAssetsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BiologicalAssetsAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBiologicalAssetsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Biological assets [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r265" ] }, "ifrs-full_DisclosureOfDeferredTaxesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDeferredTaxesExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of deferred taxes [text block]", "verboseLabel": "Schedule of net deferred tax" } }, "en": { "role": { "documentation": "The disclosure of deferred taxes. [Refer: Deferred tax liabilities; Deferred tax assets]" } } }, "auth_ref": [ "r248" ] }, "biox_PaymentsOfLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "PaymentsOfLeaseLiabilities", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "documentation": "The cash outflow for payment of lease liabilities.", "label": "Payments Of Lease Liabilities", "terseLabel": "Payment of the period/year" } } }, "auth_ref": [] }, "biox_PercentageOfIncrementalBorrowingRate": { "xbrltype": "percentItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "PercentageOfIncrementalBorrowingRate", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails" ], "lang": { "en-us": { "role": { "documentation": "Percentage of incremental borrowing rate.", "label": "Percentage Of Incremental Borrowing Rate", "terseLabel": "Incremental borrowing rate" } } }, "auth_ref": [] }, "biox_AdjustmentsForDecreaseIncreaseInIncomeAndMinimumPresumedIncomeTaxesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "AdjustmentsForDecreaseIncreaseInIncomeAndMinimumPresumedIncomeTaxesPayable", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Adjustments for decrease (increase) in income and minimum presumed income taxes paid/payable to reconcile profit (loss) to net cash flow from (used in) operating activities.", "label": "Adjustments For Decrease Increase In Income And Minimum Presumed Income Taxes Payable", "terseLabel": "Income taxes paid" } } }, "auth_ref": [] }, "biox_InvestmentsAccountedForUsingEquityMethodLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "InvestmentsAccountedForUsingEquityMethodLiability", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "documentation": "The amount of investments accounted for using the equity method, liability position.", "label": "Investments accounted for using equity method, liability", "terseLabel": "Joint ventures and associates", "verboseLabel": "Liabilities in joint ventures and associates" } } }, "auth_ref": [] }, "biox_InvestmentsAccountedForUsingEquityMethodAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "InvestmentsAccountedForUsingEquityMethodAssets", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "documentation": "The amount of investments accounted for using the equity method, asset position.", "label": "Investments Accounted For Using Equity Method, Assets", "terseLabel": "Investments in joint ventures and associates", "verboseLabel": "Assets in joint ventures and associates" } } }, "auth_ref": [] }, "ifrs-full_TradeAndOtherCurrentPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeAndOtherCurrentPayables", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 7.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayableDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayableDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Trade and other current payables", "terseLabel": "Trade and other payables", "totalLabel": "Trade and other payable" } }, "en": { "role": { "documentation": "The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]" } } }, "auth_ref": [ "r17" ] }, "biox_ChangesInNonControllingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "ChangesInNonControllingInterestMember", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "documentation": "The member stands for the changes in non-controlling interest.", "label": "Changes in non-controlling interest" } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForAmortisationExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForAmortisationExpense", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 21.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments for amortisation expense", "terseLabel": "Amortization of intangible assets" } }, "en": { "role": { "documentation": "Adjustments for amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss); Depreciation and amortisation expense]" } } }, "auth_ref": [ "r272" ] }, "ifrs-full_DisclosureOfExpensesByNatureExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfExpensesByNatureExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of expenses by nature [text block]", "terseLabel": "Schedule of expenses classified by nature and function" } }, "en": { "role": { "documentation": "The disclosure of expenses by nature. [Refer: Expenses, by nature]" } } }, "auth_ref": [ "r248" ] }, "ifrs-full_RevenueFromRoyalties": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RevenueFromRoyalties", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRevenueDetails", "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Royalty income", "terseLabel": "Royalties" } }, "en": { "role": { "documentation": "The amount of income arising from royalties." } } }, "auth_ref": [ "r252" ] }, "ifrs-full_NoncurrentAdvances": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentAdvances", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionDeferredRevenueAndAdvancesFromCustomersDetails": { "parentTag": "ifrs-full_NoncurrentContractLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionDeferredRevenueAndAdvancesFromCustomersDetails" ], "lang": { "en-us": { "role": { "label": "Non-current advances received, representing non-current contract liabilities for performance obligations satisfied at point in time", "terseLabel": "Advances from customers" } }, "en": { "role": { "documentation": "The amount of non-current advances received representing non-current contract liabilities for performance obligations satisfied at a point in time. [Refer: Advances received, representing contract liabilities for performance obligations satisfied at point in time]" } } }, "auth_ref": [ "r254", "r255" ] }, "ifrs-full_CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayableDetails": { "parentTag": "ifrs-full_TradeAndOtherCurrentPayables", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayableDetails" ], "lang": { "en-us": { "role": { "label": "Current payables on social security and taxes other than income tax", "terseLabel": "Taxes" } }, "en": { "role": { "documentation": "The amount of current payables on social security and taxes other than incomes tax. [Refer: Payables on social security and taxes other than income tax]" } } }, "auth_ref": [ "r255" ] }, "ifrs-full_RevenueFromSaleOfAgriculturalProduce": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RevenueFromSaleOfAgriculturalProduce", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeOtherIncomeOrExpensesNetDetails": { "parentTag": "ifrs-full_OtherOperatingIncomeExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeOtherIncomeOrExpensesNetDetails" ], "lang": { "en-us": { "role": { "label": "Revenue from sale of agricultural produce", "terseLabel": "Net result from commercialization of agricultural products" } }, "en": { "role": { "documentation": "The amount of revenue arising from the sale of agricultural produce. [Refer: Revenue]" } } }, "auth_ref": [ "r252" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.biocerescrops.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "ifrs-full_NoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentAssets", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Non-current assets", "totalLabel": "Total non-current assets" } }, "en": { "role": { "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]" } } }, "auth_ref": [ "r24", "r130", "r236" ] }, "ifrs-full_CurrentPrepaidExpenses": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentPrepaidExpenses", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails": { "parentTag": "ifrs-full_OtherCurrentReceivables", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Current prepaid expenses", "terseLabel": "Prepaid expenses and other receivables" } }, "en": { "role": { "documentation": "The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised." } } }, "auth_ref": [ "r252" ] }, "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutBorrowingsExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about borrowings [text block]", "terseLabel": "Schedule of borrowings" } }, "en": { "role": { "documentation": "The disclosure of detailed information about borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r277" ] }, "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutBorrowingsLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionSecuredNotesDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about borrowings [line items]", "terseLabel": "Borrowings:", "verboseLabel": "Borrowing" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_NoncurrentAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentAssetsAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "NON-CURRENT ASSETS..", "terseLabel": "NON-CURRENT ASSETS", "verboseLabel": "Non-current" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutBorrowingsTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionSecuredNotesDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about borrowings [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of borrowings." } } }, "auth_ref": [ "r277" ] }, "biox_PercentageOfEstimatedOrAppreciationOfDevaluationOfOtherCurrency": { "xbrltype": "percentItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "PercentageOfEstimatedOrAppreciationOfDevaluationOfOtherCurrency", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementCurrencyRiskDetails" ], "lang": { "en-us": { "role": { "documentation": "Represent the percentage of that a devaluation or an appreciation of the US Dollar against other currencies.", "label": "Percentage of Estimated or an Appreciation of the Devaluation of Other Currency", "terseLabel": "Percentage of that a devaluation or an appreciation of the US Dollar other currencies" } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.biocerescrops.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "biox_MiscellaneousExpenseOfIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "MiscellaneousExpenseOfIncomeExpense", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 18.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 23.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of miscellaneous expense of income expense.", "label": "Miscellaneous Expense of Income Expense", "terseLabel": "Miscellaneous" } } }, "auth_ref": [] }, "biox_InterestExpensesRelatedPartyTransaction": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "InterestExpensesRelatedPartyTransaction", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails": { "parentTag": "biox_RelatedPartyTransactions", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "Amount of interest expenses.", "label": "Interest Expenses Related Party Transaction", "terseLabel": "Interest expenses" } } }, "auth_ref": [] }, "ifrs-full_PropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentAccumulatedDepreciationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentGrossCarryingAmountsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentNetCarryingAmountDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Property, plant and equipment", "periodEndLabel": "As of the end of period", "periodStartLabel": "As of the beginning of period", "terseLabel": "Property, plant and equipment" } }, "en": { "role": { "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]" } } }, "auth_ref": [ "r9", "r59" ] }, "biox_EffectInProfitAndLossDueToDesignateDevaluationOrAppreciationOfUsDollar": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "EffectInProfitAndLossDueToDesignateDevaluationOrAppreciationOfUsDollar", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementCurrencyRiskDetails" ], "lang": { "en-us": { "role": { "documentation": "The effect on profit and loss as a result of an increase in a designated risk component that was reasonably possible at the end of the reporting period. Excludes defined benefit plan obligation", "label": "Effect in profit and loss due to designate devaluation or appreciation of US dollar" } } }, "auth_ref": [] }, "biox_IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage": { "xbrltype": "percentItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareBasedPaymentDetails" ], "lang": { "en-us": { "role": { "documentation": "Percentage of vesting of award under share-based payment arrangement.", "label": "IFRS Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage", "terseLabel": "Vesting percentage" } } }, "auth_ref": [] }, "ifrs-full_FinancialAssetsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialAssetsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails", "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialAssetsByCategoryDetails" ], "lang": { "en-us": { "role": { "label": "Financial assets" } }, "en": { "role": { "documentation": "This member stands for aggregated classes of financial assets. It also represents the standard value for the 'Classes of financial assets' axis if no other member is used. [Refer: Financial assets]" } } }, "auth_ref": [ "r164", "r183", "r184", "r203", "r204" ] }, "ifrs-full_DisclosureOfInformationAboutKeyManagementPersonnelExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureKeyManagementPersonnelCompensation" ], "lang": { "en-us": { "role": { "label": "Disclosure of information about key management personnel [text block]", "terseLabel": "KEY MANAGEMENT PERSONNEL COMPENSATION" } }, "en": { "role": { "documentation": "The disclosure of information about key management personnel. [Refer: Key management personnel of entity or parent [member]]" } } }, "auth_ref": [ "r248" ] }, "biox_NumberOfCategoriesOfDilutiveShares": { "xbrltype": "integerItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "NumberOfCategoriesOfDilutiveShares", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEarningPerShareDetails" ], "lang": { "en-us": { "role": { "documentation": "The number of categories of dilutive potential shares.", "label": "Number of Categories of Dilutive Shares", "terseLabel": "Number of categories of dilutive potential shares" } } }, "auth_ref": [] }, "biox_MinimumNumberOfCountriesWhereEntityMarketedAgriculturalInputs": { "xbrltype": "integerItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "MinimumNumberOfCountriesWhereEntityMarketedAgriculturalInputs", "presentation": [ "http://www.biocerescrops.com/role/DisclosureGeneralInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "The minimum number of countries where the entity has marketed agricultural inputs.", "label": "Minimum Number of Countries Where Entity Marketed Agricultural Inputs", "terseLabel": "Number of countries where Group's agricultural inputs are marketed" } } }, "auth_ref": [] }, "biox_GoodsAndServicesIncludingRightOfUseLicenseMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "GoodsAndServicesIncludingRightOfUseLicenseMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for goods and services, including rights of use license.", "label": "Goods And Services, Including Right Of Use License [Member]", "terseLabel": "Sale of goods and services" } } }, "auth_ref": [] }, "ifrs-full_OtherFinanceIncomeCost": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherFinanceIncomeCost", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 3.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Other finance income (cost)", "terseLabel": "Other financial results", "totalLabel": "Other finance results" } }, "en": { "role": { "documentation": "The amount of finance income or cost that the entity does not separately disclose in the same statement or note. [Refer: Finance income (cost)]" } } }, "auth_ref": [ "r257" ] }, "ifrs-full_InterestPaidClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InterestPaidClassifiedAsFinancingActivities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Interest paid, classified as financing activities", "negatedLabel": "Interest payments" } }, "en": { "role": { "documentation": "The cash outflow for interest paid, classified as financing activities." } } }, "auth_ref": [ "r116" ] }, "biox_OmnibusEquityIncentivePlan2023Member": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "OmnibusEquityIncentivePlan2023Member", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareBasedPaymentDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for 2023 Omnibus Equity Incentive Plan.", "label": "Omnibus Equity Incentive Plan 2023" } } }, "auth_ref": [] }, "biox_PastShareOptionPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "PastShareOptionPlanMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareBasedPaymentDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Past Share Option plan.", "label": "Past Share Option plan" } } }, "auth_ref": [] }, "ifrs-full_MachineryMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "MachineryMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentAccumulatedDepreciationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentGrossCarryingAmountsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentNetCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails" ], "lang": { "en-us": { "role": { "label": "Machinery and equipment [member]", "terseLabel": "Machinery and equipment" } }, "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing long-lived, depreciable machinery used in operations. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r217" ] }, "ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Impairment loss recognised in profit or loss, trade receivables", "terseLabel": "Allowance for impairment of trade debtors" } }, "en": { "role": { "documentation": "Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Impairment loss (reversal of impairment loss) recognised in profit or loss]" } } }, "auth_ref": [ "r270" ] }, "ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about intangible assets [text block]", "terseLabel": "Schedule of intangible assets" } }, "en": { "role": { "documentation": "The disclosure of detailed information about intangible assets. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r96" ] }, "ifrs-full_ConstructionInProgressMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ConstructionInProgressMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentGrossCarryingAmountsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentNetCarryingAmountDetails" ], "lang": { "en-us": { "role": { "label": "Buildings in progress", "terseLabel": "Buildings in progress" } }, "en": { "role": { "documentation": "This member stands for expenditure capitalised during the construction of items of property, plant and equipment that are not yet available for use (ie not yet in the location and condition necessary for it to be capable of operating in the manner intended by the management). [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r259" ] }, "ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about property, plant and equipment [text block]", "terseLabel": "Schedule of property plant and equipment" } }, "en": { "role": { "documentation": "The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r60" ] }, "ifrs-full_NoncurrentContractLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentContractLiabilities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 8.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionDeferredRevenueAndAdvancesFromCustomersDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionDeferredRevenueAndAdvancesFromCustomersDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Non-current contract liabilities", "terseLabel": "Deferred revenue and advances from customers", "totalLabel": "Deferred revenue and advances from customers" } }, "en": { "role": { "documentation": "The amount of non-current contract liabilities. [Refer: Contract liabilities]" } } }, "auth_ref": [ "r145" ] }, "biox_BaseShareOptionPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "BaseShareOptionPlanMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareBasedPaymentDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Base Share Option plan.", "label": "Base Share Option plan" } } }, "auth_ref": [] }, "ifrs-full_NoncurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentContractLiabilitiesForPerformanceObligationsSatisfiedOverTime", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionDeferredRevenueAndAdvancesFromCustomersDetails": { "parentTag": "ifrs-full_NoncurrentContractLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionDeferredRevenueAndAdvancesFromCustomersDetails" ], "lang": { "en-us": { "role": { "label": "Non-current contract liabilities for performance obligations satisfied over time", "terseLabel": "Deferred Revenue" } }, "en": { "role": { "documentation": "The amount of non-current contract liabilities for performance obligations satisfied over time. [Refer: Contract liabilities for performance obligations satisfied over time]" } } }, "auth_ref": [ "r254", "r255" ] }, "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of disaggregation of revenue from contracts with customers [text block]", "terseLabel": "Schedule of revenue from contracts with customers" } }, "en": { "role": { "documentation": "The disclosure of the disaggregation of revenue from contracts with customers. [Refer: Revenue from contracts with customers]" } } }, "auth_ref": [ "r147" ] }, "biox_IfEbitdaReachesAtLeastUs120MillionMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "IfEbitdaReachesAtLeastUs120MillionMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareBasedPaymentDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for scenario, if EBITDA reaches at least US$120 million.", "label": "If EBITDA Reaches at Least US$120 Million" } } }, "auth_ref": [] }, "ifrs-full_PropertyPlantAndEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PropertyPlantAndEquipmentMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentAccumulatedDepreciationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentGrossCarryingAmountsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentNetCarryingAmountDetails" ], "lang": { "en-us": { "role": { "label": "Property, plant and equipment [member]" } }, "en": { "role": { "documentation": "This member stands for property, plant and equipment. It also represents the standard value for the 'Classes of property, plant and equipment' axis if no other member is used. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r60", "r222", "r241" ] }, "ifrs-full_AdjustmentsForIncomeTaxExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForIncomeTaxExpense", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 24.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments for income tax expense", "terseLabel": "Income tax" } }, "en": { "role": { "documentation": "Adjustments for income tax expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r117" ] }, "biox_PerformanceShareOptionPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "PerformanceShareOptionPlanMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareBasedPaymentDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Performance Share Option plan.", "label": "Performance Share Option plan" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRevenueDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of disaggregation of revenue from contracts with customers [line items]", "terseLabel": "Revenue" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_CurrentProvisionsForEmployeeBenefits": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentProvisionsForEmployeeBenefits", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 4.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionEmployeeBenefitsAndSocialSecurityDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionEmployeeBenefitsAndSocialSecurityDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Employee Benefits and Social Security, Current", "terseLabel": "Employee benefits and social security", "totalLabel": "Employee benefits and social security" } }, "en": { "role": { "documentation": "The amount of current provisions for employee benefits. [Refer: Provisions for employee benefits]" } } }, "auth_ref": [ "r27" ] }, "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRevenueDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of disaggregation of revenue from contracts with customers [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the disaggregation of revenue from contracts with customers." } } }, "auth_ref": [ "r147" ] }, "biox_ThresholdEarningsBeforeInterestTaxesDepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "ThresholdEarningsBeforeInterestTaxesDepreciationAndAmortization", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareBasedPaymentDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of threshold earnings before interest taxes depreciation and amortization.", "label": "Threshold Earnings Before Interest, Taxes, Depreciation, and Amortization", "terseLabel": "Threshold earnings before interest" } } }, "auth_ref": [] }, "biox_IfEbitdaReachesAtLeastUs150MillionMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "IfEbitdaReachesAtLeastUs150MillionMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareBasedPaymentDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for scenario, if EBITDA reaches at least US$150 million.", "label": "If EBITDA reaches at least US$150 million" } } }, "auth_ref": [] }, "ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesChangesInJointVenturesInvestmentsDetails" ], "lang": { "en-us": { "role": { "label": "Gains (Losses) on Exchange Differences on Translation From Joint Venture, net of tax", "verboseLabel": "Foreign currency translation" } }, "en": { "role": { "documentation": "The amount of other comprehensive income, net of tax, related to exchange differences on translation of the financial statements of a parent company or a stand-alone entity to a different presentation currency. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r45" ] }, "ifrs-full_DisclosureOfEarningsPerShareExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfEarningsPerShareExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEarningPerShare" ], "lang": { "en-us": { "role": { "label": "Disclosure of earnings per share [text block]", "verboseLabel": "EARNING PER SHARE" } }, "en": { "role": { "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r86" ] }, "biox_MutualFundsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "MutualFundsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionCashAndCashEquivalentsDetails": { "parentTag": "ifrs-full_CashAndCashEquivalents", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionCashAndCashEquivalentsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of an investment program funded by shareholders that trades in diversified holdings and is professionally managed.", "label": "Mutual Funds At Carrying Value", "terseLabel": "Mutual funds" } } }, "auth_ref": [] }, "ifrs-full_ContingentConsiderationMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ContingentConsiderationMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails" ], "lang": { "en-us": { "role": { "label": "Consideration for acquisition of assets" } }, "en": { "role": { "documentation": "This member stands for an obligation of the acquirer to transfer additional assets or equity interests to the former owners of an acquiree as part of the exchange for control of the acquiree if specified future events occur or conditions are met." } } }, "auth_ref": [ "r276" ] }, "ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "MajorComponentsOfTaxExpenseIncomeAbstract", "lang": { "en-us": { "role": { "label": "TAXATION" } } }, "auth_ref": [] }, "ifrs-full_LongtermBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LongtermBorrowings", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Non-current portion of non-current borrowings", "terseLabel": "Borrowings" } }, "en": { "role": { "documentation": "The non-current portion of non-current borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r254" ] }, "biox_LoanReceivableNonCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "LoanReceivableNonCurrent", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails": { "parentTag": "ifrs-full_OtherNoncurrentReceivables", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the non current amount of loan receivable.", "label": "Loan Receivable Non Current", "terseLabel": "Loan receivables" } } }, "auth_ref": [] }, "biox_CustomersAndDistributorBulkOrdersPerYearMaximum": { "xbrltype": "integerItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "CustomersAndDistributorBulkOrdersPerYearMaximum", "presentation": [ "http://www.biocerescrops.com/role/DisclosureSeasonalityDetails" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of bulk orders per year of some customers and distributors of the entity.", "label": "Customers and Distributor Bulk Orders Per Year, Maximum", "terseLabel": "Some customers and distributers order per year, maximum" } } }, "auth_ref": [] }, "biox_NetLoansGrantedOrCancelledRelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "NetLoansGrantedOrCancelledRelatedPartyTransactions", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of net loans granted or cancelled by the entity in related party transactions.", "label": "Net Loans Granted or Cancelled, Related Party Transactions", "terseLabel": "Net loans granted / (cancelled)" } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.biocerescrops.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Other inflows (outflows) of cash, classified as financing activities", "terseLabel": "Other financial proceeds or payments, net" } }, "en": { "role": { "documentation": "Inflows (outflows) of cash, classified as financing activities, that the entity does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r113" ] }, "biox_TaxEffectOfUnrecognizedDeferredTax": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "TaxEffectOfUnrecognizedDeferredTax", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to unrecognized deferred taxes.", "label": "Tax Effect of Unrecognized Deferred Tax", "negatedLabel": "Unrecognized deferred tax" } } }, "auth_ref": [] }, "biox_GainsLossesOnExchangeDifferencesOnTranslationFromJointVentureNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "GainsLossesOnExchangeDifferencesOnTranslationFromJointVentureNetOfTax", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "documentation": "The gains (losses) recognised in other comprehensive income on exchange differences on the translation from joint venture of financial statements of foreign operations, net of tax.", "label": "Gains Losses On Exchange Differences On Translation From Joint Venture Net Of Tax", "terseLabel": "Foreign exchange differences on translation of foreign operations from joint ventures" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfEntitysReportableSegmentsExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureSegmentInformation" ], "lang": { "en-us": { "role": { "label": "Disclosure of entity's operating segments [text block]", "terseLabel": "SEGMENT INFORMATION" } }, "en": { "role": { "documentation": "The entire disclosure for operating segments." } } }, "auth_ref": [ "r202" ] }, "ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfEventsAfterReportingPeriodExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEventsOccurringAfterReportingPeriod" ], "lang": { "en-us": { "role": { "label": "Disclosure of events after reporting period [text block]", "terseLabel": "EVENTS OCCURRING AFTER THE REPORTING PERIOD" } }, "en": { "role": { "documentation": "The entire disclosure for events after the reporting period." } } }, "auth_ref": [ "r47" ] }, "biox_CustomersAndDistributorBulkOrdersPerYearMinimum": { "xbrltype": "integerItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "CustomersAndDistributorBulkOrdersPerYearMinimum", "presentation": [ "http://www.biocerescrops.com/role/DisclosureSeasonalityDetails" ], "lang": { "en-us": { "role": { "documentation": "The minimum number of bulk orders per year of some customers and distributors of the entity.", "label": "Customers and Distributor Bulk Orders Per Year, Minimum", "terseLabel": "Some customers and distributers order per year, minimum" } } }, "auth_ref": [] }, "ifrs-full_AcquisitionsThroughBusinessCombinationsInvestmentProperty": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AcquisitionsThroughBusinessCombinationsInvestmentProperty", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentGrossCarryingAmountsDetails" ], "lang": { "en-us": { "role": { "label": "Acquisitions through business combinations, investment property", "terseLabel": "Additions from business combination" } }, "en": { "role": { "documentation": "The increase in investment property resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Investment property]" } } }, "auth_ref": [ "r99", "r102" ] }, "biox_OtherInvestmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "OtherInvestmentMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for other investment member.", "label": "Other investments" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17Table": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfSensitivityAnalysisToChangesInRiskExposuresThatAriseFromContractsWithinScopeOfIFRS17Table", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementCurrencyRiskDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of sensitivity analysis to changes in risk variables that arise from contracts within scope of IFRS 17 [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the sensitivity analysis to changes in risk variables that arise from contracts within the scope of IFRS 17." } } }, "auth_ref": [ "r163" ] }, "ifrs-full_MeasurementAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "MeasurementAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialAssetsByCategoryDetails", "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionSecuredNotesDetails" ], "lang": { "en-us": { "role": { "label": "Measurement [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r98", "r108", "r140" ] }, "ifrs-full_SharePremiumMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SharePremiumMember", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Share premium" } }, "en": { "role": { "documentation": "This member stands for the amount received or receivable from issuance of the entity's shares in excess of nominal value." } } }, "auth_ref": [ "r6" ] }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTransactionsBetweenRelatedPartiesAbstract", "lang": { "en-us": { "role": { "label": "SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of transactions between related parties [text block]", "verboseLabel": "Schedule of transactions between the group and related parties, and the related balances owed" } }, "en": { "role": { "documentation": "The disclosure of transactions between the entity and its related parties. [Refer: Related parties [member]]" } } }, "auth_ref": [ "r70" ] }, "ifrs-full_DisposalsPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisposalsPropertyPlantAndEquipment", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentAccumulatedDepreciationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentGrossCarryingAmountsDetails" ], "lang": { "en-us": { "role": { "label": "Disposals, property, plant and equipment", "negatedTerseLabel": "Disposals" } }, "en": { "role": { "documentation": "The decrease in property, plant and equipment resulting from disposals. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r56" ] }, "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_OtherComprehensiveIncome", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Other comprehensive income that will be reclassified to profit or loss, net of tax", "totalLabel": "Items that may be subsequently reclassified to profit and loss" } }, "en": { "role": { "documentation": "The amount of other comprehensive income that will be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r213", "r214" ] }, "biox_RevaluationOfPropertyPlantAndEquipmentAndEffectOfTaxRateChangeMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "RevaluationOfPropertyPlantAndEquipmentAndEffectOfTaxRateChangeMember", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "documentation": "This member stands for revaluation of PP&E and effect of tax rate change.", "label": "Revaluation of PP&E and effect of tax rate change" } } }, "auth_ref": [] }, "biox_SunflowerMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "SunflowerMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBiologicalAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for sunflower biological assets.", "label": "Sunflower" } } }, "auth_ref": [] }, "biox_AdditionsToRightOfUseAssetsFromBusinessCombination": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "AdditionsToRightOfUseAssetsFromBusinessCombination", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseLeasedAssetDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of additions to right of use assets from business combination.", "label": "Additions to Right of Use Assets From Business Combination", "terseLabel": "Additions from business combination" } } }, "auth_ref": [] }, "ifrs-full_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS" } } }, "auth_ref": [] }, "ifrs-full_ShorttermBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ShorttermBorrowings", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current borrowings", "terseLabel": "Borrowings" } }, "en": { "role": { "documentation": "The amount of current borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r254" ] }, "ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformation" ], "lang": { "en-us": { "role": { "label": "Disclosure of share capital, reserves and other equity interest [text block]", "terseLabel": "EQUITY INFORMATION" } }, "en": { "role": { "documentation": "The entire disclosure for share capital, reserves and other equity interest." } } }, "auth_ref": [ "r33" ] }, "ifrs-full_DilutedEarningsLossPerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DilutedEarningsLossPerShare", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEarningPerShareDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Diluted earnings (loss) per share", "terseLabel": "Diluted (loss) profit attributable to ordinary equity holders of the parent" } }, "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]" } } }, "auth_ref": [ "r82", "r83" ] }, "biox_AdditionsToLeaseLiabilityFromBusinessCombination": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "AdditionsToLeaseLiabilityFromBusinessCombination", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of additions to lease liability from business combination.", "label": "Additions to Lease Liability From Business Combination", "terseLabel": "Additions from business combination" } } }, "auth_ref": [] }, "biox_MoolecScienceS.a.Member": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "MoolecScienceS.a.Member", "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents the information about Moolec Science S.A.", "label": "Moolec Science S.A." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfSharebasedPaymentArrangementsExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareBasedPayment" ], "lang": { "en-us": { "role": { "label": "Disclosure of share-based payment arrangements [text block]", "terseLabel": "SHARE-BASED PAYMENT" } }, "en": { "role": { "documentation": "The entire disclosure for share-based payment arrangements." } } }, "auth_ref": [ "r165" ] }, "biox_SecuredDebtNonCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "SecuredDebtNonCurrent", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionSecuredNotesDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "documentation": "Amount of secured debt, non-current.", "label": "Secured Debt, Non-Current", "terseLabel": "Secured notes" } } }, "auth_ref": [] }, "ifrs-full_StatementOfChangesInEquityLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfChangesInEquityLineItems", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Statement of changes in equity [line items]", "terseLabel": "Statement of changes in equity" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_StatementOfChangesInEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfChangesInEquityAbstract", "lang": { "en-us": { "role": { "label": "UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY" } } }, "auth_ref": [] }, "ifrs-full_SharebasedPaymentArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SharebasedPaymentArrangementsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails", "http://www.biocerescrops.com/role/DisclosureShareBasedPaymentDetails" ], "lang": { "en-us": { "role": { "label": "Share-based payment arrangements [member]" } }, "en": { "role": { "documentation": "This member stands for an agreement between the entity or another group entity or any shareholder of the group entity and another party (including an employee) that entitles the other party to receive (a) cash or other assets of the entity for amounts that are based on the price (or value) of equity instruments (including shares or share options) of the entity or another group entity; or (b) equity instruments (including shares or share options) of the entity or another group entity, provided that the specified vesting conditions, if any, are met. It also represents the standard value for the 'Types of share-based payment arrangements' axis if no other member is used." } } }, "auth_ref": [ "r169" ] }, "ifrs-full_OtherCurrentFinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherCurrentFinancialAssets", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 5.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Other current financial assets", "terseLabel": "Other financial assets", "totalLabel": "Other financial assets" } }, "en": { "role": { "documentation": "The amount of current financial assets that the entity does not separately disclose in the same statement or note. [Refer: Other financial assets; Current financial assets]" } } }, "auth_ref": [ "r12" ] }, "biox_InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "InvestmentInKindInOtherRelatedPartiesNonCashTransactionsInvestmentActivities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails": { "parentTag": "biox_NonCashInvestingActivities", "weight": 1.0, "order": 1.0 }, "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails": { "parentTag": "biox_RelatedPartyTransactions", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of investment in kind in other related parties, non cash transactions investment activities.", "label": "Investment in Kind in Other Related Parties, Non Cash Transactions Investment Activities", "terseLabel": "Investment in-kind in other related parties", "verboseLabel": "In-kind contributions" } } }, "auth_ref": [] }, "biox_AdvertisingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "AdvertisingExpenses", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 11.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of advertising expense relating to production costs and selling general and administrative expenses.", "label": "Advertising Expenses", "terseLabel": "Publicity and advertising" } } }, "auth_ref": [] }, "ifrs-full_StatementOfChangesInEquityTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfChangesInEquityTable", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Statement of changes in equity [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to changes in equity." } } }, "auth_ref": [ "r6" ] }, "biox_ImpairmentOfReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "ImpairmentOfReceivables", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of impairment loss recognised in profit or loss, trade receivables relating to production costs selling, general and administrative expenses.", "label": "Impairment Of Receivables", "terseLabel": "Impairment of receivables" } } }, "auth_ref": [] }, "ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureAccountingStandardsAndBasisOfPresentationPolicies" ], "lang": { "en-us": { "role": { "label": "Foreign currency" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for foreign currency translation." } } }, "auth_ref": [ "r253" ] }, "biox_InventoriesFromBusinessCombination": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "InventoriesFromBusinessCombination", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeCostOfSalesDetails" ], "lang": { "en-us": { "role": { "documentation": "Additions to inventories as results of business combination.", "label": "Inventories From Business Combination", "terseLabel": "Business combination" } } }, "auth_ref": [] }, "ifrs-full_CategoriesOfRelatedPartiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CategoriesOfRelatedPartiesAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayableDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsPayablesDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsReceivableDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Categories of related parties [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r75" ] }, "ifrs-full_StatementOfComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfComprehensiveIncomeAbstract", "lang": { "en-us": { "role": { "label": "INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME" } } }, "auth_ref": [] }, "ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureAccountingStandardsAndBasisOfPresentationPolicies" ], "lang": { "en-us": { "role": { "label": "Functional currency" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for the currency of the primary economic environment in which the entity operates." } } }, "auth_ref": [ "r253" ] }, "ifrs-full_DividendsPaidClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DividendsPaidClassifiedAsFinancingActivities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Dividends paid, classified as financing activities", "negatedLabel": "Cash dividend distributed by subsidiary" } }, "en": { "role": { "documentation": "The cash outflow for dividends paid by the entity, classified as financing activities." } } }, "auth_ref": [ "r116" ] }, "ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFairValueMeasurementOfAssetsLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of fair value measurement of assets [line items]", "terseLabel": "Fair value by hierarchy" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_Inventories": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Inventories", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current inventories", "terseLabel": "Inventories" } }, "en": { "role": { "documentation": "The amount of current inventories. [Refer: Inventories]" } } }, "auth_ref": [ "r14", "r64", "r210" ] }, "ifrs-full_DividendsPaid": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DividendsPaid", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Dividends recognised as distributions to owners", "negatedLabel": "Distribution of dividends by subsidiary" } }, "en": { "role": { "documentation": "The amount of dividends recognised as distributions to owners." } } }, "auth_ref": [ "r7" ] }, "ifrs-full_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFairValueMeasurementOfAssetsTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of fair value measurement of assets [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the fair value measurement of assets." } } }, "auth_ref": [ "r143" ] }, "biox_NetLoansGrantedToShareholdersAndOtherRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "NetLoansGrantedToShareholdersAndOtherRelatedParties", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Amount of net loans granted to shareholders and other related parties investing activities.", "label": "Net Loans Granted To Shareholders And Other Related Parties", "negatedLabel": "Net loans granted to shareholders and other related parties" } } }, "auth_ref": [] }, "biox_SalariesSocialSecurityBenefitsAndOtherBenefitsRelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "SalariesSocialSecurityBenefitsAndOtherBenefitsRelatedPartyTransactions", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails": { "parentTag": "biox_RelatedPartyTransactions", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of salaries, social security benefits and other benefits.", "label": "Salaries, Social Security Benefits and Other Benefits, Related Party Transactions", "negatedLabel": "Salaries, social security benefits and other benefits" } } }, "auth_ref": [] }, "biox_CashFlowsFromObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "CashFlowsFromObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Amount of aggregate cash flows from obtaining control of subsidiaries or other businesses, classified as investing activities.", "label": "Cash Flows From Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities", "terseLabel": "Net cash received from business combination" } } }, "auth_ref": [] }, "biox_NetAssetsAcquisitionByBusinessCombination": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "NetAssetsAcquisitionByBusinessCombination", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails": { "parentTag": "biox_NonCashInvestingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount recognised as of the acquisition date for net assets acquired or liabilities assumed in a business combination.", "label": "Net Assets Acquisition By Business Combination", "negatedLabel": "Net assets acquisition by business combination" } } }, "auth_ref": [] }, "ifrs-full_OtherCurrentPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherCurrentPayables", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayableDetails": { "parentTag": "ifrs-full_TradeAndOtherCurrentPayables", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayableDetails" ], "lang": { "en-us": { "role": { "label": "Other current payables", "terseLabel": "Miscellaneous" } }, "en": { "role": { "documentation": "The amount of current payables that the entity does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r254" ] }, "biox_CapitalizationOfConvertibleFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "CapitalizationOfConvertibleFinancingActivities", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails": { "parentTag": "biox_NonCashFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of cash inflow effect of capitalization of convertible notes.", "label": "Capitalization Of Convertible Financing Activities", "terseLabel": "Capitalization of convertible notes" } } }, "auth_ref": [] }, "biox_RgRsOxWheatMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "RgRsOxWheatMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsGrossCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsNetCarryingAmountDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for RG/RS/OX wheat.", "label": "RG/RS/OX Wheat [member]", "terseLabel": "RG/RS/OX Wheat" } } }, "auth_ref": [] }, "ifrs-full_InventoriesTotal": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InventoriesTotal", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeCostOfSalesDetails" ], "lang": { "en-us": { "role": { "label": "Inventories.", "negatedPeriodEndLabel": "Inventories as of the end of the period", "periodStartLabel": "Inventories as of the beginning of the period" } }, "en": { "role": { "documentation": "The amount of assets: (a) held for sale in the ordinary course of business; (b) in the process of production for such sale; or (c) in the form of materials or supplies to be consumed in the production process or in the rendering of services. Inventories encompass goods purchased and held for resale including, for example, merchandise purchased by a retailer and held for resale, or land and other property held for resale. Inventories also encompass finished goods produced, or work in progress being produced, by the entity and include materials and supplies awaiting use in the production process. [Refer: Current finished goods; Current merchandise; Current work in progress; Land]" } } }, "auth_ref": [ "r14" ] }, "ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ShorttermDepositsNotClassifiedAsCashEquivalents", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails": { "parentTag": "ifrs-full_OtherCurrentFinancialAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Short-term deposits, not classified as cash equivalents", "terseLabel": "Restricted short-term deposit" } }, "en": { "role": { "documentation": "The amount of short-term deposits held by the entity that are not classified as cash equivalents. [Refer: Cash equivalents]" } } }, "auth_ref": [ "r254" ] }, "biox_IncreaseDecreaseThroughBusinessCombinationTransactionsEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "IncreaseDecreaseThroughBusinessCombinationTransactionsEquity", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "documentation": "The increase (decrease) in equity resulting from business combination transactions.", "label": "Increase (Decrease) Through Business Combination Transactions, Equity", "terseLabel": "Business combination" } } }, "auth_ref": [] }, "biox_IncreaseDecreaseThroughCapitalizationOfConvertibleNotesEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "IncreaseDecreaseThroughCapitalizationOfConvertibleNotesEquity", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "documentation": "The increase (decrease) in equity resulting from capitalization of convertible notes", "label": "Increase (Decrease) Through Capitalization of Convertible Notes, Equity", "terseLabel": "Capitalization of convertible notes" } } }, "auth_ref": [] }, "biox_InsumosAgroqumicosMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "InsumosAgroqumicosMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionGoodwillDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Insumos Agroqumicos.", "label": "Insumos Agroqumicos S.A." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFairValueOfFinancialInstrumentsExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of fair value of financial instruments [text block]", "terseLabel": "Schedule of fair value by hierarchy" } }, "en": { "role": { "documentation": "The disclosure of the fair value of financial instruments. [Refer: Financial instruments, class [member]; At fair value [member]]" } } }, "auth_ref": [ "r248" ] }, "ifrs-full_DisclosureOfIncomeTaxExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfIncomeTaxExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxation" ], "lang": { "en-us": { "role": { "label": "Disclosure of income tax [text block]", "terseLabel": "TAXATION" } }, "en": { "role": { "documentation": "The entire disclosure for income taxes." } } }, "auth_ref": [ "r53" ] }, "biox_ReceivablesForPpESalesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "ReceivablesForPpESalesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for receivables for PP&E sales", "label": "Receivables For PP&E Sales [Member]", "terseLabel": "Receivables for PP&E sales" } } }, "auth_ref": [] }, "ifrs-full_RightofuseAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RightofuseAssets", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseLeasedAssetDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Right-of-use assets", "periodEndLabel": "Book value at the end of the period/year", "periodStartLabel": "Book value at the beginning of the period/year", "terseLabel": "Right of use asset" } }, "en": { "role": { "documentation": "The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee." } } }, "auth_ref": [ "r150", "r154" ] }, "ifrs-full_OtherCurrentReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherCurrentReceivables", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 4.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsReceivableDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Other current receivables", "terseLabel": "Other receivables", "totalLabel": "Other receivables" } }, "en": { "role": { "documentation": "The amount of current other receivables. [Refer: Other receivables]" } } }, "auth_ref": [ "r212" ] }, "ifrs-full_ShorttermEmployeeBenefitsExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ShorttermEmployeeBenefitsExpense", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 6.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "label": "Short-term employee benefits expense", "terseLabel": "Employee benefits and social securities" } }, "en": { "role": { "documentation": "The amount of expense from employee benefits (other than termination benefits) that are expected to be settled wholly within twelve months after the end of the annual reporting period in which the employees render the related services." } } }, "auth_ref": [ "r252" ] }, "biox_ProFarmGroupInc.Member": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "ProFarmGroupInc.Member", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionGoodwillDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Pro farm Group, Inc.", "label": "Pro farm Group, Inc. [Member]", "terseLabel": "Pro farm Group, Inc." } } }, "auth_ref": [] }, "biox_AdjustmentOfOpeningNetBookAmountForApplicationOfLas29OnPropertyAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "AdjustmentOfOpeningNetBookAmountForApplicationOfLas29OnPropertyAndEquipment", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentGrossCarryingAmountsDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of adjustment to opening net book amount for application of IAS 29 on property and equipment.", "label": "Adjustment Of Opening Net Book Amount For Application Of lAS 29 On Property And Equipment", "terseLabel": "Of the period" } } }, "auth_ref": [] }, "ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ShorttermInvestmentsClassifiedAsCashEquivalents", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails": { "parentTag": "ifrs-full_OtherCurrentFinancialAssets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Short-term investments, classified as cash equivalents", "verboseLabel": "Mutual funds" } }, "en": { "role": { "documentation": "A classification of cash equivalents representing short-term investments. [Refer: Cash equivalents]" } } }, "auth_ref": [ "r274" ] }, "biox_TrustDebtSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "TrustDebtSecuritiesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Trust Debt Securities.", "label": "Trust debt securities", "terseLabel": "Trust debt securities" } } }, "auth_ref": [] }, "ifrs-full_DeferredTaxAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DeferredTaxAssets", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Deferred tax assets", "terseLabel": "Deferred tax assets" } }, "en": { "role": { "documentation": "The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]" } } }, "auth_ref": [ "r19", "r23", "r51" ] }, "biox_AlfalfaTechnologiesS.r.lMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "AlfalfaTechnologiesS.r.lMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Alfalfa Technologies S.R.L.", "label": "Alfalfa Technologies S.R.L" } } }, "auth_ref": [] }, "biox_NonCashInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "NonCashInvestingActivitiesAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Investment activities.", "terseLabel": "Investment activities" } } }, "auth_ref": [] }, "biox_ChangeInNetRealizableValueOfAgricultural": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "ChangeInNetRealizableValueOfAgricultural", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "documentation": "Change in the net realizable value of agricultural.", "label": "Change In The Net Realizable Value Of Agricultural", "terseLabel": "Changes in the net realizable value of agricultural products after harvest" } } }, "auth_ref": [] }, "biox_SecuredGuaranteedNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "SecuredGuaranteedNotesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionSecuredNotesDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Secured Guaranteed Notes.", "label": "Secured Guaranteed Notes [Member]", "terseLabel": "Secured Guaranteed Notes" } } }, "auth_ref": [] }, "ifrs-full_AdjustedWeightedAverageShares": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustedWeightedAverageShares", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEarningPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average number of shares - Diluted", "terseLabel": "Weighted average number of shares (diluted EPS)" } }, "en": { "role": { "documentation": "The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]" } } }, "auth_ref": [ "r85" ] }, "ifrs-full_AdditionsToRightofuseAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdditionsToRightofuseAssets", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseLeasedAssetDetails" ], "lang": { "en-us": { "role": { "label": "Additions to right-of-use assets", "terseLabel": "Additions of the period/year" } }, "en": { "role": { "documentation": "The amount of additions to right-of-use assets. [Refer: Right-of-use assets]" } } }, "auth_ref": [ "r153" ] }, "biox_SeedsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "SeedsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for information pertaining to seeds.", "label": "Seeds", "terseLabel": "Seeds" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract", "lang": { "en-us": { "role": { "label": "SHARE-BASED PAYMENT" } } }, "auth_ref": [] }, "biox_DescriptionOfAccountingPolicyForPresentationCurrencyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "DescriptionOfAccountingPolicyForPresentationCurrencyTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureAccountingStandardsAndBasisOfPresentationPolicies" ], "lang": { "en-us": { "role": { "documentation": "The description of the entity's accounting policy for the currency used in presenting financial statements to regulatory agencies.", "label": "Presentation currency" } } }, "auth_ref": [] }, "ifrs-full_InvestmentFundsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InvestmentFundsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails" ], "lang": { "en-us": { "role": { "label": "Mutual funds" } }, "en": { "role": { "documentation": "This member stands for investment funds." } } }, "auth_ref": [ "r237" ] }, "ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinanceIncomeExpenseExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of finance income (cost) [text block]", "terseLabel": "Schedule of net financial cost" } }, "en": { "role": { "documentation": "The disclosure of finance income (cost). [Refer: Finance income (cost)]" } } }, "auth_ref": [ "r248" ] }, "ifrs-full_DeferredTaxExpenseIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DeferredTaxExpenseIncome", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureTaxationTaxesOnIncomeDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationTaxesOnIncomeDetails" ], "lang": { "en-us": { "role": { "label": "Deferred tax expense (income)", "negatedLabel": "Deferred tax" } }, "en": { "role": { "documentation": "The amount of tax expense (income) relating to changes in deferred tax liabilities and deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]" } } }, "auth_ref": [ "r52" ] }, "biox_DescriptionOfAccountingPolicyForChangesInAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "DescriptionOfAccountingPolicyForChangesInAccountingPoliciesTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureAccountingStandardsAndBasisOfPresentationPolicies" ], "lang": { "en-us": { "role": { "documentation": "The description of the entity's changes in accounting policies.", "label": "Changes in accounting policies" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareBasedPaymentDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of terms and conditions of share-based payment arrangement [line items]", "terseLabel": "SHARE-BASED PAYMENT" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "biox_DescriptionOfAccountingPolicyForBasisOfMeasurementTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "DescriptionOfAccountingPolicyForBasisOfMeasurementTextBlock", "presentation": [ "http://www.biocerescrops.com/role/DisclosureAccountingStandardsAndBasisOfPresentationPolicies" ], "lang": { "en-us": { "role": { "documentation": "The description of the entity's accounting policy for the basis of measurement, preparation, and presentation of the financial statements.", "label": "Basis of measurement" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareBasedPaymentDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of terms and conditions of share-based payment arrangement [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to terms and conditions of share-based payment arrangements." } } }, "auth_ref": [ "r169" ] }, "ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DeferredTaxExpenseIncomeRecognisedInProfitOrLoss", "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationMovementOnDeferredIncomeTaxDetails" ], "lang": { "en-us": { "role": { "label": "Deferred tax expense (income) recognised in profit or loss", "verboseLabel": "Charge for the period" } }, "en": { "role": { "documentation": "The amount of tax expense or income relating to changes in deferred tax liabilities and deferred tax assets, recognised in profit or loss. [Refer: Deferred tax assets; Deferred tax expense (income); Deferred tax liabilities]" } } }, "auth_ref": [ "r52" ] }, "ifrs-full_RiskExposureAssociatedWithInstrumentsSharingCharacteristic": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RiskExposureAssociatedWithInstrumentsSharingCharacteristic", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementCurrencyRiskDetails" ], "lang": { "en-us": { "role": { "label": "Risk exposure associated with instruments sharing characteristic", "verboseLabel": "Foreign currency" } }, "en": { "role": { "documentation": "The amount of risk exposure associated with financial instruments with a shared characteristic that identifies a concentration of risks. [Refer: Financial instruments, class [member]]" } } }, "auth_ref": [ "r187" ] }, "ifrs-full_SignificantInvestmentsInSubsidiariesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SignificantInvestmentsInSubsidiariesAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionGoodwillDetails" ], "lang": { "en-us": { "role": { "label": "Subsidiaries [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r80", "r81", "r138" ] }, "biox_ParentCompaniesAndRelatedPartiesToParentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "ParentCompaniesAndRelatedPartiesToParentMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsPayablesDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands parent companies and related parties to parent of an entity.", "label": "Parent companies and related parties to Parent [member]", "terseLabel": "Parent company and related parties to Parent" } } }, "auth_ref": [] }, "biox_ProceedsFromFinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "ProceedsFromFinancialAssets", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "The cash inflow (outflow) generated from financial assets that the entity classifies as investing activities.", "label": "Proceeds from financial assets" } } }, "auth_ref": [] }, "biox_OtherIncomeOrExpensesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "OtherIncomeOrExpensesNet", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeOtherIncomeOrExpensesNetDetails": { "parentTag": "ifrs-full_OtherOperatingIncomeExpense", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeOtherIncomeOrExpensesNetDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of other income or expenses net.", "label": "Other Income Or Expenses Net", "terseLabel": "Other income or expenses, net" } } }, "auth_ref": [] }, "biox_IfrsStockRepurchasedDuringPeriodShares": { "xbrltype": "integerItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "IfrsStockRepurchasedDuringPeriodShares", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased.", "label": "Ifrs Stock Repurchased During Period Shares", "terseLabel": "Number of own shares repurchased" } } }, "auth_ref": [] }, "biox_ShareBasedIncentivesExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "ShareBasedIncentivesExpenses", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 12.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 16.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of share-based incentives expenses.", "label": "Share Based Incentives Expenses", "terseLabel": "Share-based incentives" } } }, "auth_ref": [] }, "biox_SecuredConvertibleGuaranteedNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "SecuredConvertibleGuaranteedNotesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionSecuredNotesDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Secured Convertible Guaranteed Notes.", "label": "Secured Convertible Guaranteed Notes [Member]", "terseLabel": "Secured Convertible Guaranteed Notes" } } }, "auth_ref": [] }, "biox_ProductionCostAndSellingGeneralAndAdministrativeExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "ProductionCostAndSellingGeneralAndAdministrativeExpenseMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for the amount of expense relating to production costs and selling, general and administrative activities of the entity. This member is used to attribute an expense by nature to a functional line item in the statement of profit or loss.", "label": "Production Cost and Selling, General and Administrative Expense [Member]", "terseLabel": "Total" } } }, "auth_ref": [] }, "biox_StatementOfNonCashTransactionsCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "StatementOfNonCashTransactionsCashFlowsAbstract", "lang": { "en-us": { "role": { "documentation": "It represents the information pertaining to non cash transactions in cash flow.", "label": "CASH FLOW INFORMATION" } } }, "auth_ref": [] }, "biox_IfrsPaymentsToPurchaseOfOwnShares": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "IfrsPaymentsToPurchaseOfOwnShares", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails": { "parentTag": "biox_NonCashFinancingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of acquisition of own shares.", "label": "ifrs Payments to Purchase of Own Shares", "negatedLabel": "Purchase of own shares" } } }, "auth_ref": [] }, "ifrs-full_DeferredTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DeferredTaxLiabilities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Deferred tax liabilities", "terseLabel": "Deferred tax liabilities" } }, "en": { "role": { "documentation": "The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]" } } }, "auth_ref": [ "r19", "r23", "r51" ] }, "ifrs-full_InvestmentProperty": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InvestmentProperty", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInvestmentPropertiesDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Investment property", "terseLabel": "Investment properties" } }, "en": { "role": { "documentation": "The amount of property (land or a building - or part of a building - or both) held (by the owner or by the lessee as a right-of-use asset) to earn rentals or for capital appreciation or both, rather than for: (a) use in the production or supply of goods or services or for administrative purposes; or (b) sale in the ordinary course of business." } } }, "auth_ref": [ "r10", "r100", "r103" ] }, "biox_ExpensesRecovery": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "ExpensesRecovery", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeOtherIncomeOrExpensesNetDetails": { "parentTag": "ifrs-full_OtherOperatingIncomeExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeOtherIncomeOrExpensesNetDetails" ], "lang": { "en-us": { "role": { "documentation": "The amount of recovered expenses.", "label": "Expenses Recovery", "terseLabel": "Expenses recovery" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTransactionsBetweenRelatedPartiesLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayableDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsPayablesDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsReceivableDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of transactions between related parties [line items]", "terseLabel": "Components of Consolidated Statement of Financial Position", "verboseLabel": "SHAREHOLDERS AND OTHER RELATED PARTIES BALANCES AND TRANSACTIONS" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DeferredTaxLiabilityAsset": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DeferredTaxLiabilityAsset", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationMovementOnDeferredIncomeTaxDetails" ], "lang": { "en-us": { "role": { "label": "Deferred tax liability (asset)", "periodEndLabel": "Total net deferred tax", "periodStartLabel": "Beginning of the period deferred tax" } }, "en": { "role": { "documentation": "The amount of deferred tax liabilities or assets. [Refer: Deferred tax liabilities; Deferred tax assets]" } } }, "auth_ref": [ "r51" ] }, "ifrs-full_IntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IntangibleAssetsOtherThanGoodwill", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsAccumulatedAmortizationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsGrossCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsNetCarryingAmountDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Intangible assets", "periodEndLabel": "Balance at end of the period", "periodStartLabel": "Balance at beginning of the period", "terseLabel": "Intangible assets" } }, "en": { "role": { "documentation": "The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]" } } }, "auth_ref": [ "r11", "r95" ] }, "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments for increase (decrease) in trade and other payables", "terseLabel": "Trade and other payables" } }, "en": { "role": { "documentation": "Adjustments for increase (decrease) in trade and other payables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other payables; Profit (loss)]" } } }, "auth_ref": [ "r272" ] }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTransactionsBetweenRelatedPartiesTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherReceivablesDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayableDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsPayablesDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsReceivableDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of transactions between related parties [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to transactions between related parties." } } }, "auth_ref": [ "r75" ] }, "ifrs-full_ProductsAndServicesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProductsAndServicesAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRevenueDetails", "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Products and services [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r199", "r240" ] }, "ifrs-full_IntangibleAssetsOtherThanGoodwillMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IntangibleAssetsOtherThanGoodwillMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsAccumulatedAmortizationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsGrossCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsNetCarryingAmountDetails" ], "lang": { "en-us": { "role": { "label": "Intangible assets other than goodwill [member]", "terseLabel": "Intangible assets" } }, "en": { "role": { "documentation": "This member stands for intangible assets other than goodwill. It also represents the standard value for the 'Classes of intangible assets other than goodwill' axis if no other member is used. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r96", "r222", "r241" ] }, "ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughSharebasedPaymentTransactions", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) through share-based payment transactions, equity", "terseLabel": "Share-based incentives" } }, "en": { "role": { "documentation": "The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]" } } }, "auth_ref": [ "r4" ] }, "ifrs-full_CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsAccumulatedAmortizationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsGrossCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsNetCarryingAmountDetails" ], "lang": { "en-us": { "role": { "label": "Trademarks and patents", "terseLabel": "Trademarks and patents" } }, "en": { "role": { "documentation": "This member stands for a class of intangible assets representing copyrights, patents and other industrial property rights, service and operating rights. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r224" ] }, "ifrs-full_ClassesOfFinancialAssetsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfFinancialAssetsAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails", "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialAssetsByCategoryDetails" ], "lang": { "en-us": { "role": { "label": "Classes of financial assets [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r164", "r183", "r184", "r203", "r204" ] }, "ifrs-full_ProductsAndServicesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProductsAndServicesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRevenueDetails", "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Products and services [member]" } }, "en": { "role": { "documentation": "This member stands for the entity's products and services. It also represents the standard value for the 'Products and services' axis if no other member is used." } } }, "auth_ref": [ "r199", "r240" ] }, "ifrs-full_AdjustmentsForProvisions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForProvisions", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 16.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments for provisions", "terseLabel": "Provisions for contingencies" } }, "en": { "role": { "documentation": "Adjustments for provisions to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Provisions; Profit (loss)]" } } }, "auth_ref": [ "r270" ] }, "ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments for losses (gains) on disposal of non-current assets", "terseLabel": "Gain or loss on sale of equipment and intangible assets" } }, "en": { "role": { "documentation": "Adjustments for losses (gains) on disposal of non-current assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Non-current assets; Profit (loss)]" } } }, "auth_ref": [ "r267" ] }, "ifrs-full_ProfessionalFeesExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfessionalFeesExpense", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 13.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 17.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "label": "Professional fees expense", "terseLabel": "Professional fees and outsourced services" } }, "en": { "role": { "documentation": "The amount of fees paid or payable for professional services." } } }, "auth_ref": [ "r252" ] }, "ifrs-full_ClassesOfFinancialLiabilitiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfFinancialLiabilitiesAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails" ], "lang": { "en-us": { "role": { "label": "Classes of financial liabilities [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r183", "r184", "r203", "r204" ] }, "ifrs-full_AdjustmentsForReconcileProfitLossAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForReconcileProfitLossAbstract", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile loss to net cash flows", "verboseLabel": "Adjustments to reconcile profit to net cash flows" } } }, "auth_ref": [] }, "ifrs-full_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0, "order": 1.0 }, "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 25.0 }, "http://www.biocerescrops.com/role/StatementInterimCondensedConsolidatedStatementsOfComprehensiveIncomeCalc2": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Result for the year", "terseLabel": "(Loss) profit for the period", "totalLabel": "(Loss) profit for the period" } }, "en": { "role": { "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r2", "r34", "r112", "r123", "r125", "r192", "r194", "r236", "r242" ] }, "ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfIntangibleAssetsOtherThanGoodwillAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsAccumulatedAmortizationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsGrossCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsNetCarryingAmountDetails" ], "lang": { "en-us": { "role": { "label": "Classes of intangible assets other than goodwill [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r96" ] }, "ifrs-full_AdjustmentsForSharebasedPayments": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForSharebasedPayments", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 17.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments for share-based payments", "terseLabel": "Share-based incentive and stock options" } }, "en": { "role": { "documentation": "Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r270" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.biocerescrops.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r247" ] }, "ifrs-full_CurrentInventoriesInTransit": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentInventoriesInTransit", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Current inventories in transit", "terseLabel": "Goods in transit" } }, "en": { "role": { "documentation": "A classification of current inventory representing the amount of inventories in transit. [Refer: Inventories]" } } }, "auth_ref": [ "r261" ] }, "ifrs-full_FeeAndCommissionExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FeeAndCommissionExpense", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails": { "parentTag": "ifrs-full_FinanceCosts", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails" ], "lang": { "en-us": { "role": { "label": "Fee and commission expense", "negatedLabel": "Financial commissions" } }, "en": { "role": { "documentation": "The amount of expense relating to fees and commissions." } } }, "auth_ref": [ "r257" ] }, "ifrs-full_InvestmentsAccountedForUsingEquityMethodAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InvestmentsAccountedForUsingEquityMethodAbstract", "lang": { "en-us": { "role": { "label": "JOINT VENTURES AND ASSOCIATES" } } }, "auth_ref": [] }, "ifrs-full_ProfitLossAttributableToNoncontrollingInterests": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLossAttributableToNoncontrollingInterests", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementInterimCondensedConsolidatedStatementsOfComprehensiveIncomeCalc2": { "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Profit (loss), attributable to non-controlling interests", "terseLabel": "Non-controlling interests" } }, "en": { "role": { "documentation": "The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests]" } } }, "auth_ref": [ "r37", "r127" ] }, "ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsAccumulatedAmortizationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsGrossCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentAccumulatedDepreciationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentGrossCarryingAmountsDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseLeasedAssetDetails" ], "lang": { "en-us": { "role": { "label": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r54", "r59", "r91", "r95", "r100", "r101", "r103", "r108", "r109", "r171", "r179", "r180" ] }, "ifrs-full_InterestCostsCapitalised": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InterestCostsCapitalised", "calculation": { "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails": { "parentTag": "biox_NonCashInvestingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "label": "Interest costs capitalised", "terseLabel": "Capitalization of interest on buildings in progress" } }, "en": { "role": { "documentation": "The amount of interest costs that an entity incurs in connection with the borrowing of funds that are directly attributable to the acquisition, construction or production of a qualifying asset and which form part of the cost of that asset." } } }, "auth_ref": [ "r252" ] }, "ifrs-full_ProfitLossAttributableToAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLossAttributableToAbstract", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "(Loss) profit for the period attributable to:" } } }, "auth_ref": [] }, "ifrs-full_CarryingAmountMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CarryingAmountMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsAccumulatedAmortizationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsGrossCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentAccumulatedDepreciationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentGrossCarryingAmountsDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseLeasedAssetDetails" ], "lang": { "en-us": { "role": { "label": "Carrying amount [member]" } }, "en": { "role": { "documentation": "This member stands for the amount at which an asset is recognised in the statement of financial position (after deducting any accumulated depreciation or amortisation and accumulated impairment losses). It also represents the standard value for the 'Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount' axis if no other member is used. [Refer: Depreciation and amortisation expense; Impairment loss]" } } }, "auth_ref": [ "r59", "r95", "r100", "r103", "r108", "r171", "r179", "r180" ] }, "ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEarningPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Profit (loss), attributable to ordinary equity holders of parent entity", "verboseLabel": "(Loss) profit for the period (basic EPS)" } }, "en": { "role": { "documentation": "The profit (loss) attributable to ordinary equity holders of the parent entity. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r84" ] }, "ifrs-full_CurrentLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentLeaseLiabilities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 1.0 }, "http://www.biocerescrops.com/role/DisclosureLeasesLeaseLiabilityDetails": { "parentTag": "ifrs-full_LeaseLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesLeaseLiabilityDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current lease liabilities", "terseLabel": "Lease liabilities", "verboseLabel": "Current" } }, "en": { "role": { "documentation": "The amount of current lease liabilities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r151" ] }, "ifrs-full_Cash": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Cash", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionCashAndCashEquivalentsDetails": { "parentTag": "ifrs-full_CashAndCashEquivalents", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionCashAndCashEquivalentsDetails" ], "lang": { "en-us": { "role": { "label": "Cash", "terseLabel": "Cash at bank and on hand" } }, "en": { "role": { "documentation": "The amount of cash on hand and demand deposits. [Refer: Cash on hand]" } } }, "auth_ref": [ "r274" ] }, "ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEarningPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Numerator" } } }, "auth_ref": [] }, "ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEarningPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Profit (loss), attributable to ordinary equity holders of parent entity including dilutive effects", "verboseLabel": "(Loss) profit for the period (diluted EPS)" } }, "en": { "role": { "documentation": "The profit (loss) attributable to ordinary equity holders of the parent entity, adjusted for the effects of all dilutive potential ordinary shares. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r84" ] }, "ifrs-full_ProfitLossAttributableToOwnersOfParent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLossAttributableToOwnersOfParent", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementInterimCondensedConsolidatedStatementsOfComprehensiveIncomeCalc2": { "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Profit (loss), attributable to owners of parent", "terseLabel": "Equity holders of the parent" } }, "en": { "role": { "documentation": "The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r38" ] }, "ifrs-full_AdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdministrativeExpense", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 14.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 18.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "label": "Administrative expenses", "terseLabel": "Office supplies", "verboseLabel": "Office supplies and registrations fees" } }, "en": { "role": { "documentation": "The amount of expenses that the entity classifies as being administrative." } } }, "auth_ref": [ "r46", "r78", "r208" ] }, "ifrs-full_JointVenturesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "JointVenturesAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesDetails" ], "lang": { "en-us": { "role": { "label": "Joint ventures [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r80", "r81", "r139" ] }, "ifrs-full_CurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentLiabilities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current liabilities", "totalLabel": "Total current liabilities" } }, "en": { "role": { "documentation": "The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period." } } }, "auth_ref": [ "r25", "r131", "r236" ] }, "ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfPropertyPlantAndEquipmentAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentAccumulatedDepreciationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentGrossCarryingAmountsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentNetCarryingAmountDetails" ], "lang": { "en-us": { "role": { "label": "Classes of property, plant and equipment [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r60" ] }, "ifrs-full_ProfitLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLossBeforeTax", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Profit (loss) before tax", "totalLabel": "(Loss) profit before income tax" } }, "en": { "role": { "documentation": "The profit (loss) before tax expense or income. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r172", "r207", "r208", "r245", "r246" ] }, "ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughTreasuryShareTransactions", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) through treasury share transactions, equity", "terseLabel": "Purchase of own shares" } }, "en": { "role": { "documentation": "The increase (decrease) in equity resulting from treasury share transactions. [Refer: Equity; Treasury shares]" } } }, "auth_ref": [ "r5" ] }, "ifrs-full_NumberOfOutstandingShareOptions": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfOutstandingShareOptions", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails" ], "lang": { "en-us": { "role": { "label": "Number of share options outstanding in share-based payment arrangement", "verboseLabel": "Number of total converted options outstanding" } }, "en": { "role": { "documentation": "The number of share options outstanding in a share-based payment arrangement." } } }, "auth_ref": [ "r166", "r167", "r168" ] }, "ifrs-full_CashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashAndCashEquivalents", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 6.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionCashAndCashEquivalentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionCashAndCashEquivalentsDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents", "terseLabel": "Cash and cash equivalents", "totalLabel": "Cash and cash equivalents" } }, "en": { "role": { "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]" } } }, "auth_ref": [ "r16", "r118", "r136" ] }, "ifrs-full_CurrentLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentLiabilitiesAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "CURRENT LIABILITIES.", "terseLabel": "Current", "verboseLabel": "CURRENT LIABILITIES" } } }, "auth_ref": [] }, "ifrs-full_KeyManagementPersonnelCompensation": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "KeyManagementPersonnelCompensation", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureKeyManagementPersonnelCompensationSummaryOfCompensationOfDirectorsAndOtherMembersDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureKeyManagementPersonnelCompensationSummaryOfCompensationOfDirectorsAndOtherMembersDetails" ], "lang": { "en-us": { "role": { "label": "Key management personnel compensation.", "totalLabel": "Total" } }, "en": { "role": { "documentation": "The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]" } } }, "auth_ref": [ "r68" ] }, "ifrs-full_JointVenturesWhereEntityIsVenturerMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "JointVenturesWhereEntityIsVenturerMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsPayablesDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsReceivableDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Joint ventures [member]", "terseLabel": "Joint ventures and associates" } }, "en": { "role": { "documentation": "This member stands for joint ventures in which the entity is a joint venturer. A venturer is a party to a joint venture and has joint control over that joint venture. [Refer: Joint ventures [member]]" } } }, "auth_ref": [ "r72" ] }, "ifrs-full_ClassesOfShareCapitalAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfShareCapitalAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails" ], "lang": { "en-us": { "role": { "label": "Classes of share capital [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r32" ] }, "ifrs-full_TypesOfRisksAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TypesOfRisksAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementCurrencyRiskDetails" ], "lang": { "en-us": { "role": { "label": "Types of risks [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r159", "r160", "r161", "r163", "r173", "r176", "r177" ] }, "ifrs-full_CostOfSales": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CostOfSales", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails": { "parentTag": "ifrs-full_GrossProfit", "weight": -1.0, "order": 2.0 }, "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeCostOfSalesDetails", "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Cost of sales", "negatedLabel": "Cost of sales", "terseLabel": "Cost of sales" } }, "en": { "role": { "documentation": "The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories." } } }, "auth_ref": [ "r0", "r46" ] }, "ifrs-full_InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails": { "parentTag": "ifrs-full_OtherCurrentFinancialAssets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Investments other than investments accounted for using equity method", "terseLabel": "Other investments" } }, "en": { "role": { "documentation": "The amount of investments other than investments accounted for using the equity method. [Refer: Investments accounted for using equity method]" } } }, "auth_ref": [ "r254" ] }, "ifrs-full_ClassesOfShareCapitalMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfShareCapitalMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails" ], "lang": { "en-us": { "role": { "label": "Share capital [member]" } }, "en": { "role": { "documentation": "This member stands for share capital of the entity. It also represents the standard value for the 'Classes of share capital' axis if no other member is used." } } }, "auth_ref": [ "r32" ] }, "ifrs-full_IssueOfConvertibleInstruments": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IssueOfConvertibleInstruments", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Issue of convertible instruments", "terseLabel": "Issuance of convertible notes" } }, "en": { "role": { "documentation": "The change in equity resulting from the issuing of convertible instruments." } } }, "auth_ref": [ "r250" ] }, "ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "KeyManagementPersonnelCompensationSharebasedPayment", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureKeyManagementPersonnelCompensationSummaryOfCompensationOfDirectorsAndOtherMembersDetails": { "parentTag": "ifrs-full_KeyManagementPersonnelCompensation", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureKeyManagementPersonnelCompensationSummaryOfCompensationOfDirectorsAndOtherMembersDetails" ], "lang": { "en-us": { "role": { "label": "Key management personnel compensation, share-based payment", "terseLabel": "Share-based incentives" } }, "en": { "role": { "documentation": "The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]]" } } }, "auth_ref": [ "r67" ] }, "ifrs-full_TypesOfRisksMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TypesOfRisksMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementCurrencyRiskDetails" ], "lang": { "en-us": { "role": { "label": "Risks [member]" } }, "en": { "role": { "documentation": "This member stands for all types of risks. It also represents the standard value for the 'Types of risks' axis if no other member is used." } } }, "auth_ref": [ "r159", "r160", "r161", "r163", "r173", "r176", "r177" ] }, "ifrs-full_FinanceIncomeCost": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinanceIncomeCost", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Finance income (cost)", "verboseLabel": "Financial cost" } }, "en": { "role": { "documentation": "The amount of income or cost associated with interest and other financing activities of the entity." } } }, "auth_ref": [ "r257" ] }, "ifrs-full_CurrentMaterialsAndSuppliesToBeConsumedInProductionProcessOrRenderingServices": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentMaterialsAndSuppliesToBeConsumedInProductionProcessOrRenderingServices", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionInventoriesDetails" ], "lang": { "en-us": { "role": { "label": "Current materials and supplies to be consumed in production process or rendering services", "terseLabel": "Supplies" } }, "en": { "role": { "documentation": "A classification of current inventory representing the amount of materials and supplies to be consumed in a production process or while rendering services. [Refer: Inventories]" } } }, "auth_ref": [ "r261" ] }, "ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "KeyManagementPersonnelCompensationShorttermEmployeeBenefits", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureKeyManagementPersonnelCompensationSummaryOfCompensationOfDirectorsAndOtherMembersDetails": { "parentTag": "ifrs-full_KeyManagementPersonnelCompensation", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureKeyManagementPersonnelCompensationSummaryOfCompensationOfDirectorsAndOtherMembersDetails" ], "lang": { "en-us": { "role": { "label": "Key management personnel compensation, short-term employee benefits", "verboseLabel": "Salaries, social security and other benefits" } }, "en": { "role": { "documentation": "The amount of compensation to key management personnel in the form of short-term employee benefits. [Refer: Key management personnel of entity or parent [member]]" } } }, "auth_ref": [ "r66" ] }, "ifrs-full_VehiclesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "VehiclesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentAccumulatedDepreciationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentGrossCarryingAmountsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentNetCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails" ], "lang": { "en-us": { "role": { "label": "Vehicles [member]", "terseLabel": "Vehicles" } }, "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing vehicles used in the entity's operations, specifically to include aircraft, motor vehicles and ships. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r259" ] }, "ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents if different from statement of financial position", "periodEndLabel": "Cash and cash equivalents as of the end of the period", "periodStartLabel": "Cash and cash equivalents as of beginning of the period" } }, "en": { "role": { "documentation": "The amount of cash and cash equivalents in the statement of cash flows when different from the amount of cash and cash equivalents in the statement of financial position. [Refer: Cash and cash equivalents]" } } }, "auth_ref": [ "r274" ] }, "ifrs-full_NumberOfSharesAuthorised": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfSharesAuthorised", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails" ], "lang": { "en-us": { "role": { "label": "Number of shares authorised", "terseLabel": "Number of shares authorised" } }, "en": { "role": { "documentation": "The number of shares authorised." } } }, "auth_ref": [ "r29" ] }, "ifrs-full_KeyManagementPersonnelOfEntityOrParentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "KeyManagementPersonnelOfEntityOrParentMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsPayablesDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Key management personnel [member]", "terseLabel": "Key management personnel" } }, "en": { "role": { "documentation": "This member stands for those persons having authority and responsibility for planning, directing and controlling the activities of the entity, directly or indirectly, including any director (whether executive or otherwise) of that entity." } } }, "auth_ref": [ "r73" ] }, "ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": 1.0, "order": 7.0 }, "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0, "order": 15.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesChangesInJointVenturesInvestmentsDetails", "http://www.biocerescrops.com/role/DisclosureJointVenturesAndAssociatesDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Share of profit (loss) of associates and joint ventures accounted for using equity method", "negatedLabel": "Share of profit or loss of joint ventures and associates", "terseLabel": "Share of profit or loss of joint ventures and associates", "verboseLabel": "Share of profit or loss" } }, "en": { "role": { "documentation": "The entity's share of the profit (loss) of associates and joint ventures accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Joint ventures [member]; Profit (loss)]" } } }, "auth_ref": [ "r43", "r190", "r197" ] }, "ifrs-full_FinanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinanceCosts", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails" ], "lang": { "en-us": { "role": { "label": "Finance costs", "negatedTotalLabel": "Financial Costs" } }, "en": { "role": { "documentation": "The amount of costs associated with financing activities of the entity." } } }, "auth_ref": [ "r42" ] }, "ifrs-full_TypesOfSharebasedPaymentArrangementsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TypesOfSharebasedPaymentArrangementsAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails", "http://www.biocerescrops.com/role/DisclosureShareBasedPaymentDetails" ], "lang": { "en-us": { "role": { "label": "Types of share-based payment arrangements [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r169" ] }, "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentAccumulatedDepreciationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentGrossCarryingAmountsDetails" ], "lang": { "en-us": { "role": { "label": "Additions other than through business combinations, property, plant and equipment", "terseLabel": "Additions", "verboseLabel": "Depreciation of the period" } }, "en": { "role": { "documentation": "The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]" } } }, "auth_ref": [ "r55" ] }, "ifrs-full_DepreciationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DepreciationPropertyPlantAndEquipment", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 4.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "label": "Depreciation, property, plant and equipment", "terseLabel": "Depreciation of property, plant and equipment" } }, "en": { "role": { "documentation": "The amount of depreciation of property, plant and equipment. [Refer: Depreciation and amortisation expense; Property, plant and equipment]" } } }, "auth_ref": [ "r57", "r61" ] }, "ifrs-full_NumberOfSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfSharesIssued", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails" ], "lang": { "en-us": { "role": { "label": "Number of shares issued", "terseLabel": "Number of shares issued" } }, "en": { "role": { "documentation": "The number of shares issued by the entity." } } }, "auth_ref": [ "r250" ] }, "ifrs-full_CostOfSalesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CostOfSalesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails" ], "lang": { "en-us": { "role": { "label": "Cost of sales [member]", "terseLabel": "Production costs" } }, "en": { "role": { "documentation": "This member stands for the amount of all expenses directly or indirectly attributed to goods or services sold. This member is used to attribute an expense by nature to a functional line item in the statement of profit or loss." } } }, "auth_ref": [ "r249", "r252" ] }, "ifrs-full_ProfitLossFromOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLossFromOperatingActivities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Profit (loss) from operating activities", "totalLabel": "Operating profit" } }, "en": { "role": { "documentation": "The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r221", "r257" ] }, "ifrs-full_AggregatedMeasurementMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AggregatedMeasurementMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialAssetsByCategoryDetails", "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBorrowingsCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionSecuredNotesDetails" ], "lang": { "en-us": { "role": { "label": "Aggregated measurement [member]" } }, "en": { "role": { "documentation": "This member stands for all types of measurement. It also represents the standard value for the 'Measurement' axis if no other member is used." } } }, "auth_ref": [ "r98", "r108", "r140" ] }, "ifrs-full_DepreciationRightofuseAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DepreciationRightofuseAssets", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 6.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 17.0 }, "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 20.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseLeasedAssetDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Depreciation, right-of-use assets", "terseLabel": "Depreciation of leased assets", "verboseLabel": "Depreciation of the period/year" } }, "en": { "role": { "documentation": "The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]" } } }, "auth_ref": [ "r152" ] }, "ifrs-full_InterestExpenseOnOtherFinancialLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InterestExpenseOnOtherFinancialLiabilities", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails": { "parentTag": "ifrs-full_FinanceCosts", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails" ], "lang": { "en-us": { "role": { "label": "Interest expense on other financial liabilities", "negatedLabel": "Interest expenses" } }, "en": { "role": { "documentation": "The amount of interest expense on other financial liabilities. [Refer: Interest expense; Other financial liabilities]" } } }, "auth_ref": [ "r252" ] }, "ifrs-full_IssuedCapitalMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IssuedCapitalMember", "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Issued capital" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing issued capital." } } }, "auth_ref": [ "r6" ] }, "ifrs-full_CurrencyRiskMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrencyRiskMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementCurrencyRiskDetails" ], "lang": { "en-us": { "role": { "label": "Currency risk" } }, "en": { "role": { "documentation": "This member stands for a type of market risk representing the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rates. [Refer: Financial instruments, class [member]]" } } }, "auth_ref": [ "r159", "r160", "r161", "r162", "r188" ] }, "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseLeasedAssetDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of quantitative information about right-of-use assets [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to right-of-use assets." } } }, "auth_ref": [ "r155" ] }, "ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeAndOtherCurrentPayablesToRelatedParties", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayableDetails": { "parentTag": "ifrs-full_TradeAndOtherCurrentPayables", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayableDetails", "http://www.biocerescrops.com/role/DisclosureShareholdersAndOtherRelatedPartiesBalancesAndTransactionsPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Trade Payables, Related Party Transactions", "negatedLabel": "Trade payables/creditors", "terseLabel": "Trade payable, related party" } }, "en": { "role": { "documentation": "The amount of current payables due to related parties. [Refer: Related parties [member]; Payables to related parties]" } } }, "auth_ref": [ "r255" ] }, "ifrs-full_IncomeTaxExpenseContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncomeTaxExpenseContinuingOperations", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ProfitLoss", "weight": -1.0, "order": 2.0 }, "http://www.biocerescrops.com/role/DisclosureTaxationTaxesOnIncomeDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationReconciliationOfStatutoryTaxRateDetails", "http://www.biocerescrops.com/role/DisclosureTaxationTaxesOnIncomeDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Tax expense (income), continuing operations", "negatedLabel": "Income tax", "negatedTotalLabel": "Income tax expenses" } }, "en": { "role": { "documentation": "The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]" } } }, "auth_ref": [ "r44", "r48", "r49", "r50", "r79", "r137", "r191" ] }, "ifrs-full_DisclosureOfOperatingSegmentsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfOperatingSegmentsAbstract", "lang": { "en-us": { "role": { "label": "SEGMENT INFORMATION" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfOperatingSegmentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfOperatingSegmentsExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureSegmentInformationTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of operating segments [text block]", "terseLabel": "Schedule of operating results group's reporting segments" } }, "en": { "role": { "documentation": "The disclosure of operating segments. [Refer: Operating segments [member]]" } } }, "auth_ref": [ "r192" ] }, "ifrs-full_TradeAndOtherCurrentPayablesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeAndOtherCurrentPayablesAbstract", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayableDetails" ], "lang": { "en-us": { "role": { "label": "Trade and other current payables [abstract]", "terseLabel": "Current" } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.biocerescrops.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "ifrs-full_LandAndBuildingsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LandAndBuildingsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentAccumulatedDepreciationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentGrossCarryingAmountsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentNetCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureLeasesRightOfUseAssetByTypeDetails" ], "lang": { "en-us": { "role": { "label": "Land and buildings [member]", "terseLabel": "Land and buildings" } }, "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing land and depreciable buildings and similar structures for use in operations. [Refer: Buildings; Land; Property, plant and equipment]" } } }, "auth_ref": [ "r216" ] }, "ifrs-full_DisclosureOfOperatingSegmentsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfOperatingSegmentsLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of operating segments [line items]", "terseLabel": "SEGMENT INFORMATION" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeAndOtherCurrentPayablesToTradeSuppliers", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayableDetails": { "parentTag": "ifrs-full_TradeAndOtherCurrentPayables", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayableDetails" ], "lang": { "en-us": { "role": { "label": "Current trade payables", "terseLabel": "Trade creditors" } }, "en": { "role": { "documentation": "The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]" } } }, "auth_ref": [ "r211", "r255" ] }, "biox_AccountingStandardsAndBasisOfPreparationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "AccountingStandardsAndBasisOfPreparationAbstract", "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "ACCOUNTING STANDARDS AND BASIS OF PREPARATION" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfOperatingSegmentsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfOperatingSegmentsTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of operating segments [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to operating segments." } } }, "auth_ref": [ "r192" ] }, "ifrs-full_TradeAndOtherCurrentReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeAndOtherCurrentReceivables", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 7.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Trade and other current receivables", "terseLabel": "Trade receivables", "totalLabel": "Trade receivables" } }, "en": { "role": { "documentation": "The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]" } } }, "auth_ref": [ "r15", "r26" ] }, "ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset", "crdr": "credit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationMovementOnDeferredIncomeTaxDetails" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) through business combinations, deferred tax liability (asset)", "terseLabel": "Additions for business combination" } }, "en": { "role": { "documentation": "The increase (decrease) in deferred tax liability (asset) resulting from business combinations. [Refer: Deferred tax liability (asset)]" } } }, "auth_ref": [ "r258" ] }, "ifrs-full_CurrentTaxAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentTaxAssets", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current tax assets", "terseLabel": "Income and minimum presumed recoverable income taxes" } }, "en": { "role": { "documentation": "The excess of amount paid for current tax in respect of current and prior periods over the amount due for those periods. Current tax is the amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period." } } }, "auth_ref": [ "r18" ] }, "ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementAssets", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails": { "parentTag": "ifrs-full_OtherFinanceIncomeCost", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails" ], "lang": { "en-us": { "role": { "label": "Gains (losses) recognised in profit or loss on exchange differences, fair value measurement, assets", "terseLabel": "Exchange differences generated by assets" } }, "en": { "role": { "documentation": "The gains (losses) on exchange differences, recognised in profit or loss, on the fair value measurement of assets. [Refer: At fair value [member]]" } } }, "auth_ref": [ "r275" ] }, "biox_AdjustmentsForDecreaseIncreaseInDeferredRevenueAndAdvancesFromCustomers": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "AdjustmentsForDecreaseIncreaseInDeferredRevenueAndAdvancesFromCustomers", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Adjustments for decrease (increase) in deferred revenue and advances from customers to reconcile profit (loss) to net cash flow from (used in) operating activities.", "label": "Adjustments for Decrease (Increase) in Deferred Revenue and Advances from Customers", "terseLabel": "Deferred revenue and advances from customers" } } }, "auth_ref": [] }, "ifrs-full_GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GainsLossesRecognisedInProfitOrLossOnExchangeDifferencesFairValueMeasurementLiabilities", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails": { "parentTag": "ifrs-full_OtherFinanceIncomeCost", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeFinanceResultsDetails" ], "lang": { "en-us": { "role": { "label": "Gains (losses) recognised in profit or loss on exchange differences, fair value measurement, liabilities", "terseLabel": "Exchange differences generated by liabilities" } }, "en": { "role": { "documentation": "The gains (losses) on exchange differences, recognised in profit or loss, on the fair value measurement of liabilities. [Refer: At fair value [member]]" } } }, "auth_ref": [ "r275" ] }, "ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForDecreaseIncreaseInTradeAccountReceivable", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments for decrease (increase) in trade accounts receivable", "terseLabel": "Trade receivables" } }, "en": { "role": { "documentation": "Adjustments for decrease (increase) in trade accounts receivable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r269" ] }, "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) in cash and cash equivalents before effect of exchange rate changes", "totalLabel": "Net (decrease) increase in cash and cash equivalents" } }, "en": { "role": { "documentation": "The increase (decrease) in cash and cash equivalents before the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]" } } }, "auth_ref": [ "r118" ] }, "ifrs-full_CurrentTaxAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentTaxAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current tax assets, non-current", "terseLabel": "Income and minimum presumed recoverable income taxes" } }, "en": { "role": { "documentation": "The non-current amount of current tax assets. [Refer: Current tax assets]" } } }, "auth_ref": [ "r18" ] }, "ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfOtherOperatingIncomeExpenseExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of other operating income (expense) [text block]", "terseLabel": "Schedule of other income or expenses, net" } }, "en": { "role": { "documentation": "The disclosure of other operating income or expense. [Refer: Other operating income (expense)]" } } }, "auth_ref": [ "r248" ] }, "biox_BorrowingMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "BorrowingMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialLiabilitiesByCategoryDetails" ], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to borrowings.", "label": "Borrowings [Member]", "terseLabel": "Borrowings" } } }, "auth_ref": [] }, "ifrs-full_AllLevelsOfFairValueHierarchyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AllLevelsOfFairValueHierarchyMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFairValueByHierarchyDetails" ], "lang": { "en-us": { "role": { "label": "All levels of fair value hierarchy [member]" } }, "en": { "role": { "documentation": "This member stands for all levels of the fair value hierarchy. It also represents the standard value for the 'Levels of fair value hierarchy' axis if no other member is used." } } }, "auth_ref": [ "r63", "r141" ] }, "ifrs-full_NoncurrentFinancialAssetsAvailableforsale": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentFinancialAssetsAvailableforsale", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails": { "parentTag": "ifrs-full_OtherNoncurrentFinancialAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionOtherFinancialAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Non-current financial assets available-for-sale", "terseLabel": "Shares of Bioceres S.A." } }, "en": { "role": { "documentation": "The amount of non-current financial assets available-for-sale. [Refer: Financial assets available-for-sale; Non-current financial assets]" } } }, "auth_ref": [ "r206" ] }, "ifrs-full_CurrentTaxExpenseIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentTaxExpenseIncome", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureTaxationTaxesOnIncomeDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureTaxationTaxesOnIncomeDetails" ], "lang": { "en-us": { "role": { "label": "Current tax expense (income)", "negatedLabel": "Current tax expense" } }, "en": { "role": { "documentation": "The amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period." } } }, "auth_ref": [ "r215" ] }, "ifrs-full_PreferenceSharesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PreferenceSharesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails" ], "lang": { "en-us": { "role": { "label": "Preference shares [member]", "terseLabel": "Preference shares" } }, "en": { "role": { "documentation": "This member stands for equity instruments that are senior in some aspects to ordinary shares, but subordinate to debt instruments in terms of claim. [Refer: Ordinary shares [member]]" } } }, "auth_ref": [ "r256" ] }, "ifrs-full_ParValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ParValuePerShare", "presentation": [ "http://www.biocerescrops.com/role/DisclosureEquityInformationDetails" ], "lang": { "en-us": { "role": { "label": "Par value per share", "terseLabel": "Par value per share" } }, "en": { "role": { "documentation": "The nominal value per share." } } }, "auth_ref": [ "r30" ] }, "ifrs-full_DisclosureOfPerformanceObligationsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfPerformanceObligationsExplanatory", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of performance obligations [text block]", "terseLabel": "Schedule of deferred revenue and advances from customers" } }, "en": { "role": { "documentation": "The disclosure of performance obligations in contracts with customers. [Refer: Performance obligations [member]]" } } }, "auth_ref": [ "r149" ] }, "ifrs-full_CurrentTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentTaxLiabilities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current tax liabilities", "terseLabel": "Income tax payable" } }, "en": { "role": { "documentation": "The amount of current tax for current and prior periods to the extent unpaid. Current tax is the amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period." } } }, "auth_ref": [ "r18" ] }, "ifrs-full_ParentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ParentMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeAndOtherPayableDetails" ], "lang": { "en-us": { "role": { "label": "Parent company", "terseLabel": "Parent company" } }, "en": { "role": { "documentation": "This member stands for an entity that controls one or more entities." } } }, "auth_ref": [ "r71" ] }, "biox_ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities": { "xbrltype": "textBlockItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "ScheduleOfSignificantNonCashTransactionsRelatedToInvestingAndFinancingActivities", "presentation": [ "http://www.biocerescrops.com/role/DisclosureCashFlowInformationTables" ], "lang": { "en-us": { "role": { "documentation": "The tabular disclosure of significant non-cash transactions related to investing and financing activities.", "label": "Schedule of Significant Non-Cash Transactions Related to Investing and Financing Activities", "terseLabel": "Schedule of significant non-cash transactions related to investing and financing activities" } } }, "auth_ref": [] }, "ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AllowanceAccountForCreditLossesOfFinancialAssets", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails": { "parentTag": "ifrs-full_TradeAndOtherCurrentReceivables", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Allowance account for credit losses of financial assets", "negatedTerseLabel": "Allowance for impairment of trade debtors" } }, "en": { "role": { "documentation": "The amount of an allowance account used to record impairments to financial assets due to credit losses. [Refer: Financial assets]" } } }, "auth_ref": [ "r205" ] }, "biox_BioceresCropsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "BioceresCropsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionGoodwillDetails" ], "lang": { "en-us": { "role": { "documentation": "This member stands for Bioceres Crops.", "label": "Bioceres Crops [Member]", "terseLabel": "Bioceres Crops S.A.", "verboseLabel": "Bioceres Crops S.A." } } }, "auth_ref": [] }, "ifrs-full_CurrentTradeReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentTradeReceivables", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails": { "parentTag": "ifrs-full_TradeAndOtherCurrentReceivables", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionTradeReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Current trade receivables", "terseLabel": "Trade debtors" } }, "en": { "role": { "documentation": "The amount of current trade receivables. [Refer: Trade receivables]" } } }, "auth_ref": [ "r210", "r212" ] }, "ifrs-full_PresentationOfLeasesForLesseeAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PresentationOfLeasesForLesseeAbstract", "lang": { "en-us": { "role": { "label": "LEASES" } } }, "auth_ref": [] }, "ifrs-full_TradeReceivablesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeReceivablesMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureFinancialInstrumentsRiskManagementFinancialAssetsByCategoryDetails" ], "lang": { "en-us": { "role": { "label": "Trade receivables" } }, "en": { "role": { "documentation": "This member stands for trade receivables. [Refer: Trade receivables]" } } }, "auth_ref": [ "r178", "r181", "r244", "r252" ] }, "ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AmortisationIntangibleAssetsOtherThanGoodwill", "calculation": { "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 1.0 }, "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails": { "parentTag": "biox_ProductionCostsAndSellingGeneralAndAdministrativeExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeExpensesClassifiedByNatureAndFunctionsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfComprehensiveIncomeRDClassifiedByNatureDetails" ], "lang": { "en-us": { "role": { "label": "Amortisation, intangible assets other than goodwill", "terseLabel": "Amortization of intangible assets" } }, "en": { "role": { "documentation": "The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]" } } }, "auth_ref": [ "r93" ] }, "biox_AdjustmentsForDecreaseIncreaseInEmployeeBenefitsAndSocialSecurity": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "AdjustmentsForDecreaseIncreaseInEmployeeBenefitsAndSocialSecurity", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Adjustments for decrease (increase) in employee benefits and social security to reconcile profit (loss) to net cash flow from (used in) operating activities.", "label": "Adjustments for Decrease (Increase) in Employee Benefits and Social Security", "terseLabel": "Employee benefits and social security" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfPropertyPlantAndEquipmentLineItems", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentAccumulatedDepreciationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentGrossCarryingAmountsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentNetCarryingAmountDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about property, plant and equipment [line items]", "terseLabel": "Property, plant and equipment" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfPropertyPlantAndEquipmentTable", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentAccumulatedDepreciationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentGrossCarryingAmountsDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionPropertyPlantAndEquipmentNetCarryingAmountDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about property, plant and equipment [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of property, plant and equipment." } } }, "auth_ref": [ "r60" ] }, "biox_AdjustmentsForTransactionExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.biocerescrops.com/20230930", "localname": "AdjustmentsForTransactionExpenses", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 19.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "documentation": "Adjustments for transaction expenses to reconcile profit (loss) to net cash flow from (used in) operating activities.", "label": "Adjustments for Transaction Expenses", "terseLabel": "Transactional expenses" } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments for decrease (increase) in other operating receivables", "terseLabel": "Other receivables" } }, "en": { "role": { "documentation": "Adjustments for decrease (increase) in other operating receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r269" ] }, "ifrs-full_SegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SegmentsAxis", "presentation": [ "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Segments [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r88", "r148", "r192", "r220", "r243" ] }, "ifrs-full_SegmentsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SegmentsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureSegmentInformationGroupSReportingSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Segments [member]" } }, "en": { "role": { "documentation": "This member stands for all segments of an entity. It also represents the standard value for the 'Segments' axis if no other member is used." } } }, "auth_ref": [ "r88", "r148", "r198", "r220", "r243" ] }, "ifrs-full_NoncurrentLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentLeaseLiabilities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/DisclosureLeasesLeaseLiabilityDetails": { "parentTag": "ifrs-full_LeaseLiabilities", "weight": 1.0, "order": 1.0 }, "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureLeasesLeaseLiabilityDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Non-current lease liabilities", "terseLabel": "Lease liabilities", "verboseLabel": "Non-current" } }, "en": { "role": { "documentation": "The amount of non-current lease liabilities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r151" ] }, "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdditionsOtherThanThroughBusinessCombinationsBiologicalAssets", "crdr": "debit", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionBiologicalAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Additions other than through business combinations, biological assets", "terseLabel": "Cost incurred during the period" } }, "en": { "role": { "documentation": "The amount of additions to biological assets, other than those acquired through business combinations. [Refer: Business combinations [member]; Biological assets]" } } }, "auth_ref": [ "r265" ] }, "ifrs-full_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Selling, general and administrative expense", "negatedLabel": "Selling, general and administrative expenses" } }, "en": { "role": { "documentation": "The amount of expense relating to selling, general and administrative activities of the entity." } } }, "auth_ref": [ "r257" ] }, "ifrs-full_CustomerrelatedIntangibleAssetsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CustomerrelatedIntangibleAssetsMember", "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsAccumulatedAmortizationDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsGrossCarryingAmountDetails", "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionIntangibleAssetsNetCarryingAmountDetails" ], "lang": { "en-us": { "role": { "label": "Customer loyalty", "terseLabel": "Customer loyalty" } }, "en": { "role": { "documentation": "This member stands for a class of intangible assets representing assets related to customers. Such assets may include customer lists, order or production backlog, customer contracts and related customer relationships as well as non-contractual customer relationships." } } }, "auth_ref": [ "r263" ] }, "ifrs-full_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/DisclosureInformationAboutComponentsOfConsolidatedStatementsOfFinancialPositionGoodwillDetails", "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Goodwill", "terseLabel": "Goodwill" } }, "en": { "role": { "documentation": "The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Business combinations [member]]" } } }, "auth_ref": [ "r11", "r89", "r90", "r171" ] }, "ifrs-full_NoncurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentLiabilities", "crdr": "credit", "calculation": { "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.biocerescrops.com/role/StatementUnauditedInterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Non-current liabilities", "totalLabel": "Total non-current liabilities" } }, "en": { "role": { "documentation": "The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]" } } }, "auth_ref": [ "r25", "r132", "r236" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "103", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard", "URIDate": "2023-03-23" }, "r1": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_a&doctype=Standard", "URIDate": "2023-03-23" }, "r2": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "d", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_i&doctype=Standard", "URIDate": "2023-03-23" }, "r3": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "d", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "d", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r5": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d&doctype=Standard", "URIDate": "2023-03-23" }, "r6": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106&doctype=Standard", "URIDate": "2023-03-23" }, "r7": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "107", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_107&doctype=Standard", "URIDate": "2023-03-23" }, "r8": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "51", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_51&doctype=Standard", "URIDate": "2023-03-23" }, "r9": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_a&doctype=Standard", "URIDate": "2023-03-23" }, "r10": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_b&doctype=Standard", "URIDate": "2023-03-23" }, "r11": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_c&doctype=Standard", "URIDate": "2023-03-23" }, "r12": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_d&doctype=Standard", "URIDate": "2023-03-23" }, "r13": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_f&doctype=Standard", "URIDate": "2023-03-23" }, "r14": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_g&doctype=Standard", "URIDate": "2023-03-23" }, "r15": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_h&doctype=Standard", "URIDate": "2023-03-23" }, "r16": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_i&doctype=Standard", "URIDate": "2023-03-23" }, "r17": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "k", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_k&doctype=Standard", "URIDate": "2023-03-23" }, "r18": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "n", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_n&doctype=Standard", "URIDate": "2023-03-23" }, "r19": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "o", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_o&doctype=Standard", "URIDate": "2023-03-23" }, "r20": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "q", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_q&doctype=Standard", "URIDate": "2023-03-23" }, "r21": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "r", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_r&doctype=Standard", "URIDate": "2023-03-23" }, "r22": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "55", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard", "URIDate": "2023-03-23" }, "r23": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "56", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_56&doctype=Standard", "URIDate": "2023-03-23" }, "r24": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_66&doctype=Standard", "URIDate": "2023-03-23" }, "r25": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "69", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_69&doctype=Standard", "URIDate": "2023-03-23" }, "r26": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_b&doctype=Standard", "URIDate": "2023-03-23" }, "r27": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_d&doctype=Standard", "URIDate": "2023-03-23" }, "r28": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_e&doctype=Standard", "URIDate": "2023-03-23" }, "r29": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a_i&doctype=Standard", "URIDate": "2023-03-23" }, "r30": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "a", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r31": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "a", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a_iv&doctype=Standard", "URIDate": "2023-03-23" }, "r32": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a&doctype=Standard", "URIDate": "2023-03-23" }, "r33": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79&doctype=Standard", "URIDate": "2023-03-23" }, "r34": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81A", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_a&doctype=Standard", "URIDate": "2023-03-23" }, "r35": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81A", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_b&doctype=Standard", "URIDate": "2023-03-23" }, "r36": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81A", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_c&doctype=Standard", "URIDate": "2023-03-23" }, "r37": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81B", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81B_a_i&doctype=Standard", "URIDate": "2023-03-23" }, "r38": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81B", "Subparagraph": "a", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81B_a_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r39": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81B", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81B_b_i&doctype=Standard", "URIDate": "2023-03-23" }, "r40": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81B", "Subparagraph": "b", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81B_b_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r41": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "82", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_a&doctype=Standard", "URIDate": "2023-03-23" }, "r42": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "82", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_b&doctype=Standard", "URIDate": "2023-03-23" }, "r43": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "82", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_c&doctype=Standard", "URIDate": "2023-03-23" }, "r44": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "82", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_d&doctype=Standard", "URIDate": "2023-03-23" }, "r45": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "91", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_91_a&doctype=Standard", "URIDate": "2023-03-23" }, "r46": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "99", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_99&doctype=Standard", "URIDate": "2023-03-23" }, "r47": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "10", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS10_g17-22_TI", "URIDate": "2023-03-23" }, "r48": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "79", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_79&doctype=Standard", "URIDate": "2023-03-23" }, "r49": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "c", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_i&doctype=Standard", "URIDate": "2023-03-23" }, "r50": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "c", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r51": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "g", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_g_i&doctype=Standard", "URIDate": "2023-03-23" }, "r52": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "g", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_g_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r53": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS12_g79-88_TI", "URIDate": "2023-03-23" }, "r54": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_d&doctype=Standard", "URIDate": "2023-03-23" }, "r55": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "e", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_i&doctype=Standard", "URIDate": "2023-03-23" }, "r56": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "e", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r57": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "e", "Clause": "vii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_vii&doctype=Standard", "URIDate": "2023-03-23" }, "r58": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "e", "Clause": "viii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_viii&doctype=Standard", "URIDate": "2023-03-23" }, "r59": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e&doctype=Standard", "URIDate": "2023-03-23" }, "r60": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73&doctype=Standard", "URIDate": "2023-03-23" }, "r61": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "75", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_75_a&doctype=Standard", "URIDate": "2023-03-23" }, "r62": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "75", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_75_b&doctype=Standard", "URIDate": "2023-03-23" }, "r63": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "142", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_142&doctype=Standard", "URIDate": "2023-03-23" }, "r64": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "36", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2023-en-r&anchor=para_36_b&doctype=Standard", "URIDate": "2023-03-23" }, "r65": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "21", "IssueDate": "2023-01-01", "Paragraph": "52", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2023-en-r&anchor=para_52_b&doctype=Standard", "URIDate": "2023-03-23" }, "r66": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_17_a&doctype=Standard", "URIDate": "2023-03-23" }, "r67": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_17_e&doctype=Standard", "URIDate": "2023-03-23" }, "r68": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "17", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_17&doctype=Standard", "URIDate": "2023-03-23" }, "r69": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "18", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_18_b&doctype=Standard", "URIDate": "2023-03-23" }, "r70": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "18", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_18&doctype=Standard", "URIDate": "2023-03-23" }, "r71": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "19", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_19_a&doctype=Standard", "URIDate": "2023-03-23" }, "r72": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "19", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_19_e&doctype=Standard", "URIDate": "2023-03-23" }, "r73": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "19", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_19_f&doctype=Standard", "URIDate": "2023-03-23" }, "r74": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "19", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_19_g&doctype=Standard", "URIDate": "2023-03-23" }, "r75": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "19", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_19&doctype=Standard", "URIDate": "2023-03-23" }, "r76": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "20", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_20&doctype=Standard", "URIDate": "2023-03-23" }, "r77": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Section": "Disclosures", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS24_g13-24_TI", "URIDate": "2023-03-23" }, "r78": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "26", "IssueDate": "2023-01-01", "Paragraph": "35", "Subparagraph": "b", "Clause": "vi", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2023-en-r&anchor=para_35_b_vi&doctype=Standard", "URIDate": "2023-03-23" }, "r79": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "26", "IssueDate": "2023-01-01", "Paragraph": "35", "Subparagraph": "b", "Clause": "viii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2023-en-r&anchor=para_35_b_viii&doctype=Standard", "URIDate": "2023-03-23" }, "r80": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2023-01-01", "Paragraph": "16", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_16_b&doctype=Standard", "URIDate": "2023-03-23" }, "r81": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_17_b&doctype=Standard", "URIDate": "2023-03-23" }, "r82": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_66&doctype=Standard", "URIDate": "2023-03-23" }, "r83": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "67", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_67&doctype=Standard", "URIDate": "2023-03-23" }, "r84": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "70", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_70_a&doctype=Standard", "URIDate": "2023-03-23" }, "r85": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "70", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_70_b&doctype=Standard", "URIDate": "2023-03-23" }, "r86": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS33_g70-73A_TI", "URIDate": "2023-03-23" }, "r87": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2023-01-01", "Paragraph": "126", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_126&doctype=Standard", "URIDate": "2023-03-23" }, "r88": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2023-01-01", "Paragraph": "130", "Subparagraph": "d", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_130_d_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r89": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2023-01-01", "Paragraph": "134", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_134_a&doctype=Standard", "URIDate": "2023-03-23" }, "r90": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2023-01-01", "Paragraph": "135", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_135_a&doctype=Standard", "URIDate": "2023-03-23" }, "r91": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_c&doctype=Standard", "URIDate": "2023-03-23" }, "r92": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "e", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e_i&doctype=Standard", "URIDate": "2023-03-23" }, "r93": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "e", "Clause": "vi", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e_vi&doctype=Standard", "URIDate": "2023-03-23" }, "r94": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "e", "Clause": "vii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e_vii&doctype=Standard", "URIDate": "2023-03-23" }, "r95": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e&doctype=Standard", "URIDate": "2023-03-23" }, "r96": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118&doctype=Standard", "URIDate": "2023-03-23" }, "r97": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "126", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_126&doctype=Standard", "URIDate": "2023-03-23" }, "r98": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2023-01-01", "Paragraph": "32A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_32A&doctype=Standard", "URIDate": "2023-03-23" }, "r99": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2023-01-01", "Paragraph": "76", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_76_b&doctype=Standard", "URIDate": "2023-03-23" }, "r100": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2023-01-01", "Paragraph": "76", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_76&doctype=Standard", "URIDate": "2023-03-23" }, "r101": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_79_c&doctype=Standard", "URIDate": "2023-03-23" }, "r102": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "d", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_79_d_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_79_d&doctype=Standard", "URIDate": "2023-03-23" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS40_g74-79_TI", "URIDate": "2023-03-23" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "41", "IssueDate": "2023-01-01", "Paragraph": "40", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_40&doctype=Standard", "URIDate": "2023-03-23" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "41", "IssueDate": "2023-01-01", "Paragraph": "50", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_50_a&doctype=Standard", "URIDate": "2023-03-23" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "41", "IssueDate": "2023-01-01", "Paragraph": "50", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_50_f&doctype=Standard", "URIDate": "2023-03-23" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "41", "IssueDate": "2023-01-01", "Paragraph": "50", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_50&doctype=Standard", "URIDate": "2023-03-23" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "41", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_54_f&doctype=Standard", "URIDate": "2023-03-23" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "41", "IssueDate": "2023-01-01", "Paragraph": "55", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard", "URIDate": "2023-03-23" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "10", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_10&doctype=Standard", "URIDate": "2023-03-23" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "18", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_18_b&doctype=Standard", "URIDate": "2023-03-23" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "21", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_21&doctype=Standard", "URIDate": "2023-03-23" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "25", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_25&doctype=Standard", "URIDate": "2023-03-23" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "28", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_28&doctype=Standard", "URIDate": "2023-03-23" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "31", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_31&doctype=Standard", "URIDate": "2023-03-23" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35&doctype=Standard", "URIDate": "2023-03-23" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard", "URIDate": "2023-03-23" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "50", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_50_d&doctype=Standard", "URIDate": "2023-03-23" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Section": "Presentation of a statement of cash flows", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS07_g10-17_TI", "URIDate": "2023-03-23" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "30", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2023-en-r&anchor=para_30_b&doctype=Standard", "URIDate": "2023-03-23" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "24", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_24_a&doctype=Standard", "URIDate": "2023-03-23" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "24", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_24_b&doctype=Standard", "URIDate": "2023-03-23" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "32", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_32_a_i&doctype=Standard", "URIDate": "2023-03-23" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "32", "Subparagraph": "a", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_32_a_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "10", "IssueDate": "2023-01-01", "Paragraph": "22", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=10&code=ifrs-tx-2023-en-r&anchor=para_22&doctype=Standard", "URIDate": "2023-03-23" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "12", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_12_e&doctype=Standard", "URIDate": "2023-03-23" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "12", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_12_f&doctype=Standard", "URIDate": "2023-03-23" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "ix", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "v", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "viii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_viii&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B13", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B13", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B4", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B4_a&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B4", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B4_b&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_a&doctype=Standard", "URIDate": "2023-03-23" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_b&doctype=Standard", "URIDate": "2023-03-23" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_e&doctype=Standard", "URIDate": "2023-03-23" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93&doctype=Standard", "URIDate": "2023-03-23" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "14", "IssueDate": "2023-01-01", "Paragraph": "33", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2023-en-r&anchor=para_33_b&doctype=Standard", "URIDate": "2023-03-23" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "105", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_105&doctype=Standard", "URIDate": "2023-03-23" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "113", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_113_a&doctype=Standard", "URIDate": "2023-03-23" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "114", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_114&doctype=Standard", "URIDate": "2023-03-23" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "115", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_115&doctype=Standard", "URIDate": "2023-03-23" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "119", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_119&doctype=Standard", "URIDate": "2023-03-23" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "47", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_47_a&doctype=Standard", "URIDate": "2023-03-23" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "47", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_47_b&doctype=Standard", "URIDate": "2023-03-23" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "53", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_a&doctype=Standard", "URIDate": "2023-03-23" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "53", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_h&doctype=Standard", "URIDate": "2023-03-23" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "53", "Subparagraph": "j", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_j&doctype=Standard", "URIDate": "2023-03-23" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "53", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53&doctype=Standard", "URIDate": "2023-03-23" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS16_g51-60_TI", "URIDate": "2023-03-23" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Section": "Presentation", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS16_g47-50_TI", "URIDate": "2023-03-23" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "120", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_120&doctype=Standard", "URIDate": "2023-03-23" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "124", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_124&doctype=Standard", "URIDate": "2023-03-23" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "125", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_125&doctype=Standard", "URIDate": "2023-03-23" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "127", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_127&doctype=Standard", "URIDate": "2023-03-23" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "128", "Subparagraph": "a", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_128_a_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "128", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_128_a&doctype=Standard", "URIDate": "2023-03-23" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "C32", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_C32&doctype=Appendix&subtype=C", "URIDate": "2023-03-23" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "44", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_44&doctype=Standard", "URIDate": "2023-03-23" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_i&doctype=Standard", "URIDate": "2023-03-23" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "vi", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_vi&doctype=Standard", "URIDate": "2023-03-23" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_d&doctype=Standard", "URIDate": "2023-03-23" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard", "URIDate": "2023-03-23" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "47", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_a_i&doctype=Standard", "URIDate": "2023-03-23" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2023-01-01", "Paragraph": "B67", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "5", "IssueDate": "2023-01-01", "Paragraph": "33", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2023-en-r&anchor=para_33_b_i&doctype=Standard", "URIDate": "2023-03-23" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "21C", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_21C&doctype=Standard", "URIDate": "2023-03-23" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "25", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_25&doctype=Standard", "URIDate": "2023-03-23" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "31", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_31&doctype=Standard", "URIDate": "2023-03-23" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "33", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_33&doctype=Standard", "URIDate": "2023-03-23" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_34&doctype=Standard", "URIDate": "2023-03-23" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35H", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35H_b_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35H", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35H&doctype=Standard", "URIDate": "2023-03-23" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35I", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35I&doctype=Standard", "URIDate": "2023-03-23" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35M", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35M_b_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35M", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35M&doctype=Standard", "URIDate": "2023-03-23" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "42I", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_42I&doctype=Standard", "URIDate": "2023-03-23" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_6&doctype=Standard", "URIDate": "2023-03-23" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_7&doctype=Standard", "URIDate": "2023-03-23" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "B2", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B2_a&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "B8", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B8_c&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Section": "Defined terms", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&doctype=Appendix&subtype=A&dita_xref=IFRS07_APPA_TI", "URIDate": "2023-03-23" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_a&doctype=Standard", "URIDate": "2023-03-23" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_g&doctype=Standard", "URIDate": "2023-03-23" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_h&doctype=Standard", "URIDate": "2023-03-23" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard", "URIDate": "2023-03-23" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_a&doctype=Standard", "URIDate": "2023-03-23" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_b&doctype=Standard", "URIDate": "2023-03-23" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_c&doctype=Standard", "URIDate": "2023-03-23" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_d&doctype=Standard", "URIDate": "2023-03-23" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_e&doctype=Standard", "URIDate": "2023-03-23" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28&doctype=Standard", "URIDate": "2023-03-23" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "32", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_32&doctype=Standard", "URIDate": "2023-03-23" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "33", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_33_a&doctype=Standard", "URIDate": "2023-03-23" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_34&doctype=Standard", "URIDate": "2023-03-23" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS08_g20-24_TI", "URIDate": "2023-03-23" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "9", "IssueDate": "2023-01-01", "Paragraph": "7.2.34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2023-en-r&anchor=para_7.2.34&doctype=Standard", "URIDate": "2023-03-23" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "9", "IssueDate": "2023-01-01", "Paragraph": "7.2.42", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2023-en-r&anchor=para_7.2.42&doctype=Standard", "URIDate": "2023-03-23" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expired 2023-01-01", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "16", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_16&doctype=Standard&book=b", "URIDate": "2023-03-23" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expired 2023-01-01", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "8", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_8_d&doctype=Standard&book=b", "URIDate": "2023-03-23" }, "r207": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "102", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_102&doctype=Standard", "URIDate": "2023-03-23" }, "r208": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "103", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard", "URIDate": "2023-03-23" }, "r209": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "108", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_108&doctype=Standard", "URIDate": "2023-03-23" }, "r210": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "68", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_68&doctype=Standard", "URIDate": "2023-03-23" }, "r211": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "70", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_70&doctype=Standard", "URIDate": "2023-03-23" }, "r212": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_b&doctype=Standard", "URIDate": "2023-03-23" }, "r213": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "82A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82A&doctype=Standard", "URIDate": "2023-03-23" }, "r214": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "IG6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_IG6&doctype=Implementation%20Guidance", "URIDate": "2023-03-23" }, "r215": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "80", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_80_a&doctype=Standard", "URIDate": "2023-03-23" }, "r216": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "37", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_37_b&doctype=Standard", "URIDate": "2023-03-23" }, "r217": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "37", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_37_c&doctype=Standard", "URIDate": "2023-03-23" }, "r218": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "37", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_37_g&doctype=Standard", "URIDate": "2023-03-23" }, "r219": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "37", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_37_h&doctype=Standard", "URIDate": "2023-03-23" }, "r220": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "138", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_138_d&doctype=Standard", "URIDate": "2023-03-23" }, "r221": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "32", "IssueDate": "2023-01-01", "Paragraph": "IE33", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2023-en-r&anchor=para_IE33&doctype=Illustrative%20Examples", "URIDate": "2023-03-23" }, "r222": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "36", "IssueDate": "2023-01-01", "Paragraph": "127", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_127&doctype=Standard", "URIDate": "2023-03-23" }, "r223": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "119", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_119_c&doctype=Standard", "URIDate": "2023-03-23" }, "r224": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "119", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_119_e&doctype=Standard", "URIDate": "2023-03-23" }, "r225": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "41", "IssueDate": "2023-01-01", "Paragraph": "43", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_43&doctype=Standard", "URIDate": "2023-03-23" }, "r226": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "41", "IssueDate": "2023-01-01", "Paragraph": "51", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_51&doctype=Standard", "URIDate": "2023-03-23" }, "r227": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "41", "IssueDate": "2023-01-01", "Section": "Example 1 XYZ Dairy Ltd", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&doctype=Illustrative%20Examples&dita_xref=IAS41_IE_ex1_TI", "URIDate": "2023-03-23" }, "r228": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "16", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_16_a&doctype=Standard", "URIDate": "2023-03-23" }, "r229": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "16", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_16_b&doctype=Standard", "URIDate": "2023-03-23" }, "r230": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_b&doctype=Standard", "URIDate": "2023-03-23" }, "r231": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_c&doctype=Standard", "URIDate": "2023-03-23" }, "r232": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_d&doctype=Standard", "URIDate": "2023-03-23" }, "r233": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_e&doctype=Standard", "URIDate": "2023-03-23" }, "r234": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "44C", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_44C&doctype=Standard", "URIDate": "2023-03-23" }, "r235": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Section": "C Reconciliation of liabilities arising from financing activities", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_C_TI", "URIDate": "2023-03-23" }, "r236": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B10", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r237": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B23", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B23_c&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r238": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "B6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_B6&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r239": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "IE63", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_IE63&doctype=Illustrative%20Examples", "URIDate": "2023-03-23" }, "r240": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "B89", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_B89_a&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r241": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "53", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53&doctype=Standard", "URIDate": "2023-03-23" }, "r242": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "113", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_113_b&doctype=Standard", "URIDate": "2023-03-23" }, "r243": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "96", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_96_c&doctype=Standard", "URIDate": "2023-03-23" }, "r244": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35N", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35N&doctype=Standard", "URIDate": "2023-03-23" }, "r245": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard", "URIDate": "2023-03-23" }, "r246": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_b&doctype=Standard", "URIDate": "2023-03-23" }, "r247": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r248": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "10", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_10_e&doctype=Standard", "URIDate": "2023-03-23" }, "r249": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "104", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_104&doctype=Standard", "URIDate": "2023-03-23" }, "r250": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d&doctype=Standard", "URIDate": "2023-03-23" }, "r251": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "108", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_108&doctype=Standard", "URIDate": "2023-03-23" }, "r252": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "112", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard", "URIDate": "2023-03-23" }, "r253": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "117", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_117&doctype=Standard", "URIDate": "2023-03-23" }, "r254": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "55", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard", "URIDate": "2023-03-23" }, "r255": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78&doctype=Standard", "URIDate": "2023-03-23" }, "r256": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a&doctype=Standard", "URIDate": "2023-03-23" }, "r257": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "85", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_85&doctype=Standard", "URIDate": "2023-03-23" }, "r258": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81&doctype=Standard", "URIDate": "2023-03-23" }, "r259": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "37", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_37&doctype=Standard", "URIDate": "2023-03-23" }, "r260": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_d&doctype=Standard", "URIDate": "2023-03-23" }, "r261": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "37", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2023-en-r&anchor=para_37&doctype=Standard", "URIDate": "2023-03-23" }, "r262": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_c&doctype=Standard", "URIDate": "2023-03-23" }, "r263": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "119", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_119&doctype=Standard", "URIDate": "2023-03-23" }, "r264": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "40", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_79_c&doctype=Standard", "URIDate": "2023-03-23" }, "r265": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "41", "IssueDate": "2023-01-01", "Paragraph": "50", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_50&doctype=Standard", "URIDate": "2023-03-23" }, "r266": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "41", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_54_f&doctype=Standard", "URIDate": "2023-03-23" }, "r267": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "14", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_14&doctype=Standard", "URIDate": "2023-03-23" }, "r268": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "16", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_16&doctype=Standard", "URIDate": "2023-03-23" }, "r269": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "20", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_a&doctype=Standard", "URIDate": "2023-03-23" }, "r270": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "20", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_b&doctype=Standard", "URIDate": "2023-03-23" }, "r271": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "20", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_c&doctype=Standard", "URIDate": "2023-03-23" }, "r272": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "20", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20&doctype=Standard", "URIDate": "2023-03-23" }, "r273": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "31", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_31&doctype=Standard", "URIDate": "2023-03-23" }, "r274": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard", "URIDate": "2023-03-23" }, "r275": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "e", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_e_i&doctype=Standard", "URIDate": "2023-03-23" }, "r276": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "94", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_94&doctype=Standard", "URIDate": "2023-03-23" }, "r277": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_7&doctype=Standard", "URIDate": "2023-03-23" }, "r278": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Note": "Expired 2023-01-01", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "16", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2017-en-b&anchor=para_16&doctype=Standard&book=b", "URIDate": "2023-03-23" } } } ZIP 105 0001104659-23-122042-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-23-122042-xbrl.zip M4$L#!!0 ( +N!?5<;[_A172( ,F3 0 1 8FEO>"TR,#(S,#DS,"YX M;C;JXK\=R:;F4NR)4ORC#:VZ)/D2?*T!9&0S!V* M4$#2MO+IKQLD)5($05(2;?B.+S.VV6B@T3\ #72C\>/?GY>N\4BY[S#OIW?G M)V?O#.I9S':\Q4_OPF#>^>'=WW_^M[_\^.^=SF]7XQO#9E:XI%Y@6)R2@-K& MDQ,\&%.V6A'/N*6<.ZYK7'''7E##.#\[>7]R=G)^:70Z/PL>5\2',LPS!+.+ MD_/D0R]FQ[Q/QOGYZ<4/IQ=G%Y? X=/Y]Y\^7!AWMPGE+31N[I23/OOV)]]Z MH$MB!(0O:# B2^JOB$5_>O<0!*M/IZ=/3T\G,X=9E%/?XFSEGUAL*;B=?;R$ MGB!!P)U9&-!KQI=].B>A&T"O>'^$Q!5M@,YR*79'AB#U&7K7\S]!4S)U/EV> M,+Z BL[.3W^[O9F(5B;$T*#GRBV,BG ZSY1XGG$WJ>'[4_B:$/H\Z 3K%?4W MY'/BSP3IYI/@OFDY<+*##76:\8?3Z..&U"ULP^7I;S>.]RVA# ->2/KQ%+XF MA"X44C#%SS, 5$HZJ5Q9B7),8VV?R/"GIT06B62$E9RX]C"1A?7\/O"BZ$6X*1 MK-BF.T/.82XKZL_X:Z9#G3GW._/0C:'L)X7P[Z+R@#PSCRVC4JCS"^B&I%!Z ME&'K"D:9^)2IU@]67-Y*_)(E=:P"2L?*$'I4U7\Q_#9]Y1''\N6,Q:<,:_IL M/?]@E+E!/\F67O&#.3+Y$Y#__Q3#$JD,\CP5"&/Q3\L?5RO'F+/H+ M_ TGFD]8V10X&/C#_7A8,N\+K4V M5AS[CT2V@Z,H:$74.XL>\RSH4.I#3_X MS'5L'%\;:M^<7SL>#%>'N'?,=[!Y[PP'ANHQ&2;B)0+:=.YXXM//,->_[P^F@;PQ'T\%X>&OTS%%_,)K 7^"GB7DS['?Q\V0*_]T.1M.) M85X;U\-1=]0;=F^,.W,RG [-T8^GN]7M-"0$,4SO9_$SS#T^U"\TA.M27#@F M412TB&N%;OURVV85%HO_F #BB#"IJLP>6T+'/."0?*1#L &7M ?R7NR Y&!V M2HA'PT8WS#QHFD\BK89\Z1Q!A&M:\'X8F"< M9AY$ZY )1*ZBYK5H?#$T#I8KEZTI MO:(>"!/X )0)0X()M4+N!.LFH5FY-;5'[ M8JCMTSGEG-IC^DB]$&>WKOV(#CS_FK-E+_0#MJ2\T:6]9A-*$-RXQ9DT%Q9] MT5X!8!*WV)A#DPTK:7,+Y*: +#D:'O=[+NQ!A9/[:CTB ; ^(FYKUJB$Z?=' MW1@5>#C&_T&6J__N&]:FC<9L;7BBE2TP7Q"8@^<5GF'[>;# 7'<=>I;P<3<+ MU7IM* 'O,7=5!>!-VBM'+TZY\Z31+99?$,MB[Q/_R!,EC6C0+'K+:BW!ZX?F M\1J= SBBB0;C!HT;^9WAT:!%Z LB-+(OZ9CZH7O4P_G*=96@\?OFT1BW"TQ4 MT; 6?U7P-R7/HLGP/_5-+])P 7Z4M$K]_RWO*)QV?^LFQSC(#V.AXYFD55P- MQ8VIQ6!GZ3KB-W..@S?$"% @&,,X+M%EU>(EZLU9]BGU9JLPV-R 9Q6UWU "AK#X]\8A,YC]"L_"5:1*9;[/ASO<#+J3P01_0':&F_!KE59IK#X0 ML'69:U/N)RZO,771)KXC, JH?T5<<>0)7Z><>#Z)=N/IGXO&\3%Y*V$AB] ?CB=$=]0US^F4P-L:#&V%>WW7'TR' YJI[TQWU!A')=-P=3;H] MG \FD:]MTXP63570] M=WQ*/+,16Z@[4SCR/NKBA@MV4$&82+I>$KZ-=5O)' M<]YW.+7 --K@Y)8N9\7^B,;J4:+L^SS*?AG\;MQV1]W/8JMFW '8S-%H<",V M;+!;2]:6N#EH"5JI!N'O=M*DE%=W&;6J!5TC,P/C@R>8>= M,C[Y\FCQR5^ZH\\P;0U'QN!_[H?3WUN$-.Q!'7J/\(5QI]D *$DU);%/QSSU ME'I"4TUJ9Z07P]N5PURV<*R7"#\NJJL$><<\X90B;]NN-NKXI?%W!]PI#]9W M8*('8"[A\K9"XB:!6%II"2(;C[]+&OB=@??. V&ST:21+3I?'YTC&O0(YVO' M6W27F#?A5>!:V(H2_/[PNOCM""^F%;?<(*+I+:I?']6?.?/]+*(:-0CV:D@) MMC^^-K87V/9==+5VU+R06 L]<&.=DVW[!3 M[6]A_H(G!0'Q%ICB)G'ERDL0VO@-E1Q" MOVN-7ZU@*S$U7Q*XBNI+H-OXU10)=*6V;0O>5P-ORHH$[/# ^;-QB[9F$TI MW/B-:@F(T[8K236YQ?&+X?@S8_:3X[I- G6WCA(D-N[?2MK3PNSEG%N,<_8$ M*U6S;JU<+250:_SX==NB%FRO +:7LR;+ZBP!8N-GI=OV?==:C:^&3)&U@=HC M%C0;5"*K1XW B\9/B.(V&:)1+>9>\@)]E-"@X3OSV4J4:),$5C9P33Y.X] B MK0+2HEC&\@LWA71*?7_,ZSL*8FSOVM15U#^8XP5?06#X&8.:8>N/.7:*UY/R M LH8Z/.\ZOYA#D=3XRL,O_MQ'$C?G4Q,F.^G\&NKQ0I:W"S80\\/N'ADQQ\[ M_K=MD/N&(CK;N5KW0&4+QHMNV!R!HQ('EWD<;%?YX6@R'=]'$S),O,/)+^D@ M^>3:MSDB:I1L2Z"3\^WL QUWVX 6/PW@ASC\ M*W%#>K7^XE!.N/5P &H4S$JPDG.FU, *U&H\8K4(D(>DXA8AQT%(+WY%"?^Z M-S)D3$H0D?-,5$=$4IO!H;H6!]5O]8Z=Q4-@SN_]Z'=;V S*R[W*$DH-O\^; M%IL[OH)KA\T[(5[U%8PC&Z)5YC[*%$JY6B/#BLJ4E"A19FX"ERLSTB+,T_BJ M5JO-1N]N;_-K'_OF=IZS$AV2UPN.<&][VX@61XWB*,Z-??3[_[M\2S"4FV&. M@*&D"2V"*B-(O.\+_::X(U9(I]2P))66T'#GJCL1ZOQ=F'>MIHHU%;_Y>D#VYC755A5*AK;.SLX\B!CYY*SKU(X:J1\R,%+=66\7CZC/U8-/JYK6D MHE!HY_Q,3 :C,7F:7/VWNJD6"==2SS'C&FH D TX38N7S"I.;XYO^-T M1;A44Y7+*?4GR6;5[?7,^]%T./J,CK!1OSON1TL:3(]#X1&[&P]@S6LU6Z+9 M$7W:J@9F+%N<5X"21"H0Z(RH)_RA[X>85WE(_-FNEO?BH=2XY*1]-/AUJ^KO MC"XL?_WHT /5+O*(@,JGW<3>9 M8>2?E"J3G&!,8--KCKHW;::6YJ-J&@FA46N\Z6ZN20>)+ZP2-JG>T?HMCJL2R$0!XFH-9'85Q'V]T- M^&:/YHQ5*[6!S.LM' Y)L%X_5;I:P?LF/6^U6,-=7NHG5^NHFH.\U8ABW\6$ M9XZ"O4%]&!Q+)T@<-V,*UH<3S86F!T7@MUF(OZ+;CN';UKDMVF'YYX'N(#&3P7!Q.HP.W=Z4J&(4MFR\Y2OT6EOKW<_'N-! M5_=Z"JLK*G4\N#/'T_CP:VCV6VWN[\7?],4=Q^-! MJ9BY$DPO\$1]"Z=279*5H5[N%-DZNND$ZI ML@O)]1W)\[RMHH[A8I,KKG(YI2(/N*K?*K>JWTVNP,PWI9**K^.V.FCRL63Y MA'D@.Z6FF[@6V6+D&!XZ.1@JEU-J7;*;K_9$<:O:?6[C%5QS+294*.]]Q;MY M\-?VIFN]BSQ%MY'S%$K]J*_UM%IYT:>8?>%2C5_#>H$WF8OJ4R+FPWGC3^1N MVV:L-HUKL?B"1_@]Y@?F?$**$V$T5Y$2?=_G?8K'3ZN+C3+8W!#-:G%7YZS_ MECT*;9M@'LPIY]1.W#;/!4"J45*)C+_ED;'Q$72,A+O!/ /V)(8=UV$XHA(C M(,^MHO=P)13E4)93*158Y>)3JZ/##JA[#\1;4'_H94BVZVW]#,N5.:IT?RX) M%5$?T5($38(-Z M6^T8V'!\GLNM)?J.?C64')!45Y]9\&DHDTMF=66"(M1M5)P#=_)Q@!W,I;W0 M#]BR^^SX?;8D#IH_)'3S$;A5BB@F69#N+/>2<\+3 *9&Q-5 MD;$UT@8_]^< M/7\\??;M3V2U&!X9$G]%;&V^)D3?R;0$_H= M9.Z?(FK?&;[U0)?DAEF"3T3N [V :KK0@I"5*'-*H9\W; 3X3Z#J&'?J5@BN M/K5.%NP1AK-3I1&[Y/A#O5HS0\\.^"F.9^1UT3F[[%R>%S>@K*3XW=^O(3 ' M?(Q&FT<7N .5-V.WF,MYIE0'^73.+SKGW^_=CLM3Q_,#]'94:X,H@K]UDG+8 MBDMLQ>5Y/3#$[#Z(W^R@9D"493[LSOR $RN^KX,+[S^KD4>K-S;>^817/KS%,*!+G%U! MU!#(G$!< OG,6;A*"!T@>6>0F,E/[P(> KGGN"[Z:I+?(]J5N$TP%=7889*! MKDC&,<6T^()(7#O!!7Q]YY)(C#]"9Y6(-)]3*S#G4_(\AI$>[2-NZ7)&>:H/ MCL,NZB.8X3IB1OMDBV7U5?NI:_\KC'='UXRG7+"#9W3+)5X\T0D5:-,H6#(8 MOX2O*\LGEV<6>8A!&#IS@F-(:E9M?6IQC!49>LG_T;DA#,U;L J7X1)O MKL!\MCU/5&!\3VZ:HJ5,M@'LO-B:TBOJ4;RF!U).\%S'%0\9;M(%5NJG"KS> M:"\EY]'Q:WMX_&4_BAB6:\Z6T:Z)\CJ8JLSQC?88V O1-BY:''W3*YQX:HW$ M&EPU[;G#KM%*9O1C,=1LCB\/'9+T19U"FLF[/96)W*1)@\UYW^$ =K8-IXML M2]^M.?_,F!V- M \^FJ&%S/J'\T8%I-A62N,YG&$DV $=@U^0T!/.BO>\\!"(1#C-&=HE.K=T" M!\GO%;KK6 PUG;>K9CJ7S$KUBVHV-VU".,SYB'EX RFMLN1&DFQQJEU2-\FM M!VJ'./@GSL)SYHX%^W^))#&^(VRK/CD*OTEBK=-4=GK<*:6&TO4X6T$S RK6 MG?S\(/VLJ1RC$.R(0C%R7S64(G\;1V)=J8@TLZK&SI]L!CPI[_(%Q^C"#C[9SA(#Z9D0LW$9HG@@N13)-PVU<,/( M]NG-"J<8%>E?QPR-@D*"8FF3AE<[BTF)7;>@IO)7.M5[8P=/.,ZV9P61YR.5 M#$O$'(#5Q\"*=9WMG5K9 ?#AK/0X8LC*D;YXM!$ECD^(D5NQ1_;@I$>'['4! M4.I+.HB/9C9%VM\AV^R!9F%XDH#Q=8&7I+24'NJ/7#:$?X,Y"UC%TS:Z UWB M^\[<@=V&.#L*.:=>L+MGK%/R52;)TGD_K3.Q:TQM@RNYP\H*Z:'GKNNR)^RK M:P8;_2#D7NR42CL;BFDT7;1S ZZN\LH*Z:&\5 /1I0@K2T_TF9\?E>6D>@[# MPG9+YYY*U&]"T#%UEK.0^[&G2U@,( AFZRN3ND)1/;L@B5>:LDFX6KD.Y7(M ME]#I*9R84>(VIA2VNVM2DVDLVE8#9=*I*/44,&O2HQ/)0ULMEJ+B3J"LF!Y+ M2A*0DD2AY$[,B@@T/*BY"[GU0/QTWZ?/)V1?-=VP@^%%G44\;*SHD"$*6S0] MF6P5Z77U?"9-Q,QN= ZR], NPZV?1-0*M)HJ-6UO1C?*,0 \FP%E3'U* *
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�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®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end

Document and Entity Information	3 Months Ended
Document and Entity Information	Sep. 30, 2023
Document and Entity Information [Abstract]
Document Type	6-K
Entity Registrant Name	Bioceres Crop Solutions Corp.
Entity Central Index Key	0001769484
Document Period End Date	Sep. 30, 2023
Current Fiscal Year End Date	--06-30
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1
Amendment Flag	false

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - USD ($)	Sep. 30, 2023	Jun. 30, 2023
CURRENT ASSETS
Cash and cash equivalents	$ 28,373,924	$ 48,129,194
Other financial assets	14,628,202	12,135,020
Trade receivables	186,276,319	158,006,474
Other receivables	24,902,503	28,824,998
Income and minimum presumed recoverable income taxes	2,022,328	9,444,898
Inventories	138,076,822	140,426,975
Biological assets	1,141,113	146,842
Total current assets	395,421,211	397,114,401
NON-CURRENT ASSETS
Other financial assets	502,910	444,909
Other receivables	2,393,939	2,546,241
Income and minimum presumed recoverable income taxes	5,446	16,286
Deferred tax assets	8,230,402	7,312,964
Investments in joint ventures and associates	40,820,784	39,296,810
Investment properties	3,675,493	3,589,749
Property, plant and equipment	69,930,709	67,853,835
Intangible assets	173,034,536	173,783,956
Goodwill	112,163,432	112,163,432
Right of use asset	13,519,199	13,936,575
Total non-current assets	424,276,850	420,944,757
Total assets	819,698,061	818,059,158
CURRENT LIABILITIES
Trade and other payables	159,125,358	150,807,674
Borrowings	100,720,985	107,639,659
Employee benefits and social security	10,019,165	9,606,707
Deferred revenue and advances from customers	32,771,902	24,875,662
Income tax payable	536,840	509,034
Consideration for acquisition	4,202,389	1,415,099
Lease liabilities	4,326,889	3,858,699
Total current liabilities	311,703,528	298,712,534
NON-CURRENT LIABILITIES
Borrowings	48,789,492	60,670,946
Deferred revenue and advances from customers	2,202,374	2,057,805
Joint ventures and associates	638,126	622,823
Deferred tax liabilities	34,393,580	35,785,347
Provisions	668,775	891,769
Consideration for acquisition	2,540,181	3,578,157
Secured notes	76,911,874	75,213,146
Lease liabilities	9,225,862	10,030,524
Total non-current liabilities	175,370,264	188,850,517
Total liabilities	487,073,792	487,563,051
EQUITY
Equity attributable to owners of the parent	298,966,341	298,594,088
Non-controlling interest	33,657,928	31,902,019
Total equity	332,624,269	330,496,107
Total equity and liabilities	$ 819,698,061	$ 818,059,158

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)	3 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
Revenues from contracts with customers	$ 116,182,805	$ 126,843,248
Initial recognition and changes in the fair value of biological assets at the point of harvest	410,913	490,006
Cost of sales	(71,615,781)	(75,675,878)
Changes in the net realizable value of agricultural products after harvest	(1,446,316)	(227,936)
Research and development expenses	(4,581,241)	(3,852,014)
Selling, general and administrative expenses	(33,932,848)	(31,904,911)
Share of profit or loss of joint ventures and associates	1,508,671	842,240
Other income or expenses, net	(1,231,635)	478,041
Operating profit	5,294,568	16,992,796
Financial cost	(7,661,857)	(6,779,847)
Other financial results	117,865	(1,288,306)
(Loss) profit before income tax	(2,249,424)	8,924,643
Income tax	(429,040)	(5,012,643)
(Loss) profit for the period	(2,678,464)	3,912,000
Other comprehensive (loss) income	(929,957)	31,025
Items that may be subsequently reclassified to profit and loss	(929,957)	31,025
Foreign exchange differences on translation of foreign operations from joint ventures		100,868
Foreign exchange differences on translation of foreign operations	(929,957)	(69,843)
Total comprehensive (loss) profit	(3,608,421)	3,943,025
(Loss) profit for the period attributable to:
Equity holders of the parent	(4,591,634)	498,297
Non-controlling interests	1,913,170	3,413,703
(Loss) profit for the period	$ (2,678,464)	$ 3,912,000
(Loss) profit per share
Basic (loss) profit attributable to ordinary equity holders of the parent	$ (0.0731)	$ 0.0082
Diluted (loss) profit attributable to ordinary equity holders of the parent	$ (0.0731)	$ 0.0081
Total comprehensive (Loss) profit attributable to:
Equity holders of the parent	$ (5,364,330)	$ 401,715
Non-controlling interests	1,755,909	3,541,310
Total comprehensive (loss) profit	$ (3,608,421)	$ 3,943,025

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)	Equity / (deficit) attributable to owners of the parent	Issued capital	Share premium	Changes in non-controlling interest	Own shares trading premium	Stock options and share based incentives	Convertible instruments	Cost of own shares held	Retained deficit	Foreign currency translation reserve	Revaluation of PP&E and effect of tax rate change	Non-controlling Interests	Total
Balance at Jun. 30, 2022	$ 127,358,573	$ 4,637	$ 158,819,506	$ (255,893)	$ (916,202)	$ 3,767,925	$ 175,745	$ (3,530,926)	$ (32,682,893)	$ 969,402	$ 1,007,272	$ 30,940,275	$ 158,298,848
Share-based incentives	746,258	6	554,999		135,361	55,892							746,258
Business combination	154,979,344	1,640	153,357,564			1,620,140							154,979,344
Capitalization of convertible notes	12,211,638	153	12,211,485										12,211,638
Purchase of own shares	(24,291,047)							(24,291,047)					(24,291,047)
Issuance of convertible notes	9,109,516						9,109,516						9,109,516
Distribution of dividends by subsidiary												(187,977)	(187,977)
(Loss) profit for the period	498,297								498,297			3,413,703	3,912,000
Other comprehensive income (loss)	(96,582)									(96,582)		127,607	31,025
Balance at Sep. 30, 2022	280,515,997	6,436	324,943,554	(255,893)	(780,841)	5,443,957	9,285,261	(27,821,973)	(32,184,596)	872,820	1,007,272	34,293,608	314,809,605
Balance at Jun. 30, 2023	298,594,088	6,493	327,028,559	(255,893)	(780,841)	6,645,442	9,285,261	(30,553,591)	(13,903,017)	1,282,377	(160,702)	31,902,019	330,496,107
Share-based incentives	6,193,668					6,193,668							6,193,668
Purchase of own shares	(457,085)							(457,085)					(457,085)
(Loss) profit for the period	(4,591,634)								(4,591,634)			1,913,170	(2,678,464)
Other comprehensive income (loss)	(772,696)									(772,696)		(157,261)	(929,957)
Balance at Sep. 30, 2023	$ 298,966,341	$ 6,493	$ 327,028,559	$ (255,893)	$ (780,841)	$ 12,839,110	$ 9,285,261	$ (31,010,676)	$ (18,494,651)	$ 509,681	$ (160,702)	$ 33,657,928	$ 332,624,269

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Jun. 30, 2023
OPERATING ACTIVITIES
(Loss) profit for the period	$ (2,678,464)	$ 3,912,000
Adjustments to reconcile profit to net cash flows
Income tax	429,040	5,012,643
Financial results	7,543,992	8,068,153
Depreciation of property, plant and equipment	1,243,403	1,382,093
Amortization of intangible assets	2,747,206	2,476,832
Depreciation of leased assets	837,199	676,427
Transactional expenses		2,794,339
Share-based incentive and stock options	6,193,668	227,351
Share of profit or loss of joint ventures and associates	(1,508,671)	(842,240)
Provisions for contingencies	27,109	2,448
Allowance for impairment of trade debtors	352,920	156,053
Allowance for obsolescence	505,285	618,489
Initial recognition and changes in the fair value of biological assets	(410,913)	(490,006)
Changes in the net realizable value of agricultural products after harvest	1,446,316	227,936
Gain or loss on sale of equipment and intangible assets	(26,669)	(115,942)
Working capital adjustments
Trade receivables	(31,012,196)	(29,709,414)
Other receivables	3,722,853	(5,665,708)
Income and minimum presumed income taxes payable	7,113,764	(376,576)
Inventories and biological assets	(197,454)	(7,391,556)
Trade and other payables	7,499,929	(18,108,556)
Employee benefits and social security	412,458	3,226,505
Deferred revenue and advances from customers	8,040,809	373,181
Income taxes paid	(163,205)	(1,051,644)
Interest collected	2,293,676	2,125,194
Inflation effects on working capital adjustments	321,539	69,662
Net cash flows generated (used) by operating activities	14,733,594	(32,402,336)
INVESTMENT ACTIVITIES
Proceeds from sale of property, plant and equipment	35,682	115,942
Net cash received from business combination		5,933,265
Net loans granted to shareholders and other related parties		1,609
Proceeds from financial assets	(509,534)	2,729,598
Investment in financial assets	(2,215,965)	(889,342)
Purchase of property, plant and equipment	(3,985,249)	(1,414,730)
Capitalized development expenditures	(1,947,504)	(3,241,008)
Purchase of intangible assets	(64,486)	(209,863)
Net cash flows (used) generated by investing activities	(8,687,056)	3,025,471
FINANCING ACTIVITIES
Proceeds from borrowings	26,837,346	93,327,748
Repayment of borrowings and financed payments	(46,865,499)	(47,061,271)
Interest payments	(4,539,455)	(3,016,078)
Other financial proceeds or payments, net	(781,199)	(1,717,070)
Purchase of own shares	(457,085)	(376,018)
Leased assets payments	(1,170,039)	(744,365)
Cash dividend distributed by subsidiary		(187,977)
Net cash flows (used) generated by financing activities	(26,975,931)	40,224,969
Net (decrease) increase in cash and cash equivalents	(20,929,393)	10,848,104
Inflation effects on cash and cash equivalents	(24,266)	(12,404)
Cash and cash equivalents as of beginning of the period	48,129,194	33,475,266	$ 33,475,266
Effect of exchange rate changes on cash and equivalents	1,198,389	3,076,600
Cash and cash equivalents as of the end of the period	$ 28,373,924	$ 47,387,566	$ 48,129,194

GENERAL INFORMATION - (Details)	Sep. 30, 2023 country
Business information
Number of countries where Group's agricultural inputs are marketed	40

SEASONALITY (Details)	Sep. 30, 2023 item
SEASONALITY
Some customers and distributers order per year, minimum	1
Some customers and distributers order per year, maximum	2

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Cash and cash equivalents (Details) - USD ($)	Sep. 30, 2023	Jun. 30, 2023
INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
Cash at bank and on hand	$ 25,954,730	$ 48,129,194
Mutual funds	2,419,194
Cash and cash equivalents	$ 28,373,924	$ 48,129,194

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Other financial assets (Details) - USD ($)	Sep. 30, 2023	Jun. 30, 2023
Current
Restricted short-term deposit		$ 212,703
US Treasury bills	$ 9,719,486	9,163,298
Mutual funds	3,236,702	1,596,539
Other investments	1,672,014	1,162,480
Other financial assets	14,628,202	12,135,020
Non-current
Shares of Bioceres S.A.	444,575	444,635
Other investments	58,335	274
Other financial assets	$ 502,910	$ 444,909

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Trade receivables (Details) - USD ($)	Sep. 30, 2023	Jun. 30, 2023
Components of Consolidated Statement of Financial Position
Trade debtors	$ 189,222,562	$ 160,269,233
Allowance for impairment of trade debtors	(7,615,433)	(7,425,604)
Allowance for credit notes to be issued	(2,610,596)	(3,694,019)
Deferred checks	5,129,962	7,991,237
Trade receivables	186,276,319	158,006,474
Shareholders and other related parties
Components of Consolidated Statement of Financial Position
Shareholders and other related parties	1,368,373
Joint ventures and associates
Components of Consolidated Statement of Financial Position
Trade debtors	$ 781,451	$ 865,627

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Other receivables (Details) - USD ($)	Sep. 30, 2023	Jun. 30, 2023
Current
Taxes	$ 6,009,626	$ 6,113,764
Prepayments to suppliers	5,010,022	10,956,831
Reimbursements over exports	10,558	10,558
Prepaid expenses and other receivables	3,657,633	1,302,221
Miscellaneous	735,655	388,553
Other receivables	24,902,503	28,824,998
Non-current
Taxes	865,588	873,699
Reimbursements over exports	1,268,928	1,290,227
Loan receivables	230,000	230,000
Miscellaneous	29,423	152,315
Other receivables	2,393,939	2,546,241
Receivables for PP&E sales
Current
Other receivables	89,715	156,423
Shareholders and other related parties
Current
Other receivables	2,919,431	3,792,429
Joint ventures and associates
Current
Other receivables	$ 6,469,863	$ 6,104,219

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Inventories (Details) - USD ($)	Sep. 30, 2023	Jun. 30, 2023
Inventory
Goods in transit	$ 2,298,136	$ 3,620,606
Supplies	18,709,303	24,893,187
Agricultural products	19,111,345	28,436,830
Inventories	138,076,822	140,426,975
Net of agricultural products	118,965,477	111,990,145
Seeds
Inventory
Inventories	9,293,210	1,542,159
Resale products
Inventory
Inventories	71,973,203	58,544,931
Manufactured products
Inventory
Inventories	19,604,930	25,881,761
Allowance for obsolescence
Inventory
Inventories	$ (2,913,305)	$ (2,492,499)

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Biological assets (Details) - USD ($)	3 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Biological assets
Beginning of the period	$ 146,842	$ 57,313
Initial recognition and changes in the fair value of biological assets at the point of harvest	410,913	490,006
Cost incurred during the period	583,358	501,468
Exchange differences		(22,043)
End of period	1,141,113	1,026,744
Soybean
Biological assets
Beginning of the period	0
Cost incurred during the period	374,456
End of period	374,456
Corn
Biological assets
Beginning of the period	0
Cost incurred during the period	177,601
End of period	177,601
Wheat
Biological assets
Beginning of the period	87,785	44,413
Initial recognition and changes in the fair value of biological assets at the point of harvest	276,511	365,833
Cost incurred during the period		378,631
Exchange differences		(16,699)
End of period	364,296	772,178
Sunflower
Biological assets
Beginning of the period	0
Cost incurred during the period	31,301
End of period	31,301
Barley
Biological assets
Beginning of the period	59,057	12,900
Initial recognition and changes in the fair value of biological assets at the point of harvest	134,402	124,173
Cost incurred during the period		122,837
Exchange differences		(5,344)
End of period	$ 193,459	$ 254,566

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Property, plant and equipment (Details) - USD ($)	Sep. 30, 2023	Jun. 30, 2023	Sep. 30, 2022	Jun. 30, 2022
Property, plant and equipment
Property, plant and equipment	$ 69,930,709	$ 67,853,835
Gross carrying amount
Property, plant and equipment
Property, plant and equipment	96,833,359	93,634,779	$ 85,587,833	$ 71,521,454
Accumulated depreciation
Property, plant and equipment
Property, plant and equipment	$ (26,902,650)	$ (25,780,944)	$ (22,710,109)	$ (21,613,129)

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Intangible assets (Details) - USD ($)	Sep. 30, 2023	Jun. 30, 2023	Sep. 30, 2022	Jun. 30, 2022
Intangible assets
Intangible assets	$ 173,034,536	$ 173,783,956
Gross carrying amount
Intangible assets
Intangible assets	204,300,750	202,306,618	$ 194,493,789	$ 94,229,557
Accumulated depreciation
Intangible assets
Intangible assets	$ (31,266,214)	$ (28,522,662)	$ (20,000,299)	$ (17,524,688)

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Goodwill (Details) - USD ($)	Sep. 30, 2023	Jun. 30, 2023
Goodwill
Goodwill	$ 112,163,432	$ 112,163,432
Rizobacter Argentina S.A.
Goodwill
Goodwill	28,080,271	28,080,271
Bioceres Crops S.A.
Goodwill
Goodwill	7,523,322	7,523,322
Pro farm Group, Inc.
Goodwill
Goodwill	76,089,749	76,089,749
Insumos Agroqumicos S.A.
Goodwill
Goodwill	$ 470,090	$ 470,090

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Investment properties (Details) - USD ($)	Sep. 30, 2033	Jun. 30, 2033	Sep. 30, 2023	Jun. 30, 2023
INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
Investment properties	$ 3,675,493	$ 3,589,749	$ 3,675,493	$ 3,589,749

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Trade and other payable (Details) - USD ($)	Sep. 30, 2023	Jun. 30, 2023
Current
Trade creditors	$ 106,222,415	$ 104,211,238
Taxes	5,138,674	3,561,058
Miscellaneous	183,536	953,301
Trade and other payable	159,125,358	150,807,674
Shareholders and other related parties
Current
Trade payable, related party	27,708	35,292
Parent company
Current
Trade payable, related party	270,645	644,191
Joint ventures and associates
Current
Trade payable, related party	$ 47,282,380	$ 41,402,594

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Borrowings (Details) - USD ($)	Sep. 30, 2023	Jun. 30, 2023
Current
Corporate bonds	$ 29,745,450	$ 35,547,510
Borrowings	100,720,985	107,639,659
Non-current
Corporate bonds	41,202,548	50,007,680
Borrowings	48,789,492	60,670,946
Bank borrowings
Current
Borrowings	60,473,023	61,303,952
Non-current
Borrowings	7,586,944	10,663,266
Trust debt securities
Current
Borrowings	6,936,758	7,296,506
Net loans payables - Parents companies and related parties
Current
Borrowings	$ 3,565,754	$ 3,491,691

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Borrowings, carrying amount (Details) - USD ($)	Sep. 30, 2023	Jun. 30, 2023
Current
Borrowings	$ 100,720,985	$ 107,639,659
Corporate bonds	29,745,450	35,547,510
Non-current
Borrowings	48,789,492	60,670,946
Corporate bonds	41,202,548	50,007,680
Amortized cost
Current
Corporate bonds	29,745,450	35,547,510
Non-current
Corporate bonds	41,202,548	50,007,680
Fair value
Current
Corporate bonds	29,389,136	34,725,828
Non-current
Corporate bonds	39,984,876	47,014,542
Bank borrowings
Current
Borrowings	60,473,023	61,303,952
Non-current
Borrowings	7,586,944	10,663,266
Bank borrowings \| Amortized cost
Current
Borrowings	60,473,023	61,303,952
Non-current
Borrowings	7,586,944	10,663,266
Bank borrowings \| Fair value
Current
Borrowings	57,553,255	57,209,155
Non-current
Borrowings	$ 5,620,759	$ 10,374,646

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Secured Notes (Details) - USD ($)	Sep. 30, 2033	Sep. 30, 2023	Jun. 30, 2023
Borrowings:
Secured notes		$ 76,911,874	$ 75,213,146
Secured Guaranteed Notes \| At cost
Borrowings:
Borrowings	$ 25,900,000
Secured Guaranteed Notes \| Fair value
Borrowings:
Borrowings	26,100,000
Secured Convertible Guaranteed Notes \| At cost
Borrowings:
Borrowings	51,000,000.0
Secured Convertible Guaranteed Notes \| Fair value
Borrowings:
Borrowings	$ 53,300,000

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Employee benefits and social security (Details) - USD ($)	Sep. 30, 2023	Jun. 30, 2023
INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
Salaries, accrued incentives, vacations and social security	$ 9,685,549	$ 9,388,639
Key management personnel	333,616	218,068
Employee benefits and social security	$ 10,019,165	$ 9,606,707

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Deferred revenue and advances from customers (Details) - USD ($)	Sep. 30, 2023	Jun. 30, 2023
Current
Advances from customers	$ 17,019,407	$ 9,216,032
Deferred Revenue	15,752,495	15,659,630
Deferred revenue and advances from customers	32,771,902	24,875,662
Non-current
Advances from customers	272,334	620,893
Deferred Revenue	1,930,040	1,436,912
Deferred revenue and advances from customers	$ 2,202,374	$ 2,057,805

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Revenue (Details) - USD ($)	3 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Revenue
Revenues from contracts with customers	$ 116,182,805	$ 126,843,248
Royalties	554,013	729,612
Sale of goods and services
Revenue
Revenues from contracts with customers	$ 115,628,792	$ 126,113,636

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - R&D classified by nature (Details) - USD ($)	3 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Costs and expenses
Depreciation of leased assets	$ 837,199	$ 676,427
Total	4,581,241	3,852,014
R&D capitalized	1,947,504	3,241,008
Total	6,528,745	7,093,022
Research and development expenses
Costs and expenses
Amortization of intangible assets	1,164,940	1,511,118
Analysis and storage		11,568
Import and export expenses		850
Depreciation of property, plant and equipment	157,808	142,373
Freight and haulage	3,917	5,300
Employee benefits and social securities	1,307,126	861,312
Maintenance	206,778	217,066
Energy and fuel	3,628	79,121
Supplies and materials	847,382	559,044
Mobility and travel	13,771	108,694
Share-based incentives	188,250	6,975
Professional fees and outsourced services	491,787	293,776
Office supplies and registrations fees	170,375	21,454
Information technology expenses	4,375	11,996
Insurance	21,049	10,537
Depreciation of leased assets		10,650
Miscellaneous	55	180
Total	$ 4,581,241	$ 3,852,014

INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - Expenses classified by nature and functions (Details) - USD ($)	3 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Expenses classified by nature and function
Depreciation of leased assets	$ 837,199	$ 676,427
Obsolescence	505,285	618,489
Production costs
Expenses classified by nature and function
Amortization of intangible assets	30,478	43,456
Analysis and storage	570	5,425
Commissions and royalties	134,592	118,960
Import and export expenses	67,228	98,186
Depreciation of property, plant and equipment	643,006	746,609
Depreciation of leased assets	339,378	395,972
Freight and haulage	643,877	241,533
Employee benefits and social securities	2,806,939	3,994,761
Maintenance	422,757	462,743
Energy and fuel	163,122	500,359
Supplies and materials	260,043	339,843
Mobility and travel	33,407	20,940
Share-based incentives	275,432	100,206
Professional fees and outsourced services	509,450	674,014
Office supplies	149,888	32,546
Insurance	27,024	28,430
Information technology expenses	18,361	13,243
Obsolescence	505,285	539,382
Taxes	70,819	45,049
Miscellaneous	21,599	39,173
Total	7,123,255	8,440,830
Selling, general and administrative expenses
Expenses classified by nature and function
Amortization of intangible assets	1,551,788	922,258
Analysis and storage	153,473	113,265
Commissions and royalties	794,058	623,459
Import and export expenses	120,345	256,070
Depreciation of property, plant and equipment	442,589	493,111
Depreciation of leased assets	497,821	269,805
Impairment of receivables	352,920	156,053
Freight and haulage	2,989,094	3,474,028
Employee benefits and social securities	10,238,931	10,041,033
Maintenance	568,155	980,742
Energy and fuel	16,397	58,400
Supplies and materials	831,454	491,811
Mobility and travel	1,348,563	994,919
Publicity and advertising	1,161,498	1,888,497
Contingencies	27,109	2,448
Share-based incentives	5,729,986	120,170
Professional fees and outsourced services	1,575,982	4,610,610
Office supplies	370,770	289,467
Insurance	473,850	760,276
Information technology expenses	743,163	993,378
Obsolescence		79,107
Taxes	3,766,419	4,130,539
Miscellaneous	178,483	155,465
Total	33,932,848	31,904,911
Total
Expenses classified by nature and function
Amortization of intangible assets	1,582,266	965,714
Analysis and storage	154,043	118,690
Commissions and royalties	928,650	742,419
Import and export expenses	187,573	354,256
Depreciation of property, plant and equipment	1,085,595	1,239,720
Depreciation of leased assets	837,199	665,777
Impairment of receivables	352,920	156,053
Freight and haulage	3,632,971	3,715,561
Employee benefits and social securities	13,045,870	14,035,794
Maintenance	990,912	1,443,485
Energy and fuel	179,519	558,759
Supplies and materials	1,091,497	831,654
Mobility and travel	1,381,970	1,015,859
Publicity and advertising	1,161,498	1,888,497
Contingencies	27,109	2,448
Share-based incentives	6,005,418	220,376
Professional fees and outsourced services	2,085,432	5,284,624
Office supplies	520,658	322,013
Insurance	500,874	788,706
Information technology expenses	761,524	1,006,621
Obsolescence	505,285	618,489
Taxes	3,837,238	4,175,588
Miscellaneous	200,082	194,638
Total	$ 41,056,103	$ 40,345,741

TAXATION - Taxes on income (Details) - USD ($)	3 Months Ended
TAXATION - Taxes on income (Details) - USD ($)	Sep. 30, 2023	Sep. 30, 2022
TAXATION
Current tax expense	$ (6,457,134)	$ (6,020,201)
Deferred tax	6,028,094	1,007,558
Income tax expenses	$ (429,040)	$ (5,012,643)

EARNING PER SHARE (Details)	3 Months Ended
EARNING PER SHARE (Details)	Sep. 30, 2023 USD ($) $ / shares shares	Sep. 30, 2022 USD ($) category $ / shares shares
Numerator
(Loss) profit for the period (basic EPS) \| $	$ (4,591,634)	$ 498,297
(Loss) profit for the period (diluted EPS) \| $	$ (4,591,634)	$ 498,297
Denominator
Weighted average number of shares (basic EPS) \| shares	62,846,690	60,537,110
Weighted average number of shares (diluted EPS) \| shares	62,846,690	61,736,679
Basic (loss) profit attributable to ordinary equity holders of the parent \| $ / shares	$ (0.0731)	$ 0.0082
Diluted (loss) profit attributable to ordinary equity holders of the parent \| $ / shares	$ (0.0731)	$ 0.0081
Number of categories of dilutive potential shares \| category		2

EQUITY INFORMATION (Details)	3 Months Ended
EQUITY INFORMATION (Details)	Sep. 30, 2023 shares Vote USD ($) $ / shares
Disclosure of classes of share capital [line items]
Number of own shares repurchased \| $	2,231,761
Number of votes for each ordinary share \| Vote	1
Equity compensation plan
Disclosure of classes of share capital [line items]
Number of total converted options outstanding	3,951,917
Ordinary shares
Disclosure of classes of share capital [line items]
Number of shares authorised	100,000,000
Par value per share \| $ / shares	$ 0.0001
Number of shares issued	62,849,997
Number of shares outstanding	62,849,997
Preference shares
Disclosure of classes of share capital [line items]
Number of shares authorised	1,000,000
Par value per share \| $ / shares	$ 0.0001
Number of shares issued	0
Number of shares outstanding	0

CASH FLOW INFORMATION (Details) - USD ($)	3 Months Ended
CASH FLOW INFORMATION (Details) - USD ($)	Sep. 30, 2023	Sep. 30, 2022
Investment activities
Net assets acquisition by business combination		$ 150,510,313
Investment in-kind in other related parties		550,183
Capitalization of interest on buildings in progress	$ 36,589
Investing activities	$ 36,589	151,060,496
Financing activities
Capitalization of convertible notes		12,211,638
Purchase of own shares		(23,915,029)
Financing activities		$ (11,703,391)